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Chapter |
General introduction
E s c h e r i c h i a  c o l i
Bacterium coli commune or, as it is now known, Escherichia coli was first 
described in 1885 by Dr. Theodor Escherich, a German pediatrician.131 The 
organism was subsequently found to be the predominant bacterium of the 
normal facultative anaerobic microflora o f the intestine ofhumans and warm­
blooded animals, and was shown to play an important role in maintaining 
intestinal physiology.
E. coli has become the most fully documented organism currently known. Most 
studies on bacterial metabolism and biochemical processes have been 
conducted on this organism.
Bacteriological characteristics
E. coli is classified in the family Enterobacteriaceae.335 Its taxonomic features 
include Gram-negative, straight rods (1.1-1.5 M-m wide and 2.0-6.0 ^m long) 
that may be motile by peritrichous flagella or nonmotile and do not form spores. 
Colonies on nutrient agar may be smooth (S), low-convex, moist, gray, with a 
shiny surface and entire edge and easily dispersible in saline, or they may be 
rough (R), dry and difficult to disperse well in saline. S forms, which usually
grow as glistening colonies on ordinary agar media and show turbid growth 
in fluid media, have developed polysaccharide side chains as part o f their 
lipopolysaccharide (LPS) outer membrane, whereas R forms, which usually 
will show dry and wrinkled colony forms on agar and which will agglutinate 
spontaneously in fluid media, have lost their polysaccharide side chains by 
mutation.
E. coli can grow both aerobically and anaerobically and is capable o f utilizing 
simple carbon and nitrogen sources for all their metabolic and energy needs.335 
Glucose and other carbohydrates are fermented with the production of 
pyruvate, which is further converted into lactic, acetic and formic acids. Part 
o f the formic acid is split by a complex hydrogenlyase system into equal 
amounts o f CO2 and H2, although some strains are anaerogenic. Lactose is 
fermented by most strains, but fermentation may be delayed or absent. E. coli 
usually can also use acetate as a sole source o f carbon, but citrate cannot be 
used.
Serological characteristics
The principal tool for subclassifying strains o f E. coli is serotyping. In 1947, 
Kauffmann proposed a scheme for the serologic classification o f E. coli which 
is still used in modified form today.235
According to the modified Kauffmann scheme, E. coli strains are classified on 
the basis o f their O (somatic), H (flagellar), and K (capsular) surface antigens.272 
The primary subdivision is made according to the antigenicity o f the O-specific 
polysaccharide o f the cell outer membrane LPS. LPS consists o f essentially 
three parts (Fig. 1): a hydrophobic lipid A moiety composed oflong-chain fatty 
acids which anchors the LPS molecule in the outer membrane, a LPS-core 
region, and a long-chain LPS component composed of polymers o f repeating
10  oligosaccharide units. Each O antigen constitutes a distinct O group, also called 
serogroup. Presently, 167 different O antigens are listed, numbered O1-O173 
(six serogroups have been deleted from the scheme - O47, O67, O72, O93, 
O94 and Oi22)(Dr. H. Smith, Laboratory o f Enteric Pathogens, Central Public 
Health Laboratory, London, UK). Within each serogroup are one or more 
serotypes that are based on the H antigen. For example, O 26:Hii and O26:H32 
represent two serotypes o f E. coli within the same serogroup. The H antigens 
are found on the flagellar surface o f motile organisms and are composed of 
protein (Fig. 1). Each H antigen constitutes a distinct H type, o f which there 
are 55 for E. coli, numbered H1-H56 (one H type has been deleted from the 
scheme - H50). The presence of K antigens was determined originally by means 
o f the bacterial agglutination reaction: an E. coli strain that was inagglutinable 
by O antiserum but became agglutinable when the culture was heated was 
considered to have a K antigen. These K antigens were subclassified into three
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membrane; OM, outer membrane; PG, peptidoglycan; LPS, lipopolysaccharide; CPS, capsular 
polysaccharide; PL, phospholipid; POR, porin protein; P, protein; LP, Braun lipoprotein; PAL, 
peptidoglycan-associated lipoprotein; A, outer membrane protein A; PPS, periplasmic space 
(periplasm); MDO, membrane-derived oligosaccharides; FL, flagella; FIM fimbriae. Modified from 
Lambert et al.257 with permission o f the publisher.
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types: L, A, and B, according to heat stability. Since several different molecular 
structures, including fimbriae, conferred the K phenotype and many 
encountered difficulties in trying to determine these antigens, the K antigens 
have been redefined.338 The K antigens are now identified on the basis o f their 
chemical composition and include only acidic polysaccharide capsular antigens 
(Fig. 1). Nearly 80 different K antigens are recognized. Proteinaceous fimbrial 
antigens thus being removed from the K series have been given F 
designations.337 The serological characteristics o f the fimbriae may be used as 
a fourth group of surface antigens in addition to O:K:H antigens (O:K:H:F).
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Figure 2. Pathogenic schemes ofdiarrheagenic E. coli. The six recognized categories ofdiarrheagenic 
E. coli each have unique features in their interaction with eukaryotic cells. Here, the interaction o f 
each category with a typical target cell is schematically represented. It should be noted that these 
descriptions are largely the result o f in vitro studies and may not completely reflect the phenomena 
occurring in infected humans. LT, heat-labile enterotoxin; ST, heat-stable enterotoxin; BFP, bundle- 
forming pilus. Reprinted from Nataro and Kaper318 with permission o f the publisher.
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E. coli and human illness
Most strains o f E. coli are harmless commensals. However, certain strains can 
cause infection in humans and warm-blooded animals. Human infection due 
to pathogenic E. coli may be limited to the intestinal mucosa and result in a 
syndrome of diarrheal disease, or can disseminate throughout the body 
(urinary tract infections, neonatal meningitis, and septicemia).
Presently, six major groups o f diarrheagenic E. coli strains have been defined 
based primarily on pathogenic mechanisms (Fig. 2): enteropathogenic E. coli 
(EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), 
enterohemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC or 
EAggEC), and diffusely adherent E. coli (DAEC).
Enteropathogenic E. coli
The classical EPEC were the first E. coli strains that proved to cause human 
diarrhea. In the 1940s and 1950s, investigators in North America and Europe 
demonstrated that E. coli o f specific serotypes were responsible for several 
hospital and community outbreaks o f neonatal diarrhea with mortality rates 
often exceeding 5o%.64,132,155,236,443 EPEC strains have long been defined as 
diarrheagenic E. coli o f specific serogroups that historically have been 
incriminated in outbreaks o f infantile diarrhea, but whose pathogenic 
mechanisms have not been proven to be related to either heat-labile 
enterotoxins, heat-stable enterotoxins, or Shigella-like epithelial cell 
invasiveness. As the understanding o f EPEC pathogenesis has improved, it 
has now become more appropriate to define EPEC strains based on their 
characteristic virulence determinants implicated in disease patho- 1 3  
genesis.29,259,318 The hallmark o f infections due to EPEC is the attaching-and- 
effacing (AE) histopathology, which can be observed in intestinal biopsy 
specimens from patients or artificially infected animals and can be reproduced 
in cell culture. This striking phenotype is characterized by intimate adherence 
o f the bacterium to the epithelial cell membrane and effacement of microvilli 
(Fig. 2). EPEC strains are capable o f invading a variety o f epithelial cells in vitro. 
However, the clinical significance o f cell entry in the pathogenesis o f disease 
due to EPEC remains to be determined. Some EPEC strains can produce one 
or more toxins. While outbreaks o f diarrhea caused by EPEC are now 
uncommon in industrialized countries due to good standards of hygiene, EPEC 
strains are still an important cause o f infantile diarrhea in many developing 
countries. EPEC infection is usually acquired by ingestion o f the organisms 
via contaminated food or water. Humans, symptomatic or symptom-free 
carriers, are presumed to be the principal reservoir o f EPEC strains.
Enteroinvasive E. coli
EIEC strains were first isolated in Italy during World War II.133 Since then, 
several foodborne and waterborne outbreaks o f EIEC diarrhea have been 
reported throughout the world.258,289,419,460 Person-to-person transmission 
does also occur.179 Infected humans are regarded as the main reservoir o f EIEC 
strains. EIEC mimic Shigella strains in their ability to invade and multiply 
within intestinal epithelial cells (Fig. 2). When the infection is severe a strong 
inflammatory response is being elicited which is manifested grossly as 
ulceration o f the mucosa.318 The predominant site o f bacterial invasion is the 
colon. A role for enterotoxins is unproven, but their presence may explain the 
characteristic watery diarrhea attributed to EIEC. Presently, EIEC strains are 
rarely isolated in industrialized countries. However, in countries with poor 
sanitation and low socio-economic status, these strains are still a common cause 
o f diarrhea and dysentery.
Enterotoxigenic E. coli
ETEC strains were first isolated in 1968 during studies on the etiology of 
noncholera diarrhea in India and Bangladesh.163,386 Later, ETEC strains were 
shown to be the most common cause o f traveler's diarrhea for individuals who 
travel from areas with good hygiene and temperate climate to areas with lower 
hygienic standards, particularly developing countries in the tropics. While 
ETEC strains are rare in industrialized countries, they are an important cause 
o f endemic diarrhea in developing countries especially among infants and 
young children. The mechanism of pathogenicity o f ETEC is in many respects 
similar to that o f Vibrio cholerae group Oi. After ingestion, ETEC strains adhere 
to the proximal small intestine utilizing fimbrial colonization factors and 
! 4  elaborate heat-labile and/or heat-stable enterotoxins (Fig. 2), which induce 
massive fluid and electrolyte secretion into the gut lumen resulting in watery 
diarrhea.318 The heat-labile enterotoxin is structurally similar to cholera 
enterotoxin. ETEC strains do not invade the mucosa or cause histologic 
changes. ETEC infection in humans is mostly foodborne or waterborne and 
humans are supposed to be the principal reservoir o f ETEC strains that are 
pathogenic for humans. ETEC strains causing disease in humans are 
considered to be human-specific, but similar strains cause diarrhea in calves 
and piglets.418
Enterohemorrhagic E. coli
EHEC strains were first identified as human pathogens in 1982,376 when E. coli
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of serotype Oi57:H7 was associated with two separate outbreaks o f a severe 
bloody diarrheal syndrome in the United States. Since then, several serotypes 
o f E. coli have been associated with cases o f severe bloody diarrhea and so have 
also been identified as EHEC. However, E. coli Oi57:H7 is still the best known 
serotype o f the group of EHEC organisms. The mechanism of pathogenicity 
o f EHEC strains is not yet fully elucidated, but is associated with their ability 
to produce one or more toxins and the formation of AE lesions in the intestinal 
mucosa consistent with the AE lesions in human EPEC infection (Fig. 
2).28o,3I8,354 EHEC strains are generally considered as not invasive. Most EHEC 
infections have been linked with the consumption of foods o f bovine origin 
and cattle are regarded as the principal reservoir o f these pathogens. EHEC 
strains seem to occur most frequently in developed countries in contrast to 
the other types o f diarrheagenic E. coli.
Enteroaggregative E. coli
In i987, Nataro et al3i9 were the first who proposed that EAEC may be 
pathogenic after detecting these strains more frequently in feces o f children 
with diarrhea than in those o f controls. Following this initial study, numerous 
epidemiological studies in infants and children in developing countries have 
supported the association o f EAEC with diarrhea, most prominently with 
persistent diarrhea3i8,395 However, in some studies EAEC strains were isolated 
in similar numbers from cases and controls and some studies have not found 
an association with diarrhea. It has been suggested that the ability to cause 
disease is a property o f only certain EAEC strains. EAEC are currently defined 
as E. coli strains that do not secrete heat-labile or heat-stable enterotoxins and 
that adhere to HEp-2 cells in culture (of human laryngeal carcinoma origin) 
in a unique pattern o f aggregative adherence3i8 While the adherence pattern 
o f EPEC strains is described as localized adherence, denoting the presence o f 1 5  
clusters or microcolonies on the surface o f the HEp-2 cells, EAEC strains 
adhere in an appearance likened to stacked bricks to the surface o f the HEp-
2 cells (Fig. 2). The factors that are involved in causing disease are not yet 
understood. Putative virulence factors include an enterotoxin (EAST, for 
EAEC heat-stable enterotoxin) similar to the heat-stable enterotoxin o f ETEC 
strains, hemolysins and cytotoxins, and various types o f fimbriae and outer 
membrane proteins that may be involved in the adhesion process.260
Diffusely adherent E. coli
The term DAEC was initially used to refer to any HEp-2-adherent E. coli strain 
that did not form EPEC-like microcolonies. With the discovery o f EAEC strains,
DAEC strains were recognized as an independent category o f potentially 
diarrheagenic E. coli and were defined by the presence o f the diffuse adherence 
pattern in the HEp-2 adherence assay. In diffuse adherence, bacteria are seen 
dispersed over the surface o f the HEp-2 cell, with little aggregation and little 
adherence to the glass coverslip free from the cells. Several studies have 
implicated DAEC strains as agents o f diarrhea, while other studies have not 
recovered DAEC strains more frequently from diarrheal patients than from 
asymptomatic controls.3^ 395 This may be explained by an age-dependent 
susceptibility. Recently, Jallat et al.2°3 reported that DAEC strains accounted 
for a large proportion of diarrheal cases among hospitalized patients in France 
who had no other identified enteropathogen. Therefore it has been suggested 
that DAEC strains might be important diarrheal pathogens in developed 
countries. Little is known about the pathogenetic features o f DAEC-induced 
disease. Possible virulence factors include a surface fimbria, and a ioo-kDa 
outer membrane protein3i8 Furthermore, it has been shown that DAEC strains 
are able to induce finger-like projections extending from the surface of 
infected cell cultures (Fig. 2).
V e r o c y t o t o x i n - p r o d u c i n g  E .  c o l i
Historical background
During the late i97os, Konowalchuk and his colleagues249 showed that 
culture filtrates o f some strains o f E. coli produced a profound and irreversible 
cytotoxic effect on Vero cells, a cell line derived from African green monkey 
kidney cells. The cytopathic effect on Vero cells was shown to be due to the 
action o f one or more cytotoxins. The cytotoxins were termed verocytotoxins 
or verotoxins (VTs) and the E. coli strains verocytotoxin-producing E. coli, 
1 6  verotoxin-producing E. coli, or verotoxigenic E. coli (VTEC). Since 7 o f the io 
VTEC strains had been isolated from infants with diarrhea, Konowalchuk et 
al.249 speculated that VTs might play a role in the pathogenesis o f 
gastrointestinal disease. However, the major breakthroughs occurred in ^ 8 3  
with the publication o f two epidemiological studies which linked VTEC 
infection with two diseases of previously unknown etiology, hemorrhagic colitis 
(HC)376 and the hemolytic-uremic syndrome (HUS).234 
The first was the publication by Riley et al.,376 who investigated two separate 
outbreaks o f HC which occurred in i982 in the states o f Oregon (26 cases) 
and Michigan (2i cases) o f the United States o f America. In both outbreaks 
illness was linked with the consumption of ground beef sandwiches prepared 
at different outlets o f the same fast-food restaurant chain. The 47 patients 
involved in these outbreaks suffered from severe crampy abdominal pain, 
grossly bloody diarrhea, and had little or no fever. No evidence was found for
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infection with classic bacterial pathogens such as Campylobacter, Salmonella, 
Shigella, and Yersinia. However, a previously rare serotype o f E. coli expressing 
O antigen i57 and H antigen 7 was isolated from 9 o f 20 cases and not from 
any healthy control. It was also isolated from a frozen, raw ground beef patty 
from the same lot o f meat implicated in one o f the outbreaks.482 Subsequently, 
this strain was shown to produce VT.328
The second key observation was by Karmali et al.,234 who reported the close 
association o f sporadic cases o f the classical, post-diarrheal (D+) form of HUS 
(D+ HUS) with the presence o f VT and/or E. coli that produced VT in patients' 
stools. Eleven of i5 cases o f D+ HUS had some evidence ofinfection with VTEC.
Of eight patients with D+ HUS from whom VTEC strains were isolated, two 
were infected with E. coli Oi57:H7. This initial report was confirmed by a 
prospective controlled study that linked cases o f D+ HUS with isolation from 
patients' stools o f VTEC belonging to at least six different O serogroups (O26,
O iii, Oii3, Oi2i, Oi45, and Oi57).232
In the years since the discovery o f the organisms as human pathogens, there 
have been many reports from all over the world describing the association 
between VTEC and human disease. At present, over 200 different serotypes 
o f E. coli have been shown to produce VT, but not all o f these are pathogenic 
for humans.2^ 439 E. coli strains o f serotype Oi57:H7, and the nonmotile (NM) 
variant E. coli Oi57:NM, remain the most common in many parts o f the world.
E. coli Oi57 strains with other H antigens are not known to cause infections 
in humans. The most common non-Oi57:H7 VTEC serotypes associated with 
human disease are O26:Hii, Oi03:H2, Oiii:NM, and Oii3:H2i. More research 
is needed to define the characteristics that render selected VTEC organisms 
harmful to humans.
Nomenclature
!7
The term VTEC has been derived from the observation by Konowalchuk et al.249 
that these strains produced a toxin that was cytotoxic for Vero cells. O'Brien et 
al.32-5,32-6 purified and characterized the cytotoxin produced by one o f the strains 
o f Konowalchuk and they found that its structure and biological activity were 
strikingly similar to Shiga toxin (Stx), the principal extracellular cytotoxin 
produced by Shigella dysenteriae type i. Moreover, it could be neutralized by 
anti-Stx, leading to its designation as Shiga-like toxin (SLT). On this basis, VTEC 
strains have also been called Shiga-like toxin-producing E. coli (SLTEC).
In the past decade the understanding o f these toxins has rapidly increased, 
and the identification, purification, cloning and sequencing o f several 
immunologically related toxin variants led to the insight that these toxins 
constituted a family with major sequence homology at both the nucleotide and 
peptide level.242 Therefore, Calderwood et al.7i have proposed a new, more
rational nomenclature, in which VT and SLT have been renamed Stx, after the 
prototype o f the family, and the related VTEC and SLTEC organisms have been 
renamed Shiga toxin-producing E. coli (STEC). VTEC, SLTEC, and STEC are 
equivalent terms, and all three refer to E. coli strains that produce one or more 
toxins o f the Stx family. The family includes Stxi, closely related to Stx itself, 
and Stx2, which is approximately 57% homologous to Stxi at both the 
nucleotide and amino acid level, and several variant toxins immunologically 
related to Stx2 (Table 1).
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Table 1. Nomenclature o f members o f the Shiga toxin family, as proposed by Calderwood et al.71
Previous nomenclature Proposed new nomenclature Microbial source
Protein Gene
Shiga toxin Shiga toxin (Stx) stx S. dysenteriae type 1
Shiga-like toxin I (SLT-I) or vero(cyto)toxin 1 (VTi) Stxi StXi E. coli
SLT-II or VT2 Stx2 StX2 E. coli
SLT-IIc or VT2c Stx2c a stx2c E. coli
SLT-IId or VT2d Stx2d a stx2d E. coli
SLT-IIe or VT2e Stx2e b
d
e 
2d tx2e st E. coli
a H um an Stx2 variant toxin. 
b Porcine edem a disease Stx2 variant toxin.
Throughout this thesis, however, the original terms VT and VTEC will be used. 
The EHEC group mentioned above comprises a subset o f VTEC, composed 
o f those strains o f VTEC which cause bloody diarrhea in the preponderance 
o f infected patients.
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Epidemiology in humans
Incidence in humans
VTEC infections are much greater problems in developed countries than in 
developing countries. Although recently a VTEC outbreak in the Central 
African Republic was reported,154 other countries with massive enteric disease 
burdens, such as Bangladesh and India, report few if  any VTEC infections, in 
spite o f the search for VTEC strains.21,104
The true incidence ofVTEC-associated illness is difficult to estimate since many 
persons presenting only mild symptoms may not seek medical attention. 
Secondly, in many clinical laboratories selective criteria for testing are used 
and thus not all stool specimens will be screened routinely for these organisms.
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Most incidence data reported represent E. coli 0157-associated disease, because 
only very few laboratories screen specimens for non-0157 VTEC.
United States. In the United States between 1990 and 1992, a multicenter study 
at 10 medical centers located throughout the country provided data on both 
the frequency o f isolation o f E. coli 0 15 7 ^ 7  relative to that o f other bacterial 
enteric pathogens in a nationwide sampling o f patients and the clinical and 
epidemiologic features o f E. coli 0 15 7 ^ 7  infections.414 Among over 30,000 
fecal specimens tested, 2.3% yielded Campylobacter spp., 1.8% Salmonella spp.,
1.1%  Shigella spp., and 0.4% E. coli 0 15 7 ^ 7 . The rank of isolation o f E. coli 
Oi57:H7 compared with Campylobacter spp., Salmonella spp., and Shigella spp. 
varied by site; while E. coli 0 15 7 ^ 7  was the second or third most commonly 
isolated pathogen in the four medical centers in states that bordered Canada, 
it was fourth in the other six sites. Infection with E. coli 0 15 7 ^ 7  resulted in 
more severe illness than infection with the other pathogens; 47% o f persons 
with E. coli 0i57:H 7 infection were hospitalized, compared with 21%, 38%, 
and 21% of those infected with Campylobacter spp., Salmonella spp., and Shigella 
spp., respectively. E. coli 0 15 7 ^ 7  was more likely to be isolated from visibly 
bloody stool specimens than from specimens without visible blood (odds ratio 
59.2 [95% CI, 36.6 to 96.0]) and was the pathogen most commonly isolated 
from visibly bloody stool specimens that yielded a bacterial enteric pathogen; 
39% of such specimens yielded E. coli 0 15 7 ^ 7 , 28% Campylobacter spp., 14% 
Salmonella spp., and 19%  Shigella spp.
Since its identification as a pathogen in 1982, reports o f outbreaks o f 0157 
VTEC infections in the United States increased markedly from an average of
2 per year between 1982 and 1992 to 17 in 1993 and 20 in 1994.122 This 
dramatic rise may be due in part to improved recognition o f 0157 VTEC 
infection following the publicity o f a large multistate outbreak in the western 
United States in January 1993 that affected over 700 persons and caused the 
deaths o f four children.36 Although they have occurred in all regions o f the 
country, outbreaks are more commonly reported from northern states.
In 1996, the Centers for Disease Control and Prevention initiated an ongoing 
national surveillance system called the Foodborne Disease Active Surveillance 
Network (FoodNet) to continually assess the burden o f foodborne disease at 
seven sites in the United States.6 The results from 1996 show the following 
nationwide incidence rates: Campylobacter spp. 25 per 100,000 population, 
Salmonella spp. 16 per 100,000, Shigella spp. 9 per 100,000, E. coli 0 15 7 ^ 7
3 per 100,000, Yersinia spp. 1 per 100,000, Listeria spp. 0.5 per 100,000, and 
Vibrio spp. 0.2 per 100,000. These results correlate with previous estimates 
that E. coli 0i57:H 7 is the fourth most costly foodborne disease in the United 
States.290
0 nly a few studies have looked at the occurrence of non-0157 VTEC in diarrheal 
stools. In these studies, the ratio o f E. coli 0 15 7 ^ 7  to non-0157 VTEC in the 
stool specimens varied between 1.5:1 and 2 :i.57,m6 Partly because oflimitations
in surveillance, outbreaks due to non-0157 VTEC strains are not commonly 
recognized.
Canada. In Canada, since 1990 the incidence o f infection due to VTEC, mainly 
representing E. coli 0157-associated disease, has ranged between 3.0 and 5.3 
cases per 100,000 population.420 The incidence o f reported VTEC infection 
varies by province and by year within a province; from 1992 to 1995, 0ntario 
and Quebec, containing about 60% of the population in Canada, had an average 
incidence of4.3 and 4.5 cases per 100,000, respectively, and Alberta, Manitoba, 
and Prince Edward Island had the highest average incidences with rates o f 7.4, 
7.6, and 10.2 cases per 100,000, respectively. Ninety-three percent o f the VTEC 
strains isolated from clinical stool specimens were o f serotype 0 15 7 ^ 7 . 
Although it appears that both individual cases and outbreaks o f VTEC infection 
slightly decline in Canada, the rates o f infection remain higher than those in 
most other countries.
United Kingdom. In the United Kingdom, there has been a significant increase 
in the isolation o f 0157 VTEC, particularly in the last decade.416 Partly this has 
been explained by increased testing and the use o f improved isolation 
techniques, but also appears to reflect a true increase in infections caused by 
0157 VTEC. Most cases o f 0157 VTEC infection appear to be sporadic or as 
part o f family outbreaks. The rates o f infection with 0157 VTEC are variable 
throughout the United Kingdom, with the highest rates in Scotland. For the 
period from 1990 to 1996, the average annual rate in England and Wales was 
less than 1.5 per 100,000 population, whereas in Scotland the average rate for 
the same period was more than 5 per 100,000. In England, the highest rates 
of 0157 VTEC infection have been recorded in the Northern Trent, East Anglia, 
South West, and North West Health Authorities. The lowest rates were seen 
in the Thames areas. In Scotland for the period from 1990 to 1994, the highest 
rates were seen in the Grampian (9.7 per 100,000) and Borders Health Board 
(7.1 per 100,000) areas, both on the eastern side o f the country. Since then, 
2 0  rates o f between 4 and 10 per 100,000 have been recorded in several Health 
Board areas, and in 1996 the Borders had a rate o f 21.7 per 100,000 without 
any large reported outbreaks.
Continental Europe. In continental Europe, the frequency o f both sporadic 
infections and outbreaks is lower than frequencies reported from North 
America and the United Kingdom. The frequency o f VTEC infections appears 
to be higher in central Europe, particularly in Germany, than in Mediterranean 
and Scandinavian countries, even i f  recent outbreaks in Sweden and Finland 
seem to indicate a change in the epidemiology in that area.75 Accurate 
estimates o f the real burden o f disease due to VTEC infection require 
laboratory-based surveillance systems which are currently not operative in most 
countries. In general, no sharp increase in outbreak reports has been observed 
in central Europe in recent years. Most sporadic cases and outbreaks reported 
were associated with VTEC strains o f serogroup 0157. It is noteworthy that
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while the vast majority o f 0157 VTEC strains associated with human disease 
do not ferment sorbitol, a sorbitol-fermenting, nonmotile variant o f E. coli 0157 
has been reported in Germany,171 the Czech Republic,50 Hungary,183 and 
Finland.240 In Bavaria, southern Germany, this variant now accounts for about 
half o f the 0157 VTEC isolates and has also been implicated in outbreaks.75 In 
addition to 0157 VTEC, VTEC strains belonging to some non-0157 serogroups 
have an important role in causing disease in continental Europe, in particular 
those o f serogroups 026 , 0 103, and 0 i i i .
Japan. In Japan, between 1991 and 1995, 29 outbreaks o f 0157 VTEC infection 
were reported,308 most occurring within families. Between May and December 
1996, multiple outbreaks o f 0157 VTEC infection occurred in Japan involving
11,826 cases and 12 deaths.
South America. VTEC strains are also important pathogens in some countries 
o f the southern hemisphere such as Argentina, Australia, Chile, and South 
Africa, and those belonging to non-0157 serogroups are often more important 
than 0157 VTEC strains. Argentina has the highest incidence o f reported HUS 
in children in the world.275 0 n  the basis o f census data, the annual incidence 
o f HUS in Buenos Aires in children under 4 years o f age is approximately 22 
per 100,000 per year, which appears to be 7 to 10 times higher than that 
reported in other so called high-risk areas o f the world. The exceptionally high 
frequency o f HUS in Argentina may be explained by the high incidence o f 
VTEC-associated grossly bloody diarrhea (30 to 38%). A striking finding is the 
low incidence o f infection with VTEC of serogroup 0157 in HUS patients and 
bloody diarrhea patients in Argentina, being about 2 to 18% and 3%, 
respectively. Data from Chile show an isolation rate o f 9% for 0157 VTEC 
strains from HUS patients, while in Uruguay so far no 0157 VTEC strains have 
been isolated from HUS patients. Both Chile and Uruguay have a slightly 
higher incidence o f HUS than the United States and Canada.
Australia. In Australia, VTEC strains o f serotype 0 iii:NM  are currently the 
most frequent cause o f serious human disease.380 So far, only two community 21 
outbreaks o f VTEC-induced disease have been reported in Australia.1,297 
Seasonal variation. In most developed countries o f the northern hemisphere, 
there is a distinct seasonality to VTEC infection, with most sporadic cases and 
outbreaks being reported in the summer and autumn.414,416,469 It is still not 
explained why VTEC infections peak during the warmer months o f the year.
It has been hypothesized that the seasonal pattern may reflect the ecology of 
the organisms, the variation in consumption pattern with greater human 
exposure to high-risk foods during the “cook-out” months, and/or greater 
improper handling (temperature abuse) or incomplete cooking o f products 
during warmer months than other months o f the year.122,250
Animal reservoir
VTEC can be found in the fecal flora o f a wide variety o f animals including 
cattle, sheep, goats, pigs, horses, cats, dogs, gulls, feral pigeons, and 
deer.27,45,74,82,113,170,176,227,254,255,475 However, the great majority o f these strains 
are o f serotypes other than 0 15 7 ^ 7  and are o f questionable pathogenicity. 
The most important animal species in terms o f human infection is cattle. 
Reported estimates o f the prevalence o f 0157 VTEC in cattle range from 0 to 
almost 10%. The ability to compare published prevalence data is limited 
because o f the use o f a large variety o f screening methods and the different 
settings in which the samples were taken (e.g. dairy herd versus 
slaughterhouse). Furthermore, geographic and seasonal variations in 
prevalence may occur. Fecal shedding o f 0157 VTEC by cattle and sheep peaks 
during the summer,175,254,255 parallel to the seasonal variation in the reported 
cases o f 0157 VTEC infections in humans. Animals carrying 0157 VTEC are 
usually asymptomatic. Higher isolation rates are reported from juvenile cattle 
rather than adults. Colonization o f cattle with 0157 VTEC is typically o f 2 
months or less in duration, long-term carriers have not been found.43 Long­
term carriers have not been reported in any species, but only cattle, sheep, and 
humans have been sampled with sufficient intensity to assess duration of 
carriage.176
The reservoir o f VTEC in cattle is further documented by seroepidemiologic 
surveys, which showed that the incidence o f elevated 0157 LPS antibody levels 
and the frequency o f VTi neutralizing antibodies (NAbs) was higher in serum 
from dairy farm residents and abattoir workers than in serum from urban 
residents. Reymond et al.373 found that the incidence o f elevated 0157 LPS 
antibody levels in serum was threefold higher in Canadian dairy farm families 
than in urban families (12.5 and 4.7%, respectively) and the incidence of 
elevated levels o f anti-VTi antibodies was sixfold higher in farm families (42 
2 2  and 7.7%, respectively). Luzzi et al.2-82- observed a frequency o f VTi NAbs of 
15.8% in cattle slaughterers in Italy compared with a frequency o f 7% in urban 
residents.
Finally, environmental studies have shown that 0157 VTEC can persist in 
manure, water troughs, and other places on cattle farms.177,252,263,478
Transmission to humans
0157 VTEC strains are transmitted by food and water, directly from person to 
person or animal to person, and occasionally through occupational exposure 
(Fig. 3).
Food ofanimal origin. Most infections are caused by ingestion o f contaminated 
foods, particularly undercooked ground beef.305 0ther foods o f bovine origin,
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including roast beef, raw milk and yogurt, and foods derived from other species, 
including meat from pigs, poultry, sheep, and deer have also been directly 
linked with outbreaks. Meat probably becomes contaminated at the time of 
slaughter; grinding may compound the problem by introducing the pathogen 
into the interior of the meat, where it may not be exposed to lethal temperatures, 
unless the meat is thoroughly cooked. 0utbreaks linked with salami highlight 
the organism's tolerance to acid and its ability to survive fermentation and 
drying.452 The organism can adapt to acidic conditions to allow it to survive at 
pH 3.4 for several days.39,265,503 Studies published to date indicate that common 
fermentation and drying practices are only sufficient to effect a reduction of 
about 1 to 2 log10 in the numbers o f 0157 VTEC.72,s>6,I34,I35,I37,158,192 
Fruits and vegetables. In the past few years, fruits and vegetables have accounted 
for a growing number o f recognized outbreaks. Radish sprouts in mass- 
prepared school lunches appeared to be the most likely source o f the largest 
outbreak yet reported, which occurred in Sakai, Japan, in 1996 and involved 
over 6,000 cases o f HC and over 100 cases o f HUS.3°8 0 ther examples o f fruits 2 3  
and vegetables that have been implicated in foodborne outbreaks of 0157 VTEC 
infection include fresh potatoes,314 lettuce,14,307 alfalfa sprouts,7 and 
unpasteurized apple juice or cider.4,8,42 While contamination o f fresh produce 
may be due to cross-contamination from meat products, contact with feces 
from domestic or wild animals at some stage during cultivation or handling 
o f fresh produce is another presumable route o f contamination.
Water. Waterborne outbreaks o f 0157 VTEC infection have occurred as a result 
o f drinking and swimming in unchlorinated water.5,19,114,1" , 238 0ne outbreak 
linked with a municipal water system, which affected 243 individuals and 
caused four deaths, resulted from an improperly repaired water system which 
allowed unchlorinated water to be widely distributed.434 
Person-to-person. Person-to-person contact has been shown to be an important 
cause o f outbreaks in day-care and chronic-care facilities.431 This may be related
to the combination o f a high potential for transmission and a population at 
increased risk for severe outcomes.302 Besides in institutional settings, person- 
to-person transmission frequently occurs among family members.382,384 
During outbreaks, transmission from asymptomatically infected individuals 
may also be a source o f secondary infections and can further amplify the 
outbreak.36,37
Animal-to-person. Several reports identified farmed or companion animals as 
direct vehicles o f 0157 VTEC. Close contact with infected calves, horses, goats, 
and dogs has previously resulted in human infection.79,352,371,410,457 
Occupational exposure. At least three cases o f laboratory-acquired infection with 
0157 VTEC with serious consequences, including renal failure and HC, have 
been documented.58,68,364 Additionally, hospital-acquired HUS in a nurse 
caring for a patient infected with 0157 VTEC has been reported.230
Although transmission o f non-0157 VTEC is less well understood, their 
potential as foodborne pathogens has been demonstrated by foodborne 
outbreaks associated with 0 iii:NM  and 0 i04 :H 2.1,2 There is no reason to 
propose that the modes o f transmission o f non-0157 VTEC differ from those 
listed above.
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Infectious dose
Investigations o f outbreaks in which implicated foods were cultured 
quantitatively revealed that the infectious dose for 0157 VTEC infection is 
probably very low. For example, between 0.3 and 15 E. coli 0 15 7 ^ 7  cells per g 
were found in lots o f frozen ground beef patties associated with a major 
outbreak in the western United States.169 Similarly, 0.3 to 0.4 E. coli 0 15 7 ^ 7  
cells per g were found in several intact packages o f salami that were associated 
2 4  with a foodborne outbreak.3 The infectious dose is estimated at the order of 
100 to 200 organisms, similar to the number required for Shigella infection.318 
Additional evidence for a low infectious dose comes from the capability of 
transmission through water and directly from one person to another.
The ability o f the pathogen to tolerate acidic conditions likely enables 0157 
VTEC to survive the acidic environment o f the stomach.122
Clinical manifestations and treatment
Clinical manifestations
The spectrum of clinical manifestations caused by VTEC infection ranges from 
symptom-free carriage through mild uncomplicated diarrhea, to severe HC
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and HUS. The most extensive clinical observations have been made with VTEC 
of serogroup O157 (Fig. 4).
The average interval between exposure and illness is 3 to 4 days, but incubation 
periods as short as 1 day and as long as 8 days have been reported. In 
uncomplicated cases of infection, the diarrheal symptoms usually resolve 
within 2 weeks. Excretion of the organisms usually continues for about 1 to 2 
weeks.441 However, prolonged fecal shedding o f O157 VTEC has been 
observed.37,225,341,407 The true incidence ofVTEC-associated nonbloody diarrhea 
is difficult to estimate since many patients may not seek medical attention.
2 5
Similarly, the incidence o f asymptomatic carriage is difficult to determine since 
healthy stools are rarely examined.
The most common clinical presentation o f O157 VTEC infection is HC. HC 
is characterized by severe abdominal cramps, bloody diarrhea, radiologic or 
endoscopic evidence o f colonic mucosal edema, erosion, or hemorrhage, and 
the absence o f conventional enteric organisms in the stool.375 It is because of 
this clinical association that these organisms have also been designated as 
EHEC. Illness usually begins with the sudden onset o f severe abdominal 
cramps, which are followed within hours by watery diarrhea. By the second or 
third day o f illness, nonbloody diarrhea progresses to become bloody. The 
appearance of blood is often accompanied by increased abdominal pain. Nausea 
and vomiting occur in about half o f the patients and fever, usually low grade, 
in about one third. Most patients with HC recover within about 1 week, without 
specific therapy or complications, but in approximately 10% o f children 
younger than 10 years, the illness will progress to D+ HUS.438 
The most severe sequela o f infection with O157 VTEC is the development of 
D+ HUS. This syndrome is defined by a triad o f microangiopathic hemolytic 
anemia, thrombocytopenia, and acute renal failure.370 Histopathological 
studies of the kidney o f D+ HUS patients show characteristic lesions consisting 
o f swelling and detachment o f the endothelial cells o f glomeruli and deposits 
o f fibrin in glomeruli and arterioles.221,370 D+ HUS develops, on average, 1 week 
after the onset o f diarrhea and is heralded by increasing pallor, mild jaundice, 
decreasing urine output, edema, and sometimes, seizures. Most patients will 
recover with appropriate supportive therapy, but approximately 5% of affected 
patients die in the acute phase o f the illness29M13 and an equal number will 
have severe sequelae, such as long-term renal impairment, neurologic injury, 
or hypertension.413 Many patients who regain renal function have chronic 
proteinuria, and some develop end-stage renal disease years or even decades 
later. Although D+ HUS occurs in all age groups, its incidence is higher in
2 6  infants, young children, and the elderly. It is the leading cause o f acute renal 
failure in children in developed countries. During recent years, it has emerged 
that about 75 to 100%  of cases o f D+ HUS in Europe, North America, and Latin 
America, especially in Argentina, have some evidence o f pre-existing infection 
with VTEC and that VTEC belonging to serogroup O157 are responsible for 
as much as 70% of all cases o f D+ HUS in North America and Western 
Europe.370
Although such progression is rare, infection with O157 VTEC can also result 
in thrombotic thrombocytopenic purpura (TTP), a variant form of HUS which 
mainly occurs in adults. The pathological features o f TTP are essentially the 
same, but it differs from the typical form of HUS in that patients are more 
often febrile and have marked neurological involvement.227,315,358 
Although some non-Oi57 VTEC strains cause clinical syndromes 
indistinguishable from those caused by O157 VTEC, the non-Oi57 VTEC as a 
group appear to cause less HC and less D+ HUS.318
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Treatment
No specific treatment currently exists for VTEC infection other than supportive 
care. The mainstay of therapy for the colitis is fluid and electrolyte management, 
monitoring for blood loss, and observation for progression to D+ HUS. 
Management o f D+ HUS is also primarily supportive, and may include dialysis, 
hemofiltration, and transfusion o f packed erythrocytes.221,321
Pathogenesis and virulence factors
Little is known about the fate ofVTEC following oral ingestion o f the bacteria.
The pathogenesis is considered to be a multistep process, involving a complex 
interaction between bacterial and host factors. It is assumed that VTEC strains 
colonize the lower gastrointestinal tract and then produce VTs, which are 
capable o f causing endothelial cell damage to small blood vessels leading to 
the development o f HC or D+ HUS.354
Attaching-and-effacing adherence
Histopathology. In human intestinal tissue cell cultures and in animal models 
o f human infection, many VTEC strains, including those o f serogroup O157, 
produce the same AE histopathology that is seen with EPEC.247,463 This striking 
pattern is characterized by intimate attachment o f the bacteria to the epithelial 
cell membrane with effacement o f the underlying enterocyte microvilli. 
Directly beneath the adherent bacteria, marked cytoskeletal changes are seen, 
including marked accumulation o f polymerized actin, and the bacteria 
sometimes sit upon pedestal-like structures.
Signal transduction. Adherence o f O157 VTEC or EPEC to epithelial cells results 2 7  
in increases in inositol phosphates and intracellular calcium, activation o f at 
least two serine/threonine kinases, protein kinase C and myosin light chain 
kinase, and phosphorylation o f several epithelial cell proteins on serine and 
threonine residues, the most prominent o f which are myosin light chains.118,200 
Binding o f EPEC to epithelial cells also induces tyrosine phosphorylation of 
epithelial cell proteins. However, in contrast to EPEC, O157 VTEC do not induce 
tyrosine phosphorylation o f epithelial cell proteins.
Besides effects on the individual enterocyte, additional host responses to 
infection with O157 VTEC and EPEC have been observed on monolayers of 
polarized epithelial cells. Attachment o f O157 VTEC or EPEC to polarized 
epithelial cells results in a decrease in the transepithelial resistance o f the 
monolayers as a result o f opening o f tight junctions.356,357,421 The increased 
paracellular permeability could aid the transmigration o f polymorphonuclear
leukocytes (PMNs), which has been observed with EPEC and O157 VTEC 
infection.13°,266,397,464 Recently, Savkovic et al.398 reported that adherence of 
EPEC activates the eukaryotic transcription factor NF-kB, which in turn 
upregulates expression o f interleukin 8 (IL-8), a PMN chemoattractant, 
leading to transmigration o f PMNs from the basolateral to apical sides of 
epithelial cells. Increased levels o f IL-8 have also been reported in cultured 
human colon epithelial cells infected with O157 VTEC. Elliot et al.130 showed 
that pretreatment o f rabbits with a monoclonal antibody directed against the 
leukocyte adhesion molecule on PMNs blocked the influx o f PMNs in response 
to O157 VTEC infection and prevented the histologic injury in the intestine. 
Intimin. Intimin is a 94- to 97-kDa outer membrane protein that is the only 
intestinal colonization factor yet identified for VTEC. Intimin is encoded by 
the E. coli attaching-and-effacing gene (eae) and is produced by all enteric 
pathogens that induce the AE histopathology.208 The importance o f intimin 
in colonization is shown by studies in piglets using eae mutants o f E. coli 
Oi57:H7 and in volunteer studies using an eae mutant o f EPEC.II9,207,264,300,461 
Additional support for a role in human disease is seen with the anti-intimin 
immune response observed in D+ HUS patients.301
There is a striking pattern o f sequence conservation and divergence among 
the various intimin proteins from different AE-producing pathogens: the N- 
terminal regions are highly conserved, but the C-terminal regions, the putative 
receptor binding portions, vary considerably.16 For example, the overall protein 
identity between intimins from EPEC strain E2348/69 and E. coli Oi57:H7 
strain EDL933 is 83%. However, the first 75% of the proteins have 94% identity, 
while the remaining 25% C-terminal residues have only 49%  identity. It has 
been hypothesized that this sequence difference in the C-terminal region could 
explain why EPEC are small bowel pathogens and Oi57 VTEC are large bowel 
pathogens. Intimin sequences are highly conserved among strains o f a given 
serotype, but not necessarily within O groups or within a pathogen class. A 
2 8  recent report indicates that the intimin family can be grouped into four different 
classes on the basis o f antigenic differences and polymerase chain reaction 
(PCR) reactivity and suggests designations o f a  (alpha), £  (beta), y (gamma), 
and § (delta) for the four groups.^
Intimin receptor. Although two different receptors have been identified for 
intimin from EPEC, the receptor for intimin from AE-producing VTEC has 
not yet been identified. EPEC bind to the 90-kDa Tir (translocated intimin 
receptor) protein.38 Tir is produced in EPEC as a 78-kDa protein that is 
translocated via a type III secretion pathway into the eukaryotic cell, where it 
is tyrosine phosphorylated and associates with the host cell cytoskeleton, and 
can then serve as a receptor for binding by the bacterial adhesin. Other 
researchers have reported that there are native eukaryotic components, 
possibly £ i integrins, which serve as intimin receptors.^2 The apparent 
discrepancy between these two potential scenarios for the interaction of
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intimin and the eukaryotic cells may be explained by technical differences in 
the experiments. Furthermore, it is possible that different portions o f intimin 
can bind to different receptors and both scenarios are correct.
Secreted proteins and a type III  secretion system. Recently, a type III secretion 
system has been reported for EPEC and Oi57 VTEC.204,205 The proteins 
secreted by this pathway, called Esps (E. coli secreted proteins), are responsible 
for the signal transduction events seen in the AE lesions and include EspA (25 
kDa), EspB (formerly called EaeB; 38 kDa), and EspD (40 kDa).“ 8,205 Although 
the espD gene is present in Oi57:H7 VTEC, the EspD protein has not yet been 
detected for these organisms and has only been reported for EPEC. A larger 
protein o f about i00-ii0  kDa, called EspC in EPEC and EspP in Oi57:H7 VTEC, 
is also secreted extracellularly, but not via the type III pathway.205 For EPEC it 
has been shown that mutation o f the espA, espB, or espD genes abolishes the 
signal transduction in epithelial cells and the AE histopathology produced by 
wild-type EPEC. Mutation o f the espC gene in EPEC does not affect signal 
transduction or AE histopathology. The secreted proteins are highly 
immunogenic during the course ofillness; a strong antibody response against 
these proteins is seen in HUS patients infected with Oi57:H7 VTEC and 
volunteers experimentally infected with EPEC.204,205
The model proposed for type III secretion systems is one where several o f the 
widely conserved proteins o f the type III system are inserted into the inner 
and outer membranes to form a channel through which the secreted proteins 
(EspA, EspB, EspD, and Tir) are translocated from the bacterial cytoplasm into 
the host cell (Fig. 5).^8 The translocated proteins then induce the signal 
transduction events that are associated with the AE lesions, but the 
mechanisms by which they do so are not known.
The LEE pathogenicity island. All the genes necessary for the generation o f AE 
lesions are located on a chromosomal pathogenicity island termed the locus 
o f enterocyte effacement (LEE); 43 kb for Oi57: H7 VTEC strain EDL 933 and
35 kb for EPEC strain E2348/69 .299 The LEE is organized into three regions 2 9  
with known functions (Fig. 5). The middle region contains the eae gene and 
the tir gene. Downstream of eae are located the esp genes and upstream of eae 
and tir are numerous genes (esc and sep) that encode the type III secretion 
system involved in the extracellular secretion o f the proteins encoded by the 
esp genes.^8 The i00-ii0-kDa secreted protein is not encoded in the LEE, being 
plasmid-encoded.
Other adherence mechanisms
The eae gene is widely distributed among VTEC strains associated with human 
disease. However, the absence o f eae in some clinical non-Oi57 VTEC isolates 
indicates that intimin is not essential for human virulence and suggests that
these strains produce intestinal adherence factors distinct from intimin yet to 
be described.212-491 Such strains do not produce cytoskeletal rearrangements 
and AE lesions in vitro, although at least some are capable o f microvillus
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Figure 5. Proposed model for the interaction o f LEE gene products and the host cell. Secreted proteins 
(EspADB) are shown as boxes interacting with specific chaperone proteins (solid circles) in the 
bacterial cytoplasm. Components o f the type III secretion system (Esc proteins) form an apparatus 
for translocation o f EspB, Tir, and possibly other proteins into the eukaryotic cel. The EscN protein 
is predicted to provide energy for this process. The Tir protein is translocated into the host cell, where 
it is phosphorylated (at least in EPEC and VTEC O26:H- strains) and inserted into the plasma 
membane. Intimin (the product o f the eae gene) is inserted into the bacterial outer membrane, where 
it binds to Tir and possibly to integrins. With EPEC, a plasmid encoded regulator (Per) regulates 
the expression o f many LEE genes. A homologous plasmid-borne regulator has not yet been described 
for VTEC, but VTEC LEE genes are presumably regulated in some fashion. Reprinted from Kaper 
et al.218 with permission o f the publisher.
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effacement.126 Based on results o f quantitative adherence studies with a range 
o f VTEC strains, comprising both eae-positive and eae-negative strains, it has 
been hypothesized that an enhanced capacity to adhere to intestinal cells is 
one ofthe factors which distinguishes human-virulent VTEC strains from those 
o f lesser clinical significance.353 However, an eae-negative VTEC strain that 
produces the VT2 variant VT2d, which is activatable by human intestinal 
mucus, may not need to adhere avidly to the intestinal mucosa to deliver toxin 
to the bowel surface or systemically.217
Other candidate adhesins for O157 VTEC include a 94-kDa outer membrane 
protein distinct from intimin,278,408 an 8-kDa 0 15 7 ^ 7  outer membrane 
protein,502 and a 696-amino-acid surface protein designated Iha (IrgA- 
homologue adhesin) with homology to the iron-regulated protein A (IrgA) of 
Vibrio cholerae.159 However, these proteins have not been well characterized or 
specifically demonstrated to play a role in adherence in vivo. It has also been 
suggested that fimbriae might be involved in the adherence o f O157 VTEC 
strains to epithelial cells, but so far their role remains unestablished.124,285,387,495 
Furthermore, it has been demonstrated that only a minority o f O157 VTEC 
strains express fimbriae, at least in vitro.28,409,495 Fimbriae have also been 
identified on the surfaces o f non-Oi57 VTEC strains isolated from humans, 
including humans with D+ HUS.28,126 Studying the potential role o f LPS in 
adhesion to cultured epithelial cells, it was observed that the O157 
polysaccharide side chain was not involved in adherence and that loss o f the
O side chain actually resulted in increased adherence.51,97
Verocytotoxins
Among the most important virulence characteristics o f VTEC organisms is 
their ability to produce one or more VTs.327 The AE histopathology and the 
LEE-encoded gene products are thought to only play a role in the initial 3 1  
nonbloody diarrhea. VT-activity is believed to contribute to the more severe 
forms o f VTEC infection.
Types o f VT. There are two main types o f VT, called VT1 (SLT-I, Stxi) and VT2 
(SLT-II, Stx2), which are most frequently associated with human disease. VT1 
is virtually identical to Stx produced by S. dysenteriae serotype 1, differing from 
Stx by only one amino acid.428 VT2 has only 56% amino acid homology with 
VT1 and Stx. Several variant subtypes o f VT2 have been identified, including 
VT2c (SLT-IIc, Stx2c) and VT2d (SLT-IId, Stx2d), which are also linked with 
human disease,304 and VT2e (SLT-IIe, Stx2e), which is almost exclusively 
associated with edema disease in pigs.284 In two reports, however, VT2e has 
been associated with human disease.359,448 The various subtypes o f the VT 
family are immunologically distinct and differ in toxicity for tissue culture cells 
and/or animals.304 VT1 and VT2 are produced either singly or in combination.
A single strain can produce more than one type o f VT2,385 but rarely a strain 
will produce three different toxins at one time.267 Most clinical VTEC isolates 
produce only VT2 or both VT1 and VT2. VT1 alone appears more often to be 
produced by non-O157 VTEC such as VTEC strains o f serogroups O 111 and 
O26.233 The structural genes for the VTs are found on lysogenic lambdoid 
bacteriophages; the genes for Stx and VT2e are chromosomally encoded. 
Structure ofVTs. VTs are proteins with a molecular weight o f approximately 70 
kDa. They are composed of one enzymatically active A subunit (32 kDa) and 
five receptor binding B subunits (7.7 kDa each).
VT receptor. The eukaryotic cell receptor for the specific binding o f VT1, VT2, 
VT2c, and VT2d is a galactose-a-1,4-galactose-containing neutral glycolipid, 
designated globotriaosyl-ceramide (Gb3).s>8,269-271,473 Gb3 receptors have 
been identified in human renal tissue,62 human lymphocytes,388 human 
erythrocytes (the Pk antigen),53 and human endothelial cells.312 The biological 
function o f Gb3 is unknown. Although VT2e has some binding to Gb3, it 
preferentially binds to the glycolipid globotetraosylceramide (Gb4) with a 
terminal £-N-acetyl-galactosamine residue,110 also known as the P antigen on 
human erythrocytes.
Mode o f action. After binding to their functional receptor, VTs are thought to 
be internalized into target cells by capping and receptor-mediated 
endocytosis.394 In some cells, toxin-bound vesicles will undergo fusion with 
cellular lysosomes, resulting in toxin degradation. However, in cells which are 
particularly sensitive to VT, the endosomal vesicles containing toxin-receptor 
complexes move by retrograde transport to the trans-Golgi network and then 
to the rough endoplasmic reticulum and even to the nuclear membrane. 
Somewhere during the routing o f the toxin in the target cell, the A subunit is 
cleaved in A1 (28 kDa) and A2 (4 kDa) with the B pentamer remaining 
associated with the A2 fragment. The A1 peptide is an active intracellular N- 
glycosidase which enzymatically inactivates the host ribosomal RNA complex.
32  It cleaves the N-glycosidic bond o f one adenine position in the 28S ribosomal 
RNA. This results in the inhibition of ribosomal elongation factor 1-dependent 
binding o f aminoacyl transfer RNA molecules to the 60S ribosomal subunit. 
Abrogation of peptide chain elongation results in suppression of overall protein 
synthesis and ultimately causes cell death.
Recent studies suggest that in addition to inhibition o f protein synthesis, 
apoptosis or programmed cell death may be implicated in the mechanism of 
VT-mediated cell death.197,286,361,436 Apoptosis is an active process o f cell death 
("suicide”), morphologically and biochemically different from necrosis or 
accidental cell death ("murder”). It appears that the B subunit ofVT has a signal 
transduction pathway not related to protein synthesis inhibition which can 
induce the histologic changes of apoptosis: cell shrinkage, membrane blebbing, 
chromatin aggregation, nuclear and cytoplasmic condensation, and the 
formation o f apoptotic bodies.
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Entrance o f VT into the circulation. To cause intestinal vascular changes, the 
toxins must gain access to the systemic circulation. Despite reports that VTEC 
strains invade certain tissue culture cell lines,295,329 they are generally not 
considered to be invasive organisms. Moreover, human intestinal epithelial 
cells have been shown to lack the Gb3 receptor for VT binding, although these 
data are not conclusive.54,241 The pathways and mechanisms involved in the 
movement o f VT across the intestinal epithelial cell barrier are not yet 
understood.
In a tissue culture model using polarized intestinal epithelial cells, Acheson 
et al.12 found that VT is capable o f passing across epithelial cells without 
apparent cellular disruption, probably through a transcellular pathway. VT 
translocation was energy dependent and directional, with greater toxin 
movement in the apical-to-basolateral direction than vice versa. Other possible 
routes o f VT translocation include translocation through lesions in the 
mucosal barrier caused either by the effects o f the toxin itself or as a 
consequence o f other pathological processes such as the formation o f AE 
lesions, or perhaps translocation through gaps between adjacent epithelial cells.
After entrance in the circulation, the toxins will cause microvascular 
thrombosis, hemorrhage, and necrosis which exacerbates diarrhea and leads 
to dysentery.354 I f  enough toxin enters the systemic circulation injury can occur 
in the kidney. The pathogenesis o f D+ HUS is hallmarked by endothelial cell 
damage o f glomeruli and kidney arterioles. Damage o f the endothelial cells, 
mediated by VT, may trigger platelet and fibrin deposition, leading to injury 
o f passing erythrocytes (hemolysis) and occlusion o f renal microvasculature 
(renal failure).302 Thrombocytopenia is believed to reflect trapping o f platelets 
in involved organs and removal by the liver and spleen. Although the simplest 
mechanism for D+ HUS involves direct cytotoxic action o f VT on renal 
endothelial cells, inflammatory cytokines and bacterial LPS may play an 
important part in augmenting this process. Future studies need to determine 
the relative contribution o f direct toxin action, cytokine production, and other 3 3  
bacterial factors in the renal damage. In severe cases o f D+ HUS endothelial 
damage is not limited to the kidney, but extends to other organs, such as brain 
and pancreas.
Transport in the circulation. Recent results o f te Loo et al.444 strongly suggest 
that PMNs are the cells that transport VTs from the intestine to the kidney or 
other target organs. They have shown that VT binds almost exclusively to PMNs 
in whole blood; VT binding was not observed for other blood components. The 
rapid binding o f VT to PMNs may explain the failure to detect VT in blood 
plasma o f HUS patients.465 The receptor responsible for binding o f VT to 
PMNs appeared to be different from that found on endothelial cells; the 
receptor has a 100-fold lower affinity than the functional receptor for VT, Gb3. 
Therefore, transmission o f VT from PMNs to glomerular microvascular 
endothelial cells grown in vitro occurred. Additionally, PMNs loaded with VT
displayed a direct cytotoxic effect on glomerular microvascular endothelial cells 
in vitro by inhibition o f protein synthesis.
Other potential virulence factors
Enterohemolysin. Nearly all O157 VTEC strains and a high proportion o f non- 
O157 VTEC strains associated with severe human disease produce a hemolysin 
o f the family o f repeats in toxin exoproteins, designated enterohemolysin 
(HlyEHEC).44,4°° A possible role for HlyEHEC in the pathogenesis o f VTEC 
infection is further supported by the observation that patients with D+ HUS 
developed antibodies to HlyEHEC.399 HlyEHEC is encoded by a 60-MDa VTEC 
virulence plasmid, referred to as pO157, and causes the formation o f transient 
ion-permeable channels by integration into lipid bilayer membranes. The way 
in which HlyEHEC might contribute to the pathogenesis o f VTEC infection is 
still unknown. Lysis o f erythrocytes in vivo would release heme and 
hemoglobin, which could serve as a source o f iron and thereby could enhance 
the growth of O157 VTEC in the gut.261 Recently, a chromosomally encoded 
69-kDa outer membrane protein called ChuA has been discovered in E. coli 
O157:H7, but not in other human pathogenic VTEC strains, that is an iron- 
regulated heme-transport protein.454 However, cytotoxicity o f members o f the 
family o f repeats in toxin exoproteins has been reported for a range o f cell types 
and not only for erythrocytes.34,481
Serine protease. Another putative virulence factor also encoded on pO157 is the 
recently described extracellular serine protease EspP. In vitro experiments 
demonstrated that this 104-kDa protein is capable o f cleaving pepsin and 
human coagulation factor V.67 It has been suggested that secretion o f EspP by 
VTEC colonizing the gut could result in exacerbation o f hemorrhagic disease. 
EspP also shows cytotoxic activity on Vero cells117 and induces an antibody 
3 4  response in infected patients. Nevertheless, EspP appears not to be a universal 
virulence factor o f VTEC strains causing disease in man.67 
pO157 plasmid. Initially it was thought that the presence o f the pO157 plasmid 
correlated with expression o f fimbriae involved in the adherence o f O157 VTEC, 
at least in vitro.222 However, from subsequent studies with cell cultures it was 
concluded that there is no consistent in vitro evidence o f a role for pO157 in 
VTEC adherence.143,216,455 Additionally, the majority o f animal studies found 
that the presence or absence o f the plasmid had no effect on the capacity of 
VTEC strains to colonize the intestinal epithelium or to cause AE lesions.462,474 
Further research needs to establish whether pO157 plays a role in adherence 
o f human pathogenic VTEC strains to colonic epithelium.
EAST1. A final virulence factor that might contribute to the pathogenesis of 
the watery diarrhea often observed early in the course o f infection is the 
enterotoxin EAST1.396 This enterotoxin was first described in EAEC strains
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and is distinct from the heat-stable toxins produced by ETEC strains. The toxin 
is encoded by the astA gene located on the chromosome. EAST1 is found in 
many clinical VTEC isolates; in one study, all 75 O157:H7 VTEC strains 
possessed the astA gene, usually with two gene copies in the chromosome, as 
well as 8 o f 9 O 26:H h VTEC strains and 12 o f 23 VTEC strains o f other 
serotypes.396 The role o f EAST1 in secretion has not yet been determined, 
although enterotoxicity for rabbit ileal tissue has been confirmed by testing 
culture ultrafiltrates o f astA-positive O157 VTEC strains.
Detection, identification and typing
Culture isolation methods
There are no common biochemical characteristics associated with the great 
majority o f VTEC serotypes. However, there are some biochemical 
characteristics o f O157 VTEC that have been exploited in the isolation and 
identification o f these strains. Typical strains o f O157 VTEC are unable to 
ferment sorbitol within 24 h, which differentiates them from the majority 
(approx. 75 to 94%) o f other E. coli strains.288 O157 VTEC strains also do not 
ferment rhamnose on agar plates, whereas 60% of non-sorbitol-fermenting 
E. coli belonging to other serogroups ferment rhamnose.85,417 Another 
characteristic o f O157 VTEC strains that distinguishes them from most 
(approx. 94 to 96%) other strains o f E. coli is their inability to produce £-D- 
glucuronidase.366,451 This enzyme hydrolyzes 4-methylumbelliferyl-£-D- 
glucuronide (MUG) or related substrates as 5-bromo-6-chloro-3-indolyl-£-D- 
glucuronide (BCIG). A further characteristic o f O157 VTEC strains used is the 
production o f HlyEHEC.47 O157 VTEC strains do not grow well at 44 to 45.5°C, 
which is a temperature commonly used to grow E. coli from food and water
samples.120,362
Plating media. The most widely used plating medium for the isolation o f O157 
VTEC is sorbitol MacConkey agar (SMAC).288 This medium contains 1% 
sorbitol in place o f lactose in the standard MacConkey agar. Individual 
colorless, sorbitol-nonfermenting colonies, indicative o f O157 VTEC, should 
be tested for the O157 antigen by using E. coli O157 antiserum or latex reagents. 
Isolates agglutinating in O157 antiserum need to be confirmed as E. coli by 
biochemical reactions, because strains o f several species cross-react with O157 
antiserum.273 Furthermore, since not all E. coli O157 strains produce VT, it is 
necessary to confirm VT production.
The sensitivity o f SMAC is limited by the capacity to recognize sorbitol- 
nonfermenting colonies against the background of other organisms on the 
plate. Additionally, the possible presence of other non-sorbitol-fermenters, such 
as Proteus spp., Aeromonas spp. and some other E. coli often makes it necessary
to test many colonies for confirmation. Chapman et al.85 improved the isolation 
rate o f O157 VTEC by supplementing SMAC with cefixime and rhamnose (CR- 
SMAC). Cefixime inhibits Proteus spp. at a concentration not inhibitory to 
E. coli, and rhamnose is fermented by most non-sorbitol-fermenting E. coli 
strains other than those o f serogroup O157. The inclusion o f these components 
reduced the number o f colorless colonies by approximately 60%. Zadik et al.501 
reported a further improvement in O157 VTEC isolation rates by using SMAC 
supplemented with cefixime and potassium tellurite (CT-SMAC). O157 VTEC 
strains are generally less susceptible to tellurite than are many other non- 
sorbitol-fermenters such as Aeromonas spp., Pleisomonas spp., Morganella spp., 
Providencia spp., and most other E. coli strains. Inclusion o f novobiocin has 
also been reported to increase the selection for O157 VTEC.331 
The inability o f the majority o f O157 VTEC strains to produce £-D- 
glucuronidase is exploited by supplementation o f SMAC with the fluorogenic 
MUG331,435 or with the chromogenic BCIG.»2 Cleaving o f MUG or BCIG by 
£-D-glucuronidase-positive strains results in the formation o f fluorescent (at 
365 nm) or blue-colored colonies, respectively. No fluorescence or change of 
color is seen for strains negative for £-D-glucuronidase. Szabo et al.435 
developed HC agar, which contains sorbitol and MUG, to distinguish 
phenotypes based on reactions to these substrates.
Commercially available agar media based on one or more o f the properties 
mentioned above are Rainbow Agar O157 (Biolog), Fluorocult E. coli O157:H7 
agar (Merck), and CHROMagar O157 (CHROMagar). Rainbow Agar O157 
contains chromogenic substrates that are specific for both £-D-galactosidase 
and £-D-glucuronidase. Typical O157 VTEC strains being galactosidase- 
positive and glucuronidase-negative form characteristic charcoal gray or steel 
black colonies, whereas most VT-negative E. coli strains produce both enzymes 
and appear as violet or red colonies on this medium. Additionally, it has been 
claimed that some typical non-O157 VTEC strains overproduce £-D-
3 6  galactosidase relative to £-D-glucuronidase on this medium, giving the 
colonies a distinctive intermediate color (blue or purple). The addition of 
tellurite and novobiocin has shown to improve the recovery o f O157 VTEC on 
Rainbow Agar O157.423 Some of the other chromogenic media may also need 
the addition o f inhibiting compounds like cefixime, novobiocin or tellurite to 
obtain sufficient selectivity. Variations in the incubation temperature and the 
use o f agar plates which have been stored for some weeks may cause 
fluctuations in typical colony colors on chromogenic media.
The efficacy o f plating media based on the fermentation o f sorbitol and £-D- 
glucuronidase activity for clinical diagnosis will vary in accordance with the 
local VTEC serotype prevalence. In recent years, an increasing number of 
outbreaks and sporadic cases related to non-O157 VTEC have been reported 
in many countries,160,212 the majority o f these strains being sorbitol-fermenting 
and having variable £-D-glucuronidase reactions.251 Furthermore, sorbitol-
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fermenting, £-D-glucuronidase-positive VTEC strains o f serotype O157:NM 
have frequently been isolated from both outbreaks and sporadic cases o f D+
HUS in Germany.171 Such strains have also recently been isolated from 
patients with D+ HUS in the Czech Republic,50 Hungary,183 and Finland.240 
Hayes et al.182 reported the isolation o f another atypical O157:H7 VTEC strain 
that did not ferment sorbitol but produced an active £-D-glucuronidase from 
a patient with bloody diarrhea. Some strains o f sorbitol-fermenting E. coli 
O157:NM are very sensitive to tellurite and do not grow on CT-SMAC.
A nonselective, but differential plating medium is enterohemolysin agar 
(Oxoid) (washed sheep blood agar supplemented with calcium) which covers 
more VTEC strains than O157 VTEC.47 As discussed above, nearly all (approx.
90%) O157 VTEC strains and a significant proportion o f non-O157 VTEC 
strains (approx. 70%) produce HlyEHEC. Enterohemolytic E. coli are 
characterized on enterohemolysin agar by small turbid zones o f hemolysis 
around the colonies occurring after 18 to 24 h incubation at 37°C. Alpha- 
hemolytic E. coli form large, clear zones o f hemolysis after only 3 to 6 h of 
incubation. To improve the selectivity o f this medium, antibiotics such as 
novobiocin and cefsulodin may be used.
Enrichment. Human clinical stool specimens can often be examined by direct 
plating onto selective and differential agars. However, culture isolation 
methods for O157 VTEC from samples that may contain only low numbers of 
O157 VTEC, such as food and environmental samples, and samples with an 
abundant microbial flora, such as fecal samples from animals, usually include 
a selective enrichment step. Selective enrichment media used include modified 
tryptone soy broth (TSB) with acriflavin (mTSB + a),245 modified TSB with 
novobiocin (mTSB + n),121 modified TSB with vancomycin, cefsulodin and 
cefixime (EEB),480 buffered peptone water (BPW) with vancomycin, cefsulodin 
and cefixime (BPW-vcc),88 lauryl tryptose broth (LST)144 and modified E. coli 
broth with novobiocin (mEC + n).»1 Novobiocin and acriflavin reduce the 
growth of Gram-positive organisms. Vancomycin, cefsulodin and cefixime 37 
suppress the growth of Gram-positive bacteria, Aeromonas spp. and Proteus spp., 
respectively.
To be effective in enriching O157 VTEC cells, the incubation conditions during 
selective enrichment should suppress the growth o f competing microflora, 
while at the same time the outgrowth of O157 VTEC is being maximized. As 
many other non-sorbitol-fermenting organisms show optimal growth at 37°C, 
enrichment o f O157 VTEC at 41 to 42°C is preferred. However, the exact 
temperature at this level is rather critical as poor growth o f these strains has 
been observed at temperatures above 42 °C.362 The incubation period required 
will depend on the competing microflora to be expected and on the next steps 
in the isolation procedure. Though enrichment with shaking is a common 
practice for enriching O157 VTEC cells, the advantages over static incubation 
are not well documented. Furthermore, for routine analytical purposes it is
not practical to shake large numbers o f enrichment cultures o f food and 
environmental samples. However, in principle, for short enrichment periods 
(< 6 h) the use o f pre-warmed enrichment broth and a shaking water bath is 
recommended to obtain sufficient growth o f the target organism.
The occurrence ofheat-, freeze-, acid- or salt-stressed O157 VTEC in food makes 
it important to be able to detect cells that are in a stressed state, since injured 
cells mostly retain their pathogenic properties. The detection and isolation of 
stressed VTEC by direct selective enrichment or direct plating onto selective 
agar may not allow the recovery o f these strains.17,99,424 Commercial 
enrichment systems are being developed that include a release o f selective 
compounds after a repair period (SPRINT O157). Levine's eosin methylene blue 
agar modified by the addition o f sorbitol and novobiocin was found a suitable 
alternative to SMAC for the recovery o f E. coli O157:H7 from heated and dried 
meat samples.180 Where levels o f competitive bacteria are low, complete media 
such as tryptone soy agar (TSA) or phenol red sorbitol agar with MUG can be 
u se d ."  McCleery and Rowe298 found improved recoveries after a resuscitation 
period (2 h at 25°C) on TSA before overlay with SMAC supplemented with 
MUG. They obtained maximum recovery by adding catalase to the TSA. 
Probably the best approach for the effective recovery o f stressed O157 VTEC 
cells is a nonselective pre-enrichment for at least 18 to 24 h, similar to the 
classical Salmonella detection method.424 As a pre-enrichment medium BPW, 
modified BPW372 or Universal Pre-enrichment Broth209 may be used.
Tissue culture cytotoxicity assays
The profound sensitivity ofVero cells to VT was first observed by Konowalchuk 
et al.249 Since Vero cells have a high concentration o f Gb3 and Gb4 in their 
plasma membranes, they can be used to detect all known VT variants. HeLa 
3 8  cells have also been used to detect the presence o f VT, but this cell line lacks 
Gb. and therefore is less sensitive to VT2e.4
The Vero cell assay is used for screening o f clinical samples, but generally not 
for food and environmental samples. Sterile extracts or culture filtrates (mostly 
serially diluted) o f fecal specimens are applied to Vero cell monolayers and 
after 48 to 72 h o f incubation the cells are observed for cytopathic effects.232 
Cytotoxic activity should always be confirmed by neutralization with specific 
VT antiserum. Although a valuable diagnostic method, detection o f free VT 
or VTEC organisms by tissue culture cytotoxicity is labor-intensive, time­
consuming, and cumbersome. Recently, several modifications have been 
described to overcome some of these drawbacks.174,351 The same cell culture 
methods are used to test bacterial cultures for VT activity.
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Conventional methods for the isolation, confirmation, and serotyping of O157 
VTEC are time-consuming and labor-intensive, and hence costly. Recent 
advances in diagnostic technology have led to the development o f rapid 
detection and identification tests, which give a significant reduction o f the 
analysis time. These methods include miniaturized biochemical tests, 
immunoassays, and DNA-based methods, many o f which are commercially 
available.
Immunoassays for detecting E. coli O157:H7 and other VTEC serotypes rely 
on the use o f antibodies against O157, H7 and outer membrane antigens of 
E. coli O157:H7, and antibodies against VTs. Perhaps the most successful of 
immunological approaches has been the use o f immunomagnetic separation 
(IMS). The procedure involves mixing o f enrichment cultures with 
paramagnetic particles coated with anti-O157 antibodies. The target organisms 
in the sample bind to the immunomagnetic beads, which are then separated 
from other sample material and microorganisms in a magnetic field. Following 
an extensive washing procedure to remove non-specifically bound bacteria and 
sample particles the beads are plated onto solid media and incubated overnight. 
Several studies have shown that IMS is more sensitive compared to direct 
subculture from enrichment cultures.40,41,88,144,499 IMS increases the 
sensitivity by relatively concentrating E. coli O157 compared with background 
microflora, which may overgrow or mimic O157 VTEC cells on selective agars. 
Non-specific binding o f organisms other than O157 VTEC to the beads can 
pose a problem in samples with a high background flora. This problem can 
be resolved through a reduced enrichment time and/or a high selective 
subcultivation medium like CT-SMAC and by using a low-ionic-strength 
washing solution.453 Combination o f IMS with other immunological test 
systems for O157 VTEC like the 3M Petrifilm™ Test Kit-HEC and VIDASTM 
E. coli O157 was found a fast and efficient screening procedure for detecting 3 9  
E. coli O157 in food.166,471 A method combining a 250-min enrichment,
IMS and PCR enabled detection o f a single CFU o f E. coli O157:H7 in only 8 
h.162 Another rapid method combines IMS with flow cytometry.406 
Commercially available IMS systems are DynabeadsTM anti-E. coli O157 
(Dynal) and Captivate™ O157 (Lab M). Recently also immunomagnetic beads 
with anti-O26 and anti-Om antibodies have become commercially available. 
Moreover an automated immunoconcentration system has recently been 
developed.
Colony hybridization assays and PCR assays are two principal DNA-based 
methods for detecting O157 VTEC and non-O157 VTEC strains. Most DNA 
probes and PCR primers used are directed toward the detection o f genes 
encoding VT. However, since the majority o f VTEC strains present in food or 
other non-clinical samples are o f questionable clinical significance, probes and
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primers for additional virulence factors have been developed. Furthermore, 
spontaneous loss ofbacteriophages carrying VT genes upon cultivation in the 
laboratory has occurred.222 Additional virulence genes or DNA sequences that 
have been targeted to develop DNA-based methods include the eae gene, the 
DNA sequence upstream of the eae gene, the £-D-glucuronidase gene, the 60- 
MDa plasmid and its hemolysin gene, and the H7 antigen gene.
Typing methods
In recent years, bacterial subtyping (the differentiation o f isolates below the 
species level) has become an integral part o f epidemiologic investigations. 
Several molecular and biochemical typing methods have been applied to 
subtype O157 VTEC and other VTEC strains, including phage typing, VT 
subtyping, plasmid profile analysis, antimicrobial susceptibility testing, 
ribotyping, amplification-based methods, such as random amplification of 
polymorphic DNA-PCR (RAPD-PCR) and random amplification o f 
polymorphic DNA-ALFA (according to Freiburg), restriction fragment length 
polymorphism (RFLP) with bacteriophage X or VT probes, pulsed-field gel 
electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP). 
Phage typing is the only internationally standardized subtyping method. It is 
only used for VTEC of serogroup O157. Phage types are determined by the lysis 
pattern obtained when a test isolate is subjected to a panel o f lytic phages. The 
phage typing scheme for O157 VTEC was initially reported by Ahmed et al.18 
and was later extended from 14 to 62 phage types by Khakhria et al.243 The 
scheme, which uses 16 phages, now recognizes over 80 types.145 Although 
phage typing is relatively easy to perform, the biggest drawback o f using phage 
typing as the sole typing method is the occurrence o f common phage types.449 
To obtain maximum strain discrimination it has been recommended to use 
4 0  phage typing in conjunction with VT subtyping and PFGE.168,292,430,492
PFGE is probably the most widely used fingerprinting method for bacterial 
pathogens and is characterized by a high level o f discrimination. PFGE is a 
restriction fragment length polymorphism method that uses rare-cutting 
restriction enzymes to generate a relatively small number o f large DNA 
fragments. The generated fragments are too large to be separated by 
conventional electrophoresis but can be separated when subjected to a 
constantly changing (pulsed) electrical field. The greatest difficulty in 
interpreting PFGE results comes in deciding how many differences are 
required to establish that two isolates represent different strains.430 The 
interpretive criteria proposed by Tenover et al.445 for bacterial strain typing 
probably do not apply to O157 VTEC strains because they form a highly 
conserved clone. More research is needed to determine the natural frequency 
o f genetic rearrangements in these bacteria.
Verocytotoxin-producing Escherichia coli in humans and the food chain
Chapter 1 -  General introduction
Patients with VTEC infection have been reported to develop serum antibody 
responses to VTs, to the LPS antigen o f the infecting strain, to the secreted 
proteins EspA, EspB, and EspP, to HlyEHEC, and to various outer membrane 
proteins o f specific strains.228
VT serology appears not to be suitable for diagnosing a recent VTEC-asso- 
ciated illness. Antibody responses to VTs are uncommon after a primary 
infection and appear to require booster exposures to VTEC infection to 
become manifest.228 Therefore in countries with low exposure to VTEC, the 
detection o f VT-specific antibodies is generally hampered by low 
sensitivity,31,52,165,233,374,469 and in countries with a high prevalence rate of 
VTEC infection, VT-serology lacks specificity.379
While the diagnostic significance o f examination of patients' sera for antibodies 
to VTs remains questionable, methods used to measure serum antibodies to 
the LPS ofVTEC strains are o f great value in diagnosing D+ HUS in children. 
Serodiagnosis o f VTEC-related disease can be particularly valuable when 
patients present late in the course o f disease, when fecal shedding o f the 
etiological agent has ceased. Antibody response to the O157 LPS antigen can 
often be detected in the first several months after D+ HUS.92 Ideally, acute- 
and convalescent-phase sera should be tested for rising or falling antibody titers.
The measurement o f antibodies to the LPS antigens o f O157 and non-O157 
VTEC serotypes has become established not only as a valuable diagnostic tool, 
but also as an effective approach for validating the clinical significance o f non- 
O157 VTEC serotypes .279 The value o f screening sera for antibodies to the 
secreted proteins, HlyEHEC, and outer membrane proteins needs to be evaluated 
further.
O u t l i n e  o f  t h e  t h e s i s  4 1
The main objective o f the work presented in this thesis was to gain more insight 
in the epidemiology ofVTEC infection in humans and the occurrence ofVTEC 
in the human food chain, in order to be able to formulate recommendations 
to eventually reduce VTEC infection in humans. We have focused our studies 
in particular on VTEC of serogroup O157, because from a clinical and public 
health point o f view these strains are the most important in the Netherlands. 
Chapter 2 presents the results o f the characterization o f O157 VTEC strains 
isolated from patients with D+ HUS and their household members using 
several phenotypic and genotypic methods.
In Chapter3 we described the results o f a retrospective study o f children with 
D+ HUS conducted to determine the frequency o f VTEC infection in their 
household members. We reviewed the medical records o f the patients and
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analyzed the data recorded on gastrointestinal symptoms and results of 
microbiologic examination for the patients, their parents and their siblings. 
Chapter 4 presents the results o f three different surveys on the occurrence of 
O157 VTEC and other VTEC in raw meats obtained from retail outlets in the 
Netherlands.
Chapter 5 presents the results o f our study on the efficacy o f several selective 
enrichment and plating media for the isolation o f O157 VTEC. Additionally, 
we evaluated the performance o f a variety o f commercial test kits.
Because the evaluation o f the isolation methods identified the IMS technique 
as the most sensitive and cost effective method, we conducted a survey on the 
occurrence o f O157 VTEC in meats using this technique. The results are 
described in Chapter 6. This chapter also includes results of growth and survival 
experiments performed with artificially contaminated meat.
Chapter 7 describes the results o f the examination o f cow's milk from bulk 
storage tanks and o f growth and survival experiments with artificially 
contaminated cow's milk.
The next two chapters deal with the isolation and characterization of O157 VTEC 
from several food production animals. Chapter 8 describes the results obtained 
for the most commonly reared species o f ruminant food animals, cattle and 
sheep, and Chapter 9 describes the results obtained for pigs and poultry. The 
characteristics o f food and animal O157 VTEC isolates were compared with 
the characteristics o f O157 VTEC isolates from cases o f D+ HUS.
Since cattle, mainly dairy cattle, are regarded as the primary reservoir o f O157 
VTEC, we studied the occurrence o f O157 VTEC on dairy farms as described 
in Chapter 10. Following a point prevalence study on 10 farms, we conducted 
a longitudinal study on the maintenance and dissemination o f O157 VTEC on
4 of these 10 farms.
In Chapter 11, the work presented in this thesis is summarized, discussed and 
put into perspectives.
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Chapter
Characterization of verocytotoxin-producing 
Escherichia coli O157 isolates from patients with 
hemolytic-uremic syndrome in Western Europe
Summary
Fifty verocytotoxin (VT)-producing Escherichia coli (VTEC) strains o f serogroup 
O157 were characterized by phage typing, polymerase chain reaction (PCR) 
for VT genes and the E. coli attaching-and-effacing (eae) gene, and random 
amplified polymorphic DNA-PCR (RAPD-PCR) fingerprinting. The collection 
represented isolates obtained from patients with diarrhea-associated hemolytic- 
uremic syndrome (D+ HUS) and their family contacts, isolated in the 
Netherlands, Belgium and Germany between 1989 and 1993. Based on 
isolates from separate families (n = 27) seven different phage types were 
identified, types 2 (44%) and 4 (33%) were predominant. Eighty-five percent 
o f the strains contained only VT2 gene sequences and 15% both VT1 and VT2.
All strains o f the dominant phage types 2 and 4 carried the VT2 gene. Strains 
that belonged to the minor phage types 8, 14, 32 carried both VT1 and VT2 
genes, with the exception o f two isolates identified as phage types 49 and 54 
which contained only VT2 genes. All O157 VTEC strains possessed the 4 3  
chromosomally-located eae gene, which indicates its usefulness as virulence 
marker. RAPD-PCR fingerprinting identified four distinct banding patterns, 
with one profile found among 79% of the strains. Based on the combined 
results o f all typing methods used in this study, the collection o f 50 O157 VTEC 
strains could be divided into nine distinct groups. Strains isolated from 
different persons within one family could not be distinguished by any o f these 
methods. The data suggest that O157 VTEC strains are members o f one clone 
that has become widely distributed.
A.E. Heuvelink, N.C.A.J. van de Kar, J.F.G.M. Meis, L.A.H. Monnens, 
and W.J.G. Melchers.
Epidemiology and Infection 1995; 115:1-14.
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I n t r o d u c t i o n
Verocytotoxin (VT)-producing Escherichia coli (VTEC) strains are implicated 
in the pathogenesis o f the diarrhea-associated form (D+) ofhemolytic-uremic 
syndrome (HUS), which is the most common cause o f acute renal failure in 
childhood.220 Although VTEC strains that belong to serotypes O157:H7 and 
O157 nonmotile (O157:H-) are most frequently isolated from stools o f patients 
with HUS, at least 50 other human VTEC serotypes are known.227 The exact 
mechanisms of the attachment o f VTEC to the human intestinal mucosa are 
not well understood. However, based on in vitro and animal studies a model 
based on intimate adhesion with localized effacement o f the microvilli and 
disruption o f the cellular cytoskeleton at the site o f attachment has been 
proposed. The intimate attachment may be mediated by the chromosomally 
encoded E. coli attaching-and-effacing (eae) gene product, an outer membrane 
protein.119 Additional bacterial factors may contribute to the attachment-and- 
effacement phenotype ofVTEC strains.127 Accumulated evidence suggests that 
HUS may result from the systemic action o f VT on vascular endothelial cells.220 
VTEC strains produce two immunologically distinct VTs (VT1 and VT2), either 
singly or in combination. These are encoded by bacteriophages. Since these 
VTs are closely related to the Shiga toxin, they are often referred to as Shiga- 
like toxins (SLT-I and SLT-II).429 In the past few years, variants o f VT2 (VT2c 
or SLT-IIc) have been identified.450
E. coli O157:H7 has been isolated from cattle and foods o f animal origin 
(contaminated meat, unpasteurized milk).227 Waterborne and person-to- 
person transmission are also believed to be modes o f spread o f this 
pathogen.65,382,434 Several phenotypic and genotypic schemes have been 
developed to assist in epidemiological investigations. These include typing of 
the strains by VT profile,339,405,440,450 plasmid profile,339,366,405 restriction 
enzyme digestion and electrophoresis o f plasmid482 and whole cell DNA,56 
4 4  multilocus enzyme electrophoresis,485,486 phage type 18,145,243 and 
antibiogram.405,434 In this study, O157 VTEC strains and O111 VTEC strains 
were characterized which had been isolated from D+ HUS patients as well as 
from family contacts in three Western European countries. Besides phage type, 
the VTEC isolates were examined for toxin profile and the presence o f the eae 
gene by a multiplex polymerase chain reaction (PCR). To determine the genetic 
relationship o f the strains PCR-based fingerprinting was used.
M e t h o d s
Clinical VTEC isolates
Fifty-two human fecal VTEC isolates were studied, including 30 isolates from
19 children with D+ HUS, 9 isolates from family contacts (n = 9) o f 5 o f these 
HUS patients, 11 isolates from family contacts (n = 11) o f 7 patients with D+
HUS from which no VTEC had been isolated, 1 isolate from an adult with D+
HUS, and 1 isolate from a child with acute, bloody gastroenteritis. The isolates 
obtained from patients from the Netherlands, Belgium and Germany were 
collected between 1989 and 1993. Forty-six strains had been characterized as 
serotype O157:H7, four as serotype O157:H- and two as serotype Om:H-. As 
controls, six VT-negative E. coli O157 isolates from raw retail meats bought in 
the Netherlands and eight both VT-positive and VT-negative E. coli strains 
belonging to serogroups O157 (n = 3), O111 (n = 3) and O26 (n = 2) obtained 
from Dr. M.A. Karmali (Hospital for Sick Children, Toronto, Canada) and from 
Dr. W. Jansen (National Institute o f Public Health and the Environment, 
Bilthoven, The Netherlands) were included. In contrast to the VT-positive E. coli 
O157 isolates, the VT-negative E. coli O157 strains were able to ferment sorbitol 
and possessed the enzyme 6-glucuronidase. The bacterial cells were stored at 
-70°C in glycerol-containing (10%) medium.
Phage typing
Phage typing o f the 50 O157 VTEC isolates was performed by Dr. B. Rowe 
(Laboratory o f Enteric Pathogens, Central Public Health Laboratory, London,
UK).
D NA preparation
Bacteria were grown in tryptic soy broth at 37°C, overnight. Genomic DNA 
was isolated as follows: 1 ml o f an overnight culture was centrifuged in a 
microcentrifuge, and the cells were resuspended in 250 ^l STET buffer (233 4 5  
mM sucrose, 50 mM TRIS-HCl (pH 8.0), 20 mM EDTA, 5% Triton X-100). 
Lysozyme was added to a final concentration o f 1.7 mg/ml. The suspension 
was incubated at room temperature for 5 min, then heated at 100°C for 1 min 
and put on ice for another 2 min. In succession, sodium dodecyl sulphate and 
proteinase K were added to a final concentration o f 0.3% and 0.5 mg/ml, 
respectively. Then, the solution was incubated at 55 °C for 2 h. Following 
extraction with phenol, 0.03 mg/ml RNAse A was added and the mixture was 
incubated at 37°C for 20 min. The solution was extracted successively with 
phenol/chloroform/isoamylalcohol (25:24:1) and chloroform/isoamylalcohol 
(24:1). The DNA was precipitated overnight and resuspended in 100 ^l of 
distilled water.287 An aliquot was electrophoresed in an agarose gel (1%) 
containing 0.1 |ig/ml ethidium bromide to estimate the DNA yield and verify 
DNA integrity.
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Table 1. Oligonucleotide primers used for the detection o f verocytotoxin (VT) and Escherichia
coli attaching-and-effacing (eae) gene sequences
Primer Nucleotide sequence Location a Size o f PCR
product (bp)
VT1-1 5'-GGCAGATGGAAGAGTCCGTGGGATTACGC-3' 10 11-10 39 I79
VT1-2 5'-CACAATCAGGCGTCGCCAGCGCACTTGCT-3 ' 116 1-118 9
VT2-1 5'-CCACATCGGTGTCTGTTATTAACCACACC-3 ' 408-436 372
VT2-2 5'-GCAGAACTGCTCTGGATGCATCTCTGGTC-3' 75I-779
eae-i 5'-TGCGGCACAACAGGCGGCGA-3 ' 2078-2097 629
eae-2 5'-CGGTCGCCGCACCAGGATTC-3 ' 2687-2706
a The position num bers are those in  the published nucleotide sequences o f  VT1 ,10 9  VT2 202  and 050
Polymerase chain reaction
The VTEC strains were examined for the presence o f VT and eae gene 
sequences by performing a hot start multiplex PCR. Table 1 shows the 
sequences o f the oligonucleotides. The oligonucleotide primer pairs targeted 
conserved sequences found in the genes encoding VTi, VT2 and types or 
variants o f the VT2 family, and the eae gene product. PCR reaction mixtures 
(50 ^l) contained 75 mM TRIS-HCl (pH 9.0), 2.5 mM MgCl2, 20 mM 
(NH4)2SO4, 0.01%  Tween-20, 0.2 mM dNTPs each, 0.2 U of Taq DNA 
polymerase (Thermoperfectplus DNA polymerase; Integro, Zaandam, The 
Netherlands) and 20 pmol o f the primers VT1-1, VT1-2, VT2-1, VT2-2, eae-i, 
eae-2 each. The amount o f template DNA used was approximately 5 ng per 
reaction. Negative (no template DNA) and positive (5 ng o f purified genomic 
4 6  DNA from VTEC Oi57:H7 reference strain EDL931) controls were included 
in each experiment. Amplification was performed in a DNA thermal cycler 
(Perkin-Elmer Cetus, Norwalk, CT). The thermal profile involved an initial 
denaturation at 94°C for 5 min followed by 40 cycles o f denaturation at 94°C 
for 1 min, primer annealing at 59°C for 3 min, and primer extension at 72°C 
for 3 min. The final step was a 10 min incubation at 72°C. After amplification, 
15 |il aliquots were analyzed by electrophoresis in 1.5% agarose gels containing 
ethidium bromide (0.1 ^g/ml), visualized by UV transillumination and 
photographed. Molecular mass markers (100-bp ladder; Pharmacia, 
Roosendaal, The Netherlands) were electrophoresed simultaneously.
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Table 2. Primers used for polymerase chain reaction fingerprinting o f verocytotoxin- 
producing Escherichia coli
Primer Nucleotide sequence Percent G + C (Reference)
1247 5'-AAGAGCCCGT-3 ' 60 [2o]
1254 5'-CCGCAGCCAA-3 ' 70 [2o]
1281 5'-AACGCGCAAC-3' 60 [2o]
1283 5'-GCGATCCCCA-3 ' 70 [2o]
1290 5'-GTGGATGCGA-3 ' 60 [2o]
RP1-4 5'-TAGGATCAGA-3 ' 40 [26 2 ]
RP2 5'-AAGGATCAGA-3' 40 [26 2 ]
Soy 5'-AGGTCACTGA-3 ' 50 [489]
HLWL85 5'-ACAACTGCTC-3 ' 50 [2 9 6]
HLWL74 5'-ACGTATCTGC-3 ' 40 [29 6 ]
D8635 5'-GAGCGGCCAAAGGGAGCAGAC-3' 67 [2o]
ERIC1 R 5'-ATGTAAGCTCCTGGGGATTCAC-3' 50 [472]
ERIC2 5'-AAGTAAGTGACTGGGGTGAGCG-3 55 [472]
PCRfingerprinting
PCR fingerprinting ofbacterial DNA (50 ng) was performed in a 50 |il reaction 
volume containing 75 mM TRIS-HCl (pH 9.0), 2.5 mM MgCl2, 20 mM 
(NH4)2SO4, 0.01%  Tween-20, 0.2 mM dNTPs each, 50 pmol o f primer (see 
Table 2 for the primer sequences) and 0.2 U of Taq DNA polymerase 
(Thermoperfectplus DNA polymerase; Integro). A negative control, consisting 
o f the same reaction mixture but with no template DNA added, was included 
in each reaction. A Perkin-Elmer thermal cycler was used for amplification 
running either o f three programs. The cycling program when using 10- 
nucleotide primers was four cycles o f 94°C for 5 min, 36°C for 5 min, 72°C 4 7  
for 5 min, 30 cycles o f 94°C for 1 min, 36°C for 1 min, 72°C for 2 min, and 
then 72°C for 10 min.20 The cycling program when using primer D8635 was 
four cycles o f 94°C for 5 min, 40°C for 5 min, 72°C for 5 min (low stringency 
amplification), 30 cycles o f 94°C for 1 min, 55°C for 1 min, 72°C for 2 min 
(high stringency amplification), and final incubation at 72°C for 10 min.20 The 
primers ERIC1R and ERIC2 required a program consisting o f 35 cycles o f 94°C 
for 1 min, 25°C for 1 min, 74°C for 2 min, preceded by a 5-min incubation at 
94°C and followed by a final extension step at 74°C for 10 min.468 Amplified 
DNA (5 ^l) was separated by gel electrophoresis in 1.5% agarose gels and 
visualized by ethidium bromide staining (0.1 |ig/ml). A molecular size marker 
(100-bp ladder; Pharmacia) was used for reference. Gels were photographed 
and interpretation o f banding patterns was performed by visual inspection.
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Table 3. Characterization o f the human fecal VTEC strains by serotype, verocytotoxin (VT) 
genotype, Escherichia coli attaching-and-effacing (eae) gene, random amplified polymorphic 
DNA-polymerase chain reaction (RAPD-PCR) and phage type
Family Strain Serotype Source b PCR results for c: RAPD Phage Overal.
no. no. a VTi VT2 eae profile d type e type f
I 1 O 57:H 7 HUS patient - + + A 4 1
II 2a O 57:H 7 HUS patient - + + B 4 2
2b O 57:H 7 HUS patient - + + B 4 2
III 3a O i i :H- HUS patient - + - C ND
3b O i i :H- HUS patient - + - C ND
IV 4 O 57:H7 Family contact - + + B 2 3V 5 O 57:H 7 Family contact + + + B 32 4
6 O 57:H 7 Family contact + + + B 32 4
VI 7 O 57:H 7 HUS patient - + + A 4 1
8 O 57:H 7 Family contact - + + A 4 1
9 O 57:H 7 Family contact - + + A 4 1
VII 10 O 57:H 7 Family contact - + + B 2 3VIII 1 1a O 57:H 7 HUS patient - + + B 2 3
11b O 57:H 7 HUS patient - + + B 2 3
11c O 57:H 7 HUS patient - + + B 2 3
12 O 57:H 7 Family contact - + + B 2 3
!3 O 57:H 7 Family contact - + + B 2 3
14 O 57:H 7 Family contact - + + B 2 3IX 15 O 57:H 7 Family contact - + + B 4 2
16 O 57:H 7 Family contact - + + B 4 2
X 17 O 57:H 7 Family contact + + + B 14 5XI 18 O 57:H- Family contact - + + B 4 2
19 O 57:H- Family contact - + + B 4 2
XII 20 O 57:H 7 Family contact - + + B 4 2
21 O 57:H 7 Family contact - + + B 4 2
XIII 22 O 57:H 7 HUS patient - + + B 2 3XIV 23 O 57:H 7 HUS patient - + + B 2 3XV 24 O 57:H 7 HUS patient - + + B 2 3XVI 25 O 57:H- HUS patient (adult) + + + B' 8 6
XVII 26 O 57:H 7 HUS patient - + + B 2 3XVIII 27a O 57:H 7 HUS patient - + + B'' 49 7
27b O 57:H 7 HUS patient - + + B'' 49 7
27c O 57:H 7 HUS patient - + + B'' 49 7
27d O 57:H 7 HUS patient - + + B'' 49 7
27e O 57:H 7 HUS patient - + + B'' 49 7
27f O 57:H 7 HUS patient - + + B'' 49 7
27g O 57:H 7 HUS patient - + + B'' 49 7
28 O 57:H 7 Family contact - + + B'' 49 7
XIX 29 O 57:H 7 HUS patient - + + B 4 2
XX 30 O 57:H 7 HUS patient - + + B 2 3
31 O 57:H 7 Family contact - + + B 2 332 O 57:H 7 Family contact - + + B 2 3XXI 33 O 57:H 7 HUS patient - + + B 2 334 O 57:H 7 Family contact - + + B 2 3XXII 35 O 57:H 7 HUS patient (BEL) - + + B'' 2 8
XXIII 36a O 57:H 7 HUS patient (BEL) - + + B 2 3
36b O 57:H 7 HUS patient (BEL) - + + B 2 3XXIV 37 O 57:H 7 HUS patient (BEL) - + + B 2 3XXV 38 O 57:H 7 HUS patient (BEL) - + + B 4 2
XXVI 39 O 57:H 7 HUS patient (GER) - + + B 4 2
XXVII 40 O 57:H 7 HUS patient (GER) - + + B 54 9XXVIII 41 O 57:H- G astroenteritis patient + + + B' 8 6
a a-g represent sequentially isolated strains from  the sam e person. 
b (BEL), patient from  Belgium; (GER), patient from  Germany. 
c +, positive; -, negative.
d B'-B'' represent similar, but slightly different DNA patterns. 
e ND, not done.
f  Based on VT genotype, RAPD-PCR profile and  phage type.
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R e s u l t s
Phage typing
Among the 50 VTEC isolates o f serogroup O157, seven phage types were 
identified (Table 3). Sequentially isolated O157 VTEC strains from one patient 
(Table 3, no. 2a-2b, iia-iic, 27a-27g, 36a-36b) appeared to belong to the same 
phage type. The same was true for strains which had been isolated from 
different persons within one family. Based on E. coli O157 isolates from separate 
families phage type 2 was the most common (44% of the strains), followed by 
types 4 (33%), 8 (7%), 14 (4%), 32 (4%), 49 (4%), and 54 (4%).
M a  b C d e f  g 5 17 25 41 1 12 3a
m
bp
629 —  
372 — W M W V  ^  W  W
179 — (flfe OSfe 4MI OBh
Figure 1. Determination o f VT and eae genes by PCR. The specific E. coli strains are indicated on 
top. a, enteropathogenic E. coli (O ni:B4; eae); b, JB28 (VTi); c, CLi5A (O ii3:H 2i; VT2c); d, CLi3A 
(Oi45:H-; VTi, eae); e, E325ii (Oi57:H-; VT2c, eae); f, isolate from raw meat (O22:K-; VTi, VT2); g, 
EDL93i (Oi57:H7; VTi, VT2, eae). See Table 3 for details o f strains no. 5-3a. VTi-positive amplification 
resulted in a i79-bp fragment, VT2 in a 372-bp fragment and eae in a 629-bp fragment. M = size 
marker (ioo-bp ladder).
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Amplification of toxin and eae gene sequences
Figure 1 shows the DNA products generated by PCR amplification using the 
primers VT1-1, VT1-2, VT2-1, VT2-2, eae-i and eae-2 in a multiplex PCR assay 
on several strains. Amplification products were generated from positive 
control strains, including a i79-bp fragment for VTi-positive strains (Table 4, 
no. 8, io, ii, i3, i4), a 372-bp fragment for VT2-positive strains (Table 4, no. 
7, 8, io) and a 629-bp fragment for eae-positive strains (Table 4, no. 7, 8, io-
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Table 4. Characterization o f the E. coli control strains by serotype, verocytotoxin (VT) 
production, VT genotype, E. coli attaching-and-effacing (eae) gene and random amplified 
polymorphic DNA-polymerase chain reaction (RAPD-PCR)
Strain no.
(Source or 
reference no.)
Serotype Production o f VT PCR results for a: 
VTi VT2 eae
RAPD profile
1 (chicken heart) O 157 b - - - - F
2 (chicken meat) O 157 b - - - - G
3 (chicken wings) O 157 b - - - - G
4  (sausage) O 157 b - - - - H
5 (raw chicken fillet) O 157 b - - - - H
6 (raw turkey) O 157 b - - - - I
7 (E32 511) O i57:H - VT2 c - + + B'''
8 (EDL9 31) O i57:H 7 VTi+VT2 + + + B'''
9 (-) O 157 b - - - - J
10  (H30 C5) O iii:H - VT2 + + + K
1 1  (CL37A 1) O iii :H 8 VTi + + K
12  [EPEC] c O iii:B 4 - - - + L
13 (CLi 9) O2 6 :H ii VTi + - + M
i4  (H i 9 ) O2 6 :H ii VTi + - + N
a +, positive; -, negative. 
b Sorbitol- and  ß-glucuronidase-positive. 
c EPEC, enteropathogenic E. coli.
14). The E. coli O iii:H - control strain no. 10 previously identified by 
neutralization assays as a VT2-producer, also appeared to contain VTi gene 
sequences. No amplification occurred when PCR was performed with negative 
5 0  controls (Table 4, no. 1-6, 9). Of the 50 human O157 VTEC isolates characterized 
in this study, 45 were positive for the VT2 gene only and five were positive for 
both VTi and VT2 genes (Table 3). Sequentially isolated O157 VTEC strains 
from the same patient (Table 3, no. 2a-2b, iia-iic, 27a-27g, 36a-36b), and VTEC 
strains which had been isolated from different persons within one family 
showed the same toxin profile. Based on isolates from separate families, 21 of 
the 23 VT2-positive E. coli O157 isolates were characterized by the predominant 
phage types 2 and 4. The two remaining VT2-positive O157 VTEC strains (Table
3, no. 27a-28, 40) and the four O157 VTEC positive for both VTi and VT2 were 
characterized by the less frequently encountered phage types 8, 14, 32, 49 and 
54. All 50 O157 VTEC strains contained the eae gene sequences. The two 
Oiii:H- strains (Table 3, no. 3a, 3b) were only positive for the VT2 gene. Negative 
PCR results were obtained for VTi and eae gene sequences.
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Figure 2. Random amplified polymorphic DNA-polymerase chain reaction o f hum an fecal 
verocytotoxin-producing E. coli. Numbers indicate the isolates and letters are RAPD-PCR profiles, 
as described in Table 3. Strains isolated from the same family are underlined. M = size marker (100- 
bp ladder). *, Serratia marcescens; * *  E. coli O2:K-.
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Figure 3. Random amplified polymorphic 
DNA-polymerase chain reaction o f the E. coli 
control strains. Numbers indicate the 
isolates and letters are RAPD-PCR profiles, 
as described in Table 4. Isolates o f the same 
serotype are underlined. M = size marker 
(100-bp ladder).
5 2  PCR fingerprinting
PCR fingerprinting was initially performed with the 13 different primers (Table 
2) on a random selection of 10 E. coli O157 strains in a pilot experiment. The 
primers were used either as a single or a pairwise combination. Primer 1247 
gave the highest resolution and was therefore used for all strains listed in Tables
3 and 4. Each DNA preparation was tested in duplicate to ascertain the 
reproducibility o f the PCR. Figures 2 and 3 show the random amplified 
polymorphic DNA-PCR (RAPD-PCR) profiles obtained for the 52 VTEC 
isolates and the 14 controls, respectively. Banding patterns were coded by letters 
A-N, also reported in Tables 3 and 4. Genotypic codes B-B''' represented similar 
but slightly different DNA banding patterns. Profile B shared four bands with 
the banding patterns referred to as B', B'' and B''': one major band at 1000 
bp, a minor band at 680 bp and two minor bands near 340 bp. Profile B' was
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characterized by a major band at 1200 bp. Whereas profiles B and B' showed 
two minor bands in between 800 and 900 bp, profiles B'' and B''' did not. 
Profile B'' was further characterized by one major band at 830 bp, and profile 
B''' by the absence o f a minor band near 600 bp. Figure 3 demonstrates that 
strains o f different serotypes generated clearly distinct fingerprints. 
Furthermore, within a single serogroup different genotypes were encountered. 
Among the nine E. coli O157 isolates presented in Table 4, six distinct 
fingerprints were identified: the two VTEC strains no. 7 and no. 8 shared the 
same banding pattern, whereas for the seven VT-negative O157 strains five 
different patterns were obtained. The VT-negative isolate no. 12 stood apart 
from the VTEC isolates no. 10 and no. 11 (Table 4), though all three isolates 
belonged to serogroup O iii. Although VTEC isolates no. 13 and no. 14 (Table 
4) both belonged to serogroup O26, each produced distinct RAPD-PCR 
profiles. DNA fingerprints o f the O157 VTEC strains isolated from the HUS 
patients, from their relatives and from the patient with bloody enteritis 
showed highly monomorphic patterns (Fig. 2). Based on the fingerprint 
patterns, the collection o f 50 isolates could be divided into four different groups:
A, B, B' and B''. Sequentially isolated O157 VTEC strains from one patient (Table
3, no. 2a-2b, iia-iic, 27a-27g, 36a-36b), as well as strains which had been 
isolated from different persons within one family showed the same banding 
patterns. Based on isolates from separate families, fingerprint profile B was 
observed for 21 (79%) o f the 27 O157 VTEC isolates, followed by profiles B',
B'' and A each for 2 (7%) o f the strains. The B, B' and B'' profiles were highly 
similar to the B''' profile produced by the O157 VTEC reference strains (Table
4, no. 7, 8). Some strains which were different by phage typing and VT 
genotyping could not be discriminated by RAPD-PCR fingerprinting, for 
example strains no. 4 and no. 17 (Table 3). However, some strains discriminated 
by RAPD-PCR fingerprinting could not be discriminated by phage typing nor 
by VT genotyping, for example strains no. 1 and no. 29 (Table 3). Combining
the results o f all typing methods used, the collection o f 50 O157 VTEC strains 53 
could be divided into nine distinct groups (see the right part o f Table 3). It has 
to be remembered that these 50 strains were isolated from 27 families. The 
two O iii VTEC strains (Table 3, no. 3a, 3b) showed a unique banding pattern, 
encoded by the letter C.
D i s c u s s i o n
The predominant phage types identified among the O157 VTEC isolates 
characterized in this study correspond with the observation by Frost and co- 
workers.145 Among a total o f 1092 O157 VTEC strains isolated in the United 
Kingdom between 1989 and 1991, they identified types 2 (36.1%), 49 (29.6%),
1 (10.3%) and 4 (8.9%) the most frequently. Frost and colleagues145 also
observed that strains o f phage types 2 and 49 carried only VT2 genes. It is 
remarkable that, unlike phage types 2 and 4, O157 VTEC phage type 49 has 
not been reported from North America.243
The O157 VTEC isolates were also tested for their cytotoxicity by using the Vero 
cell assay (unpublished observations). Culture filtrates o f all strains were 
neutralized by antibodies to VT2 only. PCR revealed that five o f the O157 VTEC 
isolates contained VTi gene sequences in addition to VT2 gene sequences. A 
possible explanation for the failure to detect VTi in neutralization assays while 
PCR yielded positive results for the VTi gene, might be that the VTi gene does 
not become expressed. On the other hand, it has been observed that when both 
toxins are produced by the same strain, VTi predominates in cell lysates and 
VT2 was the more active toxin in supernates.429 Therefore, it might be 
possible that VTi titers in culture supernates were too low to be detected in 
neutralization assays. The higher prevalence o f infection among HUS patients 
with VTEC producing only VT2 than infection with VTEC producing either 
only VTi or a combination o f VTi and VT2, is consistent with other studies 
carried out in Western Europe and North America.227,246 However, Rowe and 
co-workers383 recently found that 22 o f the 26 0 15 7 ^ 7  VTEC isolates from 
Canadian HUS patients produced both VTi and VT2 rather than VT2 only. 
All O157 VTEC strains contained eae-specific DNA sequences. The presence 
o f the eae gene has been closely associated with O157 VTEC that caused HUS 
and is assumed to be a virulence marker.32,44,277,490 Our results strongly support 
this suggestion. Since spontaneous loss o f VT genes during cultivation of 
human E. coli strains has been documented,224 the eae gene is possibly an even 
more reliable marker than the VT genes. The eae gene is responsible for 
intimate attachment to and effacement o f the intestinal epithelial cell microvilli, 
leading to damage o f the epithelium.119 This would allow the passage of 
bacterial products which are normally excluded from the circulation. It is not 
yet clear why the family members o f the HUS patients did not develop HUS, 
5 4  although they had been colonized with VTEC strains positive for the eae gene. 
The two E. coli O iii strains appeared to be negative for the eae gene. It is known 
that the eae gene is not always present in VTEC of serogroups other than 
O157.491 The possibility exists that the HUS patient, from who the E. coli O iii 
strains had been isolated, was simultaneously infected with a second VTEC 
positive for the eae gene. Co-infection with two different serotypes o f VTEC 
has been reported before.246,378,404
Since E. coli Oi57:H7 and E. coli Oi57:H- are increasingly implicated in human 
diseases, a single and reliable method to compare these strains is needed. A 
good epidemiological typing scheme could assist in elucidating the routes of 
transmission o f these pathogens. Recently, PCR-based fingerprinting has been 
successfully used to study relatedness among epidemic isolates o f various 
species as reviewed by Van Belkum.467 This typing method uses a single or a 
pairwise combination o f primers to amplify target genomic DNA by PCR,
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resulting in specific arrays o f DNA products. Recently, Wang and co-workers477 
applied RAPD-PCR to a limited number o f O157 VTEC strains using five 
different arbitrary primers. In contrast to Wang and colleagues we did not find 
the highest resolution with primer 1290, but with primer 1247. Although the 
isolates were obtained from different cases o f HUS during a prospective study 
and no contacts between the infected persons except for family contacts were 
present, genetic homogeneity in the O157 VTEC isolates was observed by 
RAPD-PCR fingerprinting. The collection o f 50 O157 VTEC rendered only four 
different fingerprint patterns. Fingerprint profile B was obtained for 35 o f the 
isolates. It was considered very similar to the patterns produced by the O157 
VTEC reference strains E32511 and EDL931, which had been isolated in Britain 
and the USA respectively. The minor variations between the B, B', B'' and B''' 
patterns might be due to different sites o f integration o f phages into the 
bacterial chromosome. As group, fingerprint profiles B-B''' were obtained for
27 (93%) o f the 29 O157 VTEC strains tested (based on independent isolates; 
including the two reference strains E32511 and EDL931). It has to be 
emphasized that the primer with the highest resolution was used. Some O157 
VTEC isolates produced a clearly different banding pattern, referred to as A.
These findings suggest that the isolates were distinct from the strains 
producing profiles B-B''', because it is highly unlikely that such different 
patterns have arisen by phage integration at a different site. The homogeneous 
DNA fingerprints observed in the present study for VTEC o f serotypes
Oi 57:H7 and Oi 57:H- correspond with previously reported studies on analysis 
o f chromosomal DNA o f these pathogens using multilocus enzyme 
electrophoresis and pulsed-field gel electrophoresis.56,484-486 A recent clonal 
expansion from a common progenitor strain has been suggested.486 However, 
some authors have reported that epidemiologically independent O157 VTEC 
strains could be differentiated using pulsed-field gel electrophoresis or 
restriction fragment length polymorphism (RFLP).»,35°,391
Based on the combined results o f phage typing, VT genotyping and RAPD- 55 
PCR fingerprinting, the collection o f 50 O157 VTEC strains (isolated from 27 
families) could be divided into nine distinct groups. Considering the phage 
typing and RAPD-PCR results of the present study and published data on typing 
o f O157 VTEC, it seems likely that V tEC  of serotypes Oi57:H7 and O 157 H  
are members o f a single clone that has become widely distributed. Although 
the genomic DNA appears to be highly conserved, minor variations may occur 
by the integration o f phages into the bacterial chromosome.
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Verocytotoxin-producing Escherichia coli infection in 
household members of children with hemolytic-uremic 
syndrome in the Netherlands
Chapter
Summary
Strains o f verocytotoxin-producing Escherichia coli (VTEC) belonging to 
serogroup O157 (O157 VTEC) can cause a spectrum of disease that includes 
nonspecific diarrhea, hemorrhagic colitis and the diarrhea-associated form of 
the hemolytic-uremic syndrome (D+ HUS). We conducted a retrospective study 
o f 34 children with D+ HUS caused by O157 VTEC to determine the frequency 
o f VTEC infection in their household members. Gastrointestinal tract 
symptoms were reported in one or more household contacts o f 17 (50%) of 
the 34 index cases. Of the 26 household members with gastrointestinal tract 
symptoms, 15 were parents and 11 were siblings. Evidence o f VTEC infection 
was reported in one or more household contacts in 23 (68%) o f the 34 families 
(in 46%  of the siblings and in 28% of the parents). Nineteen (48%) siblings 
had a positive stool sample and in only five (12%) o f the siblings IgM-class 
serum antibodies to O157 lipopolysaccharide (LPS) were detected. Nineteen 
(31%) parents had a positive stool sample. Antibodies to O157 LPS were not 57 
detected in any o f the parents. The occurrence o f (bloody) diarrhea significantly 
correlated with the occurrence o f IgM-class serum antibodies to O157 LPS. It 
was concluded that household members o f children with D+ HUS are often 
asymptomatically infected with O157 VTEC. Differences in the pathogenesis 
o f the infection between infected individuals may be related to differences in 
the number ofingested O157 VTEC bacteria and to differences in susceptibility.
A.E. Heuvelink, N.C.A.J. van de Kar, T.J.A.M. van der Velden, H. Chart, and 
L.A.H. Monnens.
Pediatric Infectious Disease Journal 1999; 18:709-714.
I n t r o d u c t i o n
Hemolytic-uremic syndrome (HUS), characterized by the triad 
microangiopathic hemolytic anemia, thrombocytopenia and acute renal 
insufficiency, is the most common cause o f pediatric renal failure in developed 
countries.370 Two major subgroups o f HUS have been identified, typical and 
atypical. By far the most common is the typical or epidemic form which follows 
a prodromal illness o f acute gastroenteritis, frequently with bloody diarrhea, 
and which is also referred to as D+ HUS. Most patients recover with appropriate 
supportive therapy, but up to 5% o f affected children die o f the acute illness 
and an additional 5% have severe chronic sequelae o f renal impairment or 
neurologic injury.413
HUS was first described in 1955,153 although the etiology was not known. In 
1983 Karmali et al.234 first associated D+ HUS and verocytotoxin (VT)- 
producing Escherichia coli (VTEC). During recent years it has emerged that 
-9 0 %  of cases o f D+ HUS are caused by VTEC and that VTEC belonging to 
serogroup O157 (O157 VTEC) are responsible for as much as 70% of all cases 
o f D+ HUS in North America and Western Europe.370 The spectrum of clinical 
manifestations o f O157 VTEC infection is broad. O157 VTEC can cause 
asymptomatic infection, nonbloody diarrhea, hemorrhagic colitis (HC) and 
HUS. Approximately 10%  of those with clinically apparent O157 VTEC 
infection develop HUS.438 Risk factors for the development o f D+ HUS are 
age (children younger than 5 years and elderly people) and the use o f 
antimotility agents or antidiarrheal agents.94 The pathogenesis o f O157 VTEC 
infection is not yet fully understood. The formation o f attaching-and-effacing 
lesions in the intestinal mucosa o f the host, the expression o f VTs and the 
production o f enterohemolysins are considered to be key virulence factors 
expressed by strains o f O157 VTEC.354
The primary mode o f O157 VTEC infection is foodborne transmission. Many 
5 8  outbreaks and cases o f O157 VTEC infection could be traced to the consumption 
o f foods o f bovine origin, especially undercooked ground beef and 
unpasteurized cow's milk.431 The natural reservoir o f O157 VTEC and other 
VTEC is the intestinal tract o f domestic animals, particularly cattle.27 Direct 
transmission from infected animals to humans has also been reported.431 A 
third mode of O157 VTEC infection is person-to-person transmission, which 
has occurred in institutional settings such as hospitals, nursing homes and 
day-care centers and among family members.431 The infectious dose for O157 
VTEC is very low, with illness occurring after ingestion o f <100 organisms.354 
Infection with VTEC of serogroup O157 is the predominant cause o f D+ HUS 
in childhood in the Netherlands.469 Since 1989 data have been collected on 
the occurrence ofVTEC infection in household members o f children with D+ 
HUS treated at the University Hospital Nijmegen. This paper describes the 
results o f a retrospective study o f all children with D+ HUS, conducted to
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determine the frequency o f VTEC infection in household members o f children 
with D+ HUS caused by O157 VTEC. The paper includes data published 
previously.469
M e t h o d s
We reviewed the medical records o f all patients with D+ HUS who were treated 
at the pediatric nephrology department o f the University Hospital Nijmegen 
between September, 1989, and September, 1997. Thirty-four patients had 
evidence o f infection with O157 VTEC.
For each o f these patients and for the household members who lived in the 
same house with the HUS index case, the following data were recorded: sex, 
age, presenting symptoms (patients), gastrointestinal tract symptoms 
(household members) and results o f microbiologic examination for VTEC 
infection. As soon as possible after admission stool samples had been collected 
from patients as well as from their household contacts. To determine the 
presence o f VT in the specimens, the cytotoxic activity o f both stool extracts 
[free VT (FVT)] and culture broth filtrates was assayed on Vero cells.232 
Furthermore stool samples were streaked onto sorbitol MacConkey agar to 
isolate O157 VTEC strains.469 Non-sorbitol-fermenting strains o f E. coli O157 
were examined for the presence o f three main virulence-associated genes, VTi,
VT2 and E. coli attaching-and-effacing (eae) gene loci, and for toxin 
production.186 The patients and their household members had also been tested 
for serum antibodies o f the IgM-class binding to the lipopolysaccharide (LPS) 
o f E. coli O157 by ELISA and immunoblotting.92 Serum samples were taken 
on admission and when possible also after 2 to 3 weeks (convalescent phase).
The significance o f differences between the microbiologic test results of 
patients, parents and siblings was calculated by the Mantel-Haenszel test, 
taking into account the possibility o f clustering o f individual person effects 5 9  
with families that were taken as strata in the Mantel-Haenszel test. Logistic 
regression analysis for dependent observations with the method of generalized 
estimating equations was carried out to determine the dependence o f the 
presence o f antibodies to O157 LPS on the occurrence o f gastrointestinal 
symptoms and age.
R e s u l t s
Of the 34 patients enrolled in the study 18 were female and 16 were male. The 
mean age (± SD) ofthe patients was 46 (± 27) months (range, 10 to 129 months);
82% o f the patients were under 5 years o f age. All 34 patients presented with 
microangiopathic hemolytic anemia, thrombocytopenia and disturbed renal
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Table 1. Evidence o f VTEC infection in 34 patients with the diarrhea-associated form o f the 
hemolytic-uremic syndrome and their household members
Method No. o f patients No. o f siblings No. o f parents
Feces
positive positive positive
VT activity stool filtrate 21/33  (6 4 ) a,b  [2 0 /32] c 17/40  (43) [16 /38] 16/62  (2 6) [i5/56]
VT activity cu ltu re filtrate 13/33 (39 ) [12 / 32] 18/40  (45) d  [17 /38] 15/62  (24 ) [14 /56]
Isolation o f  O 157 VTEC 10/33  (30 ) [9 /32] 12/40  (30 ) [1 1 /38] 11/6 2  (l8) [10 / 56]
Total
Serology
25/33 (76) e [24 / 32] 19/4 0  (48 ) [18 / 38] 19/62  (31) [18 /5 6 ]
D etection o f  IgM-class antibodies 
to O 157 LPS
3: / 33 (9 4 ) f  [30 /32] 5/42 (12 ) g  [5/38] 0/62  (0 ) [0 /56]
Total VTEC infection
a P  < 0 .0 1  com pared  w ith  paren ts. 
b N um bers in  paren theses , percen t.
34/34  (10 0 ) [32/32] 2 0 /4 4  (4 6) [i 9/38] 19/68  (28 ) [18 /56]
c N um bers  in  brackets, n u m b e r  o f  individuals positive/to tal n u m b e r  o f  individuals w ith  com plete fecal an d  serologic 
exam ination .
d P < 0.05 com pared  w ith  paren ts.
e P  < 0 .0 1  com pared  w ith  siblings an d  P < 0 .0 0 1  com pared  w ith  paren ts . 
f  P < 0 .0 0 0 1  com pared  w ith  siblings a n d  paren ts . 
g  P  < 0.05 com pared  w ith  paren ts.
function and had a prodromal phase o f acute gastroenteritis. Bloody diarrhea 
was observed in 32 (94%) patients.
One hundred fifteen household members who lived in the same house with 
the D+ HUS index case were enrolled. Sixty-two (54%) were male and 53 (46%) 
6 0  were female; 34 were mothers, 33 were fathers, 47 were siblings (29 brothers 
and 18 sisters) and one was an aunt with whom the index case was staying at 
the time o f admission to the hospital. Forty-seven percent o f the siblings were 
younger than 5 years. Gastrointestinal tract symptoms were reported in one 
or more household contacts o f 17 (50%) o f the 34 index cases, occurring at the 
time of admission or 1 week before admission o f the D+ HUS patient to the 
hospital. O f the 26 household members with gastrointestinal tract symptoms, 
15 were parents (9 fathers and 6 mothers) and 11 were siblings (5 brothers and
6 sisters). Although none o f the 15 parents had bloody diarrhea, in 8 (73%) of 
the 11 siblings the diarrhea was bloody.
The results o f microbiologic examination o f stools and sera for evidence of 
VTEC infection are summarized in Table 1. Complete fecal and serologic 
examination was performed for 32 patients, 38 siblings and 56 parents. No 
stool sample had been collected from one o f the 34 D+ HUS patients, and no
Chapter 3 -  VTEC infection in household members
serum sample was obtained from another patient. From 3 o f the 47 siblings 
no stool or sera had been collected. All strains o f E. coli O157 isolated were 
positive for VT2 and eae gene sequences. The isolates from two families 
additionally contained VTi gene sequences. All strains demonstrated 
cytotoxicity in the Vero cell assay.
Nine patients were positive for VT-activity in both stool and culture filtrates, 
including 6 of the 10 patients whose stool cultures were positive for O157 VTEC.
Of the remaining 4 patients with positive stool cultures for O157 VTEC, 3 
additionally had VT-positive culture filtrates and 1 additionally was positive for 
FVT. Antibodies to O157 LPS were present in 31 (94%) o f the 33 D+ HUS 
patients tested. Twenty-nine (94%) o f these 31 patients had bloody diarrhea.
The 2 patients for whom no positive serologic response was observed both had 
bloody diarrhea. One ofthese two patients tested positive in all three fecal assays 
and the other tested positive only in the Vero cell assay having both VT-positive 
culture and VT-positive stool filtrates. Although the latter patient had no direct 
evidence o f infection with VTEC of serogroup O157, these pathogens were 
isolated from two household contacts o f the child. From the remaining patient 
with bloody diarrhea, no serum sample had been collected. This patient tested 
positive in all three fecal assays.
In 23 (67%) o f the 34 families one or more household members had evidence 
o f VTEC infection at the time the patient was admitted to the hospital: in 10 
families one or both parents as well as one or more siblings were positive; in
7 families only one o f the siblings was positive and both parents were negative; 
in 3 families one o f the parents was positive and all siblings were negative; and 
in the remaining 3 families one o f the parents was positive and no data were 
recorded for siblings (two patients had no siblings and no microbiologic tests 
were done for the siblings o f the third patient). Overall evidence o f VTEC 
infection was more prominent in the siblings (46%) than in the parents (28%) 
o f the patients (Table 1). Sixteen o f the 20 positive siblings were positive for 
detection o f VT in both stool and culture filtrates, including the 12 siblings 6 l  
from whom O157 VTEC strains were isolated. Antibodies to O157 LPS were 
present in 5 (12%) o f the 42 siblings tested. These siblings were 1, 2, 4 and 6 
(n = 2) years o f age and all had diarrhea. From 4 o f these 5 siblings also O157 
VTEC strains were isolated and 3 o f them had bloody diarrhea. The stool sample 
from the youngest sibling with a positive serologic response tested negative 
in all three fecal assays performed, and no blood was observed in the diarrheal 
stool sample. O f the other 5 siblings for whom bloody diarrhea was recorded,
2 had O157 VTEC strains in their stool specimens and 1 had VT-positive stool 
and culture filtrates, whereas no microbiologic data were available on the other 
2. The remaining sibling with watery diarrhea had VT activity in both stool 
and culture filtrates. O f the 16 families with positive microbiologic findings 
for one or both ofthe parents, in 3 families both father and mother had evidence 
o f VTEC infection, in 6 families only the father was positive, in another 6
families only the mother was positive and in the remaining family the mother 
was negative and the aunt with whom the child was staying was positive. Twelve 
o f the 19 positive parents (including the aunt) were positive for detection of 
VT activity in both stool and culture filtrates, including 9 o f the 11 parents whose 
stool cultures were positive for O157 VTEC. O f the remaining 2 parents with 
a positive stool culture for O157 VTEC, one additionally was positive for FVT 
and the other additionally had a VT-positive culture filtrate. In none o f the 
parents antibodies to O157 LPS were detected. The majority (67%) o f the 15 
parents with gastrointestinal tract symptoms had no evidence o f infection with 
VTEC. For only 5 o f the 15 parents VTEC infection was proven: one was positive 
for the detection o f VT activity in both stool and culture filtrates as well as for 
the isolation o f O157 VTEC; another one had VT-positive stool and culture 
filtrates; two only had VT-positive culture filtrates; and the remaining one was 
positive only for FVT.
The presence o f antibodies to O157 LPS in patients and siblings correlated 
significantly with the occurrence o f (bloody) diarrhea (P < 0.001), independent 
o f the age (younger/older than 5 years) o f the children.
D i s c u s s i o n
In recent years O157 VTEC have emerged as an important cause o f HC and 
D+ HUS. Most infections are acquired through the ingestion o f contaminated 
food; however, because o f the low infectious dose the organisms can be 
transmitted efficiently from person to person. Several approaches can be used 
to provide evidence o f infection with VTEC, including the examination of 
patients' stools for the presence o f VTEC and VT and examination for the 
presence o f serum antibodies to VT or LPS. Because patients usually clear 
VTEC from their gastrointestinal tracts rapidly, stools must be examined early 
6 2  in the course o f pathogenesis to maximize the detection o f VTEC. Tarr et al.441 
reported that the isolation rate o f O157 VTEC was 100%  for fecal specimens 
collected 2 days after the onset o f symptoms. The isolation rate was 91.7% on 
days 3 to 6 and 33.3% after 7 days o f diarrhea. HUS usually develops about 1 
week after the onset o f diarrhea; therefore the chances o f isolating the 
pathogens from the patients' stool samples are reduced significantly. However, 
prolonged fecal shedding o f O157 VTEC has been observed.37,22« 41,407 Young 
children seem to carry the organisms longer than older children and adults.341 
In addition to the rapid clearance the isolation o f VTEC from stools may be 
difficult because o f the excretion o f only low numbers and the intermittent 
shedding o f bacteria. Because the toxins generally persist longer in the stool 
than the viable bacteria, methods based on the detection o f FVT are more 
sensitive than culture o f VTEC organisms. VT serology appears not to be 
suitable for diagnosing a recent VTEC-associated illness. Antibody responses
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to VTs are uncommon after a primary infection and appear to require booster 
exposures to VTEC infection to become manifest.228 Therefore in countries 
with low exposure to VTEC, the detection ofVT-specific antibodies is generally 
hampered by low sensitivity,31,52,165,233,374,469 and in countries with a high 
prevalence rate o f VTEC infection, VT serology lacks specificity.379 Although 
the diagnostic significance o f examination o f patients' sera for antibodies to 
VTs remains questionable, methods used to measure serum antibodies to the 
LPS o f VTEC strains are o f great value in diagnosing D+ HUS in children. 
Antibody response to the O157 LPS antigen can often be detected in the first 
several months after D+ HUS.92
In this study the frequency o f VTEC infection in household members of 
children with D+ HUS caused by O157 VTEC was determined. Combined fecal 
and serologic examination provided evidence o f VTEC infection in one or more 
household members in 23 (68%) o f the 34 families studied. VTEC infection 
in siblings and parents o f children with D+ HUS has also been reported by 
others.30,103,149,229,276,281,379 However, the referred studies differ from the 
present study by either investigating only a single or a few cases o f D+ HUS 
or not performing combined fecal examination and LPS serology. The sources 
o f the infectious agents have not been identified. It is possible that infection 
occurred after simultaneous exposure o f several household members to a 
common foodborne source or that a single member was infected outside the 
home with subsequent spread of the organisms from person to person within 
the family. A higher rate o f infection was found in siblings (46%) than in 
parents (28%). The majority o f the parents (74%) and siblings (55%) with 
evidence o f VTEC infection were infected asymptomatically. On the other hand
10 parents had diarrhea at the time o f admission or 1 week before admission 
o f the D+ HUS patient to the hospital whereas no evidence o f VTEC infection 
was proven.
For the D+ HUS index cases the detection o f IgM antibodies to O157 LPS was 
the most successful method of providing evidence o f infection; however, in 6 3  
their respective infected household members stool examination provided 
evidence o f VTEC infection more often than LPS serology. Only five siblings 
had antibodies to O157 LPS, and elevated IgM antibody levels to O157 LPS were 
not detected in serum samples from infected parents.
Illness is a function o f both exposure and susceptibility to a given pathogen. 
Humans can become exposed to O157 VTEC strains via ingestion o f 
contaminated food or water and via contact with infected persons or animals. 
Experimental infection o f infant rabbits demonstrated that strains o f O157 
VTEC were capable o f causing severe diarrhea in a dose-dependent fashion.342 
With inoculum doses o f 10 10 (n = 6 rabbits), 10 9 (n = 5) and 10 8 (n = 13) bacteria 
o f O157 VTEC, the rabbits developed severe diarrhea consistently. O f the 5 
rabbits inoculated with 10 7 bacteria o f O157 VTEC, 2 rabbits developed severe 
diarrhea and the remaining 3 rabbits developed mild diarrhea. Only 2 o f the
5 rabbits inoculated with 10 6 bacteria developed diarrhea; one had severe 
diarrhea and the other had mild diarrhea. With an inoculum dose o f 10 5 
bacteria, mild diarrhea was observed for only 1 o f the 3 inoculated rabbits. 
Similarly studies with experimentally infected mice demonstrated that lethality 
for mice was related to the O157 VTEC dose.146 O f 10 mice inoculated with 1.2 
x 10 10 bacteria o f O157 VTEC and 10 mice inoculated with 1.2 x 10 9 bacteria,
8 and 3 mice died, respectively. When mice were inoculated with 4.0x 10 8 (n 
= 10) and 1.2 x 107 (n = 10) bacteria, none o f them died. In the present study 
the differences in the pathogenesis o f the O157 VTEC infections between 
infected individuals within a family also may be related to differences in the 
ingested dose o f the infectious agents. In the case o f simultaneous exposure 
to a common food source, the mass o f ingested product may have varied for 
the individual household members and the bacteria may not have been 
homogeneously distributed in the product. Furthermore differences in the 
pathogenesis o f infection may be explained by differences in susceptibility. The 
more frequent development o f the more serious manifestations o f infection 
in young children than in older children and in adults may possibly be related 
to yet unknown age-related factors in the intestine, which are involved in 
making it more easier for O157 VTEC strains to colonize the intestinal mucosa 
and deliver their toxins to the circulation.
In summary family contacts o f children with D+ HUS are often 
asymptomatically infected with O157 VTEC. Knowledge o f infection o f close 
contacts o f D+ HUS patients is important so that control measures can be taken 
to limit secondary person-to-person spread. Diarrhea was significantly 
correlated with the presence o f serum IgM-class antibodies to O157 LPS. A 
striking observation was the lack o f an antibody response in infected parents. 
Differences in pathogenesis between infected individuals may have resulted 
from differences in the number o f ingested O157 VTEC bacteria. In addition 
a difference in adherence o f O157 VTEC strains to the intestinal epithelium 
6 4  o f adults and children might be a possible reason for the increased susceptibility 
o f young children to the development o f HC and D+ HUS.
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Occurrence of Escherichia coli O157 and other 
verocytotoxin-producing E. coli in retail raw meats in 
the Netherlands
Chapter
Summary
Raw meats obtained from retail outlets in the Netherlands were examined for 
the presence o f Escherichia coli o f serogroup O157 and other verocytotoxin (VT)- 
producing E. coli (VTEC), in three different surveys. In the first survey O157 
VTEC were detected and isolated by selective plating onto sorbitol MacConkey 
agar following selective enrichment in modified tryptone soy broth with 
acriflavin. The organisms were isolated from 2 (0.3%) of 770 samples o f minced 
mixed beef and pork, but not detected in samples o f raw minced beef (n =
1,000), minced pork (n = 260), or poultry products (n = 300). In the second 
survey an additional 360 raw meats were examined with the 3M Petrifilm™
Test Kit-HEC, after selective enrichment in modified E. coli broth containing 
novobiocin. VT-negative E. coli O157 strains were isolated from 22 (6.1%) 
samples. In the third survey 180 enrichment cultures o f the first survey were 
screened for the presence o f VTi and VT2 genes with a polymerase chain 
reaction (PCR). Twenty-nine (16.1%) o f the 180 enrichment cultures showed 6 5  
a positive PCR: 1 for the VTi gene only, 17 for the VT2 gene only, and 11 for 
both the VTi and VT2 gene. A total o f 46 VTEC strains were isolated from 10 
randomly selected PCR-positive samples. Serotyping revealed that 41 o f the 
46 VTEC isolates belonged to nine different O serogroups; the remaining 5 
were unidentifiable. A number o f the serogroups recovered have been 
associated with human disease.
A.E. Heuvelink, K. Wernars, and E. de Boer. 
Journal of Food Protection 1996; 59:1267-1272.
I n t r o d u c t i o n
Strains o f Escherichia coli that produce a cytotoxin active on Vero cells, named 
verocytotoxin (VT), are implicated in the pathogenesis o f hemorrhagic colitis 
(HC) and the diarrhea-associated form (D+) o f hemolytic-uremic syndrome 
(HUS).220 These strains produce at least two distinct toxins, VTi and VT2. The 
toxins are produced either singly or in combination, and are encoded by 
bacteriophages. In the past few years, several variants ofVT2 (VT2c) have been 
identified.450 Although VT-producing E. coli (VTEC) strains o f serotype 
Oi57:H7 are most frequently isolated from stools o f patients with HC or D+ 
HUS, numerous other serotypes have been identified from clinical cases.227 
Foods o f animal origin (undercooked ground beef, unpasteurized milk) are 
probably the major sources o f VTEC infection in man. Domestic animals, 
particularly cattle, are considered to be an important reservoir o f VTEC.227 
During a 4-year prospective study from September 1989 till September 1993 
the presence ofVTEC infection in 113 children with D+ HUS from the academic 
hospitals in the Netherlands (n = 77), one university hospital in Germany 
(Cologne) (n = 21) and two in Belgium (Leuven and Antwerpen) (n = 15) was 
examined.469 Stool examination for VTEC and for free fecal VT combined with 
examination o f sera for antibodies to the lipopolysaccharide o f E. coli O157 
demonstrated a VTEC infection in 88 (78%) patients. VTEC of serogroup O157 
(O157 VTEC) were the causative agent in 76 (86%) o f these 88 patients. 
Cytotoxicity o f culture filtrates o f the isolated O157 VTEC strains was 
neutralizable with antibodies to VT2 only. No further investigation was done 
to identify the VTEC strains o f serogroups other than O157. In the Netherlands, 
the sources o f the infectious agents in sporadic cases o f D+ HUS have not been 
defined. Also, no information is available about the occurrence o f VTEC in 
the human population in the Netherlands.
The purpose o f this study was to obtain information about the occurrence of 
6 6  VTEC, particularly those o f serogroup O157, in raw meats obtained from retail 
outlets in the Netherlands. The study consisted o f three different surveys, each 
with a different method of detection and isolation. In the first survey O157 VTEC 
were detected and isolated by selective plating onto sorbitol MacConkey agar 
(SMAC), following selective enrichment in modified tryptone soy broth with 
acriflavin (mTSB + a). In the second survey the 3M Petrifilm™ Test Kit-HEC 
was used for the detection and isolation o f E. coli o f serogroup O157, following 
selective enrichment in modified E. coli broth with novobiocin (mEC + n). In 
the third survey VTEC of all serogroups were detected and isolated by a 
polymerase chain reaction (PCR) for the VT genes, following enrichment in 
mTSB + a.
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M a t e r i a l s  a n d  m e t h o d s
Meat samples
During the period October 1992 until September 1995, samples o f raw 
minced beef (n = 1,000), mixed beef and pork (n = 770), pork (n = 260) and 
raw poultry products (n = 300) were examined for the presence o f O157 VTEC 
by using the plating method. A random selection o f these samples (n = 180) 
was also examined with the PCR technique to determine the presence o f VTEC 
of all serogroups. In the same period, an additional 360 samples o f raw meats, 
comprising minced beef (n = 201), chicken products (n = 110), and minced 
pork (n = 49), were tested for E. coli O157 by using the 3M Petrifilm™ Test Kit- 
HEC. All the meats examined in this study were obtained from retail outlets 
and kept at 0 to 4°C during transport to the laboratory. They were stored either 
at 2°C for up to a maximum of 24 h or at -20°C  for up to a maximum o f 4 
weeks. The frozen meats were thawed at 2°C the day before examination.
Detection and isolation ofO t^j VTEC using the plating method
A 20-g portion o f each meat sample was added to 180 ml o f modified tryptone 
soy broth containing acriflavin (final concentration, 10 |ig/ml) (Sigma Chemical 
Co., St. Louis, MO) (mTSB + a).245 After homogenization in a stomacher for
1 min, the samples were incubated overnight at 37°C on a rotary shaker (100 
rpm). Each enrichment culture was serially diluted tenfold to 10 -6 in 0.1% 
peptone water, and 0.1-ml volumes o f the 10 -5 and 10 -6 were spread plated onto 
sorbitol MacConkey agar (Oxoid Ltd., Basingstoke, Hants, UK) (SMAC).
Plates were incubated overnight at 42°C. The selective SMAC differentiates 
O157 VTEC isolates by the absence o f sorbitol fermentation. Non-sorbitol- 
fermenting colonies were selected for confirmation, up to 12 per sample. The 6 7 
sensitivity o f the plating method was found to be about one organism per g o f 
meat.
Detection and isolation of O157 VTEC using the 3M  Petrifilm™  
Test Kit-HEC
According to the manufacturer's instructions, a 20-g portion o f each meat 
sample was homogenized in a stomacher with 180 ml o f modified E. coli broth 
containing novobiocin (final concentration, 20 |ig/ml) (Sigma) (mEC + n).334 
After 6 to 8 h incubation at 37°C on a rotary shaker (100 rpm), the enriched 
samples were diluted 1:10 in 0.1% peptone water, and i-ml volumes were 
inoculated onto Petrifilm™ E. coli plates (3M Company, St. Paul, MN). The
Petrifilms were incubated at 42°C for 18 h and then tested with the Petrifilm- 
HEC immunoassay for the presence o f O157 antigens. Putative immunoblot- 
positive colonies were streaked onto SMAC and further characterized. The 
detection limit o f this method was found to be five E. coli O157 organisms per 
g o f meat.
Detection and isolation of VTEC using the PCR
A 20-g portion o f meat sample was added to 180 ml o f mTSB + a, homogenized 
in a stomacher for 1 min, and incubated overnight at 37°C on a rotary shaker 
(100 rpm). One-hundred |il o f the enrichment culture was inoculated into 10 
ml o f brain heart infusion broth (Oxoid) (BHI) and incubated for 6 h at 37°C. 
The BHI culture was diluted 1:10 in 0.1% peptone water and 5 |il ofthe dilution 
was used in the PCR.
The primer pairs selected to amplify VTi and VT2(c) gene sequences have been 
described previously.186 PCR mixtures (25 |il) contained 50 mM TRIS-HCl (pH 
8.5), 1.5 mM MgCl2, 50 mM NaCl, 2 mM DDT, 0.2 mM dNTPs each, 0.5 U of 
Thermus aquaticus (Taq) DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT), 
0.3 |iM each primer o f a VT-specific primer pair, and 5 |il o f sample. The VTi 
and VT2(c) primers were used in separate reactions. Negative (no template 
DNA) and positive (5 |il o f 1:10 diluted culture o f VTi- and VT2-positive E. coli 
Oi57:H7 reference strain EDL931 grown overnight in BHI at 37°C) controls 
were included in every PCR procedure. Reaction mixtures were overlaid with 
mineral oil (Merck, Darmstadt, Germany) and processed in a DNA thermal 
cycler (Perkin-Elmer Cetus, model 480). The thermal profile involved an initial 
denaturation at 94°C for 5 min, followed by 40 cycles o f 94°C for 1 min, 54°C 
for 3 min, and 72°C for 3 min. In the final step, extension was carried out at 
72°C for 10 min. After amplification, 20-^1 aliquots were analyzed by 
6 8  electrophoresis in 1.5% agarose gels (SeaKem LE agarose) (Biozym, Landgraaf, 
The Netherlands) containing ethidium bromide (0.1 ^g/ml) (Boehringer, 
Mannheim, Germany), visualized by UV transillumination and photographed. 
Molecular mass markers (100-bp ladder; Pharmacia Biotech AB, Uppsala, 
Sweden) were electrophoresed simultaneously. VT genes could be detected at 
inoculum levels o f one organism per g o f meat.
Isolations o f VTEC were made from a random selection o f 10 PCR-positive 
samples. Serial tenfold dilutions o f the BHI cultures were made in 0.1% 
peptone water. Volumes (100 |il) o f the 10 -5 dilutions were plated onto tryptone 
bile agar (TBA) (Oxoid) and incubated overnight at 42°C. This usually resulted 
in plates with 100 to 300 well-separated colonies. Single colonies were picked 
from the TBA plates and tested for indole production on a cellulose nitrate 
filter (Sartorius AG, Goettingen, Germany) soaked in indole reagent (5% 4- 
(dimethylamino)-benzaldehyde (Merck) in 1 N HCl). Each indole-positive
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isolate was inoculated onto a SMAC plate so that a grid pattern o f 96 colonies 
(12 by 8) was created. Plates were incubated overnight at 37°C. The number 
o f PCR reactions necessary to trace the VTEC strains was reduced to 20 by 
pooling the E. coli isolates per row and per column in 1 ml o f 0.22-^m-pore- 
size membrane-filtered water (Millipore B.V., Bedford, MA). Five ^l o f each 
suspension was tested in the PCR for VT genes. The isolated VTEC strains 
were further characterized.
Confirmation and characterization of E. coli isolates
Isolates were confirmed biochemically as E. coli by plating onto Levine's eosin 
methylene blue agar (Oxoid) (L-EMB) and by the API 20E system (bioMerieux,
Lyon, France). Isolates were also tested for the presence o f 6-glucuronidase 
using SMAC supplemented with 4-methylumbelliferyl-6-D-glucuronide (0.1 
g/l) (Sigma) (MUG) .331 Hydrolysis o f MUG by 6-glucuronidase-producing 
organisms results in formation o f fluorescent colonies under UV light (365 
nm). Presumptive E. coli O157 isolates (typical E. coli metallic sheen on L-EMB, 
non-sorbitol-fermenting and 6-glucuronidase-negative on SMAC-MUG) were 
identified serologically by latex agglutination with the E. coli O157 latex kit 
(Oxoid). All E. coli isolates were serotyped at the National Institute o f Public 
Health and the Environment (Bilthoven, The Netherlands). VT genotypes were 
determined with the PCR assay described above, using 1:10 diluted BHI 
cultures as input. VT production was determined in the Vero cell assay using 
polymyxin B extracts (PE) o f colony sweeps (CS) (VT/PECS), as described by 
Karmali et al.232 Isolates confirmed as O157 VTEC were phage typed by Dr. B.
Rowe (Laboratory o f Enteric Pathogens, Central Public Health Laboratory, 
London, UK). In addition, all E. coli isolates were tested using PCR for the 
presence o f the E. coli attaching-and-effacing (eae) gene. In vitro and animal 
studies have shown that the eae gene is involved in the ability o f some VTEC 6 9  
and enteropathogenic E. coli strains to cause attaching-and-effacing (AE) lesions 
o f intestinal microvilli.119,300 The primer pair selected to amplify eae gene 
segments has been described previously.186 The PCR was performed as 
described above.
R e s u l t s
Detection and isolation of 0 157  VTEC using the plating method
E. coli O157 strains were isolated from 2 o f 770 samples o f raw minced mixed 
beef and pork by using selective enrichment in mTSB + a followed by selective 
plating onto SMAC. E. coli O157 could not be detected in samples o f raw minced
beef (n = 1,000), raw minced pork (n = 260) or raw poultry products (n = 300). 
The two E. coli O157 isolates showed typical E. coli metallic sheen on L-EMB, 
did not ferment sorbitol, did not possess the enzyme 6-glucuronidase, and 
met the E. coli profile o f the API 20E system. Further characterization revealed 
that one o f the isolates belonged to serotype Oi57:H7, phage type 1, and 
contained both the VTi and VT2 gene, and that the other belonged to serotype 
O157 nonmotile (Oi57:H-), phage type 4, and contained only the VT2 gene. 
Both isolates were positive in the Vero cell assay, and contained eae gene 
sequences.
Verocytotoxin-producing Escherichia coli in humans and the food chain
Detection and isolation of O157 VTEC using the 3M  Petrifilm™  
Test Kit-HEC
E. coli O157 strains were detected in 22 (6.1%) o f 360 meat samples by using 
the Petrifilm™ Test Kit-HEC (Table 1). From each of the 22 immunoblot- 
positive samples one E. coli O157 isolate was further characterized. The 
isolates showed typical E. coli metallic sheen on L-EMB, were both sorbitol- 
fermenting and 6-glucuronidase-positive, and met the E. coli profile o f the API 
20E test. Serotyping characterized the 22 isolates as E. coli O157 strains that 
possessed flagellar antigens other than H7. The PCR and the Vero cell assay 
revealed that the isolates did not belong to VTEC. The PCR for the eae gene 
showed negative results for all isolates.
Detection and isolation of VTEC using the PCR
One-hundred and eighty meat products, which were also examined for the 
presence o f E. coli O157 with the plating method, were screened for the presence 
7 0  o f VT genes by using the PCR. Twenty-nine (16.1%) enrichment cultures 
showed a positive PCR: 1 for the VTi gene only, 17 for the VT2 gene only, and
11 for both VT genes (Table 2).
A total o f 46 VTEC strains were isolated from 10 randomly selected PCR- 
positive samples (Table 3). The isolates showed typical E. coli metallic sheen 
on L-EMB, were both sorbitol-fermenting and 6-glucuronidase-positive, and 
met the E. coli profile o f the API 20E system. One isolate could not ferment 
sorbitol. From some enrichment cultures that were positive for both VTi and 
VT2, VTEC strains positive for only VTi or only VT2 were isolated. Forty-one 
o f the 46 isolates belonged to nine different serogroups. The remaining five 
strains had O antigens that were unidentifiable with the currently available 
antisera. No O157 VTEC strains were isolated. Some of the enrichment 
cultures yielded more than one VTEC serotype. VTEC strains that belonged 
to serogroup O22 were recovered from 5 o f the 10 samples examined in detail,
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Table 2. Detection o f VTEC in retail raw meats by using the PCR
Meat No. o f samples No. (%) o f samples No. o f samples o f VT type:
tested VT-positive a VT1 VT2 VT1&VT2
M inced m ixed  b e e f  an d  po rk  88 16  (18 .2 ) 1 10  5
M inced b ee f 92 13 (14 .1) 7 6
Total 180  29  (16 .1) 1 17 11
a D e te rm ined  in  5 o f  the secondary en rich m en t cu ltu re  m ade in  BHI (1 :10  d ilu ted  in  0 .1% pep tone w ater), following 
selective en rich m en t in  m TSB + a.
producing either VTi and VT2, or only VT2. Despite the presence ofVT genes, 
not all VTEC strains produced a cytotoxic effect on Vero cells. None o f the 46 
VTEC isolates showed a positive PCR for the eae gene.
D i s c u s s i o n
Epidemiological investigations have shown undercooked ground beef to be 
an important food source o f human VTEC infections.227 Although they are 
the most common VTEC isolated from patients with D+ HUS in the 
Netherlands,469 strains o f serogroup O157 were isolated from only a very low 
percentage o f the raw meats examined. VTEC of other serogroups were isolated 
in a higher frequency. Other studies on the prevalence o f VTEC in foods from 
animal origin have also failed to show a predominance o f O157 VTEC. Doyle 
and Schoeni121 recovered E. coli 0 15 7 ^ 7  from 6 (3.7%) o f 164 ground beef, 4 
(1.5%) o f 264 pork, 4 (1.5%) o f 263 poultry, and 4 (2.0%) o f 205 lamb samples
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Table 3. VTEC strains isolated from retail raw meats by using the PCR
Sample VTEC isolate a
No. Type o f  meat VT type b Serotype VT genotypec VT production d n
1 . M inced bee f VT1+VT2 O 8:H ? VT1+VT2 - i
O 22:H 8 VT1+VT2 + 3
O 7I:H auto f VT1+VT2 - i
O 88:H 8 VT1+VT2 - i
2 . M inced m ixed b e e f  an d  pork VT1+VT2 O75:H? VT1+VT2 - i
O? VT i +
3 . M inced bee f VT1+VT2 O i o i :H- VT i - i
O i23 :H? VT i + i
O? VT i + i
4 . M inced bee f VT2 O 22  g VT2 + ii
5. M inced m ixed bee f an d  po rk VT1+VT2 O 22  g VT2 +
O? VT2 + i
6. M inced bee f VT2 O ii3 :H 4 VT2 +
O? VT2 + i
7. M inced bee f VT1+VT2 O 2 g VT2 + i
8. M inced bee f VT2 O 22  g VT2 + i
9. M inced m ixed  b ee f a n d  pork VT2 O ii3  g VT2 + 2
10 . M inced m ixed  bee f an d  pork VT1+VT2 O 22 g VT1+VT2 + i0
a All VTEC isolates w ere sorb ito l-ferm enting  an d  fë-glucuronidase-positive, w ith  the  exception o f  the VTEC strain  
iso la ted  from  sam ple 7, w h ich  w as non-sorb ito l-ferm enting . All VTEC isolates w ere negative in  the PCR fo r the eae gene. 
b D ete rm ined  in  5 \ i l  o f  the  secondary en rich m en t cu ltu re m ade in  BHI (1 :10  d ilu ted  in  0 .1%  p ep tone w ater), follow ing 
selective en rich m en t in  mTSB + a.
c D e te rm ined  in  5 ^ l  o f  BHI b ro th  cu ltu re (1 :10  d ilu ted  in  0 .1%  pep tone water). 
d  D e te rm ined  by u s in g  the  Vero cell assay; +, positive; - ,  negative. 
e n , n u m b e r  o f  stra ins th a t h a d  the  sam e properties. 
f  auto, A uto-agglutinable. 
g  H  type n o t de term ined .
7 2
obtained from retail outlets in North America (Madison, Wisconsin and 
Calgary, Alberta, Canada) by using a hydrophobic grid membrane filter- 
immunoblot procedure developed specifically to isolate E. coli 0 15 7 ^ 7  from 
foods. Griffin and Tauxe170 reported the results o f a more recent and national 
survey in the United States. E. coli O157 was isolated from 0.12% of raw beef 
samples (n = 1,668) and 0.06 to 0.5% o f veal kidneys (n = 4,953), but was not 
detected in raw chicken (n = 3,977). The detection and isolation methods were 
not described. Using the Vero cell assay, Read et al368 found the prevalence of 
VTEC to be at least 36.4 and 10.6%  in ground beef (n = 225) and ground pork 
(n = 235), respectively, and 0% in mechanically separated chicken samples (n 
= 200). The samples were collected at meat-processing plants in Southwestern 
Ontario. Isolations o f VTEC were made from a selection o f positive samples,
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and some of the strains recovered belonged to serotypes which have been 
isolated from humans. However, no strains o f serogroup O157 were isolated. 
Samadpour et al.392 analyzed 294 food samples obtained from grocery stores 
in Seattle for the presence o f VTEC by using DNA probes for VTi and VT2 
genes. Fifty-one (17%) o f the samples were found positive: 14 (23%) o f 60 beef 
samples, 9 (18%) o f 51 pork samples, 10 (48%) o f 21 lamb, 5 (63%) o f 8 veal,
4 (12%) o f 33 chicken, 1 (7%) o f 15 turkey, 6 (10%) o f 62 fish, and 2 (5%) o f 44 
shellfish samples. Although none o f the VTEC strains recovered from 12 
samples examined in detail were o f serogroup O157, some were o f serogroups 
which have been associated with human diarrhea, HC, or D+ HUS. Also in 
the United Kingdom, VTEC o f serogroups other than O157 have been 
frequently detected in retail fresh meats. Smith et al.415 examined frozen and 
fresh whole chickens and fresh pork sausages obtained from retail outlets in 
north and northwest London for the presence o f VTEC by using DNA probes 
for the VT genes. They showed the presence o f VTEC in 46 (25%) o f 184 
samples from pork sausages (n = 117). VTEC were isolated from 20 o f the 46 
probe-positive samples, and three o f the serotypes identified have been 
isolated from cases o f human infection. No O157 VTEC were isolated. VTEC 
were not found in 112 samples from 71 chickens. A more recent study of 
Willshaw et al.493 showed that 54 (17%) o f 310 raw beef products contained 
VTEC, detected by DNA probes for the VT genes. VTEC strains examined in 
detail from a selection o f 35 positive samples belonged to several serogroups, 
including some which have been associated with human disease. No VTEC 
of serogroup O157 were isolated. The products were obtained from retail 
butchers' premises and supermarkets in north and northwest London. Since 
in the prevalence studies cited different detection and isolation techniques were 
applied, the results cannot be compared.
The cultural method used in our first survey has some limitations. The 
enrichment and plating medium used are not highly specific for VTEC. Non­
sorbitol-fermenting organisms are easily overgrown by sorbitol-fermenting 7 3  
competitors, and on SMAC plates sorbitol-nonfermenting organisms o f other 
members o f the family Enterobacteriaceae cannot be distinguished from O157 
VTEC. As a more selective cultural method for the isolation o f O157 VTEC from 
foods and feces, we currently prefer to use mEC + n as enrichment medium334 
and SMAC supplemented with cefixime and tellurite (CT-SMAC) as plating 
medium.501 In addition to VTEC o f serogroups other than O157, sorbitol- 
fermenting O157 VTEC, which also have been reported to cause D+ HUS,171 
will be missed by using the plating method. The two O157 VTEC isolates were 
characterized by phage types 1 and 4. Among a total o f 50 O157 VTEC strains 
isolated in the Netherlands between 1989 and 1993 from 27 cases o f D+ HUS, 
seven different phage types were identified.186 Based on isolates from separate 
families (n = 27), phage type 2 was the most common (44% of the strains), 
followed by types 4 (33%), 8 (7%), i4 (4%), 32 (4%), 49 (4%), and 54 (4%).
In contrast to the low detection rate o f O157 VTEC in our first survey, E. coli 
strains o f this serogroup not producing VT were recovered from 6.1% o f 360 
meats examined with the 3M Petrifilm™ Test Kit-HEC in our second survey. 
Since this immunoblot method is based on the detection o f E. coli O157 
antigens, VT-negative and VT-positive strains cannot be distinguished. VT- 
negative strains o f E. coli O157 have been isolated from several sources.84,405,493 
The clinical significance o f these strains is not known.
In the third survey PCR results showed that 16.1%  of 180 meat products 
contained VTEC. This is about the same percentage as Willshaw et al.493 
reported for meats from retail outlets in London, determined by using DNA 
probes for VT genes. Forty-one o f the 46 VTEC isolates recovered from 10 of 
the 29 PCR-positive samples belonged to nine different O serogroups including 
2, 8, 22, 71, 75, 88, 101, 113, and 123. The remaining five isolates were untypable. 
VTEC of serogroup O22 were most frequently encountered. They were 
recovered from five o f the 10 enrichment cultures examined in detail. VTEC 
strains o f O serogroups 2, 8, 22, 75, and 113 have also been isolated in North 
American, German, and British studies o f cattle and beef,3ii,367,392,4i5,483,493,494 
including VTEC of serotypes O22:H83Ii,367,483,49M94 and Oii3:H4.493 O f the 
other O serogroups (O2, O8, and O75) the H types did not correspond to the 
H types given in the cited studies, and in some of these studies the H types 
were not determined. In addition, E. coli o f serogroups O2, O22, O75, and Oii3 
have been associated with human diarrhea and D+ HUS.i7i,227,49i Recently, 
VTEC of serotype Oi0i:H- have been recovered from a patient with D+ HUS448 
and from healthy pigs.73 Both human and porcine isolates produced VT2e, the 
porcine variant o f VT which causes enterotoxemia and edema disease in pigs. 
The Oi0i:H- strain isolated in this study was recovered from a beef product, 
and produced only VTi. The other VTEC serogroups (O7i, O88, and Oi23) 
have not yet been reported in cases o f human or animal disease. Because of 
the lack o f a simple detection method, non-Oi57 VTEC are mostly overlooked 
74  in clinical laboratories. Unlike the conventional plating method using SMAC 
and the Petrifilm screening method, the PCR approach does not favor the 
detection o f a particular serogroup. Therefore, it reflects a more accurate picture 
o f the VTEC population in the samples. None o f the VTEC strains isolated from 
the meats using the PCR possessed the eae gene. Although the presence of 
the eae gene has been closely associated with Oi57 VTEC that caused D+ HUS, 
VTEC o f serogroups other than Oi57 do not always contain the eae gene.49i 
Because some VTEC strains isolated from the same sample shared the same 
properties, it is presumable that they originated from one single clone.
In conclusion, further investigations are required to identify the reservoirs of 
VTEC of serogroup Oi57 and other VTEC in the Netherlands. Additionally, 
future studies should focus on the distribution o f VT genes among E. coli 
serotypes, the pathogenicity o f VTEC serotypes isolated from foods and 
animals which have not been associated with human disease so far, and their 
mode of entry into the food production system, followed by the development
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and implementation o f a series o f control strategies along the entire food 
production system from farm to table, and finally the possible exchange of 
virulence factors among E. coli strains.
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Evaluation of media and test kits for the detection and 
isolation of Escherichia coli O157 from minced beef
Chapter ^
Summary
This study has evaluated the efficacy o f selective enrichment and plating media 
used for the isolation o f verocytotoxin (VT)-producing Escherichia coli (VTEC) 
o f serogroup Oi57, by examining pure bacterial cultures. In addition, the 
performance o f a variety o f commercial test kits for the detection o f E. coli Oi57 
strains inoculated into minced beef was compared, using the Ampcor E. coli 
Oi57:H7 Kit, 3M Petrifilm™ Test Kit-HEC, Dynabeads anti-E. coli Oi57, 
EHEC-TEK™, and the Tecra E. coli Oi57 visual immunoassay. The commercial 
Verotox F test for the determination o f the VT type o f VTEC isolates was 
compared with a polymerase chain reaction (PCR) assay for VT-coding genes. 
Modified E. coli broth containing novobiocin (mEC + n) and sorbitol 
MacConkey agar supplemented with cefixime and tellurite (CT-SMAC) were 
the most efficacious media for selective enrichment and isolation, respectively.
After enrichment o f the inoculated samples, all kits tested could detect less 
than one Oi57 VTEC cell per g o f minced beef. While the results o f the 77  
immunoassays need to be confirmed by isolating the organisms, the use of 
the immunomagnetic separation technique directly yields isolates. The results 
o f the Verotox F test were consistent with PCR results. A sensitive and cost- 
effective method for the isolation o f Oi57 VTEC from minced beef in food 
industry and epidemiological studies involving large numbers o f samples is 
the following: enrichment in mEC + n at 37°C for 6 to 8 h with shaking at i00 
rpm, followed by immunomagnetic separation using Dynabeads anti-E. coli 
Oi57 and spread plating o f the concentrated target cells onto CT-SMAC. The 
Verotox F test can be used to determine whether the isolates produce VTi 
and/or VT2.
A.E. Heuvelink, J.T.M. Zwartkruis-Nahuis, and E. de Boer.
Journal of Food Protection 1997; 60:817-824.
I n t r o d u c t i o n
Verocytotoxin (VT)-producing Escherichia coli (VTEC) are now recognized as 
a major cause o f hemorrhagic colitis (HC) and the diarrhea-associated form 
(D+) o f hemolytic-uremic syndrome (HUS).60 Although a wide variety of 
VTEC serogroups has been implicated in human disease, E. coli Oi57 are the 
most prevalent strains. Many cases and outbreaks o f Oi57 VTEC infection 
have been linked to the consumption of contaminated beef.60 Oi57 VTEC 
strains have also been isolated from beef products and feces o f 
cattle.84,87,88,i2i,i70,i75,i89,2i0,245,3ii,34°,483,505 Therefore, it is suggested that cattle 
are the main reservoir o f these organisms and that beef products are the 
primary sources o f infection in man. To elucidate further the reservoirs o f Oi57 
VTEC and routes o f transmission to man, sensitive methods are needed since 
these pathogens may be present in food and environmental samples in only 
small numbers. In addition, sensitive and rapid detection methods are 
necessary for the food industry to ensure a safe supply o f foods.
Several methods have been developed for the detection and isolation o f Oi57 
VTEC from food and other samples. Initially, sorbitol MacConkey agar (SMAC) 
was used to differentiate Oi57 VTEC strains, most o f which do not ferment 
sorbitol.288 However, many organisms other than Oi57 VTEC, especially other 
serogroups o f E. coli and Proteus spp., may also not ferment sorbitol. Inclusion 
o f rhamnose and cefixime improved the selectivity o f SMAC (CR-SMAC).85 
Unlike most non-sorbitol-fermenting E. coli strains, Oi57 VTEC do not 
ferment rhamnose. Low concentration o f the antibiotic cefixime inhibits the 
growth of Proteus spp. In contrast to most other E. coli, almost all Oi57 VTEC 
isolates lack 6-glucuronidase activity. Media containing either the chromogenic 
compound 5-bromo-4-chloro-3-indolyl-6-D-glucuronide (BCIG)332 or the 
fluorogenic compound 4-methylumbelliferyl-6-D-glucuronide (MUG)33i were 
developed to exploit this difference. More recently, further selectivity 
7 8  improvements resulted from the addition o f both cefixime and tellurite to 
SMAC (CT-SMAC).50i In CT-SMAC, tellurite inhibits the growth o f E. coli 
strains other than Oi57 VTEC and other non-sorbitol-fermenting species, and 
cefixime inhibits the growth of Proteus spp. Selective enrichment media 
developed to improve the detection and isolation o f Oi57 VTEC from food are 
modified tryptone soy broth with acriflavin (mTSB + a)245 or novobiocin (mTSB 
+ n),i2i modified E. coli broth with novobiocin (mEC + n),334 enterohemorrhagic 
E. coli (EHEC) enrichment broth (EEB),480 and buffered peptone water (BPW) 
supplemented with vancomycin, cefsulodin, and cefixime (BPW-vcc).84 While 
cultural isolation o f Oi57 VTEC from foods is time-consuming and labor­
intensive, and hence costly, rapid immunological detection and 
immunomagnetic separation systems have been developed. Examples are the 
Ampcor E. coli Oi57:H7 Kit (Ridascreen-Biopharm), Micro-Screen™ for E. coli 
Oi57:H7 (Neogen), V IP ™  Test for EHEC (BioControl Systems), EHEC-TEK™
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(Organon Teknika), Tecra E. coli O157 visual immunoassay (Tecra), Vidas E. coli 
O157 Assay (bioMérieux), Assurance EHEC (BioControl Systems), Petrifilm™ 
Test Kit-HEC (3M), and Dynabeads anti-E. coliO157 (Dynal). These commercial 
test kits reduce analysis time, producing presumptive results after 1 day, 
compared to cultural procedures requiring 2 days.
The aim of the present study was to identify a sensitive, rather simple and rapid 
method for the detection and isolation o f O157 VTEC from minced beef. Pure 
culture experiments were performed to evaluate the efficacy o f selective 
enrichment and plating media used for the isolation o f O157 VTEC. The 
performance o f a variety o f commercial test kits was evaluated by detection of 
E. coli O157 strains inoculated into minced beef. Finally, a commercial test kit 
for the determination o f the VT type o f VTEC isolates was compared with a 
PCR for VT-coding genes.
Table 1. Bacterial strains used in this study
Isolate Organism Serotype Toxin type a 
VTi VT2
Origin
OOCO Escherichia coli O i57:H 7 + + H U S p atien t
89OO2 Escherichia coli O i57:H 7 - + H U S p atien t
89OO3 Escherichia coli O i57:H 7 - + H U S patien t
89OO4 Escherichia coli O i57:H 7 - + H U S patien t
89OO5 Escherichia coli O i57:H 7 + + H U S patien t
9 IO3O Escherichia coli O i57:H 7 - + H U S patien t
9 i° 3 i Escherichia coli O i57:H 7 - + H U S patien t
9 1O32 Escherichia coli O i57:H 7 + + H U S patien t, EDL931
9 IO33 Escherichia coli O i57:H 7 - + H U S patien t
93O9 I Escherichia coli O i57:H- + + H U S patien t
9 2OO7 Escherichia coli O i57:non-H 7 - - Raw chicken  p roduct
92OO8 Escherichia coli O i57:non-H 7 - - Raw chicken  p roduct
93o 6 4 Escherichia coli O i57:non-H 7 - - Raw m in ced  bee f
93o 6 5 Escherichia coli O i57:non-H 7 - - Raw chicken  p roduct
9 3066 Escherichia coli O i57:non-H 7 - - Raw turkey product
93O79
9IO 2I
Escherichia coli 
Escherichia coli
O 8 :H? + + Raw m in ced  bee f 
N CTC9 0 0 1
9IO23 P seudom onas aeruginosa - - N CTC 106 6 2
93i o 5 Enterococcus fa eca lis - - ATCC29 212
9IO22 Proteus m irabilis - - N CTC 11938
83O36 Klebsiella p n e u m o n ia e - - D etergent
83°45 Citrobacter fre u n d ii - - Raw egg p roduct
1 D e te rm ined  by bo th  the Verotox F test an d  the  PCR.
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M a t e r i a l s  a n d  m e t h o d s
Bacterial strains
The bacterial strains used in this study are shown in Table 1. The clinical E. coli 
O157 isolates originated from Dr. Lior (Laboratory Centre for Disease Control, 
Ottawa, Canada), the National Institute o f Public Health and the Environment 
(Bilthoven, The Netherlands) and the University Hospital Nijmegen 
(Nijmegen, The Netherlands). The remaining strains were from official 
culture collections and from our own collection.
Selective enrichment media
Bacterial strains were cultured in brain heart infusion broth (Oxoid Unipath 
Ltd., Hampshire, UK) (BHI) at 37°C for 18 to 20 h. Serial dilutions (1:10) up 
to io -7 were made in 0.1% peptone water. Five-ml volumes o f modified tryptone 
soy broth (mTSB) containing acriflavin-HCl (10 mg/l) (Sigma Chemical Co., 
Detroit, MI) (mTSB + a)245 and modified E. coli broth containing novobiocin 
(20 mg/l) (Sigma) (mEC + n)334 were inoculated with 0.1-ml aliquots o f the 
i0 -7 dilutions, containing approximately 10 CFU. The actual inoculum levels 
were determined by spread plating appropriate dilutions (0.1 ml) in duplicate 
onto tryptone soy agar (Oxoid) (TSA), incubating the plates at 37°C for 18 to 
20 h and counting the colonies. The mTSB + a and mEC + n cultures were 
incubated at 37°C for i8 to 20 h and then the concentrations o f cells were 
determined by plate counts on TSA. Each strain was tested separately and in 
duplicate.
8 0  Selective plating media
Bacterial strains were cultured in BHI at 37°C for 18 to 20 h. Serial dilutions 
(1:10) were prepared in sterile 0.1% peptone water, and appropriate dilutions 
(0.1 ml) were surface plated in duplicate onto sorbitol MacConkey agar (Oxoid) 
(SMAC), SMAC supplemented with cefixime (0.05 mg/l) and potassium 
tellurite (2.5 mg/l) (Dynal) (CT-SMAC), and Fluorocult E. coli Oi57:H7 agar 
(Merck, Darmstadt, Germany). In addition, nonselective TSA plates were 
inoculated. Colonies formed after incubation at 42 °C for 18 to 20 h were 
enumerated.
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Commercially available test kits for the detection of E. coli O157 
in minced beef
Inoculation o f minced beef
E. coli O157 strains, both VT-producing and non-VT-producing, were cultured 
in BHI at 37°C for 18 to 20 h. Serial dilutions (1:10) up to 10 -8 were made in 
0.i%  peptone water. A batch o f minced beef was divided into 8 portions o f 20
g. Each portion was added to 180 ml o f mTSB + a and homogenized in a 
stomacher for i min. Seven portions were inoculated with 0.i ml o f each 
dilution ranging from 10-2 to 10 -8, to prepare samples containing approximately 
0.5 x 10 5, 0.5 x 104, 0.5 x 103, 0.5 x 10 2, 0.5 x 10 1, 0.5 x 10 0, and 0.5 x 10 -1 CFU 
per g of meat. The remaining portion served as an uninoculated control sample.
Each strain was tested separately, using one batch o f minced beef for one single 
strain. The actual inoculum numbers were determined by plate counts on TSA.
The mTSB + a broths were incubated at 37°C on a rotary shaker (100 rpm) for 
a maximum of 18 to 20 h and subsequently examined for the presence o f O157 
VTEC with the methods described below.
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Selective plating onto SMAC
After an incubation period o f 18 to 20 h, mTSB + a broths were serially diluted 
(1:10) in 0.1% peptone water and appropriate dilutions (0.1 ml) were spread 
plated in duplicate onto SMAC. SMAC plates were incubated at 42°C for 18 
to 20 h. Per inoculated portion o f minced beef, up to 12 non-sorbitol- 
fermenting colonies were selected for serological confirmation with the E. coli 
O157 latex agglutination assay (Oxoid).
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Ampcor E. coli 0 15 7 ^ 7  Kit
After incubation for i8 to 20 h, 0.i-ml aliquots o f the enriched beef samples 
were tested with the Ampcor E. coli Oi57:H7 Kit (Ridascreen-Biopharm), 
following the instructions o f the manufacturer. A correctly performed test 
resulted in the appearance o f a line in the control zone within 15 min after 
inoculation o f the Ampcor membranes. The presence of E. coli Oi57:H7 strains 
caused an additional line to appear in the test zone, due to the antigen-antibody 
complex. The sensitivity o f the test was assessed with pure cultures. E. coli Oi57 
strains were cultured in BHI at 37°C for i8 to 20 h. Serial dilutions (i:i0) up 
to i0 -8 were made in 0.i%  peptone water and assayed in the immunoassay 
system. The concentrations o f cells in the dilutions were determined by plate 
counts on TSA.
3M Petrifilm ™ Test Kit-HEC
After incubation for 6 to 8 h, i-ml volumes were taken from the mTSB + a 
broths and diluted i:i0  in 0.i%  peptone water. One-ml volumes o f these 
dilutions were inoculated onto Petrifilm™ E. coli plates (3M, St. Paul, MN). 
The plates were incubated at 42°C for i8 h and then tested with the Petrifilm- 
HEC immunoassay for the presence o f Oi57:H7 antigens. The assay was 
performed according to the manufacturer's instructions. All buffers and 
reagents were supplied with the kit. Putative immunoblot-positive colonies 
were streaked onto SMAC and identified serologically with the E. coli Oi57 latex 
agglutination assay. To assess the sensitivity o f the Petrifilm method, E. coli 
Oi57 strains were cultured in BHI at 37°C for i8 to 20 h and i-ml volumes of 
serial dilutions (i:i0) made in 0.i%  peptone water were tested. The bacteria 
in the dilutions were enumerated by plating onto TSA.
Dynabeads anti-E. coli O157
After 6 to 8 h incubation, about 5 ml o f each enrichment culture was filtered 
through a piece o f paper towel. The immunomagnetic separation with 
Dynabeads anti-E. coli Oi57 (Dynal) was performed with i ml o f the culture 
filtrates, following the instructions o f the manufacturer. The concentrated 
samples were inoculated (50 ^l) onto SMAC and incubated at 37°C for i8 to 
20 h. Per sample, up to i2 non-sorbitol-fermenting colonies were selected and 
identified serologically with the E. coli Oi57 latex agglutination assay. The 
sensitivity o f the method was assessed by growing E. coli Oi57 strains in BHI 
at 37°C for i8 to 20 h and subsequently testing i-ml volumes o f serial dilutions 
(i:i0) made in 0.i%  peptone. Bacterial counts o f the dilutions were prepared 
on TSA.
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EHEC-TEK™
One ml of each enrichment culture incubated for i8 to 20 h was heated at i00°C 
for 20 min, cooled to room temperature, and analyzed with the EHEC-TEK™ 
kit (Organon Teknika, Malvern, PA), according to the manufacturer's 
instructions. All buffers and reagents were supplied with the kit. Samples with 
optical density values at 450 nm equal to or greater than a cutoff value calculated 
from the negative controls were scored as positive. The sensitivity o f the test 
was assessed by culturing E. coli Oi57 strains in BHI at 37°C for i8 to 20 h and 
preparing serial dilutions (i:i0) up to i0 -8 in 0.i%  peptone water. One ml of 
each dilution was heated at i00°C  for 20 min, cooled to room temperature, 
and assayed in the ELISA system. The concentrations o f cells in the dilutions 
were determined by plate counts on TSA.
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Tecra E. coli O157 visual immunoassay
The Tecra E. coli Oi57 visual immunoassay (Tecra) was performed according 
to the manufacturer's instructions. All buffers and reagents were supplied with 
the kit. Following i8 to 20 h incubation, i-ml aliquots o f each enrichment 
culture were heated at i00°C for i5 min, cooled to room temperature, and tested 
with the E. coli Oi57 immunoassay kit. Positive results were indicated by a green 
color development and read visually by reference to a color card. To assess the 
sensitivity o f the immunoassay, E. coli Oi57 strains were cultured in BHI at 
37°C for i8 to 20 h and serial dilutions (i:i0) up to i0 -8 in 0.i%  peptone water 
were made. One ml o f each dilution was heated at i00°C  for i5 min, cooled 
to room temperature, and assayed in the ELISA system. The bacteria in the 
dilutions were enumerated by plating onto TSA.
Methods for the identification of VT type
Verotox F
Bacterial strains were cultured in BHI at 37°C for i8 to 20 h. Following 
centrifugation at i0 ,000 x g  for i5 min, supernatants were tested for the 
presence o f VTi and VT2 with the Verotox F test (Denka Seiken). The test was 
performed as directed by the manufacturer. All buffers and reagents were 
supplied with the kit. After i8 to 20 h incubation at room temperature, 
agglutination patterns o f serially diluted (i:2) supernatants were observed. The 
highest dilution factor which showed agglutination was defined as the 
agglutination titer.
Polymerase chain reaction
Bacterial strains were cultured in BHI at 37°C for i8 to 20 h. The cultures were 
diluted i:i0  in 0.i% peptone water and 5-^ volumes ofthe dilutions were tested 
in the PCR. Both the primer pairs selected to amplify VTi and VT2 gene 
sequences and the PCR procedure followed have been described 
previously.i86,i89
R e s u l t s
Selective enrichment media
Table 2 shows the efficacy o f mTSB + a and mEC + n for the selective 
enrichment o f Oi57 VTEC. The best results were observed with mEC + n. 
Enrichment o f the Oi57 VTEC strains in mEC + n resulted in significantly
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Table 2. Growth o f bacterial strains in enrichment media selective for verocytotoxin (VT)- 
producing E. coli O157
Isolate Inoculum Population a /ml)U/FC
eglo
(CFU/ml) mTSB + a b mEC + n
VT-positive E. coli O 157
8 9 0 0 1 1.0 7.3 8.8
89002 1.8 7.8 8.7
89003 2 .4 8.3 8.7
89 004 1.9 8.4 8.8
89005 2.4 7.6 8.8
91030 i .8 7.3 8.8
9 i° 3 i 2.0 7.8 8.5
91032 2.5 8.3 8.7
9 1033 2.8 8.3 8.6
930 9 1 0.8 7.0 8.2
VT-negative E. coli O 157
92007 2 .5 8.2 7.6
92008 2.7 8.2 8.2
930 6 4 3.3 7.7 7.6
930 6 5 0.2 7.2 < i .0
9 3066 i .2 7.3 < i .0
E. coli n o n -O i57
9 i 0 2 i i.7 7.7 8.2
93079 i.7 8.9 7.5
Non-E. coli
9 i 022 i.5 7.5 < i .0
9 i 023 0.2 7.2 8.2
93i05 2.4 < 1.0 < i .0
a Populations recovered on  TSA, follow ing incubation  in  the  selective en rich m en t b ro th s  at 37°C for 18  to 20  h . S trains 
w ere te sted  individually.
b mTSB + a, m odified  tryptone soy b ro th  w ith  acriflavin. 
c m EC + n, m odified  E. coli b ro th  w ith  novobiocin.
larger numbers o f cells than enrichment in mTSB + a (paired t test, P < 0.001). 
In addition, mEC + n appeared to be more selective than mTSB + a. Four of 
the strains other than O157 VTEC could not be recovered from undiluted mEC 
+ n cultures. With the exception o f the Enterococcus faecalis isolate, these strains 
grew well in mTSB + a. O f the remaining strains tested, two yielded equal 
numbers o f cells in both enrichment media, two larger numbers in mTSB + 
a, and two larger in mEC + n.
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Table 3. Growth o f bacterial strains on plating media selective for verocytotoxin 
(VT)-producing E. coli O157 and on nonselective TSA
Population a (log CFU/ml)
Strain SM AC b CT-SMAC c Fluorocult TSA
VT-positive E. coli O 157 d
E. coli O i^y.H j
89 0 0 1 8.9 8.9 8.7 9.2
89002 8.6 9.2 8.2 9 .i
89003 8.8 8.9 8.7 9 .0
89004 9.2 9 .0 9.2 9 .i
89005 9.2 8.9 8.8 9.3
9 i 030 8.5 8.6 7.2 9 .i
9 i 03 i 8.3 8.5 8.4 9 .i
9 i 032 8.7 8.7 8.5 9 .0
9i033 9 .i 8.7 8.6 9.2
9 3 0 9 i 8.7 8.6 8.5 8.9
VT-negative E. coli O i57
8.4 f9200 7 9 .i  e < i .0 9 .i
9200 8 e.29. < 1.0 7.3 f 9 .i
9 3 ° 6 4 8.2 e < i .0 8. 4 g 8 .9
9 3 ° 6 5 8.6  e < i .0 8.8 g 8.8
93066 9.2 e < i .0 9 .1 g 9 .i
E. coli n o n -O i57
9 i 0 2 i 9 .2 e < i .0 9 .i  g 9.2
Non-E. coli
83036 < 1.0 < i .0 < i .0 8.7
83045 < 1.0 < i .0 8.7 h 8.9
a Populations o f  bacterial s tra ins cu ltu red  in  BHI at 37°C for 18  to 20  h  recovered on  the various p la ting  m edia (at 4 2 °C 
for 18 to 20  h ). S trains w ere te sted  individually. 
b SMAC, sorbitol M acConkey agar. 
c CT-SMAC, SMAC w ith  cefixim e an d  tellurite.
d  All O 157 VTEC stra ins appeared  as colorless colonies on  SMAC an d  CT-SMAC, a n d  as g reen  colonies on Fluorocult 
E. coli O i57:H 7 agar. 
e Purp le colonies. 
f  Colorless colonies. 
g  Yellow colonies.
h  Purple colonies w ith  a dark  center.
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Selective plating media
The efficacy o f the selective plating media tested is shown in Table 3. When 
the O157 VTEC BHI cultures were surface plated, smaller numbers o f cells 
were detected on Fluorocult E. coli 0 15 7 ^ 7  agar than on SMAC and CT-SMAC 
(paired t test, P = 0.03 and P = 0.07, respectively). No significant differences
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Table 4. Sensitivity o f commercially available test kits for the detection o f E. coli O157
Sensitivity a (log CFU/ml)
Ampcor 
Strain E. coli
3M  Petrifilm™ 
Test Kit-HEC
Dynabeads EHEC- 
anti-E. coli Q157 TEK™
Tecra E. 
Q157 vis
VT-positive E. coli O 157 b
Kit ona£im
8 9 OOI 6.2 < I .2 <I.2 6.2 4.2
89002 6.1 <I.I 2.I 6 .I 4 .I
8 9 OO3 6.0 < i .o 2.O 6 .O 4.O
8 9 OO4 6.1 <I.I 2.I 6 .I 4 .I
8 9 OO5 6.3 < I .3 <I.3 6.3 4.3
9 IO3O 6 .I < i .i <I.I 7.I 4 .I
9 IO3I 6 .I < I.I 2.I 6 .I 4 .I
9IO32 6 .O <I.O <I.O 6 .O 4.O
9IO33 6.2 <I.2 <I.2 6.2 4.2
93O9I 5.9 <O.9 <O.9 5.9 3.9
VT-negative E. coli O 157 c
9 2 OO7 6 .I < I.I 2.I >8 .I 4 .I
92OO8 5.I <I.O 2.I >8.1 4.I
93o 6 4 5.9 <O.9 2.9 .98.> 2 .9
93o 6 5 5.8 <O .8 2.8 >8.8 4.8
a D ete rm ined  by testing  serial d ilu tions (1 :10 , m ade in  0 .1 % pep tone w ater) o f  pu re  bacterial cu ltures.
b All O 157 VTEC stra ins appeared  as colorless colonies on SMAC (D ynabeads anti-E. coli O 157 m ethod).
c All VT-negative E. coli O 157 s trains appeared  as p u rp le  colonies on  SMAC (D ynabeads anti-E. coli O 157 m ethod).
were observed in the numbers o f cells recovered on SMAC and CT-SMAC. 
Nonselective TSA supported significantly higher recovery o f the O157 VTEC 
cells than did the three selective media (paired t test, P < 0.006 all). Of the 
8 6  three selective media, CT-SMAC proved to be the most selective and Fluorocult 
E. coli Oi57:H7 agar containing sorbitol and MUG, the least selective. None 
o f the test strains other than O157 VTEC were recovered on CT-SMAC. Being 
sorbitol-fermenting organisms, the E. coli strains other than O157 VTEC yielded 
purple colonies on SMAC. The non-sorbitol-fermenting O157 VTEC appeared 
as colorless colonies on SMAC and CT-SMAC. The two non-E. coli strains were 
not recovered on SMAC. Whereas the non-sorbitol-fermenting, £- 
glucuronidase-negative O157 VTEC strains yielded green colonies on Fluorocult 
E. coli Oi57:H7 agar, four o f the six other E. coli strains tested appeared as yellow 
colonies on this medium and the remaining two as colorless colonies. The 
Citrobacter freundii isolate yielded purple colonies with a dark center, and the 
Klebsiella pneumoniae isolate could not be recovered on Fluorocult E. coli 
Oi57:H7 agar.
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Table 5. Minimum numbers o f E. coli O157 cells detected in inoculated minced beef by use o f 
commercially available test kits, following enrichment in modified tryptone soy broth with 
acriflavin (mTSB + a)
Sensitivity a  (CFU/g)
Ampcor Dynabeads t h t c -  Tecra E. coli
Strain S M A C b E. coli 3M  Petriflm anti- t f k ™  b O157 visual
T b c t  W it  H U C  c TTK j *
O i5 j:H j i w -h t c  e. coli O 157 c immunoassayb
K it b
VT-positive E. coli O 157 d
89 0 0 1 0 .9 0 .9 0 .9 0 .9 0 .9 0 .9
89002 0 .9 0 .9 0 .9 0 .9 0 .9 0 .9
89003 0.6 0.6 0.6 0.6 0.6 0.6
91030 < 0.05 < 0.05 <0.05 <0.05 <0.05 <0.05
9 10 31 5 < 0.05 <0.05 <0.05 <0.05 <0.05
91032 0.4 0 .4 0.4 < 0.04 0.4 <0.04
9 1033 0.6 < 0.06 <0.06 0.6 <0 .06 <0.06
9 30 9 1 4 .°  
'T-negative E. coli O 157 e
< 0.04 <0.04 < 0.04 <0.04 <0.04
9200 7 >0.8  x  10 5 < 0.08 <0.08 >0.8 x  10 5 >0.8 x  10 5 <0.08
93 0 6 4 >4 .4  x  10 4 < 0 .0 4 4 < 0 .044 >4.4  x  10 4 >4 .4  x  10 4 < 0 .0 4 4
a S trains w ere te sted  individually.
b P erfo rm ed  after en rich m en t in  mTSB + a at 37°C (100  rpm ) for 18  to 20  h. 
c P erfo rm ed  after en rich m en t in  mTSB + a at 37°C (100  rpm ) for 6 to 8 h.
d  All O 157 VTEC stra ins appeared  as colorless colonies on  SMAC (SMAC an d  D ynabeads anti-E. coli O 157 m ethod). 
e All VT-negative E. coli O 157 strains appeared  as purp le  colonies on  SMAC (SMAC and  D ynabeads anti-E. coli O 157 m ethod).
Commercially available test kits for the detection of E. coli O157 
in minced beef 8 7
Table 4 shows the sensitivity o f the commercially available test kits. The 3M 
Petrifilm™ Test Kit-HEC and the Dynabeads anti-E. coli O157 proved to be 
significantly more sensitive kits for the detection o f O157 VTEC strains than 
the remaining kits tested (Sign test, P = 0.002 all). The minimum numbers 
o f O157 VTEC cells detected by these two sensitive methods were not 
significantly different (Sign test, P > 0.10). Although it was about 100 times 
less sensitive than the 3M Petrifilm™ Test Kit-HEC and the Dynabeads anti- 
E. coli O157 kit, the Tecra E. coli O157 visual immunoassay was about 100 times 
more sensitive than the Ampcor E. coli Oi57:H7 Kit and the EHEC-TEK™ test. 
Although not very sensitive, the EHEC-TEK™ kit proved to be the most 
selective. VT-negative E. coli O157 were not detected. The other test kits appeared 
to be as sensitive for the detection o f VT-negative E. coli O157 strains as for the
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detection o f O157 VTEC strains.
The minimum numbers o f E. coli O157 cells detected in inoculated minced 
beef following enrichment in mTSB + a, are shown in Table 5. With all test 
kits, less than one O157 VTEC organism per g o f minced beef could be detected. 
No significant differences between the tests were found (Sign test, P > 0.50 
all). The test kits appeared to be slightly more sensitive than the conventional 
plating method (selective plating onto SMAC). The Dynabeads anti-E. coli O157 
kit, EHEC-TEK™ test, and the conventional plating method proved to be the 
most selective. Results obtained for the uninoculated portions o f minced beef 
were all negative.
Methods for the identification of VT type
The results o f the Verotox F test and the PCR are included in Table 1. VT types 
identified by the Verotox F test were identical to VT types determined by the 
PCR.
D i s c u s s i o n
Selective enrichment and plating media as well as commercial test kits were 
compared to eventually identify a sensitive, practical, and rapid method of 
detecting and isolating O157 VTEC from minced beef. It was shown that mEC 
+ n and CT-SMAC were the most efficacious media for selective enrichment 
and isolation, respectively. Although several studies proved that broth 
enrichment methods were superior to direct plating procedures in isolating 
O157 VTEC from minced beef and bovine feces,40,393,505 the number o f reports 
comparing the efficacy o f different selective enrichment broths is limited.
8 8  Johnson et al.210 determined that E. coli Oi57:H7 was more often recovered 
from beef samples (naturally contaminated) that had been enriched in mEC 
+ n than from mTSB + a enrichments o f these samples. It was suggested that 
mTSB + a, although it enhances the production or availability o f O157 antigens, 
may adversely affect cell viability after a certain incubation time. Bennett et 
al.41 also showed that the isolation rate o f E. coli O157 from inoculated minced 
beef by using Dynabeads anti-E. coli O157 was increased when samples were 
enriched in mEC + n compared with enrichment in BPW containing 
vancomycin (8 mg/l), cefsulodin (10 mg/l), and cefixime (0.05 mg/l) (BPW- 
vcc). Sanderson et al.393 found no differences between TSB containing cefixime 
(0.05 mg/l) and vancomycin (40 mg/l) (TSBcv), and TSB containing cefixime, 
vancomycin, and tellurite (2.5 mg/l) (TSBcvt). Following enrichment of 
inoculated bovine feces in both media, they spread plated the cultures onto 
CT-SMAC and compared the percentages o f positive samples detected and the
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50% detection limits. At first, we also included EEB in the evaluation of selective 
enrichment media,480 which is a modification o f BPW-vcc.84 While BPW is 
the base o f BPW-vcc, the main part o f EEB is mTSB. EEB was found to be 
inhibitory to pure cultures o f O157 VTEC during initial trials, and cefixime 
appeared to be the most critical factor in the enrichment broth (data not shown). 
Therefore, we decided to do no further experiments with EEB. EEB was first 
described by Weagant et al.,480 who compared the recovery o f E. coli Oi57:H7 
from both artificially and naturally contaminated food samples by using two 
different protocols: one was a 6-h incubation in EEB followed by plating onto 
CT-SMAC, and the other, a 24-h incubation in mTSB + n followed by plating 
onto HC agar.435 The first method proved to be clearly better than the second, 
possibly not only the result o f the newly devised enrichment medium but also 
ofthe very selective CT-SMAC. In contrast to the few reports on the comparative 
evaluation o f selective enrichment media, more literature is available on the 
comparison of selective plating media.40,85,88,288,393,435,501 In most recent 
studies the use o f CT-SMAC is recommended. Bennett et al.40 reported that 
replacement o f SMAC with CT-SMAC increased the isolation rate o f E. coli 
O157 from inoculated minced beef, both when directly plated after enrichment 
and when plated after performing the Dynabeads anti-E. coli O157 method. 
Sanderson et al.393 compared SMAC, C-SMAC, and CT-SMAC for the isolation 
o f E. coli Oi57:H7 from bovine feces directly inoculated, from feces o f naturally 
colonized dairy cattle, and from feces o f calves orally inoculated, and concluded 
that CT-SMAC was the most sensitive plating medium. Comparing CR-SMAC 
and CT-SMAC, Zadik et al.501 also reported that CT-SMAC increased the rate 
o f isolation o f O157 VTEC from cattle rectal swabs (naturally contaminated). 
Chapman et al.88 found the sensitivities o f CR-sM aC and CT-SMAC not 
apparently different for the isolation o f E. coli O157 strains from artificially 
inoculated bovine feces, but observed a greater ratio o f E. coli O157 to sorbitol- 
fermenting E. coli on CT-SMAC, which increased the ease o f selection o f non­
sorbitol-fermenting colonies for confirmation procedures. The above results 8 9  
are consistent with our observation that CT-SMAC was the most selective 
medium. The inclusion o f cefixime and tellurite markedly reduces the growth 
of both non-sorbitol-fermenting organisms mimicking O157 VTEC and 
sorbitol-fermenting E. coli possibly masking O157 VTEC. Because o f the 
increased bacterial inhibition, lower dilutions can be plated, improving the 
sensitivity.
Although substantial differences in sensitivity o f the commercial test kits were 
observed when dilutions o f pure bacterial cultures were tested, all kits could 
detect less than one O157 VTEC cell per g o f minced beef after enrichment of 
the inoculated samples in mTSB + a. The recovery o f O157 VTEC is dependent 
upon the competitive flora present, both the total number o f bacteria and the 
number o f coliforms (both counts were not performed for the minced beef 
samples used in this study). Compared with the conventional cultural approach,
sensitivity was only slightly improved by the use o f the test kits. However, the 
advantages o f the kits are simplicity, high-volume testing, and reducing time 
to give a presumptive result. While the conventional cultural approach with 
selective enrichment for 18 to 20 h gave a presumptive result after 2 days, the 
kits tested yielded presumptive results after just 1 day. All immunoassays 
evaluated are detection systems only, and need to be completed with the 
isolation o f the organisms. The primary use o f these procedures is therefore 
to identify food samples that possibly contain E. coli O157. In addition, E. coli 
O157 somatic antibody cross-reacts with bacteria o f different genera, including 
Salmonella group N species, some Yersinia enterocolitica, and Brucella spp. 
Therefore, false-positive reactions can occur.210,213,334 Recently, the specificity 
o f the EHEC-TEK ELISA for detection o f E. coli Oi57:H7 in raw meats was 
improved by a modified test protocol incorporating immunocapture.2I3 Bennett 
et alAi showed this modified ELISA system to be less sensitive than the standard 
Tecra ELISA. In contrast to the immunoassays, the immunomagnetic 
separation procedure with Dynabeads anti-E. coli Oi57 directly yields an isolate 
that may be useful in epidemiological studies. Immunomagnetic separation 
has been shown to be a sensitive method for isolation o f E. coli Oi57 from 
artificially mixed bacterial cultures, inoculated meat samples, and inoculated 
as well as naturally contaminated bovine feces.4i,88,i44,333,499 The 
immunomagnetic separation increases sensitivity by relatively concentrating 
E. coli Oi57 compared with background microflora, which may overgrow or 
mimic Oi57 VTEC cells on selective agars. Bennett et alAi showed that the 
increase in sensitivity depended on the choice o f enrichment medium, mEC 
+ n performing better than BPW-vcc. Equivalent results were achieved with 
mEC + n and lauryl tryptose broth enrichments by Fratamico et alM4 
The Verotox F test is a rapid and simple test for identifying the VT type o f Oi57 
VTEC isolates. Results were obtained after 48 h and were consistent with PCR 
results, which were obtained after 26 to 28 h. The general Vero cell assay 
9 0  requires about i week.232 Both the PCR and Vero cell assays are, despite their 
sensitivity and specificity, too expensive and technically demanding for most 
routine labs. The PCR is based on detection ofVT-coding genes, which means 
that nothing can be said about the expression o f the genes. Although the 
Verotox F test seems a good alternative for Vero cell assays and the PCR, several 
different antigenic variants or types o f toxin exist and immunological methods 
are not likely to detect all VTs with equal efficiency, while some VTs may not 
be detected at all.
In conclusion, enrichment in mEC + n at 37°C for 6 to 8 h with shaking at 
i00 rpm, followed by immunomagnetic separation using Dynabeads anti- 
E. coli Oi57 and spread plating o f the concentrated target cells onto CT-SMAC 
appears to be a sensitive and cost-effective method for the isolation o f E. coli 
Oi57 from minced beef in food industry and epidemiological studies involving 
large numbers o f samples. The commercial Verotox F test can be used to
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determine whether the isolates produce VTi and/or VT2. Further evaluation 
o f this recommended method by examining naturally contaminated samples 
is currently proceeding in our laboratory.
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Occurrence and survival of verocytotoxin-producing 
Escherichia coli O157 in meats obtained from retail 
outlets in the Netherlands
Chapter
Summary
In i996 and i997, 2,94i fresh and processed meat products obtained from 
supermarkets and butcher shops in the Netherlands were examined for the 
presence o f verocytotoxin-producing Escherichia coli o f serogroup Oi57 (Oi57 
VTEC). Additionally, the fate o f Oi57 VTEC in raw meat products stored at low 
temperatures and the effect o f different additives were evaluated. Oi57 VTEC 
strains were isolated from 6 (i.i%) o f 57i samples o f raw minced beef, 2 (0.5%) 
o f402 samples o f raw minced mixed beef and pork, i (i.3%) o f 76 samples o f 
raw minced pork, i (0.3%) o f 393 samples o f other raw pork products, and i 
(0.3%) o f 328 samples o f cooked or fermented ready-to-eat meats. Other raw 
beef products (n = 223) and meat samples originating from poultry (n = 8i9), 
sheep or lamb (n = 46), or wild animals (n = 83) were all found to be negative 
for Oi57 VTEC. For the survival experiments we used tartaar (minced beef with 
a fat content o f less than i0%) and filet americain (tartaar mixed with a 
mayonnaise-based sauce [80 to 20%]). The Oi57 VTEC strain tested was able 
to survive in tartaar and filet americain stored at -2 0 , 0, 5, or 7°C for 3 days. 93  
At both 7 and at i5°C, Oi57 VTEC counts in tartaar and filet americain remained 
virtually unchanged throughout a storage period o f 5 days. Addition o f acetic 
acid (to pH 4.0), sodium lactate (i and 2% [wt/wt]), or components o f the 
lactoperoxidase-thiocyanate-hydrogen peroxide system to filet americain did 
not result in a reduction o f viable Oi57 VTEC cells during storage at 7 or i5°C.
It was concluded that raw meat contaminated with Oi57 VTEC will remain a 
hazard even i f  the meat is held at low or freezing temperatures.
A.E. Heuvelink, J.T.M. Zwartkruis-Nahuis, R.R. Beumer, and E. de Boer. 
Journal of Food Protection 1999; 62:1115-1122.
I n t r o d u c t i o n
Verocytotoxin (VT)-producing strains o f Escherichia coli Oi57 (Oi57 VTEC) were 
first identified as human pathogens in i982, during the investigation o f two 
outbreaks o f bloody diarrhea in the United States, outbreaks which were 
associated with consumption of undercooked hamburgers from a particular 
fast-food chain.376 Since then, Oi57 VTEC strains have become one o f the most 
significant foodborne pathogens in developed countries. Infection with Oi57 
VTEC presents a wide spectrum o f clinical manifestations, ranging from 
asymptomatic carriage and nonbloody diarrhea to more serious clinical 
conditions such as hemorrhagic colitis and hemolytic-uremic syndrome.60 
The most common cause o f Oi57 VTEC infection has been consumption of 
raw or undercooked foods of bovine origin, particularly hamburgers and cow's 
milk.354 Other foods that have been identified as vehicles o f transmission 
include venison jerky, apple juice, apple cider, cantaloupe, potatoes, radish 
sprouts, and alfalfa sprouts. However, food is not the only vehicle that can 
transmit Oi57 VTEC organisms. Infection with Oi57 VTEC can also be 
acquired through contaminated drinking or swimming water, close contact 
with infected animals, and through person-to-person transmission.
Cattle are regarded as the principal reservoir o f Oi57 VTEC, and despite the 
variety o f vehicles o f transmission, it is believed that cattle feces in one form 
or another is the most common source o f human infections.27 Beef and milk 
can become contaminated with fecal matter during slaughter and milking 
practices, respectively. Vegetables and fruits can become contaminated through 
the cattle manure that may be used in the soil in which these plants are 
cultivated; in addition, plants may become contaminated through the use of 
contaminated water for irrigation and washing purposes. Animals other than 
cattle and humans that have been observed to shed Oi57 VTEC include sheep, 
horses, deer, dogs, and birds.
9 4  In a previous study/87 we examined the occurrence o f Oi57 VTEC in Dutch 
food-producing animals at slaughter, and we isolated these bacteria from about 
i0%  of adult cattle (n = 540), 0.5% o f veal calves (n = 397), 4% of ewes (n = 
52), and 4% of lambs (n = 49). Upon examination o f samples o f raw cow's 
milk (n = i,0ii) from bulk storage tanks, none o f the samples was found to be 
positive for Oi57 V TECJ84 The objective o f the study reported here was to 
examine the occurrence o f Oi57 VTEC in meats obtained from supermarkets 
and butcher shops. In addition, we studied the fate o f Oi57 VTEC in raw meats 
during storage at low temperatures and evaluated the effects o f different curing 
agents.
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M a t e r i a l s  a n d  m e t h o d s
Occurrence of 0 157 VTEC in meats
In i996 and i997, a total o f 2,94! fresh and processed meat products obtained 
from supermarkets and butcher shops in the Netherlands were examined for 
the presence o f Oi57 VTEC. The samples were randomly collected by food 
inspectors during their usual inspections o f retail outlets. After collection, the 
samples were maintained at 0 to 4°C during transport to the laboratory, where 
they were processed upon arrival or after overnight storage at 4°C.
Oi57 VTEC strains were isolated and characterized as described previously.i87 
Briefly, a 20-g portion o f meat sample was homogenized in a stomacher with 
i80 ml o f modified E. coli broth containing novobiocin (20 mg/l) (Sigma 
Chemical Co., St. Louis, MO) (mEC + n).3^  After 6 to 8 h incubation at 37°C 
(with agitation [i00 rpm]), about 5 ml o f each enriched sample was filtered 
through a piece o f paper towel in order to remove particulate matter. One ml 
o f filtrate was then added to 20 ^l o f magnetic beads coated with antibodies 
to E. coli Oi57 (Dynal, Oslo, Norway). Following immunomagnetic separation, 
which was performed according to the manufacturer's instructions, the beads 
were inoculated onto sorbitol MacConkey agar (Oxoid Unipath Ltd., 
Hampshire, UK) (SMAC) supplemented with cefixime (0.05 mg/l) and 
potassium tellurite (2.5 mg/l) (Dynal) (CT-SMAC).50I After incubation at 37°C 
for i8 to 20 h, non-sorbitol-fermenting colonies were selected and screened 
(up to i2 per sample) for lactose fermentation on Levine's eosin methylene 
blue agar (Oxoid), for the absence o f 6-glucuronidase on SMAC containing 4- 
methylumbelliferyl-6-D-glucuronide (0.i g/l) (Sigma),3^  and for the presence 
o f the Oi57 antigen by agglutination with an E. coli Oi57 latex test kit (Oxoid). 
Subsequently, the isolates thus selected were confirmed as E. coli by using an 
API 20E biochemical test strip (bioMerieux, Lyon, France) and as serogroup 
Oi57 by agglutination to titer with antiserum to E. coli Oi57 (Dr. W.J. van 95  
Leeuwen, National Institute o f Public Health and the Environment, Bilthoven,
The Netherlands).
For all isolates confirmed to be E. coli Oi57, toxicity was determined by Vero 
cell culture assay.232 Toxin type (VTi and/or VT2) and the presence o f the E. coli 
attaching-and-effacing (eae) gene were determined by a multiplex PCR assayi86 
The isolates were submitted to the Laboratory o f Enteric Pathogens o f the 
Central Public Health Laboratory in London (UK) for phage typing. The pulsed- 
field gel electrophoresis (PFGE) technique o f contour-clamped homogeneous 
electric fields (CHEF) was used for genomic typing o f the isolates.i87 Following 
digestion with XbaI (i0 U) (Boehringer Mannheim, Mannheim, Germany), 
the resulting DNA fragments were resolved by CHEF-PFGE in a CHEF DR-
III apparatus (Bio-Rad Laboratories, Richmond, Calif.) at a constant voltage o f 
200 V for 24 h at i3°C and with switch times ramped from 3 to 50 s. Recovery
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experiments demonstrated that Oi57 VTEC could be detected at inoculum 
levels o f about one organism per gram of raw meat.I9I
In addition to this continual survey, in both i996 and in i997 additional meat 
samples were collected because o f extensive inspections o f two different 
butcher shops. The samples were processed as described above.
Survival of O157 VTEC in raw meats
In order to examine the survival o f Oi57 VTEC in raw meats stored at low 
temperatures, we used tartaar (minced beef with a fat content o f less than i0%) 
and filet americain (tartaar mixed with a mayonnaise-based sauce [80 to 20%]). 
The former meat is frequently consumed after it has been half-cooked, such 
that the internal temperature is insufficient to kill microorganisms, and the 
latter meat is a ready-to-eat product. All batches o f meat used were analyzed 
for naturally occurring Oi57 VTEC according to the method described above. 
A clinical Oi57 VTEC isolate from our own collection (culture collection no. 
89005) was used as a test strain. Prior to each experiment, the strain was 
cultured in brain heart infusion broth (Oxoid) at 37°C for i8 to 20 h. Serial 
dilutions (i:i0) o f up to i0 -7 were made in 0.i%  peptone water to serve as 
inocula.
Survival o f O157 VTEC in raw meats: survival experiment 1
Meat samples were divided into i6 portions o f 25 g each, which were formed 
into balls and transferred to sterile stomacher bags. The meatballs were 
aseptically inoculated in the center o f the meatball using a sterile pipette. Four 
portions were inoculated with 0.i-ml aliquots o f the i0 -7 dilution o f the Oi57 
9 6  VTEC test culture, four portions were inoculated with 0.i-ml aliquots o f the 
i0 -6 dilution, four portions were inoculated with 0.i-ml aliquots o f the i0 -5 
dilution, and the remaining four portions served as controls. The actual 
inoculum numbers were determined by plate counts on tryptone soy agar 
(Oxoid) (TSA). After inoculation, all bags were sealed and stored at -20 , 0, 5, 
or 7°C for 3 days. About 20 g o f each meat sample was then homogenized with 
i80 ml o f mEC + n and was incubated at 37°C with agitation (i00 rpm) for 6
h. For enumeration o f Oi57 VTEC, serial dilutions (i:i0) up to i0 -4 were made 
in 0.i%  peptone water, and i ml o f each dilution was spread plated in duplicate 
onto CT-SMAC plates (0 i4 cm) and incubated at 42°C for 20 to 24 h. Typical 
colonies were picked and confirmed by agglutination with the E. coli Oi57 latex 
test kit. Confirmed populations were expressed as logi0 CFU per ml o f culture. 
For both types o f meats, two separate trials were conducted. Mean values of 
Oi57 VTEC counts were compared for significant differences (P < 0.05) by 
Student's t test.
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Meat samples were divided into i i  portions o f 25 g each, which were formed 
into balls, transferred to sterile stomacher bags, and inoculated in the center 
with i-ml aliquots o f the i0 -4 dilution o f the Oi57 VTEC test culture. After 
inoculation, the bags were sealed. Five samples were stored at 7°C, another 
five samples were stored at i5°C, and the remaining sample was analyzed 
immediately according to the method described below. After i, 2, 3, 4, and 5 
days, both a sample stored at 7°C and a sample stored at i5°C were analyzed 
for viable populations o f Oi57 VTEC and total viable counts. Samples were 
combined with 225 ml o f sterile 0.i%  peptone water and homogenized in a 
stomacher for i min. The resulting homogenates were serially diluted and 
surface plated (0.i ml) in duplicate onto CT-SMAC and TSA. Plates were 
incubated at 37°C for i8 to 20 h before colonies were counted. Selected 
presumptive Oi57 VTEC colonies on CT-SMAC were confirmed using the 
E. coli Oi57 latex agglutination assay. Confirmed Oi57 VTEC populations and 
total viable counts were expressed as logi0 CFU per g o f meat.
Survival o f O157 VTEC in raw meats: effect o f acetic acid
A batch o f tartaar was divided into four portions o f i55 g. The portions were 
transferred to sterile stomacher bags and mixed with 45 g o f a commercially 
available mayonnaise-based sauce commonly used to prepare filet americain.
Half o f the portions was acidified with acetic acid (Sigma) to pH 4.0. All four 
portions o f meat were then inoculated with the Oi57 VTEC test strain to give 
an initial inoculum o f about i07 CFU per g o f meat. After inoculation, the bags 
were sealed. One set o f samples was stored at 7°C and the other set o f samples 
was stored at i5°C. Immediately after inoculating and after i, 2, 3, and 4 days 
of incubation, 25-g portions of meat were removed aseptically for determination 9 7  
o f the viable numbers o f Oi57 VTEC cells (see experiment 2).
Survival o f O157 VTEC in raw meats: effect o f sodium lactate
A batch o f tartaar was divided into four portions o f i55 g. The portions were 
transferred to sterile stomacher bags and mixed with 45 g o f the mayonnaise- 
based sauce. Then, sodium lactate (60% [wt/wt] food-grade solution; PURAC, 
Gorinchem, The Netherlands) was added to a final concentration o f i% 
(wt/wt) in two portions and of 2% (wt/wt) in the other two portions. All four 
portions o f meat were then inoculated with the Oi57 VTEC test strain to give 
an initial inoculum o f about i07 CFU per g o f meat. After inoculation, the bags 
were sealed. One set o f samples was stored at 7°C and the other set o f samples
Survival o f O157 V TEC in raw meats: survival experiment 2
was stored at i5°C. Immediately after inoculating and after i, 2, 3, and 4 days 
o f incubation, 25-g portions o f meat were aseptically removed for determination 
o f the viable numbers o f Oi57 VTEC cells (see experiment 2).
Survival o f O157 VTEC in raw meats: effect o f the lactoperoxidase-
thiocyanate-hydrogen peroxide system
A batch o f tartaar was divided into three portions o f i55 g. The portions were 
transferred to sterile stomacher bags and mixed with 45 g o f the mayonnaise- 
based sauce. One portion was subsequently mixed with ix  components o f the 
lactoperoxidase-thiocyanate-hydrogen peroxide system (LPS): lactoperoxidase 
from cow's milk (i8.5 |ig/ml) (DMV-International, Veghel, The Netherlands); 
glucose (0.3%) (Merck, Darmstadt, Germany); glucose oxidase (0.i U/ml) 
(Boehringer); and sodium thiocyanate (0.26 mM) (Merck). Another portion 
was mixed with 2X components o f the LPS system. All three portions o f meat 
were then inoculated with the Oi57 VTEC test strain in order to give an initial 
inoculum of about i07 CFU per g o f meat. After inoculation, the bags were 
sealed and stored at 7°C. Immediately after inoculating and after i, 2, 3, 4, and
5 days o f incubation, 25-g portions were aseptically removed and analyzed for 
viable populations o f Oi57 VTEC and for the total number o f viable cells (see 
experiment 2). In a separate experiment, the samples were stored at i5°C.
R e s u l t s
Occurrence of O157 VTEC in meats
In i996, Oi57 VTEC strains were isolated from 4 (i.2%) o f 325 samples o f raw 
9 8  beef, 2 (0.8%) o f 262 samples o f raw pork, i (0.4%) o f 255 samples o f raw 
minced mixed beef and pork, and i (0.3%) o f 302 samples o f cooked or 
fermented ready-to-eat meats (Table i). In i997, Oi57 VTEC strains were 
isolated from 2 (0.4%) o f 469 samples o f raw beef and from i (0.7%) o f i47 
samples o f raw minced mixed beef and pork. Oi57 VTEC strains were not 
isolated from meat samples originating from poultry, sheep or lamb, or wild 
animals. The ii  positive meat samples came from seven different retail outlets 
and were collected on nine different dates (Table 2). The results o f the PCR 
assay, the Vero cell assay, o f the phage typing, and of the PFGE are presented 
in Table 2. On the basis ofthe combined results ofVT genotyping, phage typing, 
and PFGE, i0 distinct Oi57 VTEC strain types were identified.
In March i996, the isolation o f Oi57 VTEC from both a sample o f dry 
fermented sausage and a sample o f sausage batter obtained from butcher shop 
I prompted us to collect additional samples from this shop. Furthermore, a
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Table 1. Isolation o f O157 VTEC strains from meats obtained from retail outlets in the 
Netherlands in 19 96  and 1997
Type of  meat No. (%) o f samples positive for O157 VTEC
1996 1997
Raw m in ced  bee f 4/264 (i.5) 2 /307 (0.7)
Raw bee f 0 /61 0 / i 62
Total raw  bee f 4 / 32 5 I1.2) 2 /4 6 9 (0.4)
Raw m in ced  po rk i/5 9 (1 .7) 0 / i 7
Raw pork i /2 o 3 (°.5) 0 / i 90
Total raw  pork 2/262 (0 .8) 0 /207
Raw m in ced  m ixed b ee f a n d  pork i/255 (0.4) i / i4 7 (0.7)
Raw sheep /lam b 0/46 ND a
Raw chicken 0 /267 0 /477
O ther raw  poultry  b 0 / i 3 0/62
Total raw  poultry 0/280 0/539
Raw m eat from  w ild an im als c 0/33 0/50
C ooked /ferm en ted  m e a t products i /302 (0.3) 0/26
Total 8/ I ,50 3 (0.5) 3/i,438 (0 .2 )
a ND, n o t done.
b Inc lud ing  p heasan ts , w ild  ducks, guinea-fowl, an d  turkeys. 
c Inc lud ing  w ild boars, deer, rabbits, a n d  hares.
second sample o f dry fermented sausage obtained from butcher shop I in 9 9  
March was found to be positive for Salmonella spp. The butcher shop was 
revisited on 25 March and 2 April 1996. All 44 samples collected were found 
to be negative for O157 VTEC. However, Salmonella spp. were isolated from 4 
(28.6%) o f the 14 samples o f raw pork ingredients, 5 (55.5%) o f the 9 samples 
o f sausage batters or undried sausages, and 13 (61.9%) o f the 21 samples of 
finished sausages.
As a result o f the two positive meat samples from butcher shop VI in the 
beginning o f December 1997, additional inspections were carried out at this 
shop. Between mid-December 1997 and mid-March 1998, this butcher shop 
was revisited six times. All 5 samples collected on the first revisit (15 December
1997) were found to be positive; 3 samples o f raw minced beef, 1 sample of 
raw minced mixed beef and pork, and 1 sample o f another raw beef product.
Of the 5 samples collected on the second revisit (29 December 1997), 2 were
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Table 2. Characterization o f O157 VTEC isolates from meats obtained from retail outlets in the
Netherlands in 1996  and 1997
Type o f meat Date o f sampling Origin o f PCR results for a:
Result o f 
Vero cell
Phage PFGE
sample VTi VT2 eae
assay for type
pattern
VT
Raw m in ced  bee f 13 M arch 19 9 6 S uperm arket 1 + + + + Rdnc b A
Raw m in ced  po rk  c 22 M arch 19 9 6 Butcher shop 1 + + + + i B
Dry fe rm en ted 22 M arch 19 9 6 Butcher shop 1 + + + + 4 B
pork  sausage d
Raw po rk 9 July 19 9 6 Butcher shop 2 - + + + 4 C
Raw m in ced  bee f 3 July 19 9 6 Butcher shop 3 + + + + i D
Raw m in ced  m ixed 13 A ugust 19 9 6 Butcher shop 4 + + + + i4 E
bee f a n d  pork
Raw m in ced  bee f 5 S ep tem ber 199 6 Butcher shop 5 + + + + 8 F
Raw m in ced  bee f 29  O ctober 19 9 6 Butcher shop 2 - + + + 32 G
Raw m in ced  bee f 21  A ugust 199 7 Butcher shop 4 - + + + 2 H
Raw m in ced  bee f 8 D ecem ber 199 7 Butcher shop 6 - + + + 54 I
Raw m in ced  m ixed 8 D ecem ber 199 7 Butcher shop 6 - + + + 54 I
bee f a n d  pork
a +, positive; -, negative.
b Rdnc, reac ted  w ith  the phage set b u t d id  n o t co rrespond  to a recogn ized  phage type.
c Sam ple o f  sausage batter; p H = 6 .o  a n d  aw o. 9 .
d  Sam ple o f  en d  product; p H = 5.i an d  aw=o 9 6 .
found positive; O157 VTEC were isolated from 1 sample o f raw minced beef 
(n = 2) and from 1 sample o f raw minced mixed beef and pork, and no O157 
VTEC were isolated from samples o f other raw beef products (n = 2). Samples
IO O  o f raw meat collected on the subsequent four revisits were all found to be 
negative; 13 samples from the third revisit (9 January 1998), 6 samples from 
the fourth revisit (23 January 1998), 5 samples from the fifth revisit (27 February
1998), and 5 samples from the sixth revisit (23 March 1998). The nine O157 
VTEC isolates originating from this butcher shop could not be mutually 
distinguished by any o f the typing methods used in this study. They all showed 
cytotoxicity in the Vero cell assay, carried VT2 and eae genes, belonged to phage 
type 54, and generated identical Xbal restriction patterns (data not shown). 
Earlier in 1997 (23 May 1997), two meat samples had been collected from 
butcher shop VI - a sample o f raw minced beef and a sample o f raw minced 
mixed beef and pork - both of which were found to be negative for O157 VTEC.
Survival ofO157 VTEC in raw meats
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None o f the raw meat samples used for the survival experiments contained 
indigenous O157 VTEC.
Survival o f O157 VTEC in raw meats: survival experiment 1
The O157 VTEC test strain was able to survive in tartaar (average initial pH 
5.7) and filet americain (average initial pH 5.4) stored at -20 , 0, 5, or 7°C for
3 days (Fig. 1). For all three inoculum levels tested, it was observed that after
6 h o f enrichment in mEC + n, there was no significant difference in the 
population o f O157 VTEC related to storage temperature. However, storage of 
filet americain containing an initial number ofless than one CFU of O157 VTEC 
per g at -20 °C  resulted in a significantly lower (P < 0.05) population in the 
mEC + n culture than did storage at 7°C.
Figure 1. Populations o f the O157 VTEC test strain inoculated in tartaar (A) and filet americain (B) 
after storage at -2 0 , 0, 5, and 7°C  for 3 days and following subsequent selective enrichment in mEC 
+ n for 6 h. Error bars represent the standard deviation o f the means. *  , mean values that are 
significantly different (P < 0.05).
Survival o f O157 VTEC in raw meats: survival experiment 2
At both 7 and i5°C, O157 VTEC counts in tartaar and filet americain remained 
virtually unchanged throughout a storage period o f 5 days (Fig. 2). At 7°C, 
background microflora in tartaar grew to maximum populations in 5 days, and 
at i5°C, maximum growth was observed by 3 days. In filet americain, at both
7 and i5°C, the total microbial count increased to maximum populations at 
the end o f the storage period.
1 0 1
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Figure 2. Populations over time o f the O157 VTEC test strain inoculated in tartaar (A) and filet 
américain (B) stored at 7 and I5°C for 5 days. , O157 VTEC count at 7°C; , total microbial count 
at 7°C; ▲  ,0 157 VTEC count at I5°C; •  , total microbial count at I5°C.
Survival o f O157 VTEC in raw meats: effect o f different additives
The addition o f acetic acid or sodium lactate to filet americain did not result 
in a reduction o f viable O157 VTEC cells during storage at 7 or i5°C (results 
not shown). The addition o f components o f the LPS also did not reduce O157 
VTEC populations. The total population o f viable cells in filet americain 
supplemented with components o f the LPS also remained the same (results 
not shown). Furthermore, these treatments produced some undesirable 
changes in the product's appearance.
D i s c u s s i o n
1 0 2
Although many different types o f food have been associated with O157 VTEC 
infections, undercooked ground beef is probably the main vehicle o f O157 
VTEC transmission to man. In the present study, O157 VTEC strains were 
isolated from about 1% of samples o f raw minced beef (n = 571) obtained from 
supermarkets and butcher shops in the Netherlands in 1996 and 1997. In 
addition, O157 VTEC strains were isolated from about 0.5% o f samples o f raw 
minced mixed beef and pork (n = 402), about 1% o f samples o f raw minced 
pork (n = 76), about 0.3% of samples o f other raw pork products (n = 393), and 
0.3% of samples o f cooked or fermented, ready-to-eat meats (n = 328). Meat 
samples originating from poultry (n = 819), sheep or lamb (n = 46), or wild 
animals (n = 83) were all found to be negative for O157 VTEC. During a previous 
survey from October 1992 through September 1995,189 we isolated O157 VTEC 
strains from only 0.3% of samples o f minced mixed beef and pork (n = 770)
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and did not isolate O157 VTEC strains from samples o f raw minced beef (n =
1,000), minced pork (n = 260), or poultry products (n = 300). The application 
o f a less sensitive isolation method, selective plating onto SMAC following 
selective enrichment in modified tryptone soy broth with acriflavin, possibly 
accounted for the lower percentage o f positive meat samples found in the 
referred study. O157 VTEC may be present in contaminated foods in only small 
numbers.
Previously, dry fermented meat products were considered to be safe and ready 
to consume because o f their low final pH (ca. 4.6 to 5.0) and aw (ca. 0.87 to 
0.90). The sausages are made from fermented raw meat without any heat 
treatment. However, recently such products have been involved in foodborne 
disease outbreaks. In late 1994, an outbreak o f O157 VTEC infection in the 
Western United States was linked with consumption of contaminated dry-cured 
salami slices.3 The outbreak involved 23 cases; six patients required 
hospitalization, including two 4-year-old who developed HUS. In early 1995,
23 children were hospitalized with HUS in South Australia.1 Most required 
dialysis; one 4-year-old child died. Investigation o f the outbreak identified 
Oiii:NM (nonmotile), another serotype o f E. coli that produces VT, as the 
principal cause and a locally produced semidry (uncooked) sausage (mettwurst) 
as the source.
Raw meat used for the manufacturing o f fermented meat products may 
frequently be contaminated with pathogenic microorganisms, including 
salmonellae, pathogenic E. coli, listeriae, and staphylococci. In order to 
suppress the growth of these pathogens, a sufficient drop in pH and aw must 
be achieved during the early stages o f fermentation and drying, respectively.
The addition o f starter cultures and the application o f the Hazard Analysis 
Critical Control Point concept are essential instruments for the production of 
a safe product. However, pathogens may not be completely eliminated during 
currently accepted processing methods.138,157,158,265,324,452 Their very low 
infective dose (<50 organisms) makes the presence o f O157 VTEC at any level 1 0 3  
in ready-to-eat fermented products a risk factor o f major concern.452 Largely 
as the result o f the O157 VTEC outbreak in the Western United States, 
processors o f dry and semidry fermented sausage have been required by the 
United States Department of Agriculture and the Food Safety and Inspection 
Service to validate that processing o f these products results in at least a 5-logI0 
reduction in counts o f O157 VTEC.369
In general, studies published to date indicate that fermentation and drying are 
sufficient enough only to effect a reduction o f about 1 to 2 logI0 in the numbers 
o f O157 VTEC.72,96,134,135,137,158,192 Intensifying almost any inhibitory effect of 
common dry-sausage fermentation practice, such as increasing the 
concentrations o f inhibitory spice/cure ingredients, extending fermentation 
and/or drying at lower pH and/or higher temperature, or modifying storage 
temperature and atmosphere, either does not appreciably influence numbers
o f O157 VTEC or will adversely alter palatability and/or appearance o f the 
finished product.96,135,137,324,377 Postfermentation heating seems almost the only 
effective means to achieve the required 5-logI0 decline in pathogen 
numbers.72,192 However, such a processing change is likely to be expensive and 
could possibly result in undesirable sensory and textural changes in some 
sausage varieties. Further studies are warranted so that we can determine 
whether a composite, multiple-hurdle strategy, including some minor changes 
in product formulation combined with a mild heating step after fermentation, 
could be effective in adequately suppressing the presence o f O157 VTEC in 
fermented meat products without producing undesirable sensory changes.377 
Furthermore, Faith et al.134 recently reported some promising strategies related 
to salami processing that require additional optimization in the future; 
extended storage o f salami slices under air at ambient temperature appreciably 
reduced levels o f O157 VTEC and did not cause discoloration or contribute to 
the appearance o f yeasts or molds. It was also demonstrated that conditioning 
o f salami batter (tempering, freezing, and thawing or freezing and thawing) 
had an appreciable effect on the pathogen without affecting the chemical 
composition o f salami slices.134
Inspection of the butcher shop that produced the dry fermented pork sausages 
and pork sausage batters that were found to be positive for Oi57 VTEC and 
Salmonella spp. in our survey revealed that there was no adequate monitoring 
o f the production process. In the end-product, we measured a pH and aw of 
5.1 and 0.96, respectively. Although, according to the manufacturer, the 
sausages were ready to sell, these values demonstrate that the process o f drying 
and ripening was not yet completed. O157 VTEC can grow at a pH of as low 
as 4.5.196 In order to inhibit the growth of O157 VTEC, it is essential to continue 
the drying process to an aw o f <0.95.s>6 It is noteworthy that in the butcher 
shop described above, only pork was used for the preparation o f the dry 
fermented sausages. Cross-contamination in the shop via contaminated beef 
1 0 4  was very unlikely. Future studies will show whether normal pigs can harbor 
O157 VTEC in their intestinal tracts.
The reason for which a relatively high number o f raw meat products from 
butcher shop VI were contaminated with O157 VTEC in December 1997 could 
not be identified. Every 2 to 3 weeks, the butcher buys a cow that is slaughtered, 
cut, and boned in a neighboring slaughterhouse. We investigated the farm from 
which the cow originated that was used to prepare the positive beef samples 
in December 1997. At this farm, 28 cattle were housed and all were sampled 
individually by rectal palpation. One of the cows appeared to excrete O157 VTEC 
(results not shown). However, the animal isolates belonged to a different O157 
VTEC strain type (VT2- and eae-positive, phage type 2, PFGE pattern J) than 
did the isolates from the meat samples. Farrell et alM0 recently reported that 
O157 VTEC in artificially contaminated ground beef can be readily transferred 
to a meat-grinder surface, which underscores the importance o f good cleaning
Verocytotoxin-producing Escherichia coli in humans and the food chain
Chapter 6 -  O157 VTEC in meats
and sanitation o f the grinder after exposure to beef, such that the risk o f cross­
contamination is minimized. Inspection o f butcher shop VI, however, 
concluded that the butcher applied good hygienic production and handling 
processes.
The meat products used for the survival experiments in this study were typical 
o f products that are being consumed undercooked or that are not being cooked 
in the Netherlands today. In the first experiment, the artificially contaminated 
tartaar and filet americain were held at -20 , 0, 5, and 7°C for 3 days in order 
to simulate the storage o f raw meats by the consumer. Results indicated that 
O157 VTEC, even when their initial number was less than one CFU per g, could 
survive this type o f maintenance. Doyle and Schoeni120 reported that O157 
VTEC survives freezing at -80°C  in ground beef patties and that little change 
in numbers occurred during 9 months o f storage at -20°C . Conner and Hall99 
also noted that O157 VTEC was relatively resistant to the lethal effects of 
freezing; during 18 months o f storage at -20°C , more than 50% of the cells 
survived in chicken meat with and without food additives. In our second 
survival experiment, the numbers o f O157 VTEC during storage o f tartaar and 
filet americain at 7 (refrigeration temperature) and at 15 °C (abusive 
temperature) were monitored. In general, the numbers o f O157 VTEC in the 
inoculated samples remained the same during the 5-day storage period. 
Palumbo et al.343 reported that strains o f O157 VTEC could grow at 8, 12, and 
15 °C in ground beef. Background flora, i f  initially present in numbers greater 
than the O157 VTEC strains, will suppress this growth. However, the O157 
VTEC strains maintained themselves during nongrowth conditions. Abdul- 
Raouf et al.10 observed no change in O157 VTEC populations in beef salads 
(pH 5.4) containing up to 40% mayonnaise and held at 5°C for up to 3 days.
During the preparation o f foods like filet americain and beef salads, the 
antimicrobial effects o f mayonnaise will be diluted.
In order to study the effects o f different preservatives on the fate o f O157 VTEC 
in filet americain, we prepared this meat product according to a commonly 1 0 5  
used recipe so that we knew the ingredients precisely. None o f the preservatives 
tested seemed to affect the numbers o f O157 VTEC; whereas they did not grow 
in filet americain held at 7 or i5°C, the viable O157 VTEC count remained 
constant. The results obtained with acetic acid were similar to those obtained 
previously with culture broths, which indicates that Oi57 VTEC strains are 
relatively tolerant to acetic acid.i0° No growth occurred in tryptic soy broth with 
0.6% yeast extract acidified to pH 5.2 with acetic acid during holding at 4 or 
i0°C for 56 days. Furthermore, studies o f survival in acidic foods demonstrated 
that Oi57 VTEC are particularly acid tolerant, in general, at low temperatures.
Tsai and Chou458 suggested that the decreased antimicrobial effect exhibited 
at lower temperatures compared with the antimicrobial effect at higher 
temperatures may be attributed to the decreased metabolic activity o f 
microorganisms at lower temperatures.
Lactic acids and lactates are naturally present in meat products. Sodium and 
potassium lactate may be added to foodstuffs as flavor enhancers, flavoring 
agents, humectants, and pH control agents. Lactates decrease the aw, which 
increases the microbial stability. However, in addition, the specific lactate-ion 
effect contributes to the improvement o f the shelf life o f the product.i94 
Papadopoulos et al.344,345 reported that 3% sodium lactate was the optimum 
level to use as a bacteriostatic agent and flavor enhancer in cooked, uncured 
roast beef. Miller and Acuff309 studied the effect o f sodium lactate on pathogens 
in cooked beef during vacuum-packaged storage at i0°C. They reported that 
sodium lactate at 3 and 4% showed some control over the proliferation of Oi57 
VTEC and other pathogens, compared with control roasts (0% sodium lactate). 
However, from the food safety and sensory perspectives, they recommended 
3% sodium lactate for use in precooked, uncured roast beef products. As in 
our results, Conner and Hall99 found no significant inhibitory effect o f 3 or 
4% of sodium lactate on populations o f Oi57 VTEC in frozen chicken meat. 
The LPS is a naturally occurring system in cow's milk, which has been proven 
to be bacteriostatic to many Gram-positive microorganisms and bactericidal 
to a variety o f Gram-negative microorganisms.497 Lactoperoxidase catalyses 
the oxidation o f thiocyanate by hydrogen peroxide, yielding short-lived 
intermediary oxidation products that may be further oxidized to end products 
such as sulfate, CO2, and ammonia or that may be reduced back to thiocyanate. 
These intermediary oxidation products have been identified as the active 
antimicrobial agents o f the LPS. Studies with artificially contaminated cow's 
milk have demonstrated that addition o f components o f the LPS resulted in 
inhibition and inactivation o f Oi57 VTEC; the degree o f inhibition was related 
to initial numbers o f the pathogen, time of exposure to the LPS, and incubation 
temperature.I39,I84 The absence o f a significant antimicrobial effect in the 
inoculated filet americain may possibly be explained by the instability o f the 
lactoperoxidase, since populations ofbackground flora also remained the same.
1 0 6  Although the levels o f inoculation tested in this study are highly unlikely to 
occur, it can be concluded that raw meat that becomes contaminated with OI57 
VTEC will remain a health hazard even i f  the meat is held at low or freezing 
temperatures. Although the cells do not grow, they remain viable. Good 
Manufacturing Practices and the implementation o f an Hazard Analysis 
Critical Control Point program in food manufacturing and food preparation 
can help to control OI57 VTEC. Prevention o f cross-contamination and of 
unsanitary handling practices by food manufacturers and consumers are 
critical elements in controlling the contamination o f foods and, consequently, 
can address the need to minimize the risk o f human infection. Finally, the 
consumer needs to be aware o f the potential health risks associated with 
consumption of meats that are not heated or that are only partly heated prior 
to consumption.
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Occurrence and survival of verocytotoxin-producing 
Escherichia coli OI57 in raw cow’s milk in the 
Netherlands
Chapter
Summary
From May through November i997, i,0 ii samples o f raw milk from bulk 
storage tanks were examined for the presence o f verocytotoxin-producing 
Escherichia coli o f serogroup OI57 (OI57 VTEC) by immunomagnetic separation 
following selective enrichment. The samples originated from i,0 ii different 
dairy herds located throughout the Netherlands. OI57 VTEC were not isolated 
from any o f the milk samples examined. Additionally, survival o f OI57 VTEC 
in raw and UHT-sterilized cow's milk at 7 and i5°C was studied, both in the 
absence and presence o f an activated lactoperoxidase-thiocyanate-hydrogen 
peroxide system (LPS). Results indicated that the OI57 VTEC strain tested was 
able to grow in raw milk at 7°C as well as at i5°C. Naturally occurring amounts 
o f thiocyanate and hydrogen peroxide in the raw milk tested were not sufficient 
to activate the LPS. Although the LPS exhibited an antimicrobial activity against 
OI57 VTEC in LPS-activated sterilized milk, OI57 VTEC populations were not 
(or not as obviously) reduced in LPS-activated raw milk. Possibly background 1 0 7  
microflora were more sensitive to the LPS than the OI57 VTEC test strain. It 
was concluded that raw milk contaminated with OI57 VTEC will remain a 
hazard i f  kept at 7 or i5°C. Effective pasteurization and avoiding 
postpasteurization contamination are necessary to ensure the safety o f milk.
A.E. Heuvelink, B. Bleumink, F.L.A.M. van den Biggelaar, M.C. te Giffel, 
R.R. Beumer, and E. de Boer.
Journal ofFood Protection 1998; 61:1597-1601.
I n t r o d u c t i o n
Verocytotoxin (VT)-producing Escherichia coli strains o f serogroup OI57 (OI57 
VTEC) are recognized as the primary cause o f hemorrhagic colitis (HC) and 
the diarrhea-associated form (D+) o f the hemolytic-uremic syndrome (HUS).60 
The mechanisms by which OI57 VTEC strains cause disease are not completely 
understood. Virulence factors contributing to the pathogenesis include the 
production o f VTs (VTi and/or VT2), which are thought to cause the vascular 
endothelial damage observed in HC and D+ HUS patients446 and probably 
the formation o f attaching-and-effacing lesions in the intestine o f the host 
similar to those observed in animal studies.300 Man can become infected with 
OI57 VTEC following the consumption of contaminated foods or by direct 
transmission o f the pathogens from infected humans or animals.27 The 
majority o f outbreaks have resulted from transmission of OI57 VTEC through 
the consumption of ground beef. Since healthy cattle can harbor OI57 VTEC 
in their intestinal tract, they are regarded as a natural source o f these 
pathogens. Beef may be contaminated during slaughter. Cow's milk has also 
been documented as a vehicle for OI57 VTEC infections.59,86,237,294,457 Even 
pasteurized milk and yogurt have been implicated in outbreaks,3^ 466 
apparently due to contamination via raw milk or improper processing.
The lactoperoxidase-thiocyanate-hydrogen peroxide system (LPS) is a naturally 
occurring system which has been proven to be bacteriostatic to many Gram­
positive microorganisms and bactericidal to a variety o f Gram-negative 
microorganisms.497 Lactoperoxidase (LP) catalyses the oxidation o f thiocyanate 
(SCN-) by hydrogen peroxide (H2O2), yielding short-lived intermediary 
oxidation products which may be further oxidized to end products such as 
sulfate, CO2, and ammonia or may be reduced back to SCN-. These 
intermediary oxidation products have been identified as the active antimicrobial 
agents o f the LPS. The major intermediary oxidation product o f SCN- is the 
1 0 8  hypothiocyanite ion (OSCN-). LP is the most abundant enzyme in cow's milk, 
constituting about 0.5 to i.0%  of the whey proteins or 30 to 60 mg/ml o f milk. 
SCN- is derived from glucosinolates and cyanogenic glucosides present in feed. 
Concentrations in cow's milk have been estimated at i to I5 mg/l o f milk, 
varying with breed, species, udder health, and type o f feed. H2O2 is present 
only in traces in freshly drawn milk. It may be generated by polymorphonuclear 
leukocytes or catalase-negative bacteria, e.g., lactic acid bacteria. Although the 
detailed mode of action o f the system remains unclear, the oxidation of 
sulfhydryl groups in various enzymes and other essential proteins in the 
bacterial cell wall is considered to play a key role.m
The organism's link with dairy cattle and raw milk prompted us to examine 
the occurrence and survival o f OI57 VTEC in raw cow's milk. Samples o f milk 
from bulk storage tanks o f different dairy farms located throughout the 
Netherlands were analyzed for the presence o f OI57 VTEC. Survival o f OI57
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VTEC in cow's milk was studied both in the absence and presence o f an 
activated LPS.
M a t e r i a l s  a n d  m e t h o d s
Occurrence of 0 157 VTEC in raw cow’s milk
From May through November I997, i,0 ii samples o f raw milk from bulk 
storage tanks o f dairy farms (n = i,0ii) were examined for the presence o f OI57 
VTEC. The samples were obtained from the Netherlands Milk Control Station 
(Zutphen, The Netherlands). At the dairy farms, the milk in the bulk storage 
tanks was continuously stirred and kept at 0 to 4°C. About I00 ml o f raw milk 
was spooned from the bulk storage tank into a sterile container. The milk 
samples were kept at 0 to 4°C during transport to the Netherlands Milk Control 
Station. There volumes o f about i0  ml o f milk were transferred to new sterile 
tubes for microbiological examination at our laboratory, which was started 
within one day after collection o f the milk samples at the dairy farms.
Milk samples (i0 ml) were diluted i:i0  in modified E. coli broth containing 
novobiocin (20 mg/l) (Sigma Chemical Co., St. Louis, MO) (mEC + n).334 
Following 6 to 8 h incubation at 37°C with agitation (I00 rpm), selective 
enrichment was continued at 42°C for another i6  to i8 h. Then, 
immunomagnetic separation (IMS) with magnetic beads coated with antibody 
to OI57 was performed with i ml o f the cultures, according to the instructions 
o f the manufacturer (Dynal, Oslo, Norway). The concentrates were inoculated 
onto sorbitol MacConkey agar (Oxoid Ltd., Basingstoke, Hampshire, UK)
(SMAC) supplemented with cefixime (0.05 mg/l) and potassium tellurite (2.5 
mg/l) (Dynal) (CT-SMAC)50I and the plates were incubated at 37°C for i8 to 
20 h. Non-sorbitol-fermenting colonies were selected for confirmation, up to
i2 per sample.i8s> Isolates were inoculated onto Levine's eosin methylene blue 1 0 9  
agar (Oxoid) (L-EMB) and onto SMAC supplemented with 4- 
methylumbelliferyl-£-D-glucuronide (0.I g/l) (Sigma) (SMAC-MUG).3^  
Presumptive OI57 VTEC isolates (typical E. coli metallic sheen on L-EMB agar, 
both non-sorbitol-fermenting and £-glucuronidase-negative on SMAC-MUG) 
were tested for agglutination with an E. coli OI57 latex test kit (Oxoid). 
Recovery experiments demonstrated that OI57 VTEC could be detected at 
inoculum levels o f less than one organism per ml o f raw milk.
Survival of O157 VTEC in cow’s milk
UHT-sterilized milk was purchased from a local retail market. Raw milk was 
obtained from the experimental farm of the University and used within 4 h
after collection. Background microflora o f the raw milk was determined by 
plating serial dilutions (i:i0) made in 0.i%  peptone water onto tryptone soy 
agar (Oxoid). Plates were incubated at 37°C for i8 to 20 h. All milk samples 
were analyzed for naturally occurring OI57 VTEC as was described above and 
none o f the samples was found to contain detectable levels o f OI57 VTEC. 
One-hundred-ml samples o f milk were dispensed into sterile 250-ml screw- 
cap flasks. Each trial, 8 flasks were prepared with sterilized milk and i2 flasks 
with raw milk. In both four o f the flasks containing sterilized milk and four 
o f the flasks containing raw milk, the LPS was activated by increasing the 
concentrations o f H2O2 and of SCN- and the addition o f LP from cow's milk 
(I8.5 ^g/ml) (DMV-International, Veghel, The Netherlands). H2O2 was 
generated by the addition o f glucose (0.3%) (Merck, Darmstadt, Germany) and 
glucose oxidase (0.I U/ml) (Boehringer, Mannheim, Germany) to the milk. 
Increased concentrations o f SCN- were obtained by the addition o f NaSCN 
(0.26 mM) (Merck). Another four flasks containing raw milk were 
supplemented with only NaSCN (0.26 mM). The remaining eight flasks, four 
with sterilized milk and four with raw milk, served as controls. All activated 
and control milk samples were inoculated at a concentration o f about I04 CFU 
per ml with the OI57 VTEC test culture, a clinical E. coli Oi57:H7 isolate from 
our own collection (culture collection number 89005) grown for i8 to 20 h in 
brain heart infusion broth (Oxoid) at 37°C. Then, half o f the flasks were 
incubated at 7°C and half o f the flasks at i5°C.
Immediately after inoculation and at various intervals up to I44 h ofincubation, 
OI57 VTEC counts were determined. At each sampling, duplicate portions of
i ml were taken and serially diluted (i:i0) in 0.i%  peptone water. Appropriate 
dilutions (0.I ml) were spread plated in duplicate onto CT-SMAC. Following 
incubation at 37°C for i8 to 20 h, non-sorbitol-fermenting colonies were 
enumerated as presumptive OI57 VTEC. Per inoculated sample, up to i2 non­
sorbitol-fermenting colonies were selected for serological confirmation with 
110 the E. coli OI57 latex test kit (Oxoid).
Immediately after inoculation and at various intervals during incubation, 
concentrations o f components o f the LPS were measured. SCN- content was 
evaluated in duplicate according to the method described by Cosby and 
Summer.™2 Milk was deproteinized with 20% (wt/vol) trichloroacetic acid 
(TCA), and SCN- was determined as the colored complex formed with the ferric 
nitrate reagent. The absorbance was measured at 460 nm using a Beckman 
DU62 spectrophotometer, and the SCN- concentration was calculated from a 
standard curve. The concentration o f H2O2 was determined in duplicate as 
described by Ferrier et a l.^  Following precipitation with 2% (wt/vol) TCA, 
titanium tetrachloride was added, and the absorbance was measured at 425 
nm. The H2O2 concentration was calculated from a standard curve. LP activity 
was analyzed in duplicate according to the method o f Marshall et al.29 The 
oxidation o f 2,2'-azinodi-3-ethylbenzthiazoline-6-sulfonic acid (Boehringer) 
was followed as absorbance at 4i3 nm.
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Three trials were conducted, and the mean values o f O157 VTEC counts and 
of concentrations o f components o f the LPS were calculated for each sample 
time.
Figure 1. Survival o f verocytotoxin-producing E. coli O157M 7 in UHT-sterilized milk ( — • — ) and in 
UHT-sterilized milk supplemented with glucose (0.3%), glucose oxidase (0.1 U/ml), NaSCN (0.26 mM), 
and LP (18.5 |lg/ml) ( —  •  —  ) at 7°C (A) and at I5°C (B). Points represent mean (± SD) o f three trials.
R e s u l t s
Occurrence of 0 157 VTEC in raw cow’s milk
O157 VTEC could not be isolated from 1,0 11 examined samples o f raw milk 
from farm bulk tanks. The samples originated from different dairy herds 
located throughout the Netherlands. Based on these findings, it can be 
assumed that in the Netherlands the occurrence o f O157 VTEC in raw milk 
from bulk tanks is less than 0.3% (95% confidence level; Poisson distribution).
Survival o f0 i5 7  VTEC in cow’s milk
Populations o f the O157 VTEC test strain in sterilized milk held at 7 and I5°C 
for up to 144 h are shown in Figure iA  and i B, respectively. While at 7°C O157 
VTEC counts in untreated milk remained virtually unchanged throughout the 
incubation period, at I5°C a 3.7-log^ increase was achieved after 144 h. Addition 
o f components o f the LPS resulted in a clear reduction o f O157 VTEC survival 
and growth. At 7°C, populations continued to decrease at each analysis time. 
After 144 h, the O157 VTEC count was 3 logI0 lower than the respective value 
in untreated sterilized milk. At I5°C O157 VTEC populations also suffered an 
initial decrease. After 48 h, an O157 VTEC count 5.5 logI0 lower than in control
1 1 1
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Figure 2. Concentrations o f components o f 
the lactoperoxidase-thiocyanate-hydrogen 
peroxide system in UHT-sterilized milk 
supplemented with glucose (0.3%), glucose 
oxidase (0.1 U/ml), NaSCN (0.26 mM), and 
LP (18.5 |J,g/ml) at 7°C. Points represent 
mean (± SD) o f three trials.
milk was reached. Although the number o f viable O157 VTEC cells detected 
had increased by 1.2 logI0 from 48 h to the end o f incubation, it remained more 
than 5 logI0 lower than in control milk. The concentrations o f SCN- and H2O2 
and LP activities measured during the first 96 h o f incubation at 7°C are shown 
in Figure 2. SCN- concentrations decreased as SCN- was consumed in the 
enzymatic reaction o f the LPS. H2O2, continuously generated by the glucose­
glucose oxidase system and immediately consumed by the LPS, was not 
detected until 72 h o f incubation, which coincided with depletion o f SCN- and 
inactivation o f LP. Similar results were obtained for milk incubated at I5°C, 
except that concentrations o f SCN- and LP activities decreased faster (results 
not shown).
Populations o f the O157 VTEC test strain in raw milk held at 7 and I5°C for 
up to 144 h are shown in Figure 3A and 3B, respectively. Although counts of 
the pathogen in untreated raw milk remained essentially constant during the
1 1 2
Figure 3. Survival o f verocytotoxin-producing E. coli 0 1 5 7 ^ 7  in raw cow’s milk (—• —), in raw cow’s 
milk supplemented with NaSCN (0.26 mM) ( —  •  — ), and in raw cow’s milk supplemented with 
glucose (0.3%), glucose oxidase (0.1 U/ml), NaSCN (0.26 mM), and LP (18.5 |lg/ml) (— • — ) at 
7°C  (A) and at I5°C (B). Points represent mean (± SD) o f three trials.
Chapter 7 -  O157 VTEC in raw cow’s milk
first 24 h o f incubation at 7°C, growth occurred during the next 120 h. The 
O157 VTEC count reached after 144 h o f incubation was 1.5 logI0 higher than 
in milk at 0 h. At I5°C, an increase in O157 VTEC count o f 1.6 logI0 was observed 
after 24 h. After 144 h o f incubation, the number o f viable O157 VTEC cells 
detected was 2.0 logI0 higher than in milk at 0 h. The initial level ofbackground 
microflora o f the raw milk was I05 CFU per ml. The initial concentration of 
SCN- in the raw milk was 2.56 mg/l. OI57 VTEC counts in milk supplemented 
only with SCN- did not differ virtually from the respective values in untreated 
milk, either at 7°C or at I5°C. Addition o f SCN-, H2O2 (glucose-glucose oxidase), 
and LP resulted in reduced growth of the pathogen in milk held at 7°C. After 
an initial increase o f 0.4 logI0 during the first 24 h, the number o f viable cells 
decreased 0.9 logI0 during the next 24 h, reaching an OI57 VTEC count 0.9 
logI0 lower than the respective value in untreated raw milk. From 48 to I44 h 
o f incubation the number o f viable OI57 VTEC cells increased by 0.9 logI0, 
and a difference between treated and untreated milk o f i .i logI0 was observed.
At 15 °C, O157 VTEC counts in milk supplemented with SCN-, H2O2, and LP 
were similar to the respective values in control milk during the 144 h o f 
incubation. Concentrations o f SCN- measured at various intervals during the 
period o f incubation were similar for milk incubated at 7°C and at I5°C. While 
in milk supplemented with SCN- only, SCN- concentrations remained fairly 
constant during the first 48 h, SCN- concentrations rapidly decreased in milk 
supplemented with all components o f the LPS (results not shown).
D i s c u s s i o n
Epidemiological investigations have shown undercooked ground beef and raw 
milk to be important vehicles for O157 VTEC infections. Dairy cattle, a source 
o f both beef products and raw milk, are regarded as a natural host o f human 
pathogenic O157 VTEC strains. Recently, we have isolated these pathogens from 1 1 3  
57 (10.6%) o f 540 adult cattle randomly selected at slaughter.187 In addition, 
we have isolated the organisms from 6 (0.8%) o f 794 samples o f raw beef 
obtained from retail outlets190 and from two milk filters from dairy farms188, 
by performing IMS following selective enrichment. In the present study O157 
VTEC were not isolated from any o f the milk samples collected from holding 
tanks, although the methodology used has proven to be very sensitive, 
detecting levels o f less than one organism per ml o f raw milk. Reported 
estimates on the prevalence o f O157 VTEC in raw cow’s milk range from 0 to 
10%. In a survey o f the incidence o f O157 VTEC in the dairy industry in the 
United Kingdom, the organisms were not detected in 586 samples o f 
unpasteurized milk (ex-farm and ex-tanker).320 The samples were examined 
by conventional selective plating following selective enrichment. Some samples 
were additionally examined by either o f two commercially available
immunoassays. Studies by Hancock and colleagues175 and Ansay and Kaspar23 
also failed to detect O157 VTEC in raw milk. The former study examined bulk 
milk samples from 603 individual dairy farms. In the latter study 42 samples 
taken from 15 dairy plants were examined. In both studies samples were 
analyzed by performing selective plating after selective enrichment. However, 
Padhye and Doyle340 isolated O157 VTEC from 11 (10%) o f 115 raw milk samples 
from the bulk tanks o f 69 different farms. The 11 positive samples originated 
from seven different farms. Selective enrichment cultures were applied to a 
sandwich ELISA, and positive ELISA results were confirmed by isolation of 
the organism. Failure to detect O157 VTEC in milk samples taken from bulk 
tanks may be due to dilution o f contaminated samples from individual cattle 
to a level o f contamination undetectable by most available assays. During two 
investigations o f dairy herds associated with O157 VTEC infection in humans, 
the pathogens could not be isolated from milk from bulk tanks but were isolated 
from milk samples from individual cattle (IMS technique following selective 
enrichment).303,499 Although O157 VTEC organisms were not found in any of 
the milk samples examined in the present study, the presence o f other E. coli 
(isolates yielding the typical E. coli metallic sheen on L-EMB) and the previous 
isolation o f O157 VTEC from milk filters188 indicate that potential modes of 
contamination o f raw milk with pathogenic E. coli are present during the 
collection o f milk on dairy farms.
The possibility o f raw milk becoming contaminated with O157 VTEC prompted 
us to study the survival o f O157 VTEC in cow’s milk, during both milk 
refrigeration at 7°C and temperature abuse at I5°C. In addition, the antibacterial 
action o f the LPS on O157 VTEC was examined. The O157 VTEC test strain 
remained viable in sterilized milk at 7°C during the entire holding period. In 
raw milk, populations even started to increase after 24 h o f incubation. Wang 
et al. 479 determined that O157 VTEC did not grow in milk held at 5°C, and the 
populations slowly decreased. At 8°C, Wang et al.479 observed growth. The five- 
1 1 4  strain mixture used grew more slowly in unpasteurized milk than in 
pasteurized milks, likely caused by antagonistic activity from preexisting 
bacteria. Palumbo et al.343 also observed that growth of O157 VTEC strains in 
milk held at 8°C can occur, depending on both level o f background microflora 
and strains tested. Similar to earlier findings,343,479 we observed growth of O157 
VTEC in milk held at I5°C. The slower growth of O157 VTEC in raw milk 
compared with sterilized milk was most likely caused by suppression by 
background microflora. Inhibitory activity o f the LPS on O157 VTEC was 
evidently exhibited by the experiments with sterilized milk supplemented with 
SCN-, glucose-glucose oxidase, and LP. At I5°C, surviving cells resumed growth 
after SCN-was depleted. When milk was incubated at 7°C, the number of viable 
cells determined after 144 h was <0.7 logI0 CFU per ml. In principle, it is 
possible that the bacterium was completely inactivated between 48 and 144 h 
o f incubation. O157 VTEC did not react with the LPS naturally occurring in
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raw milk. The response o f O157 VTEC in raw milk supplemented only with 
SCN- was not essentially different from the response o f the pathogen in 
untreated raw milk. Also, concentrations o f SCN- remained fairly stable. These 
results indicated that in addition to the amount o f SCN-, the natural amount 
o f H2O2 in the raw milk was not sufficient to activate the LPS. When all three 
components o f the LPS were added, growth of O157 VTEC appeared to be 
reduced in milk kept at 7°C, although less pronounced than in treated 
sterilized milk kept at 7°C. In raw milk stored at I5°C, no effect o f the activation 
o f the LPS on O157 VTEC populations could be demonstrated. These findings 
imply that bacteria constituting the normal microflora o f raw milk were more 
sensitive to the antibacterial action o f the activated LPS than the O157 VTEC 
test strain. Farrag et al.139 demonstrated survival and growth of O157 VTEC in 
raw milk incubated at 4°C and at 30°C, respectively. Addition o f components 
o f the LPS resulted in inhibition and inactivation o f O157 VTEC, the degree 
o f inhibition being related to initial numbers o f the pathogen, time of exposure 
to the LPS, and incubation temperature. The discrepancy between the results 
o f Farrag et al.139 and the results o f the present study may be explained by a 
lower level o f background microflora in milk samples examined by Farrag et 
al. who reported initial populations o f circa 103 to 104 CFU per ml o f raw milk. 
It can be concluded that raw milk contaminated with O157 VTEC and kept at 
7°C, a temperature frequently encountered during storage and processing o f 
food, will remain hazardous. At temperature abuse the risk will be increased. 
Therefore, the consumption of raw milk needs to be strongly dissuaded. 
Hygienic milking practices may reduce the level o f fecal contamination of raw 
milk, but proper pasteurization and avoiding contamination after 
pasteurization are necessary to ensure the safety o f milk.
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Isolation and characterization of verocytotoxin- 
producing E scherich ia  co li O 157 strains from  Dutch 
cattle and sheep
Chapter
Summary
In the periods from July to November 1995 and 1996, fecal samples from Dutch 
cattle and sheep were collected at the main slaughterhouses ofthe Netherlands, 
located at different geographic sites. The samples were examined for the 
presence ofverocytotoxin (VT)-producing Escherichia coli (VTEC) o f serogroup 
O157. E. coli O157 strains could be isolated from 57 (10.6%) o f 540 adult cattle,
2 (0.5%) o f 397 veal calves, 2 (3.8%) o f 52 ewes, and 2 (4.1%) o f 49 lambs. 
Immunomagnetic separation with Oi57-specific-antibody-coated beads 
appeared to be significantly more sensitive than conventional plating for 
detection o f the organism in feces. With the exception o f two isolates from 
adult cattle which appeared to be negative for VT genes, all animal isolates 
were positive for both VT (VTi and/or VT2) and E. coli attaching-and-effacing 
gene sequences, and therefore, they were regarded as potential human 
pathogens. Although genomic typing by pulsed-field gel electrophoresis 
revealed a wide variety o f distinct restriction patterns, comparison of the 63 1 1 7  
animal isolates with 33 fecal O157 VTEC strains previously isolated from 
humans with the diarrhea-associated form of the hemolytic-uremic syndrome 
by their phage types and VT genotypes showed a marked similarity between 
animal and human isolates: 30 (90.9%) o f the 33 human isolates appeared to 
be o f E. coli O157 strain types also isolated from cattle and sheep. It was 
concluded that Dutch cattle and sheep are an important reservoir o f E. coli O157 
strains that are potentially pathogenic for humans.
A.E. Heuvelink, F.L.A.M. van den Biggelaar, E. de Boer, R.G. Herbes, 
W.J.G. Melchers, J.H.J. Huis in 't Veld, and L.A.H. Monnens.
Journal o f Clinical Microbiology 1998; 36:878-882.
I n t r o d u c t i o n
Verocytotoxin (VT)-producing Escherichia coli (VTEC) can be associated with 
a variety o f human diseases, including mild diarrhea, hemorrhagic colitis, and 
the diarrhea-associated (D+) form of the hemolytic-uremic syndrome (HUS).170 
Of the numerous VTEC serotypes identified, Oi57:H7 and Oi57:H- (nonmotile) 
continue to be the dominant causes o f illness in humans.27,6° VTEC produce 
either or both o f two phage-encoded toxins, VTi and VT2. VTs are thought to 
cause the vascular endothelial damage observed in hemorrhagic colitis and 
HUS patients.446 An additional virulence factor contributing to the 
pathogenicity o f VTEC is the formation o f attaching-and-effacing lesions in 
the intestine o f the host. The formation o f attaching-and-effacing lesions is 
mediated by multiple genes encoded on a chromosomal region called the locus 
o f enterocyte effacement.299 Humans can become infected with VTEC 
following the consumption of contaminated foods or by direct transmission 
o f VTEC from infected humans or animals.27,60,170 Undercooked ground beef 
and raw milk have most often been implicated in foodborne infections. Since 
healthy domestic animals, in particular, ruminants like cattle, sheep, and goats, 
can harbor VTEC in their feces, they are regarded as natural reservoirs o f these 
pathogens.45
In the Netherlands, similar to the situation in the rest o f the world, an infection 
with O157 VTEC is the predominant cause o f D+ HUS.469 The sources o f the 
infectious agents in these cases o f D+ HUS have not been defined. Upon 
examination o f raw meats obtained from retail outlets in the Netherlands, O157 
VTEC strains were isolated from 2 (0.3%) o f 770 samples o f raw minced mixed 
beef and pork.189 The organisms were not detected in samples o f raw minced 
beef (n = 1,000), minced pork (n = 260), or poultry products (n = 300).189 An 
epidemiological survey on the occurrence o f O157 VTEC strains in Dutch 
domestic animals had never been undertaken.
1 l 8  As a contribution to the understanding o f the epidemiology o f human VTEC 
infections, the present study describes the isolation and characterization of 
O157 VTEC strains from Dutch cattle and sheep. Fecal samples from adult 
cattle, veal calves, and sheep were collected at several slaughterhouses located 
at different geographic sites in the country. The samples were examined for 
the presence o f O157 VTEC by performing both conventional plating and 
immunomagnetic separation (IMS). To determine the isolates’ potential as 
human pathogens, they were tested for the presence o f three main virulence- 
associated genes (the VTi, VT2, and E. coli attaching-and-effacing [eae; encoded 
on the locus o f enterocyte effacement] gene loci) and for toxin production. In 
addition, isolates were further characterized by phage typing, PCR-based 
fingerprinting, and pulsed-field gel electrophoresis (PFGE). The characteristics 
o f the animal isolates were compared with those obtained previously for fecal 
O157 VTEC isolates from patients with D+ HUS.186
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M a t e r i a l s  a n d  m e t h o d s
Collection and storage offecal samples
In the periods from 24 July to 30 October 1995 and from 12 July to 22 October 
1996, fecal samples from adult cattle and veal calves were collected weekly at 
the major slaughterhouses ofthe Netherlands. Five adult cattle slaughterhouses 
and four veal calves slaughterhouses were visited; these were located in 
different regions o f the country. Immediately after slaughter, samples o f the 
rectal contents were collected aseptically and were kept at 4 to 8°C. The adult 
cattle sampled were randomly selected. To trace the locations o f the farm of 
origin o f the animals, the ear tag numbers were recorded at the time that the 
fecal samples were taken. In the Netherlands, veal calves are fattened in an 
all-in all-out system. Per group of veal calves derived from one herd, a random 
selection o f 10% of the total number o f calves was sampled, with a maximum 
of 10 calves being sampled.
Feces from ewes and lambs were collected on two occasions (2I October and 
25 November 1996) at the only major sheep slaughterhouse in the country.
The samples were taken by rectal palpation, just before slaughter. Animals were 
randomly selected, and no information on the farms o f origin was recorded.
The collected fecal samples were transported immediately to the laboratory, 
where the microbiological examination was started within 20 h.
Isolation ofO 157 VTEC by selective plating
A 20-g portion o f each fecal sample was added to 180 ml o f modified E. coli 
broth containing novobiocin (20 mg/l) (Sigma Chemical Co., St. Louis, MO)
(mEC + n).334 After homogenization in a stomacher for 1 min, the samples 
were incubated for 18 to 20 h at 37°C on a rotary shaker (100 rpm). Each 1 1 9  
enrichment culture was serially diluted tenfold to 10 -6 in 0.1% peptone water.
One hundred-^l volumes o f the 10 -5 and 10 -6 dilutions were spread plated onto 
sorbitol MacConkey agar (Oxoid Ltd., Basingstoke, UK) (SMAC), and i00-^l 
volumes o f the 10 -3 and 10 -4 dilutions were spread plated onto SMAC 
supplemented with cefixime (0.05 mg/l) and potassium tellurite (2.5 mg/l)
(Dynal, Oslo, Norway) (CT-SMAC).501 The plates were incubated at 42°C for 
18 to 20 h. Sorbitol-nonfermenting colonies (up to 12 per sample) were selected 
for confirmation. The isolates were inoculated onto SMAC supplemented with 
4-methylumbelliferyl-£-D-glucuronide (0.1 g/l) (Sigma) (MUG)331 and onto 
Levine’s eosin methylene blue agar (Oxoid) (L-EMB). Presumptive O157 VTEC 
isolates (those with a typical E. coli metallic sheen on L-EMB; the isolates were 
both sorbitol-nonfermenting and £-glucuronidase-negative on SMAC-MUG) 
were tested for agglutination with an E. coli O157 latex test kit (Oxoid). Isolates
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that gave a positive latex test result were confirmed to be E. coli by using an 
API 20E biochemical test strip (bioMerieux, Lyon, France) and were confirmed 
to be o f serotype Oi57:H7 or serotype Oi57:H- by serotyping at the National 
Institute o f Public Health and the Environment, Bilthoven, The Netherlands 
(Dr. W.J. van Leeuwen). The sensitivity o f the plating method was found to be 
about one organism per g o f feces by performing inoculation experiments as 
described previously.191
Isolation of O157 VTEC by IM S
After 6 to 8 h o f incubation, about 5 ml o f each mEC + n broth culture was 
filtered through a piece o f paper towel to remove particulate matter. IMS with 
magnetic beads coated with antibody to O157 (Dynal) was performed with 1 
ml o f the filtrates, according to the instructions o f the manufacturer. The 
concentrates were inoculated onto CT-SMAC, and the plates were incubated 
at 37°C for 18 to 20 h. For each sample, up to 12 sorbitol-nonfermenting colonies 
were selected and confirmed as described above. Recovery experiments 
demonstrated that O157 VTEC could be detected at inoculum levels o f about 
one organism per g o f feces.191
VT and E. coli attaching-and-effacing genes
The presence o f VTi, VT2, and eae gene sequences was determined by a 
multiplex PCR assay as described previously.186
VT production
1 2 0
Colony sweeps o f the isolates were grown overnight at 37°C (I00 rpm) in 
Penassay broth (antibiotic medium no. 3; Difco Laboratories, Detroit, Mich.) 
containing mitomycin (0.2 mg/l). Supernatants obtained by centrifuging the 
cultures at 10,000 x g  for 10 min were filtered through 0.2-^m-pore-size 
membrane filters (Schleicher & Schuell, Dassel, Germany). Volumes (50 ^l) 
o f serial twofold dilutions o f the filtrates were applied to confluent Vero cell 
monolayers and were evaluated for toxic activity as described by Karmali et al.232
Phage typing
Isolates confirmed to be E. coli O157 were phage typed at the Laboratory of 
Enteric Pathogens, Central Public Health Laboratory, London, United Kingdom 
(Dr. B. Rowe).
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PCR fingerprinting
PCR fingerprinting o f bacterial DNA was performed with primer 1247 as 
described previously.186 To compare the randomly amplified polymorphic DNA 
(RAPD) profiles obtained by PCR (RAPD-PCR profiles) o f the animal isolates 
with those obtained previously for O157 VTEC isolates from patients with D+
HUS, two human isolates were included in this assay as representatives of 
strains with the two basically distinct profiles that had been observed among 
the collection o f human strains in the previous study.186
PFG E
PFGE was performed by a modification o f the method described by Bohm and 
Karch.56 Bacterial cultures were transferred twice in brain heart infusion broth 
(Oxoid) for 18 h at 37°C with shaking (100 rpm). Then the cells were harvested 
(1 ml o f culture), washed three times with saline (0.85% NaCl), resuspended 
in 300 ^l o f 100 mM TRIS (pH 7.5^100 mM EDTA (pH 7.5^150 mM NaCl, 
carefully mixed with an equal volume of melted 2% agarose (Molecular Biology 
Certified Agarose; Bio-Rad Laboratories, Richmond, Calif.), and dispensed into 
plug molds (Bio-Rad). After 10 to 15 min at 4°C, the solidified preparations 
were transferred to tubes containing a buffer o f 6 mM TRIS (pH 7.5), 1 M NaCl,
100 mM EDTA (pH 7.5), 0.5% Brij 58, 0.2% deoxycholate, and 0.5% N- 
laurylsarcosine and the tubes were incubated for 5 h at 37°C with gentle 
agitation (80 rpm). The plugs were then washed twice for 30 min each time 
at room temperature in 100 mM TRIS (pH 7.5^100 mM EDTA (pH 7.5) (TE 
buffer). Cell lysis was carried out overnight at 50°C in 0.4 M EDTA (pH 9.3)- 
1% N-laurylsarcosine containing 1 mg of proteinase K per ml. After lysis, the 
plugs were washed at room temperature with gentle agitation (50 rpm) for four 
i-h intervals in TE buffer. The plugs were stored in TE buffer at 5°C until they 121 
were used. Prior to digestion o f the agarose-embedded DNA, the plugs were 
cut into appropriately sized pieces that were washed five times for 1 h at room 
temperature in 100 mM TRIS (pH 8)-5 mM MgCl2, preincubated for 1 h at 
4°C in complete restriction enzyme buffer (10 mM TRIS-acetate [pH 7], 10 
mM magnesium acetate, 50 mM potassium acetate, 0.I mg of RNAse A per 
ml) without restriction enzyme, and preincubated for I h at 4°C in complete 
restriction enzyme buffer containing the enzyme. Digestion was carried out 
with XbaI (10 U) (Boehringer Mannheim, Mannheim, Germany) at 37°C for 
15 h. The resulting DNA fragments were resolved in 1.2% agarose gels (Pulsed 
Field Certified Agarose; Bio-Rad) in 0.5X TRIS-borate-EDTA buffer at I3°C in 
a contour-clamped homogeneous electric field (CHEF) DR-II apparatus (Bio­
Rad). The run time was 24 h, with a constant voltage o f 200 V and a linearly 
ramped pulse time of 3 to 50 s. Lambda concatemers (Bio-Rad) were used as
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DNA size markers. After staining with ethidium bromide (1 |ig/ml), the gels 
were photographed under UV transillumination. The genomic patterns were 
analyzed with a Biogene program (Vilber Lourmat, Marne la Vallée, France), 
which uses the algorithm Nei and Li (2% confidence). To compare the PFGE 
patterns o f isolates o f animal and human origin, chromosomal DNAs from 
O157 VTEC strains (n = 33) isolated from patients with D+ HUS between 1989 
and 1996 were analyzed by PFGE as well.
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Table i. Isolation o f fecal E. coli O157 from Dutch adult cattle and veal calves at slaughter
Year o f 
isolation
Animal source 
o f isolates
No. (%) o f animals 
E. coli O157 positive
No. o f isolates obtained by 
the following method a: 
SM AC CT-SMAC IM S
1995 Adult cattle 3o/27o (11.1) 0 4  30
Veal calves i / :8 3 ( ° .5) 0 1 0
9& Adult cattle 27/270 (10.0) ND b 4  27
Veal calves i /2 i4  (0.5) ND 0 1
a SM AC, isolation on SM AC following enrichm ent in m EC + n for 18 to 20  h; CT-SMAC, isolation on CT-SMAC
following enrichment in m EC + n for 18 to 20  h; IMS, isolation on CT-SM AC following enrichm ent in m EC + n for 6 to
8 h and IMS o f  E. coli O157.
b ND, not done.
R e s u l t s
Isolation of E. coli O157
122  In 1995, E. coli O157 strains were isolated from 30 (11.1%) o f 270 fecal samples 
from adult cattle and from 1 (0.5%) o f 183 samples from veal calves (Table 1). 
Similar results were obtained in 1996: E. coli O157 strains were isolated from
27 (10.0%) o f 270 fecal samples from adult cattle and from 1 (0.5%) o f 214 
samples from veal calves. For both adult cattle and veal calves, the location of 
slaughter was not linked to the location o f origin o f the animals. The majority 
o f adult cattle sampled comprised dairy cows originating from different dairy 
farms located throughout the country (Fig. 1). No marked geographic variation 
in the prevalence o f E. coli O157 was demonstrated. Cattle originating from 
farms located in the western part o f the country seemed to be less often infected 
than cattle originating from farms located in other parts o f the country, but 
this may be the result o f the smaller number o f animals originating from the 
west delivered for slaughter (Fig. 1). The farms o f origin o f 39 animals, 
including 6 animals positive for E. coli O157, could not be traced. The farms
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Figure i. Geographic distributions o f adult 
cattle found to be positive for E. coli O157 at 
slaughter, adult cattle sampled, and all dairy 
cattle within the Netherlands.323 The 
locations o f the farms o f origin for 39 o f the 
540 adult animals sampled, including 6 
animals positive for E. coli O157, could not 
be traced.
of origin o f the 397 veal calves sampled (45 herds) were located predominantly 
in the central part o f the country, where calf-fattening herds are most 
concentrated.
E. coli O157 strains were isolated from 4 (4.0%) o f 101 fecal samples from sheep: 
from 2 (3.8%) o f 52 ewes and from 2 (4.1%) o f 49 lambs. Although no 
information on the origins o f the animals was collected, it is plausible that the 
sheep came from all over the country since there is only one major sheep 
slaughterhouse in the Netherlands.
Comparison of isolation methods
The IMS technique proved to be significantly more sensitive for the detection 
o f E. coli O157 in fecal samples from naturally colonized cattle than the 1 2 3  
conventional plating methods (Sign test, P < 0.0001) (Table 1), although in
1995 one false-negative result was obtained by IMS. Therefore, only the IMS 
procedure was performed for the isolation o f fecal O157 VTEC from sheep.
Characterization of E. coli 0 157 isolates
The results of the PCR assay, the Vero cell assay, and phage typing are presented 
in Table 2. RAPD-PCR of the E. coli O157 isolates from cattle and sheep showed 
highly monomorphic patterns which mutually differed only by minor 
differences in the intensities o f single bands. The banding profile produced 
by the animal isolates could not be distinguished from the DNA fingerprint 
exhibited by the human isolate that represented the major group o f human
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Table 2. Characterization o f fecal E. coli O157 isolates from Dutch cattle, sheep, and humans 
with D+ HUS
£ 
« 
^
 
£ 
&
 
Ph Vero cell PCR result for the No. o f isolates No. o f distinct 
XbaI patterns
assay for 
VT
following gene 
VTi VT2 eae
Cattle 
(n = 59)
Sheep 
(n = 4)
Human 
(n = 33)
2 + - + + 1 (1.7) 0 i 5 (45 .5) 1 1  a
2 + + + + 0 1 b (25.°) 0 1
4 + + + + i (1.7) 0 0 1
4 + - + + 3 (5.1) 0 i 0 (30.3) 1 1  c
8 + + + + 9 (15.2 ) 0 3 (9 .i) 10  d
8 + - + + i (1.7) 0 0 1
8 - - - + i (1.7) 0 0 1
10 + - + + 3 (5.1) 0 0 1 c
14 + + + + 4 (6 .8) 0 i (3.0) 4  e
14 + - + + 6 Z  (10.2) 0 0 4  g
21 + + + + i (1.7) 0 0 1
23 + + + + 2 (3.4 ) 0 0 2
31 + - + + 7 (11.8) 0 0 5 h
32 + - + + 2 (3.4 ) 0 0 1
32 + + + + 0 0 i (3.0) 1
34 + + + + 2 (3.4 ) i (25.0) 0 2 i
34 + - + + 2 (3.4 ) 0 0 2
49 + - + + 0 0 2 (6.i) 2
54 + + + + i (1.7) 0 0 1
54 + - + + 3 (5.1) i (25.0) i (3.0) 5
Rdnc J + + + + 1 Z  (1 .7) 0 0 1
Rdnc + - + + 8 (13.5) 1 b (2 5.°) 0 8
Rdnc - - - + 1 (1 .7) 0 0 1
a Including a group o f  four and a group o f  three identical patterns, all o f  which were generated from  hum an isolates. 
b Isolate from  a lamb.
c The three cattle isolates o f phage type 4  and the three cattle isolates o f phage type 10  generated identical patterns. 
d Including a group o f  three identical patterns generated from  two cattle and one hum an isolate. 
e Two cattle isolates shared the same pattern. 
f  One isolate from  a veal calf. 
g  Three isolates generated identical patterns. 
h Including two groups o f  two identical patterns.
i One o f  the cattle isolates showed a pattern identical to that o f  the sheep isolate. 
j  Rdnc, reacted with phage set but did not correspond to recognized phage type.
isolates (79% of the strains) characterized previously.186 Digestion o f genomic 
DNA from the animal and human isolates with XbaI and analysis by CHEF- 
PFGE yielded between 17 and 25 discernible fragments that ranged from 
approximately 20 to 590 kb in length. The results are summarized in the last 
column of Table 2. Forty-six distinct genomic patterns were generated from 
the 59 cattle isolates. The four isolates from sheep exhibited four distinct
<------------------------------------► X
7 8 V 10 11 12 13 14 IS 14 17 18
PT2 PT4 PT8
X M------------------------------------------------►x. M-------------------------------► <«---- ►
1 2 3 4 5 6 7 8 9 10 11 12 13 14 IS 16 17 18 1» 20 21 22 23 24 25 26 27 28 21 30
kb
582.0 -
533.5 -
485.0 -
436.5 -
388.0 -
339.5 -
291.0-
242.5 -
194.0-
145.5- 
97.0 -
48.5 -
97.0 -
48.5 ■
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Figure 2 . Agarose gels showing XbaI digestion patterns (designated A to AI) of fecal E. coli O157 isolates of phage types (PT) 2 , 4 , and 8 from cattle (A) and 
from patients with D+ HUS (B). (A) Lanes 1 and 18 , molecular size markers (bacteriophage lambda ladder); lanes 2 to 5 and lane 16 , isolates positive for VT2 
and eae genes; lanes 6 to 15, isolates positive for VTi, VT2 , and eae genes; lane 17 , isolate positive only for the eae gene. (B) Lanes 1 and 17 , molecular size 
markers (bacteriophage lambda ladder); lanes 2 to 16 and lanes 18 to 27 , isolates positive for VT2 and eae genes; lanes 28 to 30 , isolates positive for VTi, 
VT2 , and eae genes.
patterns. Among the collection o f 33 human isolates, 28 distinct restriction 
patterns could be discriminated. Figure 2 shows the fragment patterns 
generated from the cattle and human isolates o f phage types 2, 4, and 8.
D i s c u s s i o n
Cattle are regarded as a major source ofhuman pathogenic O157 VTEC strains. 
Reported estimates o f the prevalence o f O157 VTEC in North American and 
European cattle range from 0 to almost i0% .27 Sheep, the second most 
commonly reared species o f ruminant food animals, appears to have a role 
similar to that o f cattle as a natural reservoir o f O157 VTEC. Kudva et al.254 
studied 35 free-ranging healthy ewes o f a single flock in Idaho and reported 
that the incidence o f fecal shedding varied from 31% of sheep in June to none 
in November. In the United Kingdom, O157 VTEC strains were found in the 
feces from 18 (2.6%) of 700 sheep sampled at a slaughterhouse.83 In the present 
study, O157 VTEC strains could be isolated from about 10% of Dutch adult 
cattle, from 0.5% of Dutch veal calves, and from 4.0% of Dutch sheep. The 
ability to compare published prevalence data is limited because o f the use of 
a large variety o f screening methods. Several recent studies have demonstrated 
that selective enrichment significantly improved the sensitivity o f direct 
plating o f fecal samples from cattle and sheep.254,255,393,505 Chapman et al.88 
showed that IMS was fourfold more sensitive than direct culture for the 
detection o f O157 VTEC in cattle feces. Although Sanderson et al.393 found that 
the IMS technique was only slightly more sensitive (not statistically significant) 
than broth enrichment for the detection o f O157 VTEC in cattle feces, in our 
study the use o f IMS resulted in a sevenfold increase in the rate o f isolation 
o f O157 VTEC from adult cattle compared with the rate after plating onto CT- 
SMAC following selective enrichment. The application o f less sensitive 
1 2 6  screening methods possibly accounted for the lower prevalence reported in 
most previous studies. In addition to the screening method used, the rate of 
isolation o f O157 VTEC is greatly influenced by the setting in which the samples 
are taken (e.g., dairy herd versus slaughterhouse). Furthermore, geographic 
and seasonal variations in prevalence may occur. It has been observed that 
shedding o f O157 VTEC by cattle and sheep peaks during the summer,175,2^,255 
parallel to the seasonal variation in the reported cases o f O157 VTEC infections 
in humans.60,170 The noted difference in the rate o f isolation o f O157 VTEC 
from mature cattle and veal calves may be due to differences in the composition 
o f the gastrointestinal flora resulting from differences in diet. Orally 
administered antibiotics can also interfere with the gastrointestinal flora. 
Besides differences in the composition o f the intestinal flora, differences in 
the handling of the animals may explain the differences in the rate o f isolation 
o f O157 VTEC. Whereas veal calves are directly sold and transported from
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fattening herds to a slaughterhouse, adult cattle (as well as sheep) can pass 
several stations and therefore are at risk o f coming in contact with infected 
animals.
With the exception of two isolates, all E. coli O157 isolates from cattle and sheep 
contained VT and eae genes and therefore appeared to be potential human 
pathogens. It might be possible that the two VT-negative E. coli O157 isolates 
have lost their VT-encoding phages.224 By comparison of the animal and human 
isolates by their phage types and VT genotypes, 23 types o f E. coli O157 were 
identified among the 96 isolates, o f which only 5 were found in both animals 
and humans. Of the 33 human isolates, 30 (90.9%) were o f types also isolated 
from cattle, whereas only 20 (33.9%) o f the 59 cattle isolates were o f types also 
found in humans. A similar degree o f shared strain types among cattle and 
sporadic human isolates has been reported by Chapman and Siddons,80 based 
on phage type, VT genotype, and plasmid content. The marked similarity 
between cattle and human isolates further supports the theory that cattle are 
an important reservoir o f O157 VTEC potentially pathogenic for humans. 
However, it remains unclear why certain types appeared to be more often 
associated with human disease than others. In our study, VT2-producing 
strains o f phage types 2 and 4 represented approximately 75% of the human 
isolates, whereas these types accounted for only circa 7% of the cattle isolates. 
Among the four isolates from sheep, we identified four strain types, o f which 
one was also isolated from one patient with D+ HUS. The RAPD-PCR profiles 
o f the E. coli O157 isolates were highly monomorphic, whereas there was 
polymorphism among the PFGE profiles. Seventy-six distinct XbaI patterns 
were identified among the 96 E. coli O157 strains. On the basis o f the 
combined results o f phage typing, VT genotyping, and PFGE, 77 distinct E. coli 
O157 types were identified, and only i (3.0%) o f the 33 human isolates could 
not be discriminated from 2 (3.4%) ofthe 59 isolates from cattle (Fig. 2, pattern 
K). These two identical cattle isolates possibly originated from the same farm, 
since their ear tag numbers corresponded to the same postal box number. The 1 2 7  
small degree o f overlap between the animal and human isolates observed by 
comparing PFGE results does not lead to a different conclusion regarding the 
potential pathogenicity o f E. coli O157 strains harbored by cattle and sheep for 
humans, but it supports the observations o f previous studies demonstrating 
the value o f PFGE as an epidemiologic tool for the differentiation o f E. coli 
O157 strains.33,38,181,211,306 Although PFGE was clearly more sensitive, in one 
instance phage typing could distinguish between two strain types that 
generated identical XbaI patterns.
From the data presented in this survey, it can be concluded that Dutch cattle 
and sheep are natural hosts o f E. coli O157 strains potentially pathogenic for 
humans. The use o f a sensitive isolation technique has proven to be essential 
for the detection o f these pathogens in fecal samples. PFGE has appeared to 
be a highly sensitive method for distinguishing between apparently unrelated
E. coli O157 strains. A further study to determine the prevalence o f O157 VTEC 
in dairy herds in the Netherlands is being performed in our laboratory. By 
analyzing the relationship between these pathogens and the farm environment, 
we hope to eventually reduce the risk o f O157 VTEC-positive animals going to 
slaughter and, in turn, the risk o f O157 VTEC infections in humans.
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Isolation and characterization of verocytotoxin- 
producing E scherich ia  co li O 157 from slaughter pigs 
and poultry
Chapter
Summary
Rectal contents and tonsils from Dutch slaughter pigs collected immediately 
after slaughter were examined for the presence o f verocytotoxin (VT)-producing 
Escherichia coli (VTEC) o f serogroup O157 (O157 VTEC). In addition, fresh fecal 
material from poultry layer flocks and turkey flocks collected on poultry farms 
was examined for the presence o f O157 VTEC. E. coli O157 strains were isolated 
from 2 (1.4%) o f 145 pigs. The strains were isolated from samples o f rectal 
contents, all samples oftonsils being negative. While all 501 fecal samples from 
chicken flocks were found negative, E. coli O157 strains were isolated from 6 
(1.3%) o f 459 pooled fecal samples from turkey flocks. One o f the porcine 
isolates and one o f the turkey isolates contained the VT2 gene, the E. coli 
attaching-and-effacing gene, as well as the enterohemorrhagic E. coli hemolysin 
gene. Production o f VT was confirmed by cytotoxicity tests on Vero cells. Based 
on these characteristics, the two stains were regarded as potentially pathogenic 
for humans. The porcine and the turkey isolate were further characterized as 1 2 9  
being of phage types 4 and 14, respectively. While biochemically typical o f E. coli 
O157, the remaining six isolates were nonverocytotoxigenic and negative for 
both the E. coli attaching-and-effacing gene and the enterohemorrhagic E. coli 
hemolysin gene. All eight E. coli O157 isolates did not carry genes that encode 
E. coli heat-labile and heat-stable enterotoxins. It was concluded that pigs and 
poultry can be a source o f O157 VTEC strains characteristic o f those causing 
illness in man. The extent to which pigs and poultry play a role in the 
epidemiology o f human O157 VTEC infection needs further research.
A.E. Heuvelink, J.T.M. Zwartkruis-Nahuis, F.L.A.M. van den Biggelaar,
W.J. van Leeuwen, and E. de Boer.
International Journal o f Food Microbiology 1999:52:67-75.
I n t r o d u c t i o n
Verocytotoxin (VT)-producing strains o f Escherichia coli (VTEC) were first linked 
with human disease in the early 1980s.234,376 Since then, infections with VTEC 
have been reported with increasing frequency. VTEC can cause a spectrum of 
illness which includes mild nonbloody diarrhea, hemorrhagic colitis and the 
diarrhea-associated form o f the hemolytic-uremic syndrome.438 Some 
infections may be asymptomatic.
At present, more than 200 serotypes o f E. coli are known to produce VT, but 
only a limited, though increasing number is considered as pathogenic for 
humans.76,161,212,439 The pathogenicity o f VTEC strains is mainly associated 
with the ability to produce either or both o f two phage-encoded toxins, VTi 
and VT2, their capacity to adhere to the intestinal epithelium by the formation 
o f attaching-and-effacing lesions, and the production o f enterohemorrhagic 
E. coli hemolysin (HlyEHEC).354 However, more research is needed to further 
define the characteristics that render selected VTEC organisms harmful to 
humans. In many countries, strains o f serogroup O157 carrying the H7 flagellar 
antigen or being nonmotile are the predominant pathogenic VTEC strains.354 
Most human infections have resulted from the consumption of contaminated 
foods, particularly undercooked ground beef and unpasteurized cow's milk.305 
Transmission by contact with infected livestock and person-to-person 
transmission has also been documented. Several epidemiological studies have 
revealed that O157 VTEC and other VTEC strains are prevalent in the 
gastrointestinal tract o f healthy cattle, and therefore cattle are regarded as the 
principal reservoir o f VTEC organisms.27 At present, there is limited 
information on the prevalence o f O157 VTEC in food animals other than cattle. 
Also in the Netherlands, O157 VTEC are the most common VTEC strains 
associated with illness in man.469 In a previous study, O157 VTEC strains were 
found in the fecal flora o f about 10%  o f Dutch adult cattle (n = 540), 0.5% of 
1 3 0  Dutch veal calves (n = 397), and 4.0% of Dutch sheep (n = 101), sampled at the 
main slaughterhouses o f the Netherlands.187 Upon examination o f raw meats 
obtained from retail outlets in the Netherlands, O157 VTEC strains were isolated 
from about i% of minced beef (n = 571), i%  of minced pork (n = 76), 0.5% of 
minced mixed beef and pork products (n = 402), and 0.3% of other raw pork 
products (n = 393).190 Additionally, a sample o f a ready-to-eat dry fermented 
pork sausage was found positive. The organisms were not isolated from poultry 
products, products o f ovine origin or meats originating from wild animals.
In view of the isolation o f O157 VTEC from pork products, a study was 
undertaken to examine the occurrence o f O157 VTEC in normal slaughter pigs 
that enter the food production chain. Another study included in this paper 
concerns a survey on the occurrence o f O157 VTEC in poultry. Although we 
did not isolate O157 VTEC strains from poultry products to date, we examined 
these food animals because poultry is the second most frequently consumed
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type o f meat in the Netherlands following pork (Product Boards for Livestock,
Meat and Eggs; personal communication).
M a t e r i a l s  a n d  m e t h o d s
Collection and storage of samples from slaughter pigs
In the period from 10 December 1997 to 26 March 1998, samples o f rectal 
contents and tonsils from 8 to 15 normal, randomly selected, slaughter pigs 
were collected weekly. The samples o f rectal contents were taken aseptically 
through an incision in the rectum, immediately after evisceration. Tonsils were 
also taken as aseptically as possible using sterile gloves and instruments for 
each sample. The samples were kept at 4 to 8°C and transported to the 
laboratory the same day. The microbiological examination was started within 
20 h after collection o f the samples. All samples were collected at the same 
pig slaughterhouse, which is located in the center o f the Netherlands and has 
a capacity o f >i x 10 6 slaughters per year. At the time that the samples were 
taken, ear tag numbers were recorded in case they were needed to trace the 
farms o f origin o f Oi57 VTEC-positive pigs.
Collection and storage of samples from poultry
In the period from 6 January to 24 March i997, a total o f 50i poultry layer 
flocks were sampled. Per flock, one pooled fecal sample was taken consisting 
o f fresh fecal material randomly collected from i0 different places throughout 
the layer house and mixed thoroughly. In the period from 6 January to i5 
December i997, a total o f i80 turkey flocks were sampled. In general, one 
pooled fecal sample was collected per flock consisting o f fresh fecal material 1 3 1  
randomly collected from i0 different places throughout the house and mixed 
thoroughly. Sometimes, more than one house was sampled on a turkey farm.
Each o f the i80 flocks was sampled two to three times during the study period.
After collection, the fecal samples were kept at 4 to 8°C and microbiological 
examination was started within i week.
Isolation and characterization of 0 157 VTEC
Oi57 VTEC strains were isolated and characterized as described previously.i87 
Briefly, fecal samples (20 g for pigs and i0 to 20 g for poultry) were diluted 
i:i0  in modified E. coli broth containing novobiocin (20 mg/l) (Sigma Chemical 
Co., St. Louis, MO) (mEC + n)3^  and then homogenized in a stomacher for i
min. The homogenates were transferred to 500-ml screw-cap flasks and 
incubated at 37°C on a rotary shaker (i00 rpm). Porcine tonsils were cut 
aseptically into cubes and 20-g portions o f tissue were transferred to 500-ml 
screw-cap flasks containing i80 ml o f mEC + n. The flasks were put at 37°C 
on a rotary shaker (i00 rpm). After 6 to 8 h o f incubation, about 5 ml o f each 
mEC + n culture was filtered through a piece o f paper towel to remove 
particulate matter. One ml o f filtrate was added to 20 ^l o f magnetic beads 
coated with antibody to Oi57 (Dynal, Oslo, Norway) and immunomagnetic 
separation was performed according to the manufacturer's instructions. 
Finally, the magnetic beads were inoculated onto sorbitol-MacConkey agar 
(SMAC) (Oxoid Ltd., Basingstoke, UK) supplemented with cefixime (0.05 mg/l) 
and potassium tellurite (2.5 mg/l) (Dynal).50i After incubation at 37°C for i8 
to 20 h, non-sorbitol-fermenting colonies were selected and screened (up to 
i2 per sample) for lactose fermentation on Levine's eosin methylene blue agar 
(Oxoid), the absence o f 6-glucuronidase on SMAC containing 4- 
methylumbelliferyl-6-D-glucuronide (0.i g/l) (Sigma),33i and for the presence 
o f the Oi57 antigen by agglutination with an E. coli Oi57 latex test kit (Oxoid). 
Subsequently, the isolates thus selected were confirmed as E. coli by using an 
API 20E biochemical test strip (bioMerieux, Lyon, France) and confirmed as 
serogroup Oi57 by agglutination to titer with antiserum to E. coli Oi57. 
Additionally, the H antigens o f the isolates were examined according to the 
standard serologic procedure.336
All isolates confirmed to be E. coli Oi57 were subjected to a multiplex PCR 
assay to determine the presence of VT genes (VTi and/or VT2) and the presence 
o f the E. coli attaching-and-effacing (eae) gene.i86 Isolates positive for the VT2 
gene were further tested with VT2e specific primers.2i4 All E. coli Oi57 isolates 
were additionally tested for the hlyEHEC gene488 and the presence o f genes that 
encode E. coli heat-labile (LT) and heat-stable (STa and STb) enterotoxins.ii 
Production o f VT was determined by Vero cell culture assay.232 Phage typing 
1 3 2  was done at the Laboratory o f Enteric Pathogens o f the Central Public Health 
Laboratory in London (UK). The pulsed-field gel electrophoresis (PFGE) 
technique o f contour-clamped homogeneous electric fields (CHEF) was used 
for genomic typing o f the isolates.i87 Genomic DNAs were digested in agarose 
plugs with XbaI (i0 U) (Boehringer Mannheim, Mannheim, Germany). The 
resulting fragments were resolved by CHEF-PFGE with a CHEF DR-II 
apparatus (Bio-Rad Laboratories, Richmond, Calif.) at a constant voltage o f 200
V for 24 h at i3°C and a linearly ramped pulse time of 3 to 50 s. The banding 
patterns were read and compared with each other by using Gelcompar 
Software (Applied Maths, Kortrijk, Belgium). A well-characterized strain of 
E. coli Oi57:H7 (strain G5244, Centers for Disease Control and Prevention, 
Atlanta, Canada) was included in the gels for reference. Cluster analysis was 
done using the unweighted pair group method with arithmetic averages 
clustering algorithm (maximum tolerance, i.5%); comparison between isolates 
was based on the Dice coefficient.ii5
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Table 1. Characteristics o f E. coli O157 isolates from fecal samples o f normal Dutch slaughter
pigs and Dutch turkeys
Strain Date o f F a" 3 H-type PCR for the following gene: Phage PFGE
no. sampling / r VTi VT2 eae hlyEHEC LT STa STb type
Pig isolates
1 02/05/98 I NM a -  + b + + -  -  - 4 A
2 12/10/9 7 II H? c - 31 B
Turkey isolates
3 o 6 / i7/ 97 III h 7 -  + b + + -  -  - 14 C
4 o 8 /o i /97 IV h 7 -  -  -  -  -  -  - Rdnc d D
5 0 9 /03/97 V h 7 -  -  -  -  -  -  - UT e UT
6 10/07/97 VI H? -  -  -  -  -  -  - ND f E
7 io / 3i / 97 VI H? -  -  -  -  -  -  - ND E
8 io /3i / 97 VI H? -  -  -  -  -  -  - ND E
a NM = nonmotile.
b Negative with the V T2e primers.
c H? = motile, but H antigen being unidentifiable with the currently available antisera.
d Rdnc = reacted with the phage set but did not correspond to a recognized phage type.
e UT = untypable.
f  ND = not done.
R e s u l t s
E. coli O157 strains were isolated from 2 (1.4%) o f 145 pigs sampled. The strains 
were isolated from samples o f rectal contents. The tonsils o f the respective 
pigs were found to be negative for E. coli O157. The positive pigs originated 
from two different farms (Table 1). While on farm I only pigs were fattened, 1 3 3  
on farm II in addition to pigs, steers and calves were kept.
Six (1.3%) o f 459 pooled fecal samples from turkey flocks were found to be 
positive for E. coli O157. The samples were collected from four different farms 
(Table 1), where only turkeys were fattened. E. coli O157 was not isolated from 
any o f the 501 pooled fecal samples from poultry layer flocks.
The characteristics o f the E. coli O157 isolates are presented in Table 1. For the 
two isolates containing the VT2 gene, production o f VT was confirmed by 
cytotoxicity tests on Vero cells. The nonverocytotoxigenic isolates were 
biochemically typical o f E. coli O157. Isolates from samples collected on the 
same farm showed identical XbaI restriction patterns (Fig. 1). One E. coli O157 
isolate could not be subjected to PFGE analysis because the DNA degraded 
easily, despite repeated experiments. This strain is reported in Table 1 as being 
untypable by PFGE.
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Figure 1. Agarose gel showing the Xbal digestion 
patterns o f the fecal E. coli O157 isolates from 
pigs (1 and 2) and turkeys (3 to 8) listed in Table 
1. R, reference E. coli 0 1 5 7 ^ 7  strain (strain 
G5244, Centers for Disease Control and 
Prevention, Atlanta, Canada).
D i s c u s s i o n
During the last decade, VTEC strains o f serogroup O157 have emerged as 
important foodborne pathogens in developed countries. The occurrence of 
O157 VTEC in retail meats is widespread. O157 VTEC strains have been isolated 
from retail beef, pork, poultry, and lamb products.121,190 Cattle are regarded as 
the principal reservoir o f these pathogens, which potentially can enter the 
human food chain by contamination o f carcasses with soiled hide or intestinal 
contents o f clinically healthy carriers at slaughter.27 Recent studies have 
shown that healthy sheep can also harbor O157 VTEC.82,i87,254,255 In the 
present study, we have isolated O157 VTEC strains from 1 (0.7%) o f 145 normal 
slaughter pigs and from 1 (0.2%) o f 459 pooled fecal samples from turkeys. 
The positive pig originated from a farm where only pigs were fattened.
1 3 4  Similarly, the positive turkey sample was collected on a farm where only turkeys 
were fattened. Therefore, contamination o f pigs and turkeys from cattle or other 
ruminants at the herd level could not occur. The isolates were biochemically 
typical, produced VT, and contained the eae gene and the hlyEHEC gene, and 
therefore, were characteristic o f E. coli O157 strains causing human infection. 
From these results it can be concluded that pigs and poultry also can be a source 
o f potentially virulent O157 VTEC.
The study on the occurrence o f O157 VTEC in normal slaughter pigs was 
initiated as a consequence o f the isolation o f these pathogens from several pork 
products in a recent survey o f Dutch retail meats, as referred above.190 Doyle 
and Schoeni121 isolated Vero cell cytotoxic E. coli Oi57:H7 strains from 1.5% of 
264 pork samples obtained from retail outlets in North America (Wisconsin 
and Alberta, Canada). VTEC strains o f serogroups other than O157 have been 
more frequently detected in pork. Read et al.368 reported that the prevalence
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of VTEC in ground pork (n = 235) collected at meat-processing plants in 
Southwestern Ontario was at least 10.6% . Samadpour et al.392 found 18% of 
pork samples (n = 51) purchased from grocery stores in Seattle positive for 
VTEC. Smith et al.415 showed the presence o f VTEC in 25% of 184 samples 
from pork sausages (n = 117) obtained from retail outlets in north and 
northwest London. And one VTEC strain was isolated in a survey o f pork 
samples (n = 111) in Thailand.433 Although no VTEC strains o f serogroup O157 
were isolated in these four studies, some of the VTEC strains isolated belonged 
to serotypes which have been associated with human disease.
Since cattle are regarded as the primary reservoir o f O157 VTEC, isolation o f 
O157 VTEC strains from pork has often been explained by cross-contamination 
from beef products or by contamination with bovine feces.
Strains o f E. coli O157 have been isolated frequently from pigs with 
diarrhea.15°,151,317,38s>,498 However, these isolates have not been characteristic of 
E. coli O157 strains causing illness in man, being either enterotoxigenic 
(synthesizing ST and LT enterotoxins) or nontoxigenic. In a recent Canadian 
study,156 however, VT-producing strains were isolated from swab samples from 
the mouths o f two o f 40 pig carcasses emerging from the polishing operation 
in a pig carcass dressing process. No further characterization o f the isolates 
was reported. From a further two of those swab samples non-Oi57 VTEC strains 
(serotypes not given) were isolated. In a i-year study o f E. coli O157 in different 
food animals at slaughter in the United Kingdom, strains o f E. coli O157 have 
been isolated from 0.4% o f pigs (n = i ,o ° ° ) .82 All four isolates were 
nonverocytotoxigenic and negative for the eae gene. Like the 
nonverocytotoxigenic and eae-negative E. coli O157 isolate in our study, three 
o f the four E. coli O157 isolates belonged to phage type 31. The remaining isolate 
reacted with the phage set, but did not conform to a recognized phage type.
Based on findings o f a National Animal Health Monitoring System study, it 
has been reported recently that swine herds in the United States appear to be 
free (<0.07%) o f O157 VTEC.22 Although reports on the natural occurrence o f 1 3 5  
human pathogenic O157 VTEC in pigs are limited, the isolation o f VTEC of 
other serogroups from pigs has been reported more often. In Germany, Beutin 
et al.45 isolated VTEC strains from 7.5% o f pigs (n = 120) from the Berlin area. 
Although none o f the nine isolates were identified as O157 VTEC, one o f the 
serotypes isolated (O9i:H-) has been implicated as a human pathogen. None 
o f the porcine isolates were positive for eae sequences.46 In another German 
study, VTEC were detected among 32% o f field isolates from pigs (n = 306) in 
the region o f Sachsen-Anhalt.148 Consistent with the results o f Beutin et al.,45 
it was reported that HlyEHEC and VT production were not associated in the 
porcine isolates. Because no information on the occurrence o f eae gene 
sequences was reported no conclusions can be drawn on the potential human 
pathogenicity o f the strains. In Australia, 16.3% of slaughter pigs (n = 129) 
were found positive for VTEC.412 No VTEC were recovered from positive PCR
samples. Pigs have occasionally been shown to harbor specific types o f VTEC, 
which produce a variant o f VT2, termed VT2e, and may cause a severe 
enterotoxemia known as edema disease.150,268 The most frequently isolated 
porcine VTEC strains belonged to the serogroups O138, O139, and O141, which 
are not associated with human disease.
During an outbreak o f O157 VTEC infection in 1987 in the United Kingdom, 
illness was associated with eating turkey-roll. It was suspected that the turkey­
roll was cross-contaminated, possibly by raw beef in the private kitchen where 
the meal was prepared.390 The present study, however, has demonstrated that 
turkeys themselves may serve as a source o f O157 VTEC strains characteristic 
o f those causing illness in man. In 1993, an outbreak o f hemolytic-uremic 
syndrome in Italy was linked to contact with chicken coops.456 However, VTEC 
were not isolated from stool samples obtained from the chicken coops 
involved. Only a limited number of studies on the isolation o f O157 and other 
VTEC serotypes from poultry and poultry products have been published to date. 
In our recent survey o f retail meats,190 all raw chicken (n = 744) and other raw 
poultry products (n = 75) were found negative for O157 VTEC. In a previous 
study, we have isolated E. coli O157 strains from 13.6% of chicken products (n 
= 110)189 and 7.7% of turkey products (n = 13) (unpublished data). However, 
the isolates were sorbitol-fermenting, £-glucuronidase-positive, 
nonverocytotoxigenic and did not contain the eae gene, and therefore were not 
typical o f human pathogenic E. coli O157 strains. In the survey o f Doyle and 
Schoeni,121 Vero cell cytotoxic E. coli Oi57:H7 strains have been isolated from 
1.5% of retail poultry samples (n = 263). The prevalence o f non-sorbitol- 
fermenting, £-glucuronidase-negative E. coli Oi57:H7 in raw chicken samples 
in Egypt was found to be 4% .9 In a survey in the United States, none o f 3,977 
chicken backs and necks contained O157 VTEC.»° Samadpour et al.392 reported 
the presence o f VTEC in 12% of chicken samples (n = 33) and 7% of turkey 
samples (n = 15) from grocery stores in Seattle. None o f the recovered strains 
1 3 6  were o f serogroup O157. One non-Oi57 VTEC strain was isolated in a survey 
o f chicken samples (n = 107) in Thailand.433 VTEC strains were not detected 
in samples o f chicken (n = 200) from meat-processing plants in Ontario, 
Canada,368 in retail chicken samples (n = 112) in the United Kingdom,415 and 
in samples o f poultry meat in Belgium (n = 255).360 In a study on the 
prevalence o f VTEC in Ontario broiler chickens, none o f the cloacal samples 
(n = 500) revealed the presence ofVTEC.198 In the United Kingdom, Chapman 
et al.82 did not find O157 VTEC strains in chickens (n = 1,000) sampled at 
slaughter. Although O157 VTEC and other VTEC have never been found in 
live chicken, experimental infection studies have shown that small populations 
o f O157 VTEC can readily colonize the caeca o f young chickens and that they 
can continue to shed the microorganism for several months.35,403,422,502 
Hakkinen and Schneitz173 reported that newly hatched chickens can 
significantly be protected against O157 VTEC by competitive exclusion
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treatment o f the chickens with fecal microflora from adult birds. From the 
standpoint o f food hygiene, competitive exclusion treatment appears to be a 
useful tool to minimize the risk o f contamination o f chicken meat with O157 
VTEC at slaughter.
Recently, O157 VTEC and/or other VTEC serotypes have been isolated from 
wild birds as well as from meat from wild birds. Wallace et al.475 isolated O157 
VTEC strains from fecal samples from wild birds, mainly gulls, collected at 
an urban landfill site and at an intertidal area in the United Kingdom. 
Dell'Omo et al.113 isolated eae-positive VTEC strains from feral pigeons sampled 
at two different squares in Rome, Italy. O157 VTEC strains were not isolated 
in the Italian study. In December 1997, we examined fecal samples from 
homing-pigeons (n = 103). No O157 VTEC strains were isolated (unpublished 
data). Pierard et al3 6° isolated non-Oi57 VTEC strains from meat samples of 
a partridge, an ostrich, a pigeon, and two pheasants.
In conclusion, the results o f the present study indicate that pigs and turkeys 
may be a source o f human O157 VTEC infection. Considering that young 
chickens can be readily colonized by small populations o f O157 VTEC and 
continue to be long-term shedders, it is presumably that chickens also can serve 
as a source o f this human pathogen. The extent to which pigs and poultry play 
a role in the epidemiology o f human O157 VTEC infection needs further 
research. More data on the occurrence o f O157 VTEC on Dutch pig-fattening 
herds and poultry farms will be obtained from a national surveillance program 
which has started recently at the National Institute o f Public Health and the 
Environment.
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Chapter 10
Occurrence of verocytotoxin-producing E scherich ia  coli 
O 157 on Dutch dairy farms
Summary
During the period from September 1996 through November 1996, 10 Dutch 
dairy farms were visited to collect fecal samples from all cattle present. The 
samples were examined for the presence o f verocytotoxin (VT)-producing 
Escherichia coli (VTEC) o f serogroup O157 (O157 VTEC) by immunomagnetic 
separation following selective enrichment. Cattle on 7 ofthe 10 dairy farms tested 
positive for O157 VTEC, with the proportion o f cattle infected varying from 0.8 
to 22.4%. On the seven farms positive for O157 VTEC, the excretion rate was 
highest in calves ages 4 to 12 months (21.2%). In a follow-up study, two O157 
VTEC-positive farms and two O157 VTEC-negative farms identified in the 
prevalence study were revisited five times at intervals of approximately 3 months.
Cattle on each farm tested positive at least once. The proportion o f cattle infected 
varied from 0 to 61.0%. Excretion rates peaked in summer and were lowest in 
winter. Again, the highest prevalence was observed in calves ages 4 to 12 months 
(11.8%). O157 VTEC strains were also isolated from fecal samples from horses, 139  
ponies, and sheep and from milk filters and stable flies. O157 VTEC isolates were 
characterized by VT production and type, the presence o f the E. coli attaching- 
and-effacing gene, phage type, and pulsed-field gel electrophoretic genotype. No 
overlapping strain types were identified among isolates from different farms 
except one. The predominance o f a single type at each sampling suggests that 
horizontal transmission is an important factor in dissemination o f O157 VTEC 
within a farm. The presence o f more than one strain type, both simultaneously 
and over time, suggests that there was more than one source o f O157 VTEC on 
the farms. Furthermore, this study demonstrated that the O157 VTEC status of 
a farm cannot be ascertained from a single visit testing a small number o f cattle.
A.E. Heuvelink, F.L.A.M. van den Biggelaar, J.T.M. Zwartkruis-Nahuis, R.G.
Herbes, R. Huyben, N. Nagelkerke, W.J.G. Melchers, L.A.H. Monnens, and 
E. de Boer.
Journal o f Clinical Microbiology 1998; 36:3480-3487.
I n t r o d u c t i o n
In recent years, verocytotoxin (VT)-producing Escherichia coli (VTEC) strains 
o f serogroup O157 (O157 VTEC) have emerged as important human 
pathogens.60 They have been associated with a variety o f human diseases, 
including mild diarrhea, hemorrhagic colitis, and the diarrhea-associated form 
o f the hemolytic-uremic syndrome. The mechanisms by which O157 VTEC 
strains cause disease are not completely understood. Virulence factors 
contributing to the pathogenesis include the production o f either or both of 
two phage-encoded toxins (VTi and VT2) which are thought to cause the 
vascular endothelial damage observed in patients with hemorrhagic colitis and 
the hemolytic-uremic syndrome446 and probably the formation o f attaching- 
and-effacing lesions in the intestine o f the host, as observed in experimentally 
infected animals.300 Since healthy domestic animals, in particular, ruminants 
like cattle, sheep, and goats, can harbor O157 VTEC and other VTEC in their 
feces, they are regarded as natural reservoirs o f these organisms.45 O157 VTEC 
can be transmitted to humans through direct or indirect contamination o f foods 
by fecal material. Undercooked ground beef and raw milk have most often been 
implicated in foodborne infections.27 In addition to consumption of 
contaminated foods, humans can become infected by direct transmission of 
O157 VTEC from infected animals or by secondary spread from person to
person.27,60
Reported estimates o f the prevalence o f O157 VTEC in North American and 
European cattle range from 0 to almost io %.27 The isolation rate is greatly 
influenced by factors such as the target population, the sampling strategy, and 
the screening method used. Furthermore, geographic and seasonal variation 
in prevalence may occur. Although knowledge about O157 VTEC has expanded, 
the interaction between these agents and the farm environment remains poorly 
understood. At present, data on the occurrence o f O157 VTEC in cattle in the 
1 4 0  Netherlands are limited. In a recent survey, we isolated fecal O157 VTEC from 
approximately 10% of Dutch adult cattle (mainly dairy cattle) and from 0.5% 
o f Dutch veal calves sampled at the major slaughterhouses o f the country.187 
An epidemiological survey on the occurrence o f O157 VTEC in Dutch dairy 
herds has never been undertaken.
The aim of the present study was to investigate the occurrence o f O157 VTEC 
on Dutch dairy farms. Following a point prevalence study on 10 farms, we 
conducted a longitudinal study on the maintenance and dissemination of O157 
VTEC on 4 o f these 10 farms. It was determined i f  fecal excretion o f the 
pathogens by cattle was affected by age and season. Also, the distribution of 
different O157 VTEC strain types within a farm and within an animal and the 
length o f shedding were studied.
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M a t e r i a l s  a n d  m e t h o d s
Study design
Ten dairy farms were selected for the present study: five farms (farms I to V) 
were randomly chosen from a list o f farms which in August 1996 had 
delivered for slaughter cattle that tested positive for fecal O157 VTEC, and five 
farms were randomly chosen from a list o f farms which in August 1996 had 
delivered for slaughter cattle that tested negative for fecal O157 VTEC (farms
VI to X).i87 The farms were visited during the period from September 1996 
through November 1996. In a follow-up study, two farms that were O157 VTEC- 
positive and two farms that were O157 VTEC-negative on the initial sampling 
were revisited five times at intervals o f approximately 3 months.
Collection of samples
At each visit, attempts were made to sample all cattle present on the farm 
individually by digital rectal retrieval (ca. 50 g o f feces). However, during the 
summer months no samples could be obtained by rectal palpation from cattle 
that were continuously at pasture. To identify individual cattle, ear tag numbers 
were recorded at the time that the feces were taken. Other animals, milk filters, 
silage, and water were randomly sampled at each visit. All samples collected 
were transferred to sterile containers and were immediately transported to the 
laboratory, where the microbiological examination was started within 20 h.
Isolation ofO i57 VTEC
A 20-g portion o f each sample was homogenized in a stomacher for 1 min 1 4 1  
with 180 ml o f modified E. coli broth containing novobiocin (20 mg/l) (Sigma 
Chemical Co., St. Louis, Mo.) (mEC + n).334 Milk filters and stable flies (one 
composite sample o f about 30 flies per farm) were added to flasks containing 
180 ml o f mEC + n without being weighed and homogenized. After 6 to 8 h 
o f incubation at 37°C on a rotary shaker (100 rpm), about 5 ml o f each mEC + 
n culture was filtered through a piece o f paper towel to remove particulate 
matter. Then, 1 ml o f filtrate was added to 20 |il o f magnetic beads coated with 
antibody to O157 (Dynal, Oslo, Norway), and immunomagnetic separation was 
performed according to the manufacturer's instructions. Cultures containing 
samples o f water were not filtered prior to immunomagnetic separation. The 
concentrates finally obtained were inoculated onto sorbitol-MacConkey agar 
(Oxoid Ltd., Basingstoke, UK) (SMAC) supplemented with cefixime (0.05 mg/l) 
and potassium tellurite (2.5 mg/l) (Dynal).501 The plates were incubated at 37°C
Chapter 10 -  O157 VTEC on dairy farms
for 18 to 20 h. Sorbitol-nonfermenting colonies (up to 12 per sample) were 
selected for confirmation. The isolates were inoculated onto Levine's eosin 
methylene blue agar (Oxoid) (L-EMB) and onto SMAC supplemented with 4- 
methylumbelliferyl-£-D-glucuronide (0.1 g/l) (Sigma) (MUG).331 Presumptive 
O157 VTEC isolates (typical E. coli metallic sheen on L-EMB and both sorbitol- 
nonfermenting and £-glucuronidase-negative on SMAC-MUG) were tested for 
agglutination with an E. coli O157 latex test kit (Oxoid). Isolates that gave a 
positive latex test result were confirmed to be E. coli by using an API 20E 
biochemical test strip (bioMerieux, Lyon, France) and were confirmed to be of 
serotype Oi57:H7 or serotype O i57:H - (nonmotile) by serotyping at the 
National Institute o f Public Health and the Environment, Bilthoven, The 
Netherlands (Dr. W.J. van Leeuwen). A maximum of three confirmed isolates 
from each positive sample were stored in glycerol-containing (10%) medium 
at -7 °°C . Recovery experiments demonstrated that O157 VTEC could be 
detected at inoculum levels o f about one organism per g o f feces.l87
Characterization of 0 157 VTEC isolates
A single isolate from each o f the positive samples was further characterized. 
Toxin production was determined by Vero cell culture assay. Colony sweeps 
o f the isolates were grown overnight at 37°C (100 rpm) in Penassay broth 
(antibiotic medium 3; Difco Laboratories, Detroit, Mich.) containing mitomycin 
(0.2 mg/l). Supernatants obtained by centrifuging the cultures at 10,000 x g  
for 10 min were filtered through °.2-^m-pore-size membrane filters (Schleicher 
& Schuell, Dassel, Germany). Volumes (50 ^l) o f serial twofold dilutions of 
the filtrates were applied to confluent Vero cell monolayers and were evaluated 
for toxic activity as described by Karmali et al.232 Toxin type and the presence 
o f the E. coli attaching-and-effacing (eae) gene were determined by a multiplex 
1 4 2  PCR assay as described previously.186 Isolates were phage typed at the 
Laboratory o f Enteric Pathogens, Central Public Health Laboratory, London, 
United Kingdom (Dr. B. Rowe). Genomic typing o f the O157 VTEC isolates 
was performed by pulsed-field gel electrophoresis (PFGE) as described 
previously.187 Genomic DNAs were digested in agarose plugs with X bal (10 
U) (Boehringer Mannheim, Mannheim, Germany). The resulting fragments 
were resolved by contour-clamped homogeneous electric field (CHEF)-PFGE 
with a CHEF DR-II apparatus (Bio-Rad Laboratories, Richmond, Calif.) at a 
constant voltage o f 200 V for 24 h at i3°C and a linearly ramped pulse time of
3 to 50 s. Interpretation o f the PFGE patterns was performed by visual 
inspection. Patterns that differed by one or more fragment differences were 
considered to be different and coded with different letters.
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Statistical analysis
In the prevalence study, we explored the dependence o f the risk o f being 
infected with O157 VTEC on the age o f the cattle. Therefore, the animals were 
classified into the following groups: calves younger than 4 months, calves ages 
4 to 12 months, heifers ages 1 to 2 years, cows ages 2 to 3 years, and adult cows 
older than 3 years. Because some farms may be more heavily infected than 
others, the risk o f being infected may cluster within farms (the “units of 
observation”). To take this clustering into account, we carried out a logistic 
regression for dependent observations using the method o f generalized 
estimating equations (GEE).116 The GEE analysis was performed by the PROC 
GENMOD procedure in s A s release 6.12 (SAS Institute, Cary, N.C.). In the 
follow-up study, the units o f observation were the individual cattle. Similarly, 
logistic regression by GEE was performed. The risk factors for O157 VTEC 
infection considered were season (analyzed per quarter), age (classified as 
described above), and farm. To confirm our analyses, we also tried to address 
the questions stated above using the conditional logistic regression (CLR) 
approach,427 with infection as the outcome variable. The CLR analysis was 
performed by the PROC PHREG procedure in SAS release 6.12. In the 
prevalence study, we used farm as a stratifying variable and age (classified as 
described above) as a covariable. In the follow-up study, we stratified by both 
individual animal and age to analyze the effect o f season. Thus, cattle which 
were observed only once during the same age period were excluded from 
analysis. Similarly, cattle which were always either positive or negative during 
the same age period were also excluded from analysis. Analysis o f the effect 
o f age by CLR did not yield interpretable results because o f the low number 
o f usable observations after stratifying by both individual animal and season.
R e s u l t s  1 4 3
Prevalence study
Cattle on 7 o f the 10 dairy farms selected tested positive for O157 VTEC (Table
1). The proportion o f cattle infected on the farms that yielded positive samples 
varied from 0.8 to 22.4%. None of the O157 VTEC-positive animals had 
diarrhea. Within the seven positive farms, the excretion rate was highest in 
calves ages 4 to 12 months (21.7%), with the prevalence in calves younger than 
4 months o f age being 6.7%, that in heifers ages 1 to 2 years being 3.7%, that 
in cows ages 2 to 3 years being 2.2%, and that in cattle older than 3 years being 
10.7% (Fig. 1). By performing logistic regression by using GEE, only the 
prevalence o f O157 VTEC excretion for calves ages 4 to 12 months was found 
to be statistically significantly higher (P < 0.05) than the prevalence o f O157
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Table . Isolation and characterization o f fecal O157 VTEC strains from cattle from the IO
Dutch dairy farms investigated in the prevalence study
Farm Date o f 
sampling
No. o f cattle O157 
VTEC-positive /
Phage
type
Result o f 
Vero cell 
assay for 
VT
PCR results for the 
following gene:
PFGE No. o f 
pattern isolates
total no. o f cattle (%) VTi VT2 eae
I Sept 19 9 6 27/ i4 °  (i 9 -3) 34 + + + + A 23
34 + - + + A 2
31 + - + + B I
Rdnc + + + + C I
II Sept 19 9 6 i 5/67 (22.4) 8 + + + + D I5
III Sept 19 9 6 7/H2 (6 .3) 31 + - + + E 7
IV Oct 19 9 6 3/ i6 2  (1 .9 ) Rdnc a + + + F 3
V Oct 19 9 6 i 7/83 (20.5) 14 + - + + G I7
VI Oct 19 9 6 I/I20  (0 .8) 14 + - + + H I
VII Nov 19 9 6 5/ io °  (5.°) 8 + + + + I 5
VIII Nov 19 9 6 O/IOO (0 .°)
IX Nov 19 9 6 o / i95 ( ° .° )
X Nov 19 9 6 0/73 (0.0)
a  Rdnc, reacted with the phage set but did not correspond to a recognized phage type.
Ï 4 4
Figure 1. Fecal excretion o f O157 VTEC by 
cattle from  the seven farm s that tested 
positive in the prevalence study relative to 
age o f cattle. □  , percentage o f cattle found to 
be O157 VTEC-positive in the age group; •, 
estimated percentage o f O157 VTEC-positive 
cattle in the age group by GEE analysis; *, 
statistically significantly different (P < 0.05). 
Values above the bars are number o f cattle 
found to be O157 VTEC-positive / total 
number o f cattle examined in the age group.
VTEC excretion for cows ages 2 to 3 years (Fig. 1). By CLR, the following 
significant differences (P < 0.05) in excretion rates were found: the excretion 
rate o f O157 VTEC for calves ages 4 to 12 months appeared to be statistically 
significantly higher than that for animals in all other age groups, and cattle 
older than 3 years were statistically significantly more often infected than heifers 
ages 1 to 2 years and cows ages 2 to 3 years (data not shown).
A single isolate from each of the 75 positive cattle was further characterized 
(Table 1). It appeared that isolates obtained from different farms were o f distinct
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O157 VTEC strain types and isolates obtained from different cattle on the same 
farm were generally o f the same strain type. However, among the isolates from 
farm I four distinct strain types were identified. To determine i f  different O157 
VTEC strain types were simultaneously present in the two animals from which 
the strains characterized by PFGE patterns B and C were isolated, we also 
performed PCR and PFGE with the other two O157 VTEC isolates from each 
of these two animals. For both animals it appeared that all three isolates were 
o f identical strain types (data not shown). Additionally, we performed a PCR 
with the other two O157 VTEC isolates from each of the two animals from which 
the VT2-producing isolates characterized by PFGE pattern A were isolated. It 
appeared that these isolates also contained VT2 genes only, with the exception 
that one isolate was positive for both the VT i and VT2 genes (data not shown).
In addition to fecal samples from cattle, a total o f 63 other samples were 
examined for the presence o f O157 VTEC: droppings from pigs (n = 32), horses 
(n = 4), one pony, one sheep, one dog, and one rabbit; one sample o f pig's dung; 
milk filters (n = 7); samples o f silage (n = 8); and samples o f animal drinking 
water (n = 7). O157 VTEC strains were isolated from only one o f the horses, 
the one sheep, and one o f the milk filters (data not shown). The positive horse 
sample originated from farm II, and the positive sheep sample and milk filter 
originated from farm V. The isolates were of the same strain types as the cattle 
isolates obtained from the respective farms, as determined by phage typing, 
the Vero cell assay, the PCR assay, and PFGE.
Follow-up study
Two farms with cattle positive on the initial sampling (farm II and farm V) 
and two farms with cattle negative on the initial sampling (farm VIII and farm 
X) were revisited five times. However, farm X could not be visited in the early 
summer o f 1997 since at the time classical swine fever was prevalent in the 1 4 5  
part o f the country where farm X was located. The results o f the isolation of 
O157 VTEC strains from cattle are summarized in Table 2. Table 3 presents 
the results for additional samples collected at the four farms. During the study 
period, the proportion o f cattle infected on the farms varied from 0 to 61.0%
(Table 2). None o f the O157 VTEC-positive animals had diarrhea. Overall, 86 
cattle were sampled once, 58 cattle were sampled twice, 82 cattle were sampled 
three times, 109 cattle were sampled four times, 104 cattle were sampled five 
times, and 77 cattle were sampled six times (data not shown). Ninety-three cattle 
tested positive for O157 VTEC: 78 had a single positive sample, 14 had two 
positive samples, and 1 had three positive samples. Six o f the 14 cattle with 
two positive samples excreted the pathogens on two consecutive samplings.
The remaining cattle with two positive samples tested negative at two or more 
samplings carried out in the period between the positive ones. The one animal
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Table 2. Isolation and characterization o f fecal O157 VTEC strains from cattle from the four 
Dutch dairy farms investigated in the follow-up study
Farm
VIII
Date o f N° . o f cattle O l57 
sampling V r EC-positive /
total no. o f cattle (%)
Sept I99 6  
Dec I99 6
Mar 199 7 
Jun 199 7 
Sept I997
Nov I997
Oct I99 6  
Jan I997
APr I 997
Jun I997
Sept I997
Nov I997
Nov I99 6  
Jan I997
APr I 997 
Jul I997 
Sept I997 
Nov I997
Nov I99 6  
F eb I9 9 7
Apr I997 
Sept I997 
Nov I997
i 5/67 (2 2 .4 ) 
8/ i ° 6 (7 .5)
o /99  (° . o) 
o /99  (o.o) 
36/59  (6 l .0 )
i 5/ io 4  (I4 .4 )
i7 /83 (2 ° . 5) 
i / 83 (i .2) 
2/79  (2 .5) 
9 /52 (I7.3 )
2/38 (5.3)
o/4 I ( o .o)
o /io o  (o.o) 
o/I29 (o.o)
i / i3i (o .8) 
o /99  (o.o) 
o/8 i (o.o) 
o / iio  (o.o)
o/7 3 (o.o) 
o/7 3 (o.o) 
o/64 (o.o)
2/22 (9 .I) 
i / 74 (i.4 )
Result o f 
Phage Vero cell
PCR results for the 
following gene:
PFGE No. o f
8
assay for 
VT
+
VTi
+
VT2
+
eae
+ D I5
8 + + + + J 7
8 + + + + D I a
21 + + + K 35 b
54 + _ + + L I
21 + - + + K I5 C
I4 + - + + G I7
I4 + - + + G I d
4 + + + M 2 e
I4 + + + N 8 ƒ
48 g + _ + + N I
I4 + _ + + O I h
54 + + + P I
4 + + + M I
34
34
a Isolate from  a calf 4  to 12 months o f age which also tested positive in September 19 9 6 .
b Including two isolates from  adult cows >3 years o f age which also tested positive in September 19 9 6  and three isolates 
from  cattle ages 2 to 3 years which also tested positive in December 19 9 6 .
c Including one isolate from  a calf younger than age 4  months and three isolates from calves 4  to 12 months o f  age which 
all also tested positive in September 1997, one isolate from  a heifer 1 to 2 years o f  age which also tested positive in 
December 199 6 , and one isolate from  a heifer 1 to 2 years o f  age which also tested positive in September 19 9 6 . 
d Isolate from  a ca lf 4  to 12 months o f  age which also tested positive in October 199 6 . 
e Including an isolate from an adult cow which also tested positive in October 199 6 . 
f  Including an isolate from  a ca lf 4  to 12 months o f age which also tested positive in October 19 9 6 . 
g  Phage type 48 differs from  phage type 14 in only one phage reaction. 
h Isolate from  an adult cow which also tested positive in October 19 9 6  and April 1997.
II
V
X
Table 3. Isolation and characterization o f O157 VTEC strains from additional samples collected 
at the four Dutch dairy farms investigated in the follow-up study
No. o f samples O157 VTEC-positive / no. o f samples tested
Farm Date o f 
sampling Cattlea Pigs Horses Ponies Sheep
Stable
flies
Milk
filter
Animal 
Silage drinking 
water
Sep tI99 6 i b / 2 c O / I
Dec I996 I d / I
Mar I997 O / i O 0 4 O / I
Jun I997 O / i O / 2
Sept I997 O / i 3 e /  3 c I e / I
Nov I997 O / 2 O 0 3
i  e / i 
O / I
V Oct I9 9 6 f O / IO
Jan I99 7 h O / 2 l O / 6
Ap r I 997 O 0 3 j O 0 3
Jun I997 i k '1 / 5 O / 5
Sept I997 O / 5 m O 0 4
Nov I997 I n / 7 O / 5
V III Nov I99 6 O / I5
Jan I997
Ap r I 997 O / I O / 5
Jul I997 O / 5
Sept I997 O / I O 0 3
Nov I997 O / 5
X  N o vI9 9 6 O / 7
Feb I997 O 0 4
Ap r I 997 O 0 3
Sept I997 I4 o/  IS O 0 4
O / 2
I g  / I
4  g / 5 
O / 5
I I  / 4
O 0 9
O / I
O / I
O / I O / I
O / I
i  e / i O / I
O / I O / 2 O / 2
i g  / i O / 2 O / I
O / I O 0 3
O / I
O / I
O / I
O / I O / 2
O / I O / I O / I
O / I O / I
O / I O / I
O / I O / I
O / I O / I
O / I O / I O / I
O / I O / I O / I
O / I O / I O / I
O / I O / I
O / I O / 2
O / I O / I O / INov 199 7
a Fecal samples from  cattle which could not be identified individually since either the cattle wore no ear tag numbers or 
the samples were taken from  fresh droppings in farm building (adult steers) or in pastures (heifers). 
b The isolate was characterized as being phage type 8, Vero cell assay positive, VTi-positive, VT2-positive, eae-positive, 
and PFGE pattern D. 
c Including one fowl.
d The isolate was characterized as being phage type 32, Vero cell assay positive, VTi-positive, VT2-positive, eae-positive, 
and PFGE pattern S.
e The isolates were characterized as being phage type 21, Vero cell assay positive, VTi-negative, VT2-positive, eae-positive, 
and PFGE pattern K.
f  Additionally, fecal sam ples from  a dog, a rabbit, and the pig’s dung were collected. A ll tested negative. 
g  The isolates were characterized as being phage type 14, Vero cell assay positive, VTi-negative, VT2-positive, eae-positive, 
and PFGE pattern G.
h Additionally, fecal samples from a dog and the pig’ s dung were collected. Both tested negative.
1 Including one adult steer. 
j All adult steers. 
k An adult steer.
l The isolate was characterized as being phage type 14, Vero cell assay positive, VTi-negative, VT2-positive, eae-positive, 
and PFGE pattern N. 
m Including three steers.
n Sample taken from  a fresh dropping in the pasture. The isolate was characterized as being phage type i4, Vero cell 
assay positive, VTi-negative, VT2-positive, eae-positive, and PFGE pattern N.
0 Samples taken from fresh droppings in the pasture. Twelve o f  the isolates were characterized as being phage type 34, Vero 
cell assay positive, VTi-negative, VT2-positive, eae-positive, and PFGE pattern Q, and the remaining two were characterized 
as being phage type 2, Vero cell assay positive, VTi-negative, VT2-positive, eae-positive, and PFGE pattern T.
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Figure 2. Fecal excretion o f O157 VTEC by 
cattle from the four farms examined in the 
follow-up study relative to season and age of 
cattle. Heifers ages 1 to 2 years could not be 
sampled in the period from July to Sep­
tember because they were continuously at 
pasture. Bars, total percentage o f cattle found 
to be O157 VTEC-positive in the quarter; •, 
estimated total percentage o f O157 VTEC- 
positive cattle in the quarter by GEE analysis; 
*  , statistically significantly different (P < 
0.05). Values above the bars are number o f 
cattle found to be O157 VTEC-positive / total 
number o f cattle examined in the quarter.
Figure 3. Fecal excretion o f O157 VTEC by 
cattle from the four farms examined in the 
follow-up study relative to age o f cattle. □, 
percentage o f cattle found to be O157 VTEC- 
positive in the age group; •, estimated 
percentage o f O157 VTEC-positive cattle in 
the age group by GEE analysis; 
statistically significant difference (P < 0.05) 
between estimated percentage o f  O157 
VTEC-positive cattle in the age groups. 
Values above the bars are number o f cattle 
found to be O157 VTEC-positive / total 
number o f cattle examined in the age group.
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with three positive samples had alternately positive and negative samples. 
Excretion rates peaked in summer and were lowest in winter (Fig. 2). Both by 
the GEE method (Fig. 2) and by the CLR method (data not shown), the quarterly 
differences in excretion rates were found to be statistically significant (P < 0.05). 
However, because o f the low number o f usable observations, the period from 
J anuary to March did not yield interpretable results when the CLR method was 
used. Within each age group, shedding varied with a similar seasonal pattern 
(Fig. 2). However, heifers ages 1 to 2 years could not be sampled individually 
in the period from July to September because they were continuously at pasture. 
In agreement with the results o f the prevalence study, the highest rate of 
excretion was observed in calves ages 4 to 12 months (11.8%) (Fig. 3). The 
highest prevalence in this group of animals was consistent in all seasons (Fig. 
2). The results o f the isolation o f O157 VTEC from fecal samples obtained from
Chapter 10 -  O157 VTEC on dairy farms
cattle that could not be identified individually are included in Table 3. These 
samples were taken from cattle wearing no ear tag and from fresh cowpats in 
farm buildings (adult steers) and in pastures (heifers). Fourteen o f the 16 
positive samples were obtained from farm X, which previously always tested 
negative. The 18 samples from farm X were taken from the inner part o f fresh 
cowpats in adjacent pastures in which heifers ages 1 to 2 years were grazing.
In addition to feces from cattle, feces from horses, ponies, and sheep also 
occasionally tested positive for O157 VTEC (Table 3). Furthermore, the 
pathogens were isolated from milk filters and stable flies. O157 VTEC strains 
were not isolated from any o f the fecal samples from pigs or from any o f the 
samples o f silage and water.
A single isolate from each of the positive samples was further characterized 
(Table 2 and Table 3). Again, it appeared that isolates obtained from different 
farms were o f distinct O157 VTEC strain types. However, the two isolates from 
farm V and the one isolate from farm VIII isolated in April 1997 could not be 
distinguished (Table 2). Sometimes, more than one strain type was present 
simultaneously within a farm, but one type was predominant. The six cattle 
that tested positive on sequential samplings appeared to excrete isolates o f a 
consistent strain type during the 3-month period (Table 2, footnotes a, c, and 
d). The remaining cattle with more than one positive sample excreted isolates 
o f different strain types on different samplings (Table 2, footnotes b, c, e, f , and 
g). To determine i f  different O157 VTEC strain types were simultaneously 
present in the animals, we characterized the remaining two stored isolates for 
a selection o f animals from farm II and farm V: the animal from which the 
strain characterized by PFGE pattern D was isolated in December 1996 (Table
2), the animal from which the strain characterized by PFGE pattern L was 
isolated in September 1997 (Table 2), the animal from which the strain 
characterized by PFGE pattern S was isolated in December 1996 (Table 3, 
footnote d), the two animals from which the two strains characterized by PFGE 
pattern M were isolated in April 1997 (Table 2), and the two animals from which 1 4 9  
the strains characterized by PFGE pattern O and PFGE pattern P were isolated 
in September 1997 (Table 2). For each ofthese selected animals, all three strains 
isolated from the same fecal sample were identified as being identical strain 
types (data not shown).
D i s c u s s i o n
Our findings support those o f previous farm studies indicating that the 
prevalence o f O157 VTEC excretion is higher in immature cattle than in adult 
cattle.175,178,303,483 The higher prevalence in younger animals is consistent with 
the higher numbers (numbers o f CFU per gram) and the longer duration of 
shedding observed in calves experimentally infected with O157 VTEC than in
adult animals.106 The differences in excretion rates between age groups may 
be attributed to age-related differences in rumen function. Adult cattle possess 
a fully developed rumen, the largest o f the four chambers o f a ruminant's 
stomach, where the combination o f high concentrations o f volatile fatty acids 
and a low pH inhibit the growth of O157 VTEC.365 Furthermore, the differences 
in excretion rates may reflect differences in diet, immune response, aspects 
o f cattle management, or other unknown factors. While immature cattle are 
fed on a high-roughage diet, lactating cows are fed on a diet supplemented 
with concentrates high in nutrients. The diet o f the youngest calves, those 
younger than 4 months, initially consists o f milk or milk replacer, which over 
the course o f time will gradually be replaced with roughage. The influence of 
diet on shedding o f O157 VTEC by ruminants has been clearly demonstrated 
by experiments with experimentally inoculated sheep.253,256 Kudva and 
colleagues253,256 hypothesized that diets high in nutrients and low in fiber 
induce a lower incidence o f transmission and/or shedding o f fewer O157 VTEC 
cells but do not induce clearance o f the organisms from the intestine. 
Conversely, diets low in nutrients and high in fiber induce shedding o f larger 
numbers o f O157 VTEC and/or increased susceptibility to new intestinal 
colonization but also induced elimination o f the organisms. High-nutrient and 
low-fiber feeds increase the concentrations o f volatile fatty acids and decrease 
the pH in the ruminant gut, while low-nutrient and high-fiber feeds have the 
opposite effect. The relatively low rate o f excretion observed in the youngest 
calves is consistent with the findings o f Garber and colleagues.152 They 
reported that calves ages 8 weeks or older were three times more likely to shed 
O157 VTEC than calves less than 8 weeks old.
The seasonal variation in the prevalence o f O157 VTEC-positive cattle observed 
in the follow-up survey has also been reported by others.82,175,178,303 While 
younger cattle often were kept indoors year-round, cattle ages 1 year and older 
were at pasture from early summer through midautumn. Lactating cows were 
I 50  moved indoors only at the time o f milking. The seasonal movements o f cattle 
into farm buildings and out to pasture were accompanied by changes in diet. 
When cattle were kept indoors they were fed relatively more feeds high in 
nutrients, besides their regular diet based on silage, than when they were 
grazing in pastures. Referring to the findings o f Kudva et al.,253,25 6 these dietary 
changes may have contributed to the seasonal variation in O157 VTEC-positive 
cattle. In the course o f the grazing season the risk o f infection o f animals that 
are at pasture will be increased because the pastures will increasingly be 
contaminated with feces from animals occupying the pastures. Furthermore, 
the warmer and more moist conditions o f the summer months may favor the 
survival and growth of O157 VTEC in the environment.
No overlapping strain types were identified among isolates from different 
farms, with the exception o f one: two isolates from farm V and the one isolate 
from farm VIII could not be distinguished. Although more than one distinct
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strain type was sometimes present simultaneously within a farm, one type 
always clearly predominated. Since VT production is encoded by phages, VT 
profiles can change over time.224 Therefore, all 25 isolates from farm I 
characterized by phage type 34 and PFGE pattern A can be considered as being 
o f a single strain type (Table 1). The predominance o f a single strain type 
supports the idea that horizontal transmission among animals is an important 
factor in the dissemination o f O157 VTEC within a farm.136,253,256 Generally, 
calves ages 4 to 12 months were grouped together year-round in close contact 
indoors. Heifers were either together at pasture or grouped in close contact 
indoors. The same was true for lactating cows. However, 3 o f the 10 farms 
(farms V, VI, and X) were organized more conventionally, with lactating cows 
having less close contact together indoors, being continuously individually tied.
On all o f the 10 farms, calves younger than 4 months o f age were kept 
individually or in small groups o f about three animals. Either all cattle shared 
the same farm building (farms I, VIII, and IX) or immature cattle and lactating 
cows were kept in separate buildings (farms II to VII and X). Cattle, horses, 
and sheep alternately occupied the same pastures. Furthermore, the horses 
on farm II were housed in the same building as cattle younger than 12 months 
o f age. Management factors such as grouping o f animals in close contact and 
communal housing may favor horizontal transmission o f O157 VTEC among 
animals within a farm.136,152,253,2 5 6 Both Faith et al3 6 and Kudva et al.256 isolated 
O157 VTEC strains that were identical to the strains isolated from animals from 
common water troughs. Therefore, they concluded that contaminated animal 
drinking water may be an important mode of dissemination o f O157 VTEC 
among animals on farms. The isolation o f identical O157 VTEC strains from 
stable flies and animals in the present study (farm II) suggests that flies may 
also be vehicles for transmission o f the pathogens within a farm.
Although it cannot be ruled out, concurrent excretion o f different O157 VTEC 
strains by individual animals was not likely to occur in the present study. The 
isolates further characterized were randomly selected from the three isolates 1 5 1  
stored from each sample. Since it appeared that the vast majority o f isolates 
obtained from a single farm on the same date were o f the same strain types, 
we decided to characterize only all three isolates stored from a single sample 
for a selection o f animals (mainly those animals from which the initially 
selected isolate was not identical to the majority o f isolates obtained from that 
farm on the same date) and found that all three isolates from a single sample 
were identical. However, Besser and colleagues43 found multiple PFGE types 
in 2 o f 12 bovine fecal samples from which multiple isolates were typed, with 
one sample containing two different types and the other sample containing 
three different types. Also, Faith and coworkers136 reported that animals may 
harbor O157 VTEC strains that display different PFGE patterns: 7 o f the 29 
animals from which multiple isolates were typed appeared to harbor different 
O157 VTEC strains.
The longest period o f excretion identified in the follow-up study was about 3 
months. However, most O157 VTEC-positive cattle became culture negative 
within 3 months. Besser et al.43 found that the duration o f detected excretion 
o f O157 VTEC by individual cattle was less than 1 month for 35 (63%) o f 56 
cattle. The length o f excretion varied from 8 to at least 46 days in a study of 
Wells et al.483 Experimental infection studies showed that fecal shedding of 
O157 VTEC varied widely among cattle o f the same age group but persisted 
longer in calves than in adults. The feces o f calves fed with 10 10 CFU o f O157 
VTEC were positive for 2 (8 o f 8 calves), 7 (8 o f 8), 14 (3 o f 8), and 20 (2 o f 8) 
weeks postinoculation, and the feces o f adult steers were positive for 2 (9 of 
9 adults), 7 (2 o f 9), and 14 (1 o f 9) weeks.106 In the present study, one to six
O157 VTEC strain types were identified on each o f the four farms over time. 
The transient nature o f excretion by individual animals and the excretion of 
different strains at different times supports the idea o f clearance o f O157 VTEC 
followed by reinfection with different strains.43,136,363,483,505 However, persistent 
latent infection cannot be ruled out. The presence o f more than one strain type 
on farms, both simultaneously and over time, suggests the presence o f more 
than one source o f O157 VTEC on the farms.
Raw cow's milk has been associated several times with human O157 VTEC 
infection.59,86,237,294,457 The organisms have been isolated from samples o f raw 
milk both from individual cattle303,499 and from bulk tanks.340 It has been 
suggested that the organisms are not being excreted in the milk but that 
contamination probably results from fecal contamination o f milk as it is 
collected. The isolation o f O157 VTEC from milk filters in the present study 
implies the presence o f O157 VTEC in the respective bulk tanks. Based on the 
risk o f the presence o f O157 VTEC and other enteric pathogens in raw milk, 
people need to be strongly dissuaded from consuming raw milk. Finally, there 
is also a need for awareness that farmed or companion animals can be a direct 
vehicle o f O157 VTEC infection in humans. Close contact with infected 
I 52  calves, horses, goats, and dogs has previously resulted in human 
infection.79,352,371,410,457
By elucidating the epidemiology o f O157 VTEC on farms, we hope to eventually 
identify strategies to reduce the risk o f O157 VTEC-positive animals entering 
the food production system and, as a result, to reduce the risk o f O157 VTEC 
infections in humans. The results o f the present study indicate that the O157 
VTEC status o f a herd cannot be defined by testing only a limited number of 
cattle on a single visit. Further research is required to identify risk factors which 
promote fecal shedding of O157 VTEC. In addition, long-term reservoirs remain 
to be identified. Eventually, this all may lead to changes in farm management 
practices that may decrease the prevalence o f O157 VTEC in farm animals and 
consequently the number o f O157 VTEC-positive animals entering the food 
production chain.
Verocytotoxin-producing Escherichia coli in humans and the food chain
A c k n o w l e d g m e n t s
We thank all the farmers involved in this study for cooperation with this 
research. The study was supported by the Prevention Fund (grant number 28
2354).
Chapter 10 -  O157 VTEC on dairy farms
I53

Chapter 1 1
Summary, general discussion, and future perspectives
I n t r o d u c t i o n
Verocytotoxin (VT)-producing Escherichia coli (VTEC) were first identified as 
human pathogens in 1982, when E. coli strains o f a previously rarely isolated 
serotype, Oi57:H7, were implicated in two outbreaks o f hemorrhagic colitis 
(HC), a distinctive clinical entity characterized by abdominal cramps, severe 
bloody stools, and little or no fever.376 Illness was associated with consumption 
of undercooked hamburgers at a fast-food restaurant chain. Since then, 1 5 5  
strains o f E. coli Oi57:H7 and the nonmotile variant E. coli Oi57:NM have 
emerged as one o f the most significant foodborne pathogens in developed 
countries. Moreover, more than 100 different VTEC serotypes other than 
Oi57:H7 and Oi57:NM have now been recognized to cause human illness.430 
However, some VTEC serotypes found in food and animals have never or only 
rarely been associated with severe human disease. The pathogenicity o f VTEC 
strains is mainly associated with their ability to produce VT304 and their capacity 
to adhere to the intestinal epithelium by the formation of attaching-and-effacing 
(AE) lesions.2is> Two main types o f VT have been distinguished, VTi and VT2, 
with additional variants within these types. More research is needed to further 
define the characteristics that render selected VTEC organisms harmful to 
humans. In many parts o f the world strains o f serogroup Oi57 (Oi57 VTEC) 
are still the predominant VTEC strains causing human illness. Infection with
VTEC presents a wide spectrum o f clinical manifestations, ranging from 
asymptomatic carriage and uncomplicated nonbloody diarrhea to more serious 
clinical conditions such as HC and the diarrhea-associated (D+) form of the 
hemolytic-uremic syndrome (HUS), which is the leading cause o f acute renal 
failure in children.354 Approximately i0%  ofthose with clinically apparent Oi57 
VTEC infection will develop HUS,438 but in outbreaks it has been reported to 
be as high as 30%. Although most infections have been acquired following 
consumption o f contaminated food, mainly undercooked ground beef and other 
foods o f bovine origin, both transmission by contact with infected livestock, 
waterborne and person-to-person transmission have also been documented. 
Retrospective examination o f stored sera from D+ HUS patients for circulating 
antibodies to the lipopolysaccharide (LPS) o f E. coli Oi57 has demonstrated 
that E. coli Oi57 infection occurred in the Netherlands as early as i974.s>i Of 
33 serum samples collected between i974 and i98i, i4 (42.4%) were found to 
be positive for antibodies to Oi57 LPS. These results strongly suggest that Oi57 
VTEC has been an important human pathogen for at least a decade before it 
was formally associated with D+ HUS by Karmali and colleagues234 in ^ 8 3 . 
The Dutch patient from whom the serum sample had been taken in i974 still 
remains the earliest known case o f D+ HUS caused by this organism. 
Subsequent epidemiological studies have shown that VTEC, and in particular 
VTEC of serogroup Oi57, are the main cause o f D+ HUS in children in the 
Netherlands.93,469 During a 4-year prospective study from September ^ 8 9  
till September i993, stools and sera from ii3 children with D+ HUS admitted 
to the academic hospitals in the Netherlands (n = 77), one university hospital 
in Germany (Cologne) (n = 2i) and two in Belgium (Leuven and Antwerpen) 
(n = i5) were examined for culturable VTEC and free fecal VT and for 
antibodies to Oi57 LPS, respectively.469 Evidence o f infection with VTEC was 
proven for 88 (78%) patients and strains o f serogroup Oi57 were the causative 
agents in 76 (86%) o f these 88 patients. In addition, stools and sera were
I 56  obtained from 95 family contacts o f 28 patients admitted to the pediatric 
department o f the University Hospital Nijmegen (The Netherlands). In i7 
(6i%) families one or more members appeared to be infected with VTEC at 
the time o f admission o f the patient to the hospital. Thirty-three (35%) family 
members had evidence ofVTEC infection. The sources o f the infectious agents 
in these cases o f D+ HUS have not been defined.
Due to the lack o f a national HUS surveillance system, trends over time in the 
incidence o f HUS in the Netherlands have not been documented. Figure i 
shows the number o f D+ HUS patients admitted to the pediatric department 
o f the University Hospital Nijmegen from ^ 6 5  till i998. Since the peak in 
the early i970s the number o f D+ HUS patients has declined gradually to a 
relatively stable level during the last decade. It seems reasonable to assume 
that this figure is representative for all academic hospitals in the country. An 
inquiry at the pediatric departments o f all academic hospitals into the number
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Figure 1. The number o f patients with D+ HUS admitted to the pediatric nephrology department 
o f the University Hospital Nijmegen (The Netherlands) from 1965 till 1998.
of D+ HUS patients admitted to their department in 1998 proved that 19 
children were treated for D+ HUS in the Netherlands in 1998.310 This 
indicates that D+ HUS remains a serious problem in the Netherlands and that 
the risk o f major outbreaks o f VTEC infection is still present.
Information on the frequency o f isolation o f O157 VTEC from patients with 
gastroenteritis in the Netherlands is collected in two ways. First, since May
1996 all Regional Public Health Laboratories (Streeklaboratoria voor de 
Volksgezondheid) weekly report to the National Institute o f Public Health and 
the Environment (Rijksinstituut voor Volksgezondheid en Milieu; Bilthoven, 1 5 7  
The Netherlands) their number o f E. coli O157 isolates. Ten isolates were 
reported in 1996 (from May), 29 in 1997, and 31 in 199 8 .^ ° To rule out the 
possibility o f reporting false-positive isolates, it is highly recommended to 
routinely send presumptive O157 VTEC isolates to a central laboratory for 
confirmation. Second, at the end of 1997 the National Coordination Centre 
for Communicable Disease Outbreak Management (Landelijke 
Coördinatiestructuur Infectieziekten) asked all medical microbiologists in the 
Netherlands to report E. coli O157 isolations to the Municipal Health Services 
(Gemeentelijke Gezondheidsdiensten). The Municipal Health Services 
subsequently have to report these isolations to the National Coordination 
Centre for Communicable Disease Outbreak Management and will try to 
identify the source o f the infections. Besides confirmation o f presumptive 
isolates, a reliable reporting system requires uniform indications for
laboratories as to which specimens to culture for E. coli O157 and the use of 
uniform isolation methods. Currently, it is not clear what the criteria for 
laboratories in the Netherlands are for deciding to examine stools for E. coli 
O157. Given that approximately 10% ofindividuals with evidence o f O157 VTEC 
infection develop D+ HUS and that the total number o f D+ HUS patients in 
the Netherlands in 1998 was 19, the total number o f O157 VTEC infections in 
the same year is being estimated at about 190.
While the two reporting systems above only detect O157 VTEC infections, 
during a 3-year study (May 1996 - May 1999) into gastroenteritis in sentinel 
practices (n = 33) stool samples were examined for both O157 VTEC and non- 
O157 VTEC strains. Results o f the first 2 years showed that O157 VTEC strains 
were isolated from only 1 (0.2%) o f the 602 samples examined.112 Other VTEC 
serotypes isolated were O98:K- and Oi45:K- (0.4%). Based on these data, it 
seems likely to assume that O157 VTEC and non-0157 VTEC strains only 
incidentally cause gastroenteritis in the Netherlands. Results o f the third year 
are not yet available.
The incidence o f O157 VTEC infections in the general human population is 
being estimated in a i-year population-based study, which has started at the 
National Institute o f Public Health and the Environment in December 1998. 
Results probably will become available at the beginning o f the year 2000.
So far, large outbreaks ofVTEC infection have not occurred in the Netherlands. 
Only two small outbreaks have been reported. The first occurred in June 
1993.103 Four children developed D+ HUS and unchlorinated swimming water 
was identified as the possible source. However, bacteriologic examination of 
the swimming water could not confirm this assumption. The second reported 
outbreak occurred in April 1998 and concerned an outbreak in a large 
family.185 Two of the six children o f the family needed hospitalization, one with 
symptoms of D+ HUS. The family lived on a farm where veal calves were raised, 
and the calves were identified as the possible source o f the infections. However,
1 5 8  subtyping o f the O157 VTEC isolates revealed that the human and animal 
isolates were similar, but not identical.
The purpose o f this thesis was to gain more insight in both the epidemiology 
ofVTEC infection in humans and the occurrence and survival o f VTEC in the 
human food chain, in order to be able to formulate recommendations to 
eventually reduce VTEC infections in humans. We have focused our study in 
particular on VTEC of serogroup O157, because from a clinical and public health 
point o f view these strains are currently the most important in the Netherlands. 
Chapter 1 gives an overview of current knowledge on VTEC. Subsequently 
discussed are epidemiological aspects (the incidence o f VTEC infection in 
humans, the transmission o f VTEC organisms, and their reservoirs), the 
clinical manifestations and treatment o f a VTEC infection, the pathogenesis 
and putative bacterial virulence factors, and finally detection, isolation, and 
typing methods. In the outline o f the thesis the objectives o f the different 
studies are chronologically described.
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Characterization of human O157 VTEC isolates
Chapter 2 presents the results o f the phenotypic and genotypic characterization 
o f 50 human O157 VTEC strains. The collection represented isolates obtained 
from D+ HUS patients and their family contacts, isolated in the Netherlands 
(n = 43), Belgium (n = 5) and Germany (n = 2) during the prospective study 
referred above.469 Besides phage type, the isolates were characterized by their 
toxin genotype (VTi and/or VT2) and the presence o f the E. coli attaching-and- 
effacing (eae) gene using a multiplex polymerase chain reaction (PCR). VTi 
and VT2 are encoded by bacteriophages. The eae gene is located in a 
chromosomal pathogenicity island, designated the locus o f enterocyte 
effacement, which encodes multiple genes necessary to induce the 
characteristic AE histopathology. The eae gene encodes an adhesion molecule 
called intimin that mediates the intimate adherence o f the bacteria to the 
intestinal epithelium. To determine the genetic relationship o f the isolates 
random amplified polymorphic DNA-PCR (RAPD-PCR) fingerprinting was 
used. Among the 50 O157 VTEC isolates, seven phage types were identified.
Based on isolates from separate families (n = 27), phage type 2 was the most 
common (44% of the strains), followed by types 4 (33%), 8 (7%), 14 (4%), 32 
(4%), 49 (4%), and 54 (4%). Eighty-five percent o f the isolates contained only 
VT2 gene sequences and 15% both VTi and VT2. Whereas all isolates o f the 
dominant phage types 2 and 4 carried only the VT2 gene, strains that belonged 
to the minor phage types carried both VTi and VT2 genes, with the exception 
o f the two isolates identified as phage types 49 and 54 carrying only VT2 genes.
All 50 isolates possessed the eae gene, which indicates its usefulness as 
virulence marker. RAPD-PCR fingerprinting identified four distinct banding 
patterns, with one profile found among 79% of the strains. Based on the 
combined results o f all typing methods used in this study, the collection o f 50 1 5 9  
Oi57 VTEC strains could be divided into nine distinct groups. Strains isolated 
from different individuals within one family could not be distinguished by any 
o f the methods applied. The data suggest that Oi57 VTEC strains are members 
o f one clone that has become widely distributed.
It is noteworthy to mention that in a later study (Chapter 8) we have 
demonstrated that the pulsed-field gel electrophoresis (PFGE) technique 
using Xbal as the restriction enzyme is far more discriminatory than the RAPD- 
PCR technique applied in this study. Among a collection o f 33 human isolates, 
including one isolate from each of the 27 families enrolled in the present study,
28 distinct restriction patterns could be discriminated by using PFGE.
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VTEC infection in household members of children with D+ H U S
Following the initial family studies,469 we continued to collect data on the 
occurrence o f VTEC infection in household members of children with D+ HUS 
in the subsequent years. Knowledge o f infection o f close contacts o f D+ HUS 
patients is important so that control measures can be taken to limit secondary 
person-to-person spread. Chapter 3 presents the results o f a retrospective study 
conducted to determine the frequency o f VTEC infection among household 
members o f children with D+ HUS caused by VTEC of serogroup Oi57. We 
reviewed the medical records o f all children with D+ HUS treated at the 
pediatric nephrology department o f the University Hospital Nijmegen between 
September ^ 8 9  and September i997. Thirty-four cases o f D+ HUS were 
caused by Oi57 VTEC. Evidence ofVTEC infection was reported in one or more 
household contacts in 23 (68%) o f the 34 families. A higher rate o f infection 
was found in siblings (46%) than in parents (28%). The majority o f the parents 
(74%) and siblings (55%) with evidence o f VTEC infection were infected 
asymptomatically. Whereas for the D+ HUS index cases the detection o f IgM- 
class serum antibodies to Oi57 LPS was the most successful method of 
providing evidence o f infection with VTEC (94% o f patients examined had 
antibodies to Oi57 LPS), in their respective infected household members stool 
examination provided evidence o f VTEC infection more often than LPS 
serology. Only 5 (i2%) o f 42 siblings examined had serum antibodies to Oi57 
LPS. Elevated antibody levels to Oi57 LPS were not detected in any o f the 62 
parents examined. The occurrence o f (bloody) diarrhea correlated significantly 
with the occurrence o f IgM-class serum antibodies to Oi57 LPS. The vehicles 
o f transmission o f the infectious agents have not been identified. Differences 
in the pathogenesis o f the infection between individual household members 
infected with the same strain may be related to differences in the number of 
ingested Oi57 VTEC bacteria, consistent with animal studies demonstrating 
1 6 0  that strains o f Oi57 VTEC were capable o f causing severe diarrhea in a dose- 
dependent fashion.H6,342 Furthermore, differences in the pathogenesis of 
infection may be related to differences in host susceptibility. The more 
frequent development o f the more serious manifestations o f infection, such 
as HC and D+ HUS, in young children than in older children and in adults 
may possibly be related to yet unknown age-related factors in the intestine, 
which are involved in making it more easier for Oi57 VTEC strains to colonize 
the intestinal mucosa and deliver their toxins to the circulation. It was 
concluded that household members o f children with D+ HUS are often 
asymptomatically infected. Further research is required to determine the factors 
that may account for the selective development o f D+ HUS among those 
infected with apparently the same Oi57 VTEC strain.
V T E C  i n  t h e  f o o d  c h a i n
Although person-to-person transmission is thought to play an important role 
in transmitting the organisms among household members and individuals in 
institutional settings such as hospitals, nursing homes, and day care centers, 
the primary mode of Oi57 VTEC infection is foodborne transmission. A variety 
o f foods has been identified as vehicles o f Oi57 VTEC-associated illnesses. 
Consumption o f raw or undercooked foods o f bovine origin, especially 
undercooked ground beef and unpasteurized cow's milk, has been the most 
common means o f transmitting Oi57 VTEC organisms documented in 
literature. This prompted us to initiate surveys on the occurrence o f Oi57 VTEC 
in raw beef and unpasteurized cow's milk as well as in other raw meats.
Occurrence of O157 VTEC and other VTEC in retail raw meats
Chapter 4 presents the results o f three different surveys on the occurrence of 
Oi57 VTEC in raw meats obtained from retail outlets in the Netherlands.
In the first survey meats were examined for Oi57 VTEC by spread plating serial 
dilutions o f enrichment cultures made in modified tryptone soy broth with 
acriflavin (mTSB + a) onto sorbitol MacConkey agar (SMAC). The selective 
SMAC differentiates Oi57 VTEC isolates by the absence o f fermentation of 
sorbitol; unlike approximately 75 to 94% of other E. coli strains, most Oi57 
VTEC do not ferment sorbitol. The organisms were isolated from 2 (0.3%) o f 
770 samples o f minced mixed beef and pork. Samples o f raw minced beef (n 
= i,000), minced pork (n = 260), and poultry products (n = 300) were all found 
to be negative.
In the second survey raw meats were examined with the 3M Petrifilm™ Test 
Kit-HEC following selective enrichment in modified E. coli broth containing 
novobiocin (mEC + n). This immunoblot method is based on the detection o f 1 6 1  
Oi57 LPS antigens. E. coli Oi57 strains were isolated from 6 (3.0%) o f 20i 
samples o f minced beef, i5 (i3.6%) o f ii0  samples o f chicken products, and i 
(2.0%) o f 49 samples o f minced pork. However, all 22 isolates were 
biochemically not typical o f Oi57 VTEC, and additionally, were not 
verocytotoxigenic.
In the third survey i80 enrichment cultures o f the first survey were screened 
for the presence o f VTi and VT2 genes by performing a PCR. Unlike the 
conventional selective plating method using SMAC and the commercially 
available Petrifilm screening method, the PCR approach does not favor the 
detection o f a particular serogroup. PCR results demonstrated the presence 
ofVTEC organisms in 29 (i6.i%) of the i80 meat products examined; i showed 
a positive PCR for the VTi gene only, i7 for the VT2 gene only, and i i  for both 
the VTi and VT2 gene. A total o f 46 VTEC strains were isolated from i0
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randomly selected PCR-positive samples. None o f the 46 VTEC isolates 
possessed the eae gene. Serotyping revealed that 4 i o f the 46 VTEC isolates 
belonged to nine different O serogroups; the remaining five isolates were 
unidentifiable with the currently available antisera. Although no Oi57 VTEC 
strains were isolated, some o f the serogroups recovered have been associated 
with human disease in literature. Because o f the lack o f a simple detection 
method, non-Oi57 VTEC organisms are mostly overlooked in clinical 
laboratories and therefore, the clinical significance o f many non-Oi57 VTEC 
isolates from food, animals, and environmental samples remains unknown. 
Despite the preponderance o f eae-positive VTEC in severe human disease,55 
many non-Oi57 VTEC isolates that are clearly associated with human disease 
do not possess the eae gene,2i2,49i which indicates that there are additional, as 
yet unknown virulence factors that distinguish pathogenic from nonpathogenic 
non-Oi57 VTEC strains.
Since several countries have reported an increasing number o f outbreaks and 
sporadic cases related to non-Oi57 VTEC,i6i more research is required on the 
distribution o f VT genes among E. coli serotypes, the pathogenicity o f VTEC 
serotypes isolated from food, animals and the environment which have not 
been associated with human disease so far, and on further characterization of 
virulence factors o f non-Oi57 VTEC strains lacking AE ability. Furthermore, 
future studies may be aimed at the possible exchange o f virulence factors 
among E. coli strains. Recently, Muniesa and Jofre3i6 demonstrated high levels 
o f phages carrying the VT2 gene in urban sewage, which indicates a great 
abundance o f such phages circulating among the human population. They 
suggested that bacteriophages may have a crucial role as a reservoir o f the VT2 
gene in nature. Additionally, these researchers reported that there are reasons 
to believe that transduction and consequent phage conversion between native 
bacteria can occur in natural environments including, for example, food and 
water, and that theoretically ingestion of phages themselves, either by humans 
1 6 2  or by animals, can cause infection o f the existing E. coli flora. Schmidt et al.40i 
documented an outbreak o f colitis and D+ HUS at a German kindergarten 
caused by a VT2-producing Citrobacter freundii that had contaminated parsley 
used in a salad. Since verocytotoxigenicity seems not to be common among 
C. freundii it was suggested that VT2-carrying phages had infected C. freundii 
cells, perhaps, during their growth in manure.459 A recent report o f Beutin 
and colleagues48 further supports the idea that toxin-converting bacteriophages 
can jump between species. They isolated a Shigella sonnei strain that produced 
Shiga toxin from a patient with diarrhea. Shiga toxin is virtually identical to 
VTi, differing from VTi by only one amino acid.428 Production o f Shiga toxin 
had only been reported for Shigella dysenteriae type i. Whereas the toxin gene 
o f S. dysenteriae type i is chromosomally located, the toxin gene o f S. sonnei 
was found to be encoded by a bacteriophage that was able to transduce the 
gene to toxin-negative reference strains of S. sonnei and to a toxin-negative E. coli
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K-i2 strain that became lysogenic for the bacteriophage. The lysogenic 
recipients became positive for production o f toxin and the presence o f the toxin 
gene in the recipients was shown by PCR.
Detection and isolation methods for E. coli O157
The sensitivity o f SMAC is limited by the capacity to recognize non-sorbitol- 
fermenting colonies against the background o f other organisms on the agar 
plate. Additionally, some serogroups o f E. coli other than Oi57 do not ferment 
sorbitol, and other gram-negatives, especially Proteus spp., also appear colorless. 
Therefore, several modifications o f SMAC have been developed now to 
improve selectivity. In addition to their inability to ferment sorbitol, another 
characteristic o f most Oi57 VTEC strains that distinguishes them from most 
(approx. 94 to 96%) other E. coli is their lack o f 6-glucuronidase activity. Several 
chromogenic and fluorogenic media have been developed to exploit this 
difference. Furthermore, several selective enrichment media have been 
developed. While cultural isolation o f Oi57 VTEC from food is time-consuming 
and labor-intensive, and hence costly, rapid immunological detection and 
immunomagnetic separation (IMS) systems have been developed, producing 
presumptive results after i day, compared to cultural procedures requiring 2 
days.
Chapter 5 presents the results o f our study on the efficacy o f several selective 
enrichment and plating media and the performance o f a variety o f commercial 
test kits. The objective o f this study was to identify a sensitive, rather simple 
and rapid method for the detection and isolation o f Oi57 VTEC from minced 
beef.
The selective enrichment media evaluated were mTSB + a, mEC + n, and 
enterohemorrhagic E. coli enrichment broth and the selective plating media 
evaluated were SMAC, SMAC supplemented with cefixime and tellurite (CT- 1 6 3  
SMAC), and Fluorocult E. coli Oi57:H7. Experiments with pure bacterial cultures 
showed that mEC + n and CT-SMAC were the most efficacious media for 
selective enrichment and isolation, respectively. In CT-SMAC, tellurite inhibits 
the growth o f E. coli strains other than Oi57 VTEC and other non-sorbitol- 
fermenting species, and cefixime inhibits the growth of Proteus spp.
The commercial test kits evaluated included the Ampcor E. coli Oi57:H7 Kit,
3M Petrifilm™ Test Kit-HEC, Dynabeads anti-E. coli Oi57, EHEC-TEK™, and 
the Tecra E. coli Oi57 visual immunoassay. Although substantial differences 
in sensitivity o f the commercial test kits were observed when dilutions o f pure 
bacterial cultures were tested, all kits could detect less than one Oi57 VTEC 
cell per g o f minced beef after enrichment o f the inoculated samples in mTSB 
+ a. Compared with the conventional cultural approach, sensitivity was only 
slightly improved by the use o f the test kits. However, the advantages o f the
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kits are simplicity, high-volume testing, and reducing time to give a 
presumptive result. While all immunoassays evaluated are detection systems 
only and their results need to be confirmed by isolating the organisms, the 
use o f the IMS technique using Dynabeads anti-E. coli Oi57 directly yields 
isolates.
Finally, the commercial Verotox F test for the determination o f the VT type of 
VTEC isolates was compared with a PCR assay for VT-encoding genes. The 
Verotox F test is a rapid and simple test for identifying the VT type o f VTEC 
isolates. Results were obtained after 48 h and were consistent with PCR results, 
which were obtained after 26 to 28 h. The classical Vero cell assay requires 
about i week. Both the PCR and Vero cell assays are, despite their sensitivity 
and specificity, too expensive and technically demanding for most routine labs. 
It was concluded that a sensitive and cost-effective method for the isolation of 
Oi57 VTEC from minced beef in food industry and epidemiological studies 
involving large numbers o f samples is the following: enrichment in mEC + n 
at 37°C for 6 to 8 h with shaking at i00 rpm, followed by IMS using Dynabeads 
anti-E. coli Oi57 and spread plating o f the magnetic beads onto CT-SMAC. The 
Verotox F test can be used to determine whether the isolates produce VTi 
and/or VT2. The isolation procedure recommended here corresponds with the 
draft International Standard for the detection o f E. coli Oi57 in food,20i which 
is now in discussion within the International Organization for Standardization 
(ISO) and the European Committee for Standardization (CEN) (Fig. 2).
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Occurrence and survival of O157 VTEC in retail meats
Because the evaluation o f the isolation methods identified the IMS technique 
as the most sensitive and cost-effective method for the examination o f minced 
beef for Oi57 VTEC, we conducted a survey on the occurrence o f Oi57 VTEC 
in meats using this technique. The results are described in Chapter 6.
In total, 2,94i fresh and processed meats obtained from supermarkets and 
butcher shops in the Netherlands were examined. Oi57 VTEC were isolated 
from 6 (i.i%) o f 57i samples o f raw minced beef, 2 (0.5%) o f 402 samples of 
raw minced mixed beef and pork, i (i.3%) o f 76 samples o f raw minced pork, 
i (0.3%) o f 393 samples o f other raw pork products, and i (0.3%) o f 328 samples 
o f cooked or fermented ready-to-eat meats. Other raw beef products (n = 223) 
and meat samples originating from poultry (n = 8i9), sheep or lamb (n = 46), 
or wild animals (n = 83) were all found to be negative for Oi57 VTEC.
Additionally, the fate o f Oi57 VTEC in tartaar (minced beef with a fat content 
o f less than i0%) and filet americain (tartaar mixed with a mayonnaise-based 
sauce [80 to 20%]) stored at low temperatures and the effect o f different 
additives was evaluated in this chapter. Tartaar and filet americain are typical 
o f products that are being consumed undercooked or that are not being cooked 
in the Netherlands today; tartaar is frequently consumed after it has been half­
cooked, such that the internal temperature is insufficient to kill 
microorganisms and filet americain is a ready-to-eat product. The Oi57 VTEC 
strain tested was able to survive in tartaar and filet americain stored at -2 0 , 0,
5, or 7°C for 3 days, conditions simulating a short period o f storage by the 
consumer. Both at 7°C (refrigeration temperature) and at i5°C (abusive 
temperature), Oi57 VTEC counts in tartaar and filet americain remained 
virtually unchanged throughout a storage period o f 5 days. Addition o f acetic 
acid (to pH 4.0), sodium lactate (i and 2% [wt/wt]), or components o f the 
lactoperoxidase-thiocyanate-hydrogen peroxide system to filet americain did 
not result in a reduction o f viable Oi57 VTEC cells during storage at 7 or i5°C. x 6 5 
It was concluded that raw meat contaminated with Oi57 VTEC will remain a 
hazard even i f  the meat is held at low or freezing temperatures. While not 
growing the cells remain viable. Good Manufacturing Practices (GMP) and 
the implementation o f an effective Hazard Analysis Critical Control Point 
(HACCP) program in food manufacturing and food preparation can assist in 
controlling Oi57 VTEC. Particular attention should be paid to the 
manufacturing o f fermented meat products. Such products that previously 
were considered safe and ready to consume have recently been vehicles of 
outbreaks.^3 Processors o f dry and semidry fermented sausages have been 
required by the United States Department o f Agriculture and the Food Safety 
and Inspection Service to validate that processing o f these products results in 
at least a 5 logi0 reduction in counts o f Oi57 VTEC.369 In general, studies 
published to date indicate that fermentation and drying are only sufficient
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to effect a reduction o f about i to 2 logi0 in the numbers o f Oi57 
VTEC.72,96,i34,i35,i37,i58,i92 Further studies are warranted to determine whether 
a composite, multiple hurdle strategy including some minor changes in 
product formulation together with a mild heating step after fermentation could 
be effective to adequately suppress the presence o f Oi57 VTEC in fermented 
meat products without producing undesirable sensory changes.377
Occurrence and survival of O157 VTEC in raw cow’s milk
Chapter 7 describes the results o f the examination o f cow's milk from bulk 
storage tanks for the presence o f Oi57 VTEC and of survival experiments with 
artificially contaminated cow's milk. A total o f i,0 ii samples o f raw milk from 
bulk storage tanks was examined using the IMS technique. The samples 
originated from i,0 ii different dairy herds located throughout the Netherlands. 
Oi57 VTEC were not isolated from any o f the milk samples examined.
The lactoperoxidase-thiocyanate-hydrogen peroxide system (LPS) is an 
antimicrobial system naturally occurring in milk. It has been proven to be 
bacteriostatic to many Gram-positive microorganisms and bactericidal to a 
variety o f Gram-negative microorganisms.497 The Oi57 VTEC strain tested was 
able to grow in raw milk at 7°C as well as at i5°C. Naturally occurring amounts 
of thiocyanate and hydrogen peroxide in the raw milk tested were not sufficient 
to activate the LPS. Although the LPS exhibited an antimicrobial activity against 
Oi57 VTEC in LPS-activated sterilized milk, Oi57 VTEC populations were not 
(or not as obviously) reduced in LPS-activated raw milk. Bacteria constituting 
the normal microflora o f raw milk possibly were more sensitive to the 
antibacterial action o f the activated LPS than the Oi57 VTEC test strain.
It was concluded that raw milk contaminated with Oi57 VTEC and kept at 7°C, 
a temperature frequently encountered during storage and processing o f food, 
1 6 6  will remain hazardous. At temperature abuse the risk will be increased. 
Therefore, the consumption of raw milk needs to be strongly dissuaded. 
Hygienic milking practices may reduce the level o f fecal contamination o f raw 
milk, but effective pasteurization and avoiding contamination after 
pasteurization are necessary to ensure the safety o f milk.
Occurrence of O157 VTEC in cattle and sheep
The next two chapters o f this thesis deal with the isolation and characterization 
o f Oi57 VTEC from the main food production animals.
Chapter 8 describes the results obtained for the most commonly reared 
species o f ruminant food animals, cattle and sheep. Fecal samples from Dutch 
cattle and sheep were collected at the main slaughterhouses o f the Netherlands,
Verocytotoxin-producing Escherichia coli in humans and the food chain
Chapter 11 -  Summary, general discussion, and future perspectives
located at different geographic sites. The samples were examined both by 
directly plating diluted enrichment cultures onto SMAC and CT-SMAC and 
by the IMS procedure.
E. coli Oi57 strains were isolated from 57 (i0.6%) o f 540 adult cattle, 2 (0.5%) 
o f 397 veal calves, 2 (3.8%) o f 52 ewes, and 2 (4.i%) o f 49 lambs. The IMS 
procedure appeared to be significantly more sensitive than the conventional 
plating method. With the exception o f two isolates from adult cattle which 
appeared to be negative for VT genes, all animal isolates were positive for both 
VT (VTi and/or VT2) and eae gene sequences. VT production was confirmed 
by cytotoxicity tests on Vero cells, and therefore these isolates were regarded 
as potential human pathogens. Although genomic typing by PFGE revealed a 
wide variety o f distinct XbaI restriction patterns, comparison of the 63 animal 
isolates with 33 fecal Oi57 VTEC isolates from human cases o f D+ HUS by 
their phage types and VT genotypes showed a marked similarity between 
animal and human isolates: 30 (90.9%) o f the 33 human isolates appeared to 
be o f E. coli Oi57 strain subtypes also isolated from cattle and sheep.
It was concluded that Dutch cattle and sheep are important natural hosts o f 
E. coli Oi57 strains that are potentially pathogenic for humans. The noted 
difference in the rate o f isolation o f Oi57 VTEC from mature cattle and veal 
calves may be due to differences in the composition o f the gastrointestinal flora 
resulting from differences in diet. Orally administered antibiotics can also 
interfere with the gastrointestinal flora. Besides differences in the composition 
o f the intestinal flora, differences in the handling o f the animals may explain 
the differences in the rate o f isolation o f Oi57 VTEC. For example, whereas 
veal calves are directly sold and transported from fattening herds to a 
slaughterhouse, adult cattle (as well as sheep) can pass several stations and 
therefore are at risk o f coming in contact with infected animals. The use o f a 
sensitive isolation technique has proven to be essential for the detection o f Oi57 
VTEC in livestock. The application o f a less sensitive isolation method, 
selective plating onto SMAC following selective enrichment in mTSB + a, 1 6 7  
possibly accounted for the failure to isolate Oi57 VTEC from Dutch adult cattle 
at slaughter in a previous study.i08 Cattle may be colonized by only low doses 
o f Oi57 VTEC, the reported density o f these organisms shed in feces from 
naturally infected cattle ranging from <i02 to i0 5 CFU per g o f feces.505 Finally, 
it was concluded that PFGE o f XbaI-digested total DNA is a valuable 
epidemiologic tool for the differentiation o f E. coli Oi57 strains, being clearly 
more sensitive than RAPD-PCR.
Occurrence of O157 VTEC in pigs and poultry
Chapter 9 describes the results obtained for pigs and poultry. Rectal contents 
and tonsils from normal Dutch slaughter pigs were collected at a single pig
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slaughterhouse. Fresh fecal material from poultry layer flocks and turkey flocks 
was collected on poultry farms. All samples were examined by IMS of E. coli 
O i57.
E. coli Oi57 strains were isolated from 2 (i.4%) o f i45 pigs. The strains were 
isolated from samples o f rectal contents, all samples o f tonsils being negative. 
While all 50i fecal samples from chicken flocks were found negative, E. coli 
Oi57 strains were isolated from 6 (i.3%) o f 459 pooled fecal samples from 
turkey flocks. One of the porcine isolates and one o f the turkey isolates 
contained the VT2 gene, the eae gene, as well as the enterohemorrhagic E. coli 
hemolysin (hlyEHEC) gene. HlyEHEC is found in nearly all Oi57 VTEC strains,47 
but whether it is involved in pathogenesis o f disease is still subject to 
speculation. Production o f VT was confirmed by cytotoxicity tests on Vero cells. 
Based on these characteristics, the two strains were regarded as potentially 
pathogenic for humans. The porcine and the turkey isolate were further 
characterized as being o f phage types 4 and i4, respectively. While 
biochemically typical o f Oi57 VTEC, the remaining six E. coli Oi57 isolates were 
nonverocytotoxigenic and negative for both the eae gene and the hlyEHEC gene. 
All eight E. coli Oi57 isolates did not carry genes that encode E. coli heat-labile 
and heat-stable enterotoxins (toxins synthesized by enterotoxigenic E. coli 
strains).
It was concluded that pigs and turkeys can be a source o f Oi57 VTEC strains 
characteristic o f those causing illness in man. Although Oi57 VTEC have never 
been found in live chicken, experimental infection studies have shown that 
small populations o f Oi57 VTEC can readily colonize the caeca o f young 
chickens and that these animals can continue to shed Oi57 VTEC for several 
months.35,403,422,502 Therefore is presumably that chickens also can serve as a 
source o f this human pathogen. The extent to which pigs and poultry play a 
role in the epidemiology o f human Oi57 VTEC infection needs further 
research.
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Occurrence of O157 VTEC on dairy farms
Since cattle, mainly dairy cattle, are regarded as the primary reservoir o f Oi57 
VTEC, the occurrence o f Oi57 VTEC on dairy farms was studied, as described 
in Chapter 10. Following a point prevalence study on i0 farms, we conducted 
a longitudinal study on the maintenance and dissemination o f Oi57 VTEC on 
4 o f these i0  farms. All cattle present on the farms were sampled individually 
by rectal retrieval. The samples were examined by the IMS procedure.
Cattle on 7 o f the i0  dairy farms tested positive for Oi57 VTEC, with the 
proportion o f cattle infected varying from 0.8 to 22.4%. On the seven farms 
positive for Oi57 VTEC, the excretion rate was highest in calves ages 4 to i2 
months (2i.2%). In the follow-up study, two Oi57 VTEC-positive farms and
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two Oi57 VTEC-negative farms identified in the prevalence study were 
revisited five times at intervals o f approximately 3 months. Cattle on each farm 
tested positive at least once. The proportion o f cattle infected varied from 0 to 
6i.0%. Most Oi57 VTEC-positive cattle became culture-negative within 3 
months. Excretion rates peaked in summer and were lowest in winter. Again, 
the highest prevalence was observed in calves ages 4 to i2 months (ii.8%).
The highest prevalence in this group of animals was consistent in all seasons.
In addition to feces from cattle, Oi57 VTEC were isolated occasionally from 
fecal samples from horses, ponies, and sheep and from milk filters and stable 
flies. Oi57 VTEC were not isolated from fecal samples from pigs or from 
samples o f silage and water. Based on characterization by VT production, VT 
genotype, the presence o f the eae gene, phage type, and PFGE genotype, one 
to six Oi57 VTEC strain types were identified on each o f the four farms over 
time. No overlapping strain types were identified among isolates from different 
farms, except one. Sometimes more than one strain type was present 
simultaneously within a single farm, but one type always clearly predominated 
which suggests that horizontal transmission is an important factor in 
dissemination o f Oi57 VTEC within a farm. The presence o f more than one 
strain type, both simultaneously and over time, suggests that there was more 
than one source o f Oi57 VTEC on the farms.
This study demonstrated that the Oi57 VTEC status o f a farm cannot be 
ascertained from a single visit testing a small number o f cattle. Further research 
is required to identify risk factors which promote fecal shedding o f Oi57 VTEC.
In addition, long-term reservoirs remain to be identified. Eventually, this all 
may lead to changes in farm management practices that may decrease the 
prevalence o f Oi57 VTEC in farm animals and consequently the number of 
Oi57 VTEC-positive animals entering the food production chain. The isolation 
o f Oi57 VTEC from milk filters implies the presence o f Oi57 VTEC in the 
respective bulk tanks, and thus reaffirms the need for pasteurization o f milk 
prior to consumption. Finally, this study underscores the need for awareness 1 6 9  
that farmed or companion animals can be a direct vehicle o f Oi57 VTEC 
infection in humans. Close contact with infected calves, horses, goats, and dogs 
has previously resulted in human infection.79,352,37i,4i°,457 
Our results support the following hypothetical ecological model, recently put 
forward by Hancock et al.^6 Briefly, Oi57 VTEC occur widespread in nature 
and can temporarily become part o f the gastrointestinal flora o f humans, cattle, 
sheep, deer, dogs, horses, birds, and perhaps other species. In a defined 
ecosystem such as a farm, the repertoire o f E. coli strains is subject to 
continuous amendment and may contain several distinct DNA subtypes of 
Oi57 VTEC. New E. coli strains can be introduced by movement o f cattle and 
other livestock into a farm, or possibly by animal feeds. Although Oi57 VTEC 
strains have not been found, commercial feeds frequently contain generic E. coli 
indicating common fecal contamination and the ability o f E. coli to survive for
prolonged periods in dry feeds. Feeds are important environmental exposures 
for cattle due to the high volume o f daily intake. Similarly, water may play a 
key role in disseminating Oi57 VTEC due to high volume of daily intake. Water 
troughs may serve as a long-term reservoir which maintain Oi57 VTEC strains 
in farms especially during periods oflow infection prevalence. Oi57 VTEC can 
persist at least several months in water trough sediments, and especially in 
warm weather Oi57 VTEC may even multiply in this environment. The 
likelihood that cattle will become colonized by Oi57 VTEC or any transient 
E. coli strain is a function o f exposure dose and susceptibility. The exposure 
dose is influenced greatly by replication in feeds and/or water troughs. 
Susceptibility to colonization is a function o f age and factors that decrease 
gastrointestinal floral stability, such as temporary feed withholding. The 
transient nature o f excretion o f Oi57 VTEC by individual animals and the 
excretion o f different strain subtypes at different samplings observed in our 
study is consistent with the idea o f continuous alteration o f the E. coli 
repertoire in farms. Shedding o f Oi57 VTEC was strongly seasonal with a much 
higher prevalence in summer. The warmer and more moist conditions o f the 
summer months may favor the multiplication o f Oi57 VTEC in the farm 
environment and hence may result in increased exposure doses o f cattle to 
these organisms. However, we failed to isolate Oi57 VTEC from water or feeds. 
This may be explained by the limited number o f such samples examined, being 
collected on only a few occasions. Supporting the idea o f age-dependent 
susceptibility to colonization, fecal shedding o f Oi57 VTEC was most common 
among calves. How the Oi57 VTEC strains were introduced on the farms 
enrolled in our study remains unclear.
P r e v e n t i o n  a n d  c o n t r o l  o f  h u m a n  V T E C  
i n f e c t i o n
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Treatment of human VTEC infection
The possible severity o f the clinical symptoms caused by Oi57 VTEC and other 
VTEC strains combined with their apparent low infectious dose (~i00-200 
cells) qualify these organisms to be among the most serious o f known 
foodborne pathogens. Although we have learned much about VTEC in the years 
since their pathogenicity was first described, treatment o f infection is still 
primarily supportive care. Purposes o f treatment o f symptomatic patients 
include decreasing the severity and duration o f symptoms, preventing severe 
complications, and preventing further transmission.322 
Antimicrobial treatment o f VTEC infection might be expected to fulfill all three 
purposes of treatment. However, the use o f antibiotic treatment is controversial. 
Most clinicians have found either that there was no significant benefit
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associated with administration o f antibiotics or that patients who received 
antibiotics may be at greater risks o f developing HUS.77,95,»9,355,376,425 On the 
contrary, a retrospective nationwide survey o f VTEC infections diagnosed in 
Japan in i996 proved that early treatment (within 3 days o f onset) with the 
antibiotic fosfomycin, the drug o f first choice for pediatric gastrointestinal 
infections in Japan, was associated with a reduced risk o f D+ HUS.437 In i996,
Oi57 VTEC were the cause o f serious outbreaks o f diarrheal illness with cases 
o f HC and HUS in Japan. During this epidemic o f Oi57 VTEC infection the 
disease spread throughout Japan and more than 9,000 people were affected, 
resulting in ii  death. The incidence o f D+ HUS among children (<i5 years of 
age) with bacteriologically or serologically proven Oi57 VTEC infection treated 
with only fosfomycin (n = 429) was i4.7%, while the corresponding incidence 
in patients without antibiotic therapy was 40.5% (n = 37). This difference proved 
statistically significant (%2 test, P = 0.000i). The use o f other antibiotics was 
not effective in reducing D+ HUS, even though these drugs were administered 
early; the incidence o f D+ HUS among children treated with norfloxacin (n = 
i3), cephalosporin (n = 47), and penicillin (n = 8) being 38.5%, 3i.9%, and 
25.0%, respectively.
Apart from the lack o f clear-cut clinical benefits, there are theoretical arguments 
against the use o f antibiotics. First, antibiotics which result in cell lysis might 
actually promote, rather than decrease, the amount o f free VT in the gut lumen 
available for systemic absorption. Although VT is extracellular, much of the 
toxin remains attached to the VTEC cell surface. Second, in vitro data have 
shown that subinhibitory concentrations o f antibiotics increased the release 
o f free VT from Oi57 VTEC in the culture medium, probably by a mechanism 
of increased induction o f toxin-converting bacteriophages.i67,226,476,496 And 
third, antimicrobial resistance amongst VTEC appears to be an emerging 
issue.i0i,244,305,402,4i4 Empirical treatment with an inappropriate drug might 
confer a selective advantage on the VTEC over other members o f the gut flora 
and cause overgrowth, thereby increasing the systemic absorption o f toxin. A 1 7 1  
prospective, randomized, placebo-controlled clinical trail is required to 
conclusively determine whether and how antimicrobial therapy should be used 
in the treatment o f VTEC infections.
A promising therapy to treat the early stages o f VTEC infection is oral 
administration o f Synsorb-Pk, indigestible particles coated with a VT receptor 
analogue.24,26 D+ HUS develops, on average, i week after the onset o f 
diarrhea.438 During this latent period, VT possibly remains confined to the 
intestinal lumen. If given early enough in the course o f the illness, agents like 
Synsorb-Pk may possibly absorb this free VT and hence prevent subsequent 
injury to extraintestinal sites such as the kidney. A phase II trial on the use o f 
this novel agent has shown that Synsorb-Pk appears safe, is tolerated by more 
than 90% o f children with acute diarrhea, and that there is no evidence that 
it increases the risk o f HUS.25 Further clinical trials have to approve whether
treatment with Synsorb-Pk can prevent progression to HUS after children have 
developed the clinical symptoms of VTEC gastroenteritis.
Also more research is required on the therapeutic application o f Lactobin®, a 
standardized immunoglobulin preparation obtained from the colostra o f non­
immunized cows.274 In vitro studies have shown that Lactobin® contains high 
levels o f antibodies and neutralizing activity against VTi and VT2. Therefore, 
the oral administration o f this drug might modify the severity o f diarrheal 
illness in humans and prevent D+ HUS.
Another approach under investigation to prevent extraintestinal manifestations 
is the intraperitoneal administration o f VT-neutralizing antibodiesi29 or Gb3 
receptor analogs.6i Chimeric VTi and VT2 antibodies neutralized the toxic 
activity o f VTi and VT2, respectively, both in vitro and in vivo (mouse protection 
assays). Boyd et al.6i synthesized a receptor analog that was capable o f blocking 
both Gb3 binding sites on the VTi B subunit and protected Vero cells against 
VTi and to a lesser extent to VT2 activity. These results suggest that these agents 
will be good candidates for use in passive immune therapy o f patients infected 
with VTEC. In addition to being useful therapeutic agents for patients infected 
with VTEC, Synsorb-Pk, Lactobin®, the humanized VT-neutralizing antibodies, 
and the receptor analog may be useful as possible prophylactic agents for those 
in close contact with individuals infected with VTEC.
Surveillance of human VTEC infection
For any o f these new therapeutic agents, successful treatment will depend on 
the early recognition o f VTEC infections. In addition to being critical for 
effective treatment, early microbiologic diagnosis o f individual patients enables 
the prompt notification o f outbreaks and implementation o f control measures 
to prevent more cases.
1 7 2  In recent years, an increasing number o f outbreaks and sporadic cases related 
to non-Oi57 VTEC have been reported in many countries.i6i Medical diagnostic 
laboratories should therefore be encouraged to use techniques that detect VT 
or VT genes in clinical specimens and should not restrict themselves to looking 
for VTEC strains o f serogroup Oi57. Furthermore, ideally all stools for which 
bacterial culture is requested should be screened, not just samples which are 
bloody. It has been reported that as a group non-Oi57 VTEC appear to cause 
less bloody diarrhea and less D+ HUS. However, the methods required for 
demonstrating the presence o f VT or VT genes are often too expensive and/or 
technically demanding for most routine laboratories. Additionally, financial 
resources often do not permit testing o f all specimens submitted. Laboratories 
which are not competent o f universal screening o f all specimens by methods 
which are not serogroup restricted are recommended to apply the following 
selective screening policy. All stool specimens, or at a minimum all visibly
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bloody stools and stool specimens from all patients reporting a history o f acute 
bloody diarrhea, should routinely be cultured for Oi57 VTEC.66,4i4,438 Stools 
from all cases o f D+ HUS should routinely be examined for both Oi57 VTEC 
and other VTEC. Their sera should routinely be tested for antibodies to the 
LPS o f the most important human pathogenic VTEC serogroups recognized 
at present: Oi57, O26, Oi03, O iii, and Oi45. Laboratories that do not have 
facilities for tissue culture assays, nucleic acid-based detection assays or 
serologic diagnosis ofVTEC infections should refer stool and serum specimens 
from suspected D+ HUS patients to a reference laboratory. I f  adequate 
resources are available, stools from patients with a history o f bloody diarrhea, 
visibly bloody stools, stools from children <5 years old and persons >60 years 
old, and stools from patients with severe diarrhea requiring hospitalization 
from whom Oi57 VTEC or other enteric pathogens have not been isolated 
should be examined for non-Oi57 VTEC.487 In addition, LPS serology should 
be encouraged in such cases.
The most widely used medium for isolating Oi57 VTEC from human fecal 
samples is SMAC. SMAC plates are inoculated with the fecal specimen and 
examined after i8 to 24 h o f incubation for the presence o f sorbitol-negative 
(colorless) colonies. Suspect colonies are then screened for agglutination with 
Oi57 antiserum. Since some other organisms cross-react with Oi57 antiserum, 
presumptive E. coli Oi57 isolates should always be identified biochemically as 
E. coli. Suspect isolates should then be submitted to a reference laboratory for 
full O:H serotyping and confirmation o f VT production. Since the use o f CR- 
SMAC and CT-SMAC has been proven to result in increased sensitivity of 
isolation of Oi57 VTEC strains from clinical samples,85,50i clinical laboratories 
should be encouraged to use these improved selective plating media. Some 
clinical laboratories may use chromogenic and fluorogenic plating media for 
isolating Oi57 VTEC from human stools. So far, no comparative evaluations 
o f such media for isolating Oi57 VTEC from clinical samples have been 
published. By the use o f sorbitol-based isolation media or isolation media 1 7 3  
containing chromogenic or fluorogenic substrates, sorbitol-fermenting £- 
glucuronidase-positive VTEC isolates o f serotype Oi57:NM will be missed.
These strains have been isolated from humans in several European 
countries.50,52,i7i,240
Nearly all Oi57 VTEC strains as well as a significant portion (-80-90%) o f non- 
Oi57 VTEC strains belonging to serotypes implicated in human disease 
produce HlyEHEC.i72 Enterohemolytic strains can easily be distinguished 
phenotypically from alpha-hemolytic strains by using washed sheep blood agar 
supplemented with calcium (WSBA-Ca).47 While the enterohemolytic 
phenotype is characterized by small turbid zones o f hemolysis occurring after 
incubation o f the bacteria at 37°C for i8 to 24 h, alpha-hemolytic strains form 
large, clear zones o f hemolysis which are visible after only 3 to 6 h of 
incubation. Suspected enterohemolytic colonies must be selected to confirm
VT production. Positive isolates should subsequently be submitted for complete 
O:H serotyping. Although WSBA-Ca appears to be a potentially useful isolation 
medium for all VTEC strains o f serogroup Oi57, its usefulness as a generic 
screen for primary isolation o f VTEC is diminished by the fact that some 
disease-causing non-Oi57 VTEC strains may not demonstrate the 
enterohemolytic phenotype.354
Several investigators recommend IMS for use in routine diagnostic 
laboratories. The inclusion o f this selective enrichment and concentration step 
in the isolation procedure o f Oi57 VTEC has been proven to increase the 
recovery o f these organisms compared with direct plating on SMAC or 
modified versions o f SM AC.8i,i07,223 IMS is most advantageous when 
examining specimens in which Oi57 VTEC are expected to be present in only 
small numbers, for example when screening repeat fecal samples from 
known cases and samples from asymptomatic carriers.
Commercial ELISAs12« 49 and immunofluorescence assays347 for detection of 
the Oi57 antigen in stool specimens are also available. Being at least as sensitive 
as SMAC, these assays have the advantage o f being rapid and, importantly, 
capable o f detecting sorbitol-fermenting Oi57 VTEC strains. However, all 
immunoassays are detection systems only, and require confirmation by the 
isolation o f the organisms.
Diagnostic procedures used for screening o f clinical samples for evidence of 
infection with VTEC which are not restricted to a certain serogroup are based 
on the detection o f VT or genes encoding VT. The gold standard for 
demonstrating the presence o f VT is the Vero cell cytotoxicity assay.227 Serial 
dilutions o f crude filtrates or fecal culture filtrates are applied to monolayers 
o f Vero cells and after 48 to 72 h o f incubation the cells are examined for 
cytopathic effects. Positive results should be confirmed by testing for 
neutralization o f cytotoxicity by specific antibodies to VTi and VT2. Although 
a sensitive and specific method for diagnosing VTEC infections, the Vero cell 
!7 4  assay is labor-intensive, time-consuming, and cumbersome.
In the last decade, numerous immunological assays have been developed for 
the detection o f VT in fecal cultures, including colony immunoblot assays and 
antibody capture or toxin receptor-mediated enzyme immunological assays, 
and some are now commercially available. The commercial assays are easy to 
perform and do not require specialized equipment and laboratory 
skills.i3,49,23i,239,283,348 However, they may be too expensive to use in routine 
screening o f stools. Furthermore, these immunoassays are generally less 
sensitive than the verocytotoxicity assay and false-positive reactions have been 
reported. Positive reactions should therefore always be confirmed by 
verocytotoxicity assays, the detection o f VT genes or the isolation o f the 
causative VTEC organisms.
A third type o f methods that can be used for VTEC screening are DNA-based 
methods for the detection o f VT genes. Both colony hybridization assays and
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PCR amplification methods have been developed. Although colony 
hybridization with DNA probes for VT genes is not a particularly sensitive 
method of screening broth cultures or fecal extracts for the presence o f VTEC, 
it has the advantage o f directly identifying VTEC isolates that can be selected 
for further characterization. Both crude lysates or DNA extracts from single 
colonies, mixed broth cultures, colony sweeps, or even direct extracts o f feces 
can be used as templates for PCR. However, at present, testing enrichment 
broths is the most sensitive screening strategy for detecting VTEC. Amplifying 
DNA isolated directly from stools needs further optimization. As discussed 
previously, routinely screening o f clinical samples for non-Oi57 VTEC strains 
is hampered by the lack o f a definitive biochemical characteristic which 
distinguishes these strains from commensal fecal E. coli strains.
Since patients usually clear VTEC organisms from their gastrointestinal tracts 
rapidly, stools must be examined early in the course o f pathogenesis to 
maximize the detection and isolation o f VTEC.44i However, prolonged fecal 
shedding of Oi57 VTEC has been observed.37,225,34i,407 In addition to the rapid 
clearance, the isolation ofVTEC from stools may be difficult due to the excretion 
o f only low numbers and the intermittent shedding of bacteria. Since the toxins 
generally persist longer in the stool than the viable bacteria, methods based 
on the detection o f free VT are generally more sensitive than culture o f VTEC 
organisms.
In the absence of a culturable VTEC or fecal VT, serology has been proven useful 
for providing evidence ofinfection in patients with D+ HUS and HC.90 Patients 
with D+ HUS and HC produce serum antibodies to the LPS o f E. coli Oi57 
and certain other E. coli serogroups. Serum antibodies to LPS persist for several 
months following onset o f disease, which enables both current and 
retrospective serologic testing. Studies examining both sera and feces for 
evidence ofVTEC infection may demonstrate whether or not all VTEC strains 
cause the production o f serum antibodies to VTEC LPS in D+ HUS patients. 
Preliminary studies have demonstrated the potential use o f salivary antibodies 1 7 5  
to LPS.89 This approach may be o f particular help in case ofvery young patients, 
where (repeatedly) taking samples o f blood may be difficult, and therefore 
warrants further research. Siddons and Chapman4ii reported the presence of 
fecal antibodies to the LPS of E. coli Oi57 in patients with HC. However, because 
o f the relatively high number o f control feces that also contained antibodies 
to the LPS o f E. coli Oi57, the use o f fecal antibodies for the routine screening 
o f infections with E. coli Oi57 remains to be determined. Antibodies to VT 
proved not useful for serodiagnosis. Antibody responses to VTs are uncommon 
after a primary infection and appear to require booster exposures to VTEC 
infection to become manifest. Therefore in countries with low exposure to 
VTEC, the detection o f VT-specific antibodies is generally hampered by low 
sensitivity and in countries with a high prevalence rate ofVTEC infection, VT- 
serology lacks specificity. Other approaches under investigation are the
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potential use o f antibodies to secreted proteins expressed by VTEC capable of 
producing the AE histopathology, HlyEHEC, flagella, and outer membrane 
proteins for providing evidence o f infection with VTEC.206 
From our experience, we recommend the simultaneous use o f bacteriologic 
procedures for detecting culturable VTEC (culturing stools on CT-SMAC and 
testing stool culture filtrates in the Vero cell assay) and free VT (testing filtrates 
from stool extracts in the Vero cell assay) and serologic procedures (LPS 
serology) (Table i).
Laboratory personnel should be warned to realize that VTEC strains can cause 
severe illness and have a very low infectious dose. At least three cases of 
laboratory-acquired infection with Oi57 VTEC with serious consequences, 
including renal failure and HC, have been documented.58,68,364 Prevention of 
laboratory-acquired infection means the application o f Good Laboratory 
Practices and a laboratory well equipped for working with these high-risk 
organisms. In the United Kingdom, VTEC are considered as pathogens of 
hazard group 3 like Salmonella typhi and S. dysenteriae type i, with great 
consequences for physical and operational requirements.
1 7 6
Table 1. Recommended combination o f methods for diagnosing human VTEC infection.
Method
Culture onto CT-SMAC a
Principle
Isolation o f  SNF b Oi57 VTEC
Advantage
Isolate available for 
confirmation and 
subtyping
Limitations
No detection o f  SF c 
Oi57 VTEC and 
non-Oi57 VTEC
Vero cell assay using sterile 
stool extracts
Detection o f  free VT VTs persist longer in 
stools than VTEC do
No isolate available 
for confirmation and 
subtyping
Vero cell assay using fecal 
culture filtrates
Detection o f  VTEC Detection o f  both Oi57 
VTEC and non-Oi57 
VTEC
No isolate available 
for confirmation 
and subtyping
LPS d serology Detection o f  anti-LPS 
serum antibodies
Serum antibodies 
persist for several 
months after the 
onset o f symptoms
No isolate available 
for confirmation and 
subtyping 
Infection with only 
certain VTEC serotypes 
will be detected
a CT-SMAC, sorbitol MacConkey agar supplemented with cefixime and tellurite. 
b SNF, sorbitol-nonfermenting. 
c SF, sorbitol-fermenting. 
d LPS, lipopolysaccharide.
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Prevention and control in the food chain
Because therapies currently applicable do not ameliorate the clinical course 
o f gastrointestinal infection with VTEC, prevention o f primary infection 
remains the best way to prevent the life-threatening complications. Most Oi57 
VTEC infections in humans are foodborne and contamination o f beef with 
Oi57 VTEC during slaughter is the principal route by which these pathogens 
enter the food supply. Reduction o f Oi57 VTEC contamination o f beef products 
will reduce the risk of infection to consumers. Reduction o f the potential risk 
o f contaminated beef products has to be achieved by a combination o f Good 
Hygienic Practices for both producers o f beef products and consumers of these 
products. The latter is a matter o f education and adequate consumer 
information on proper handling o f food. The former needs a combination o f 
steps throughout the whole chain o f the meat production process. Total 
prevention o f Oi57 VTEC colonization in cattle at the farm level is the most 
effective way to reduce contamination o f beef products. Other tools include 
processing improvements at the slaughterhouse level and treatment o f end- 
products.
Prevention and control at the farm level
Whereas Oi57 VTEC were thought to be relatively uncommon, it has now been 
recognized that these agents are more widespread in nature than early studies 
appeared to show. Repeated sampling has demonstrated that Oi57 VTEC are, 
at least intermittently, present on most cattle farms, where they appear to 
behave as one o f the numerous transient E. coli strains which typically occur 
on any farm.^6 Animals other than cattle and humans that have been observed 
to shed Oi57 VTEC include sheep, horses, deer, dogs, and wild birds, and in 
the present thesis we have demonstrated that pigs and turkey also may harbor 1 7 7  
Oi57 VTEC in their gastrointestinal tract. Long-term carriers have not been 
reported in any species, but only cattle, sheep, and humans have been sampled 
with sufficient intensity to assess the duration o f carriage.^6 
Oi57 VTEC can survive in dairy cattle manure for at least 70 days, depending 
on temperature and available moisture, and retain their ability to produce 
VTs.478 Kudva et al.252 found that Oi57 VTEC may survive in an unaerated sheep 
manure pile incubated outside under fluctuating environmental conditions 
for 2i months with concentrations ranging from i0 2 to i0 6 CFU per g. A cow 
manure pile was found culture-positive for 47 days.252 Oi57 VTEC have also 
been shown to persist in drying manure and to be present in incompletely 
composted dairy and feedlot waste. Besides animal manure, Oi57 VTEC strains 
have been detected in the environment in soil, water, and water trough 
sediments. They have been observed to remain viable in soils and water for
considerable periods. Oi57 VTEC can survive in inoculated soil samples for 
at least i8 weeks. And they can survive in water trough sediments for at least
4 months and appear to be able to multiply in this environment.263 
Given the widespread occurrence o f Oi57 VTEC in cattle, the natural occurrence 
in a number o f other species, including wild animal species, the transient 
nature o f  carriage, and the persistence and m ultiplication in certain 
environmental niches, traditional means o f controlling infectious agents, such 
as eradication or testing and removal o f carrier animals, do not appear to be 
feasible for Oi57 V T E C J76 Nevertheless, certain farm management practices 
may provide practical means to substantially reduce the prevalence o f Oi57  
V TEC in cattle. Particular attention should be paid to maintaining the 
cleanliness o f animals and prevention o f spread o f fecal material, which is the 
primary source o f dissemination. Exposure doses would be decreased by 
preventing multiplication in moist feeds and water troughs. Frequently 
cleaning water troughs would not only prevent replication but also blocks the 
long-term maintenance o f Oi57 VTEC in sediments.
Potential control strategies that warrant further research are vaccination o f  
cattle and possibly also o f other animals considered important in sustaining 
Oi57 VTEC, such as sheep, competitive exclusion and probiotica treatment. 
Because Oi57 V TEC are not associated with illness in these animals, the 
purpose o f vaccination would be to prevent colonization and to reduce fecal 
shedding and subsequent contamination o f food and the environment. Since 
V TEC strains that are most commonly implicated in human disease, including 
Oi57 VTEC strains, require intimin for adherence to intestinal epithelial cells, 
this adhesin has been targeted as a potential vaccine antigen.426 Studies have 
been planned in which intimin will be expressed in plants that can be fed to 
cattle and are expected to mount a specific antibody response to intimin, thereby 
preventing colonization o f cattle by V TEC strains that produce intimin. 
Another approach m ight be the oral administration o f toxin-negative mutants 
1 7 8  o f V TEC to animals to induce antibodies to surface components o f the 
bacteria. However, Hoffman et al.i93 found that such vaccination o f calves 
resulted in anti-O antibodies but that there was no reduction in shedding o f  
the wild type Oi57 VTEC strain as a result o f  vaccination. Therefore, much  
more needs to be learned about the im m une response o f cattle to V TEC before 
an effective transmission-blocking vaccine will be available.
Competitive exclusion is the establishment o f  a gastrointestinal flora, through 
strategic oral inoculation, that is less susceptible to colonization by a target 
organism. Hakkinen and Schneitzi73 reported that newly hatched chickens 
could significantly be protected against Oi57 VTEC by competitive exclusion 
treatment o f the chickens with fecal microflora from adult birds. To our 
knowledge, no studies have been published about competitive inhibition o f
Oi57 V TEC in cattle. Since the higher prevalence o f Oi57 VTEC in immature 
cattle than in adult cattle may be attributed mainly to greater instability o f  the
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gastrointestinal microflora in immature cattle, the establishment o f  an adult 
intestinal flora in newborn calves appears to be a promising tool to reduce the 
carriage o f O157 V TEC by cattle.
Probiotic bacteria are those that beneficially affect the host by improving its 
microbial balance, eliminating or reducing microorganisms that are carried 
by the host and that are harmful to humans. Preliminary results indicate that 
selected probiotic bacteria administered to cattle prior to exposure to E. coli 
Oi57:H 7 can reduce the level o f carriage o f E. coli 0 1 5 7 ^ 7  by these animals.504
Prevention and control at slaughter
Since eliminating O157 VTEC from the cattle population seems not (yet) to be 
feasible and pre-slaughter testing o f all cattle is also unlikely to be successful, 
prevention o f contamination o f b eef should be achieved by processing 
improvements at the slaughterhouse level. Furthermore, decontamination 
treatment should be considered.
Because the hide and the gastrointestinal tract are likely the main sources o f  
bacterial contamination o f carcasses,164 particular care should be taken during 
the dehiding stage and during evisceration. Contamination o f a carcass can 
occur by direct contact with a hide or intestinal tract contents or by indirect 
contact with workers' hands or clothing, other carcasses, aerosols, 
contaminated equipment or walls, floors, or steps.
In the Netherlands, slaughterhouses should have in place an effective GM P  
system. In the beginning o f 1998 the cattle industry and the government agreed 
on the necessity to improve drastically the hygiene in Dutch cattle and calf 
slaughterhouses. The slaughterhouses promised to put all effort in preventing 
fecal contamination o f meat, and the government decided to intensify their 
inspections and to strictly maintain the already statutory “zero-tolerance for 
fecal contamination o f meat”. Recently, the results o f this joint effort were 179  
verified and unfortunately it was concluded that the hygiene in the Dutch cattle 
and calf slaughterhouses is still insufficient.195 Slaughterhouse personnel 
appeared not to recognize the importance o f  good hygienic practices; they did 
not wash their hands frequently enough and did not clean and decontaminate 
efficaciously their slaughterhouse equipment. In almost h alf o f the 33 
slaughterhouses inspected structural failures were noted creating the 
probability o f structural cross-contamination o f carcasses, either via mutual 
contact o f carcasses or via floors, walls or steps. In response to these findings 
the industry took additional measures to prevent fecal contamination o f  
carcasses. The government will intensify their inspections and evaluate 
whether the hygiene has improved.
Pre-slaughter measures which may be effective to reduce the risk o f bacterial 
contamination o f carcasses during slaughter are efforts to reduce the level o f
hide soiling and withholding feed before slaughter to reduce gut fill. In order 
to reduce the level o f hide soiling animals should be clean and free o f visible 
fecal contamination when leaving the farm and should be transported and held 
prior to slaughter in a manner that maintains cleanliness, minim izes fecal 
contamination from other animals, and limits undue stress. In between 
different loads, transport vehicles should be thoroughly cleaned and 
disinfected. In the Netherlands, currently there are no regulations on the 
cleanliness o f animals entering the human food chain. However, in some other 
European countries the delivery o f dirty animals at slaughter is being fined. 
It has been suggested that chemical dehairing m ight be applied successfully 
to control a major source o f pathogenic bacteria to beef carcasses.78 It may help 
preventing fecal contamination from the hide to the carcass surface. By 
reducing gut fill, the chance o f gastrointestinal punctures during the slaughter 
process will be reduced and hence the risk o f contamination o f carcasses with 
intestinal contents. Given that w ithholding feed results in increased  
susceptibility to colonization with transient E. coli and creates conditions for 
multiplication o f Oi57 V TEC ,i0W65 the practice o f withholding feed for more 
than a few hours prior to slaughter is likely contraindicated.
Other pre-slaughter approaches currently being investigated target creating 
appropriate conditions in the animal gut to suppress the numbers o f E. coli or 
more specifically Oi57 VTEC in the period immediately prior to slaughter by 
appropriate nutrition.i23,2i5
Prevention and control at processing
Besides the cleanliness o f cattle entering the human food chain and the hygiene 
o f slaughtering procedures, the hygiene during cutting o f carcasses and further 
processing o f  the meat needs to be improved by the implementation and strict 
1 8 0  maintenance o f hygiene codes. In the Netherlands, the application o f an 
effective H A C C P  plan in meat processing plants is already legally obligated. 
Inspection o f the fulfillment o f  the hygiene codes by the government needs 
to be intensified. Particular care should be taken over cold or fermented meats 
that will not be heated prior to consumption. Manufacturers o f  such meat 
products should assure the absence o f Oi57 VTEC in a serving portion 
(demonstrate that their process is sufficient to remove or destroy the organisms 
in the end product).
Decontamination steps at slaughter and processing
Decontamination steps can significantly reduce the numbers o f  Oi57 VTEC  
and other pathogens on a carcass or trim. The m ost com m only used
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decontamination step is knife trimming o f fecal contamination and associated 
bacteria. Various nontoxic chemical washes and rinses, for example using 
organic acids like acetic, lactic, and citric acids, have been proven to safely and 
efficiently reduce surface colony counts on beef carcasses, which may harbor 
pathogens associated with fecal contamination like Oi57 VTEC. Also, physical 
sanitizing technologies like steam vacuuming (contaminated spots) and steam 
pasteurization (whole carcasses) will significantly reduce num bers o f  
pathogenic microorganisms that may contaminate beef carcasses. Direct 
application o f heat to carcasses by flaming is another possible decontamination 
step. However, the most powerful tool to effectively decontaminate beef is 
irradiation. Gam m a irradiation at dosages within the range o f i.5 to 3.0 kGy 
proved to be very effective in killing O i57 V T E C  in ground b e e f and 
m echanically deboned chicken m eat.447 W hile in the U nited States 
decontamination by the treatments m entioned is approved, under the 
European Union legislation the cattle and meat industry is not allowed to apply 
decontamination methods other than knife trimming. In the Netherlands, 
irradiation is permitted only for a few products under certain conditions. 
However, irradiation is not generally accepted by the consumer.
If approved, additional reductions o f populations o f Oi57 VTEC in meat 
products may be achieved by the (combined) use o f food preservatives. 
However, further research needs to determine the efficacy o f  different 
(combinations of) preservatives.
Prevention and control o f transmission via raw cow’s milk
While contamination ofb eef with Oi57 VTEC during slaughter is the principal 
route by which these organisms enter the food supply, fecal contamination o f  
raw cow's m ilk during its collection on dairy farms is another major 
transmission route. “Keten Kwaliteit Melk” (k Km ) is a quality assurance 1 8 1  
program implemented by the foundation KKM in the beginning o f i998. The 
main objective o f  this program is to demonstrate in an objective and 
independent manner that milk in the Netherlands is being produced well and 
responsibly. Activities important for the quality o f farm m ilk are divided in six 
modules. In the module concerning the health and welfare o f cattle particular 
attention could be drawn to VTEC.
Prevention and control o f transmission via fresh produce
Vegetables and fruits are increasingly implicated in foodborne infections. 
Besides cross-contamination during food preparation, contamination o f  
vegetables and fruits with Oi57 VTEC can occur during their production and
harvesting. For instance, vegetables may be grown in contaminated soil, 
fertilized with animal slurry or irrigated with contaminated water, and ripening 
fruits may accidentally fall in contaminated soil or animal feces or also be 
irrigated with contaminated water. Farm animal manure or manure slurry may 
disseminate, transmit, or propagate O i57 V TEC  organisms. Given the 
persistence o f  Oi57 V TEC in the environment, future research should focus 
on appropriate farm waste m anagement to curtail environmental spread.
Prevention and control at food handling and preparation
The final step in the human food chain is the food handling and preparation. 
Since up to now previous steps in the human food chain cannot guarantee the 
absence o f Oi57 VTEC in the end product this step is very important for the 
prevention o f human infection. Food handlers should be trained in the 
principles o f food hygiene and the application o f H A CCP , with particular 
attention to the special precautions for preparing and serving food to vulnerable 
groups. The role o f asymptomatic food handlers in outbreaks is unclear but 
it may be important in view o f the low infectious dose. In addition, the 
consumer needs to be informed about the risk o f consum ing raw foods, the 
need for thorough cooking o f their food and preventing cross-contamination 
in the kitchen.
Prevention and control o f non-foodborne infection
Non-foodborne transmission o f Oi57 VTEC other than laboratory-acquired 
infection include waterborne transmission, attributed to drinking untreated 
well-water and to swimming and playing in untreated water, and transmission 
1 8 2  via close contact with farm animals. Prevention o f these types o f infection 
require a change in farm management practices concerning the application 
o f manure on lands and education o f humans in the risk o f close contact with 
livestock.
Vaccination ofhumans
There are no currently available vaccines to prevent disease caused by Oi57  
VTEC and other VTEC, but a number o f experimental approaches are being 
investigated in animals. Considerable interest exists in the use o f intestinal 
colonization factors as im m unogens in vaccines to block the intestinal 
adherence o f the organisms.70 Vaccines directed against LPS may also be 
effective against gut colonization o f V TEC ,248 although LPS-based vaccines
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would provide serogroup-specific protection only. Vaccines based on V T  
would be expected to be effective in preventing the serious system ic 
complications ofV T EC infection, such as H C and D+ H U S.i2,63,H7,432 Proteins 
mediating signal transduction events are additional potential targets for 
vaccine development.69
However, there are several practical issues and implications to consider in the 
approach o f active immunization ofhum ans.442 Testing the efficacy o f vaccines 
will be hampered by the lack o f an appropriate animal model. Furthermore, 
it has to be decided which parts o f the population should be protected, the entire 
population or a subpopulation at greatest risk o f  D+ H US and other severe 
complications o f infections. The decision to vaccinate the population implies 
that our food is not safe enough for us to eat. This will have major policy 
implications that affect international trade and travel.
Given the relatively rarity o f VTEC infections in the Netherlands vaccination 
does not seem  to be an efficient prevention strategy in this country. 
Nevertheless, vaccinating the population may be an effective strategy in 
countries with a high number ofV T EC infections such as Argentina, provided 
that an appropriate and effective im munogen can be defined.
Conclusion
The most important goal for the prevention o f VTEC infection in humans is 
to reduce the risk o f contamination o fb e e f at slaughter. However, the present 
modes o f production and distribution o f raw meat are inadequate to protect 
the consumer. Decontamination o f carcasses or meat by chemical and physical 
methods, like the use o f organic acids and ionizing radiation, will not have a 
broad acceptance within the next few years. This means that the prevention 
o f foodborne VTEC infection is mainly in the hands o f those preparing food.
These people should be informed on the possible presence o f pathogens in x83 
raw meat and poultry, for instance by informative labels. Education in the basic 
sanitary principles o f  food preparation and storage should start at elementary 
and high schools.
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Samenvatting
Inleiding
Hoofdstuk 1. Verocytotoxine (VT)-producerende Escherichia coli (VTEC) werden 
voor het eerst beschreven in 1977 en zijn genoemd naar het cytotoxisch effect 
van de toxines die zij produceren op zogenaamde Verocellen (in vitro gekweekte 
epitheelcellen oorspronkelijk geïsoleerd uit nieren van de Afrikaanse groene 
aap). Sinds het begin van de tachtiger jaren is bekend dat bepaalde VTEC  
stammen bij de mens hemorragische colitis (HC), een ernstige bloederige 
diarree met hevige buikkrampen, kunnen veroorzaken, waarbij als complicatie 
het hemolytisch-uremisch syndroom (HUS) op kan treden. H U S treft met 
name jonge kinderen en wordt gekarakteriseerd door het optreden van 
bloedarm oede, een tekort aan bloedplaatjes en plotseling optredende 
stoornissen in de nierfunctie. Het is de meest voorkomende oorzaak van acute 
nierinsufficiëntie op de kinderleeftijd.
Inmiddels is bekend dat meer dan 200 verschillende serotypen van E. coli V T  
kunnen produceren en zijn verschillende im munologisch gerelateerde V T  
varianten geïdentificeerd. Niet alle VTEC serotypen blijken echter pathogeen 
te zijn voor de mens. Dit betekent dat naast de productie van V T  ook nog andere, 
deels nog onbekende, factoren een rol bij de pathogenese spelen. Een 
belangrijke factor is bijvoorbeeld de adhesie van de bacterie aan de 
darmmucosa. Studies met diermodellen en in vitro kweeksystemen hebben  
aangetoond dat de meeste klinische V TEC isolaten een typische darmschade 
veroorzaken die wordt gekarakteriseerd door afvlakking van de microvilli 2 1 7  
alsmede verstoring van het cytoskelet in de ondergelegen epitheelcellen. 
Essentieel voor deze karakteristieke AE (attaching-and-effacing) laesies is het 
bacteriële buitenmembraaneiwit intimine. Het is de enige kolonisatiefactor 
die tot nu toe bekend is voor VTEC. Aangenom en wordt dat de niet-bloederige 
diarree die aanvankelijk optreedt bij een infectie met VTEC het gevolg is van 
deze AE laesies. De systemische manifestaties van H C en H US worden 
toegeschreven aan de activiteit van het VT. Van de vele V TEC serotypen die 
inmiddels bekend zijn, zijn E. coli 0 1 5 7 ^ 7  en E. coli Oi57:NM  (non motile) 
het meest frequent geïsoleerd uit patiënten met H C en H US.
De belangrijkste oorzaak van VTEC infecties bij de mens is de consumptie 
van besmet voedsel. Zowel sporadische gevallen als explosies van VTEC  
infecties zijn vaak geassocieerd met de consumptie van onvoldoende verhit 
(gemalen) rundvlees (met name hamburgers) en ongepasteuriseerde melk.
Landbouwhuisdieren, met nam e runderen, schapen en geiten, worden 
beschouwd als het voornaamste natuurlijke reservoir van VTEC. Directe 
overdracht van landbouwhuisdieren op de m ens, overdracht via 
gecontamineerd water (open zwemwater en drinkwater) en overdracht van 
mens op mens is ook beschreven. De infectieuze dosis is niet exact bekend 
maar wordt verondersteld laag te zijn (-100-200 organismen).
Uit retrospectief onderzoek met bewaarde sera van H US patiënten is gebleken 
dat O157 VTEC infecties al vanaf 1974 in Nederland voorkomen. Geschat wordt 
dat jaarlijks een 30-tal kinderen in Nederland een H US doormaakt. Tot op 
heden zijn in Nederland voornam elijk individuele gevallen van H U S  
beschreven en is het nim m er gelukt de bron van de V TEC infecties te 
achterhalen.
Gezien de toename van het aantal explosies van VTEC infecties wereldwijd en 
de ernst van het ziektebeeld H US is het noodzakelijk meer inzicht te verkrijgen 
in de epidemiologie van VTEC infecties. Het doel van het in dit proefschrift 
beschreven onderzoek was het verkrijgen van een beter inzicht in het 
voorkomen van VTEC bij de mens en in de voedselproductieketen, om op basis 
hiervan uiteindelijk te komen tot voorstellen voor maatregelen om VTEC  
infecties bij de mens terug te dringen. Daar eerder verricht epidemiologisch  
onderzoek heeft aangetoond dat een infectie met O157 VTEC de belangrijkste 
oorzaak van H US bij kinderen in Nederland vormt, richtte het onderzoek zich 
met name op dit type VTEC.
VTEC bij de mens
Karakterisering humane O157 VTEC isolaten
Hoofdstuk 2. Vijftig humane O157 VTEC isolaten werden gekarakteriseerd 
2 1 8  middels (1) faagtypering, (2) een PCR (polymerase chain reaction) voor de 
aanwezigheid van V T  (VTi en/ofVT2) genen en het gen dat het eiwit intimine 
codeert, het eae (E. coli attaching-and-effacing) gen, en (3) RAPD-PCR (random 
am plified polym orphic D N A-PCR). De collectie omvatte isolaten uit 
fecesmonsters van H U S patienten en gezinsleden van H U S patienten, 
afkomstig uit Nederland (n = 43), België (n = 5) en Duitsland (n = 2). O157 VTEC  
isolaten die uit opeenvolgende fecesmonsters van een zelfde patiënt waren 
geïsoleerd en isolaten van verschillende individuen binnen één gezin konden 
onderling niet worden onderscheiden. De 50 isolaten behoorden tot 7 
verschillende faagtypen: faagtype 2 (44%; n = 27 families), faagtype 4 (33%), 
faagtype 8 (7%), faagtype 14 (4%), faagtype 32 (4%), faagtype 49 (4%) en 
faagtype 54 (4%). Alle isolaten bleken in het bezit van het VT2 gen en het eae 
gen. Slechts 5 (15%) isolaten waren bovendien positief voor het V T i gen. Er 
bleek een zeker verband te bestaan tussen V T  genotype en faagtype; alle isolaten 
van faagtype 2 en faagtype 4 waren positief voor het VT2 gen en negatief voor
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het V T i gen, terwijl alle isolaten van de minder frequent voorkomende 
faagtypen 8, 14 en 32 positief waren voor beide V T  genen. De isolaten van 
faagtype 49 en 54 waren uitsluitend positief voor het VT2 gen. Met behulp 
van RAPD-PCR werden vier verschillende D NA patronen onderscheiden. Het 
merendeel (79%) van de isolaten werd gekarakteriseerd door een zelfde DNA  
patroon. Op basis van de combinatie van de verschillende typeringsmethoden 
werden de O157 V T E C  isolaten onderverdeeld in negen verschillende  
subgroepen. Geconcludeerd werd dat de collectie humane O157 VTEC isolaten 
een vrij homogene groep was.
In een latere studie (Hoofdstuk 8) hebben we aangetoond dat het 
onderscheidend vermogen van de PFGE (pulsed-field gel electrophoresis) 
techniek waarbij het genomisch DNA van de bacteriën wordt geknipt met het 
restrictie-enzym XbaI aanzienlijk groter is dan het onderscheidend vermogen 
van de RAPD-PCR techniek die werd aangewend in deze studie. Een collectie 
van 33 humane O157 VTEC isolaten, waarin begrepen één isolaat van elk van 
de 27 fam ilies die in deze studie waren opgenom en, produceerde 28 
verschillende restrictiepatronen met behulp van de PFGE typeringstechniek.
VTEC infectie bij gezinsleden van kinderen met H US
Hoofdstuk 3. In hoofdstuk 3 werd retrospectief onderzoek verricht naar het 
voorkomen van V TEC infecties bij gezinsleden van kinderen m et H US  
veroorzaakt door O157 VTEC. Hiertoe werden de statussen van H US patiënten 
die tussen september 1989 en september 1997 waren opgenomen in het 
Academ isch Ziekenhuis in N ijm egen bestudeerd. Voor 17 (50%) H U S  
patiënten (n = 34) was gerapporteerd dat één o f meer van hun gezinsleden  
m aagdarm klachten hadden ten tijde o f  2 weken voorafgaand aan de 
ziekenhuisopname van de patiënt. Fecesonderzoek naar de aanwezigheid van 
V TEC en /o f vrij V T  gecombineerd m et serologisch onderzoek naar de 2 1 9  
aanwezigheid van antilichamen tegen het 0157-antigeen had voor 23 (68%) 
van de 34 families een V TEC infectie aangetoond in tenminste één van de 
gezinsleden van de patiënt; in 4 6 %  van de broertjes en zusjes en 28%  van de 
ouders. Het merendeel van de ouders (74%) en broertjes en zusjes (55%) 
waarvoor een VTEC infectie was aangetoond was asymptomatisch geïnfecteerd. 
Negentien (48%) broertjes en zusjes hadden een positief fecesmonster en in 
slechts 5 (12%) broertjes en zusjes was een serologisch immuunrespons tegen 
het 0157-antigeen waargenomen. Negentien (31%) ouders hadden een positief 
fecesmonster. Antilichamen tegen het 0157-antigeen waren niet aangetoond 
in sera van ouders. Er werd een statistisch significant verband aangetoond 
tussen het voorkomen van (bloederige) diarree en het voorkomen van 
serumantilichamen tegen het 0157-antigeen. Voor géén van de 34 families was 
de bron van de infecties geïdentificeerd. Geconcludeerd werd dat gezinsleden
van H US patiënten dikwijls asymptomatisch met VTEC zijn geïnfecteerd. 
Verschillen in de pathogenese van een VTEC infectie tussen individuen binnen 
één gezin die zijn geïnfecteerd met dezelfde stam zijn mogelijk te verklaren 
door verschillen in het aantal opgenomen O157 V TEC bacteriën en door 
verschillen in de gevoeligheid van geïnfecteerde personen.
VTEC in de voedselproductieketen
Het voorkomen van O157 VTEC en overige VTEC in rauw vlees
Hoofdstuk 4. Hoofdstuk 4 omvat de resultaten van een drietal studies naar het 
voorkomen van E. coli O157 en overige VTEC in rauwe vleesproducten in 
Nederland.
In de eerste studie werden O157 V TEC geïsoleerd met behulp van een 
conventionele kweekmethode: selectieve verrijking in gemodificeerde trypton 
soya bouillon met acriflavine (18 tot 20 uur bij 37°C) gevolgd door uitplaten 
van verschillende decimale verdunningen op sorbitol M acConkey agar 
(SMAC). Uit 2 (0,3%) monsters gem engd (rund/varken) gehakt (n = 770) 
werden O157 VTEC stammen geïsoleerd. O157 VTEC werden niet aangetoond 
in m onsters rundergehakt (n = 1.000), varkensgehakt (n = 260) en 
pluimveevlees (n = 300).
In de tweede studie werden vleesproducten (n = 360) onderzocht met de 3M 
Petrifilm ™ Test Kit-HEC, na een korte selectieve verrijking in gemodificeerde 
E. coli bouillon met novobiocine (mEC + n) (6 tot 8 uur bij 37°C). De 3M 
Petrifilm ™ Test Kit-HEC is een immunoblotmethode die is gebaseerd op de 
detectie van het 0157-antigeen. Uit 22 (6,1%) producten werden E. coli O157 
stammen geïsoleerd: uit 6 (3,0%) monsters rundergehakt (n = 201), 1 (2,0%) 
monster varkensgehakt (n = 49) en 15 (13,6%) monsters van kipproducten (n 
2 2 0  = 110). Echter alle 22 isolaten waren biochemisch niet karakteristiek voor O157 
VTEC, waren negatief in de PCR voor V T  genen en het eae gen en vertoonden 
ook geen cytotoxiciteit in de veroceltest.
In de derde studie werden 180 verrijkingscultures uit de eerste studie 
gescreend op de aanwezigheid van V T  genen met behulp van de PCR techniek. 
In 29 (16,1%) verrijkingscultures werden V T  genen aangetoond: 1 cultuur was 
positief voor uitsluitend het V T i gen, 17 voor uitsluitend het VT2 gen en 11 
voor beide V T  genen. Uit 10 positieve cultures werden in totaal 46 VTEC  
stammen geïsoleerd en nader getypeerd. Alle isolaten waren negatief voor het 
eae gen en 41 van de 46 isolaten behoorden tot negen verschillende O- 
serogroepen. De overige 5 isolaten bleken niet typeerbaar met de beschikbare 
O-antisera. Terwijl géén O157 VTEC stammen werden geïsoleerd behoorde een 
aantal isolaten tot serogroepen die in de literatuur zijn geassocieerd met ziekte 
bij de mens.
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Detectie- en isolatiemethoden voor E. coli O157
Hoofdstuk 5. Voor het identificeren van reservoirs van O157 VTEC en mogelijke 
transmissievectoren zijn gevoelige detectie- en isolatiemethoden noodzakelijk.
O157 V T E C  kunnen in zeer lage aantallen in voedingsm iddelen en 
om gevingsm onsters voorkom en. Bovendien is vanuit de 
voedingsmiddelenindustrie behoefte aan gevoelige en snelle detectiemethoden 
om te kunnen garanderen dat een veilig product op de markt wordt gebracht.
Voor het isoleren van O157 VTEC uit niet-klinisch materiaal wordt veelal 
begonnen met een selectieve verrijkingsstap, waarna de cultuur wordt 
uitgeplaat op een selectief isolatiemedium. Bij de selectieve verrijkingsstap 
wordt gebruik gemaakt van de relatieve ongevoeligheid van O157 V TEC voor 
galzouten, novobiocine en acriflavine. Als isolatiemedium wordt in het 
algemeen SM AC gebruikt. In tegenstelling tot verreweg het merendeel van 
alle E. coli stammen zijn de meeste O157 VTEC stammen niet in staat binnen  
24 uur sorbitol te fermenteren. Recent zijn verschillende modificaties van 
SM AC beschreven. Omdat conventionele kweekmethoden tijdrovend en 
arbeidsintensief zijn, en daarmee dus ook duur, zijn verschillende  
im m unologische detectie- en im m unom agnetische scheidings (IMS)- 
methoden ontwikkeld.
In hoofdstuk 5 hebben we de productiviteit en selectiviteit van verschillende 
selectieve verrijkings- en isolatiemedia geëvalueerd alsmede de selectiviteit en 
gevoeligheid van een aantal commercieel verkrijgbare testkits voor E. coli O157. 
Bovendien werd de commercieel verkrijgbare Verotox F test voor het bepalen 
van de aanwezigheid van de toxines V T i en VT2 vergeleken met de PCR voor 
het bepalen van de aanwezigheid van de V T i en VT2 genen. m EC + n en SM AC  
m et cefixim e en telluriet (CT-SM AC) bleken het m eest geschikt als 
respectievelijk selectief verrijkings- en selectief isolatiemedium. Telluriet 
remt de groei van niet-0157 VTEC en andere niet-sorbitol-fermenterende 
bacteriën en cefixime remt de groei van niet-sorbitol-fermenterende Proteus 221  
spp. Na een selectieve verrijkingsstap (18 tot 20 uur in m TSB + a bij 37°C) kon 
met alle testkits een besmettingsniveau van < 1 O157 VTEC cel per gram gehakt 
worden aangetoond. Terwijl de resultaten van immunologische testkits dienen 
te worden bevestigd middels het isoleren van de bacteriën, worden met de IMS- 
techniek direct O157 V TEC isolaten in handen verkregen. De resultaten van 
de Verotox F test waren in overeenstem m ing m et die van de PCR. 
Samenvattend werd gesteld dat een korte selectieve verrijking in m EC + n (6 
tot 8 uur bij 37°C), gevolgd door een IMS-procedure met Dynabeads anti-E. coli 
Oi57 (magneetbolletjes gecoat met antilichamen tegen E. coli Oi57) en het 
uitplaten van de m agneetbolletjes op C T -SM A C  een gevoelige en 
kosteneffectieve methode is voor het isoleren van O157 VTEC, voor toepassing 
in zowel de voedingsmiddelenindustrie als epidemiologische studies waarin 
grote aantallen monsters worden onderzocht.
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Het voorkomen en overleven van O157 VTEC in vlees
Hoofdstuk 6. In hoofdstuk 6 staan de resultaten vermeld van een survey 
betreffende het voorkomen van O157 VTEC in vleesproducten in Nederland 
waarbij de monsters werden onderzocht volgens de in het vorige hoofdstuk 
aanbevolen isolatiemethode (selectieve verrijking in m EC + n, IMS van E. coli 
O157 en uitplaten van de magneetbolletjes op CT-SM AC). In totaal werden 
2.941 vleesproducten onderzocht. O157 VTEC stammen werden geïsoleerd uit 
6 (1,1%) monsters rauw rundergehakt (n = 571), 2 (0,5%) monsters rauw 
gemengd (rund/varken) gehakt (n = 402), 1 (1,3%) monster rauw varkensgehakt 
(n = 76), 1 (0,3%) monster niet-gemalen rauw varkensvlees (n = 393) en 1 (0,3%) 
van de monsters gekookte o f gefermenteerde vleesproducten (n = 328). Alle 
onderzochte monsters niet-gemalen rauw rundvlees (n = 223), pluimveevlees 
(n = 819), schapen/lamsvlees (n = 46) en wild (n = 83) werden negatief 
bevonden voor O157 VTEC.
Behalve het voorkomen van O157 VTEC in verschillende vleesproducten 
beschrijft dit hoofdstuk de resultaten van groei- en overlevingsexperimenten 
in tartaar en filet americain, beide risicovolle producten. Tartaar wordt soms 
(half) rauw geconsum eerd en de veiligheid van filet americain berust 
uitsluitend op de conserverende werking van de préparésaus. In een eerste 
experiment werd een korte bewaarperiode bij de consument gesimuleerd. 
Kunstmatig besmette tartaar en filet americain werden 3 dagen bewaard bij 
-2 0 , 0, 5 en 7°C, waarna na een selectieve verrijkingsstap (6 uur in m EC + n 
bij 37°C) het aantal levensvatbare O157 VTEC kiemen werd bepaald. De O157 
V TEC teststam bleek deze bewaarcondities goed te kunnen doorstaan. In een 
volgend experiment werd dagelijks gedurende 5 dagen het aantal levensvatbare 
O157 V T E C  kiem en in tartaar en filet am ericain bewaard bij 7 
(koelkasttemperatuur) en i5°C (slechte bewaartemperatuur) bepaald. Zowel 
bij 7 als bij i5°C werd geen duidelijke toe- o f afname van het aantal O157 VTEC  
2 2 2  cellen waargenomen. Het toevoegen van azijnzuur (aanzuren filet americain 
tot een pH van 4,0), natriumlactaat (1 en 2%  [w/w]) o f componenten van het 
lactoperoxidase-thiocyanaat-waterstofperoxide systeem (zie Hoofdstuk 7) aan 
filet americain had geen reducerend effect op de O157 VTEC populatie en 
resulteerde in sensorische afwijkingen van het product. Op grond van de 
resultaten van de verschillende experimenten werd geconcludeerd dat rauw 
vlees eenm aal gecontam ineerd m et O157 V T E C  een gevaar voor de 
volksgezondheid blijft, ondanks bewaring in de koelkast o f  in de vriezer. Voor 
het reduceren o f afdoden van O157 VTEC in rauw vlees zijn meer stringente 
conserveringsmethoden vereist, terwijl tegelijkertijd de sensorische kwaliteit 
van het vlees behouden dient te blijven.
Het voorkomen en overleven van 0157 VTEC in rauwe melk
Hoofdstuk 7. In hoofdstuk 7 werden 1.011 monsters tankmelk onderzocht op 
de aanwezigheid van O157 VTEC, met behulp van de IMS-methode. De 
monsters waren afkomstig van i.0 ii verschillende melkveebedrijven uit heel 
Nederland. Uit geen van de monsters werden O157 VTEC stammen geïsoleerd.
Hierbij dient te worden opgemerkt dat door het verzamelen van m elk van een 
groot aantal koeien in een boerderijtank een enorm verdunningseffect optreedt, 
als gevolg waarvan enkele O157 VTEC kiemen aanwezig in de m elk van één 
o f enkele koeien mogelijk niet worden gedetecteerd.
Verder werd in dit hoofdstuk de overleving van O157 V T E C  in 
ongepasteuriseerde en UH T-gesteriliseerde koeienm elk bewaard bij 7 
(koelkasttemperatuur) en i5°C (slechte bewaartemperatuur) bestudeerd, zowel 
in de aan- als afwezigheid van een geactiveerd lactoperoxidase-thiocyanaat- 
waterstofperoxide systeem. Het lactoperoxidase-systeem is een antimicrobieel 
systeem dat van nature onder andere voorkomt in koeienmelk. Het systeem  
bestaat uit het enzym  lactoperoxidase en de co-factoren thiocyanaat en 
waterstofperoxide. De werking van het systeem berust op de reactie van 
kortlevende oxidatieproducten van thiocyanaat, zoals hypothiocyanaat, met 
vrije disulfide groepen in eiwitten. Hierdoor worden membranen, enzymen  
en transportsystemen beschadigd, waardoor bacteriën in hun groei worden 
geremd o f zelfs gedood. De experimenten met ongepasteuriseerde melk 
toonden dat de O157 V TEC teststam zowel bij 7 als bij i5°C kon groeien. De 
van nature in de m elk voorkom ende hoeveelheden thiocyanaat en 
waterstofperoxide bleken niet voldoende om het lactoperoxidase-systeem te 
activeren. Wanneer de componenten van het lactoperoxidase-systeem werden 
toegevoegd aan gesteriliseerde m elk werd een duidelijke reductie van de 0 i57  
VTEC populatie waargenomen. De 0 i57 VTEC teststam bleek dus wel gevoelig 
te zijn voor een actief lactoperoxidase-systeem. De 0 i57 V TEC populatie in 
ongepasteuriseerde m elk werd echter niet o f nauwelijks gereduceerd na het 2 2 3  
activeren van het lactoperoxidase-systeem (c.q. het toevoegen van componenten 
van het lactoperoxidase-systeem). Een mogelijke verklaring hiervoor is dat de 
begeleidende microflora gevoeliger was voor het lactoperoxidase-systeem dan 
de 0 i5 7 V TEC teststam.
Alhoewel tijdens deze studie geen 0 i57 VTEC stammen werden geïsoleerd 
uit monsters tankmelk, werden in de studie naar het voorkomen van Oi57  
VTEC op Nederlandse melkveebedrijven (Hoofdstuk 10) 0 i5 7 VTEC stammen 
geïsoleerd uit melkfilters. Op grond hiervan en op grond van de resultaten van 
de overlevingsexperim enten werd geconcludeerd dat consum ptie van 
ongepasteuriseerde melk dient te worden ontmoedigd en dat gecontamineerde 
melk na bewaring bij 7°C nog steeds een gevaar voor de volksgezondheid vormt.
O m  de veiligheid van m elk te kunnen garanderen is een effectieve  
pasteurisatiestap een eerste vereiste en dient daarnaast contaminatie van de 
m elk na het pasteuriseren te worden voorkómen.
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Het voorkomen van O157 VTEC in runderen en schapen
Hoofdstuk 8. Uit de literatuur is bekend dat VTEC frequent aanwezig zijn in 
de darmflora van gezonde landbouwhuisdieren, met name herkauwers zoals 
runderen, schapen en geiten. In hoofdstuk 8 van dit proefschrift werd 
onderzoek verricht naar het voorkomen van O157 VTEC in Nederlandse 
runderen en schapen. Bij een aantal grote slachterijen verspreid over Nederland 
werden fecesmonsters verzameld van slachtrunderen, vleeskalveren, ooien en 
lammeren. De monsters werden onderzocht op de aanwezigheid van O157 
V TEC met behulp van zowel een conventionele plaatmethode (18 tot 20 uur 
selectieve verrijking in m EC + n bij 37°C, gevolgd door uitplaten van 
verschillende decimale verdunningen op SM AC en CT-SM AC) als de IMS- 
methode. E. coli O157 stammen werden geïsoleerd uit 57 (10,6%) volwassen 
slachtrunderen (n = 540), 2 (0,5%) vleeskalveren (n = 397), 2 (3,8%) ooien (n 
= 52) en 2 (4,1%) lammeren (n = 49). De IMS-methode bleek een significant 
gevoeligere methode dan de conventionele kweekmethode. Met uitzondering 
van twee isolaten van volwassen runderen die negatief waren voor de V T  genen, 
gaven alle dierlijke isolaten een positief resultaat in de PCR voor V T  genen 
(VTi en /of VT2) en het eae gen. De productie van V T  werd bevestigd middels 
de veroceltest. Op grond van deze resultaten werden de isolaten als potentieel 
pathogeen voor de mens beschouwd. De dierlijke isolaten werden vergeleken 
met een aantal humane O157 VTEC isolaten (n = 63) uit gevallen van H US. 
Alhoewel PFGE genotypering resulteerde in een enorme verscheidenheid aan 
D N A patronen werd een duidelijke overeenkomst tussen dierlijke en humane 
isolaten waargenomen op basis van de resultaten van faagtypering en V T  
genotyping. Op grond van de resultaten van deze studie kon worden  
geconcludeerd dat zowel Nederlandse runderen als schapen belangrijke 
reservoirs zijn van E. coli O157 stammen die potentieel pathogeen zijn voor de 
mens; in het scala aan subtypen dat werd geïdentificeerd binnen de collectie 
2 2 4  dierlijke E. coli O157 isolaten middels faagtypering en V T  genotypering waren 
begrepen de subtypen waarmee 30 (90,9%) van in totaal 33 geteste E. coli O157 
isolaten uit Nederlandse HUS-patiënten werden gekarakteriseerd.
Het voorkomen van O157 VTEC in varkens en pluimvee
Hoofdstuk 9. In hoofdstuk 9 hebben we onderzoek verricht naar het voorkomen 
van O157 V TEC in varkens en pluimvee. Hiertoe werden bij een grote 
varkensslachterij monsters rectuminhoud en tonsillen verzameld en werden 
op diverse pluimveebedrijven verse uitwerpselen (mengmonsters) van kippen 
en kalkoenen verzameld. De monsters werden onderzocht met behulp van de 
IMS-procedure. Uit 2 (1,4%) varkens (n = 145) werden E. coli O157 stammen 
geïsoleerd. De bacteriën werden geïsoleerd uit monsters rectuminhoud. Alle
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onderzochte tonsillen werden negatief bevonden. Terwijl E. coli 0 i57 niet werd 
aangetoond in fecesmonsters (n = 50i) van kippen, werden de bacteriën wel 
geïsoleerd uit 6 (i,3%) fecesmonsters (n = 459) van kalkoenen. Eén van de 2 
varkensisolaten en i van de 6 kalkoenisolaten was positief voor het VT2 gen, 
het eae gen en het hlyEHEC (enterohemorrhagic E. coli hemolysin) gen. In de 
literatuur is beschreven dat bijna alle 0 i5 7 VTEC stammen het hlyEHEC gen 
bezitten. Welke rol het echter speelt in de pathogenese is nog onduidelijk. De 
productie van V T  werd bevestigd met de veroceltest en daarom werden deze 
twee isolaten als potentieel humaanpathogeen beschouwd. Alhoewel de 
overige zes isolaten biochemisch typisch waren voor humaanpathogene E. coli 
0 i57, waren alle negatief voor V T  genen, negatief voor het eae gen en ook 
negatief voor het hlyEHEC gen. Alle acht isolaten waren negatief voor genen die 
coderen voor de hittelabiele en hittestabiele enterotoxinen die worden gepro­
duceerd door enterotoxinogene E. coli. Enterotoxinogene E. coli 0 i57 stammen 
komen regelmatig voor in varkens en veroorzaken diarree bij deze dieren. 
Geconcludeerd werd dat varkens en pluimvee ook een mogelijke bron van 
humaanpathogene 0 i5 7 VTEC stammen kunnen zijn.
Het voorkomen van O157 VTEC op Nederlandse melkveebedrijven
Hoofdstuk 10. Als vervolg op de studie bij de slachterijen (Hoofdstuk 8) werd 
een onderzoek gestart naar het voorkomen van 0 i5 7 V TEC op Nederlandse 
m elkveebedrijven. Op i0  bedrijven werden alle aanw ezige runderen  
individueel bemonsterd (rectaal). De monsters werden onderzocht met behulp 
van de IMS-procedure. 0 i5 7 VTEC stammen werden aangetroffen op 7 van 
de i0 bedrijven. Het percentage geïnfecteerde runderen op de zeven positieve 
bedrijven liep uiteen van 0,8 tot 22,4%. Overeenkomstig literatuurgegevens 
bleek de excretie het hoogst onder kalveren (4 tot i2 maanden oud). Tijdens 
een vervolgstudie waarin twee “positieve” en twee “negatieve” bedrijven nog 2 2 5  
eens vijfmaal werden bemonsterd met tussenpozen van circa 3 maanden, 
bleken alle vier bedrijven tenminste éénmaal positief te zijn. Het percentage 
geïnfecteerde runderen liep tijdens deze vervolgstudie uiteen van 0 tot 6i,0 % .
Er werd een duidelijk seizoenseffect aangetoond. De excretie piekte in de zomer 
en was het laagst in de winter. Opnieuw bleek de excretie het hoogst onder 
kalveren (4 tot i2 maanden oud), consistent bij elke monstername. Behalve 
uit runderen werden Oi57 VTEC stammen ook geïsoleerd uit feces van 
paarden, pony's en schapen en uit melkfilters en vliegen. Uitgebreide typering 
van de Oi57 VTEC isolaten toonde géén overlap aan tussen stammen afkomstig 
van verschillende bedrijven (uitgezonderd één isolaat). Omdat bij iedere 
bemonstering van een bepaald bedrijf één subtype Oi57 VTEC duidelijk 
overheerste is het aannemelijk dat horizontale transmissie een belangrijke rol 
speelt in de verspreiding van Oi57 VTEC binnen een bedrijf. De aanwezigheid
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van verschillende subtypen op één bedrijf, zowel op een bepaald m oment als 
in de loop der tijd, doet vermoeden dat er meer dan één bron aanwezig kan 
zijn op de boerderijen. Bovendien heeft deze studie aangetoond dat de Oi57 
V TEC status van een bedrijf niet vastgesteld kan worden door éénmalig een 
beperkt aantal dieren te bemonsteren.
P r e v e n t i e  v a n  V T E C  i n f e c t i e s  b i j  d e  m e n s
Hoofdstuk 11. In hoofdstuk ii  werden de resultaten van de bovengenoemde 
studies samengevat, bediscussieerd en worden suggesties voor verder 
onderzoek gegeven.
Concluderend kan het volgende worden gesteld. Maatregelen ter preventie van 
V TEC infecties bij de mens dienen m et name gericht te zijn op het verbeteren 
van de slachthygiëne. Hierbij dient het voorkómen van fecale besmetting van 
karkassen tijdens het slachtproces centraal te staan. De huidig toegepaste 
methoden van productie en distributie van rauw vlees zullen de consument 
echter onvoldoende bescherming bieden. Theoretisch is het mogelijk het risico 
van V TEC infecties te verkleinen door het toepassen van verschillende 
behandelingen op karkassen e n /o f producten, waaronder verhitting, 
m elkzuurbehandeling (of gelijkwaardige behandeling) en doorstraling. 
A fgezien  van wettelijke voorschriften zal toepassing van dergelijke 
behandelingen afhangen van acceptatie door de consument. Dit betekent dat 
in de praktijk het voorkómen van een VTEC infectie vooralsnog met name 
gelegen is in het veilig bereiden en omgaan met voedsel. De mens moet worden 
geïnformeerd over het mogelijk aanwezig zijn van pathogenen in rauw vlees, 
bijvoorbeeld middels informatielabels. Verder moet reeds op basisscholen 
worden aangevangen met voorlichting aangaande de basisbeginselen van het 
veilig bereiden en bewaren van voedsel.
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je belangstelling en betrokkenheid bij mijn onderzoek en de snelle correctie 
van publicaties. Ik ben blij met de mogelijkheid die je m e hebt geboden om  
deel uit te maken van de researchgroep Moleculaire Microbiologie. Het was 
een plezierige tijd waarin ik veel heb geleerd.
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het onderzoek van genetisch gemodificeerde microorganismen werd de 
intensiteit van onze contacten wat minder, maar ik heb je belangstelling, steun 
en waardevolle suggesties zeer gewaardeerd.
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bacteriologisch lab waren H annie en Janet en later (ook) Elise en Yvonne mijn  
kamergenoten. Ik wil jullie allemaal hartelijk danken voor jullie interesse, hulp 
en gezelligheid. Bij de afdeling Kindergeneeskunde heb ik behalve van prof. 
Monnens en Nicole, veel hulp, steun en belangstelling van Bert van de Heuvel,
Thea van de Velden en Margriet Cornelissen gehad. Bedankt hiervoor.
Many thanks to Dr. H. Chart and Dr. H .R. Sm ith  (Laboratory o f Enteric 
Pathogens, Central Public Health Laboratory, London, UK). Dear Henrik, thank 
you very m uch for all your good advices and your kind help with the 
implementation o f the LPS serology in our laboratory. Dear Henry, many 
thanks for all the phage typing o f our isolates, the fruitful discussions we had 
on VTEC meetings and your quick reply to all my questions.
Maroeska te Loo wil ik succes toewensen met haar onderzoek op het gebied 
van de pathogenese van H U S onderzoek en Marije Schouten en Rob Reinders 
wens ik succes met het epidemiologisch onderzoek van VTEC.
Een bijzondere plaats neemt ex-collega Petra van Setten in. Petra, aan jouw eigen 
onderzoek kon ik zien welke pieken en dalen mij te wachten stonden. Bedankt 
voor al je hulp, je stimulerende opmerkingen, het veelvuldig fungeren als 
praatpaal, je nim m er aflatende interesse, je gezelschap tijdens V T E C  
congressen, etc., etc. We zullen ongetwijfeld nog veel contact blijven houden.
Jouw lijfspreuk “ut kum p allemoal goed” heb ik altijd diep in mijn oren 
geknoopt, o f was het nou mijn zakdoek...
Verder wil ik ook mijn familie en vrienden bedanken voor hun voortdurende 
steun, interesse en vriendschap, hetgeen voor mij een onmisbare stimulans 
is geweest. M ijn ouders wil ik bedanken voor de mij geboden gelegenheid te 
gaan studeren. Bedankt voor jullie continue zorg, betrokkenheid en 2 2 9  
onvoorwaardelijke steun. Christel, bedankt voor de omslag.
Tenslotte Herbert, zonder jouw steun was het nooit gelukt. Bedankt voor alles!

Curriculum vitae
Annet (Antonia Egbertha) Heuvelink werd op 28 augustus 1969 geboren in 
Vierakker (gemeente Warnsveld). In 1987 behaalde zij het VWO-fè diploma 
aan het Baudartius College te Zutphen. In hetzelfde jaar begon zij aan de studie 
Levensmiddelentechnologie aan de toenmalige Landbouwuniversiteit (LUW; 
thans Wageningen Universiteit) te Wageningen. In augustus 1993 studeerde 
ze a f in de richting Levensmiddelenleer. Het afstudeervak Levensmiddelen- 
chemie werd uitgevoerd aan de LUW  (prof. dr. ir. A.G.J. Voragen en dr. ir. H. 
Gruppen). Het afstudeervak Levensm iddelenm icrobiologie werd deels 
uitgevoerd aan de LUW  (prof. dr. ir. F.M. Rombouts) en deels bij het 
Laboratorium voor Water- en Levensmiddelenmicrobiologie (dr. ir. S.H.W. 
Notermans), thans M icrobiologisch Laboratorium voor G ezondheids­
bescherming geheten, van het Rijks Instituut voor Volksgezondheid en Milieu 
(RIVM) in Bilthoven. Stages werden doorlopen bij de afdeling Levens­
middelenmicrobiologie (dr. J. Brooks) van Massey University in Palmerston 
North, Nieuw Zeeland en bij de afdeling Microbiologie van de toenmalige 
Inspectie Gezondheidsbescherm ing, Keuringsdienst van Waren (thans 
Inspectie Gezondheidsbescherming, Waren en Veterinaire Zaken; Inspectie 
W &V) te Zutphen. Na haar afstuderen b le e f zij nog 5 m aanden bij 
laatstgenoemde organisatie werken om zich verder te verdiepen in Escherichia 
coli O157.
Van februari 1994 tot februari 1996 was zij aangesteld als Assistent in 
Opleiding bij de vakgroep Voedingsmiddelen van Dierlijke Oorsprong van de 
Faculteit Diergeneeskunde (prof. dr. J.H.J. Huis in 't Veld), Universiteit 2 3 1  
Utrecht, waarna het dienstverband werd voortgezet bij de afdeling Kinder­
geneeskunde (prof. dr. L.A.H. Monnens) van het Academisch Ziekenhuis Sint 
Radboud in Nijmegen. Het praktische gedeelte van het in dit proefschrift 
beschreven wetenschappelijke onderzoek werd grotendeels uitgevoerd bij de 
afdeling Medische Microbiologie (prof. dr. J.A.A. Hoogkamp-Korstanje) van 
het Academisch Ziekenhuis Sint Radboud in Nijmegen en bij de afdeling 
Microbiologie van de Inspectie Gezondheidsbescherming, Keuringsdienst van 
Waren in Zutphen.
Van februari 1998 tot februari 19 9 9  werkte zij als w etenschappelijk  
medewerker bij het Microbiologisch Laboratorium voor Gezondheidsbescher­
m ing van het RIVM in Bilthoven. Sinds 1 februari 1999 werkt zij als weten­
schappelijk medewerker bij de afdeling Signalering Veterinaire Producten van 
de Inspectie W & V  te Zutphen.

